{
	"@context": {
		"rdf": "http://www.w3.org/1999/02/22-rdf-syntax-ns#",
		"dct": "http://purl.org/dc/terms/",
		"owl": "http://www.w3.org/2002/07/owl#",
		"xsd": "http://www.w3.org/2001/XMLSchema#",
		"rdfs": "http://www.w3.org/2000/01/rdf-schema#",
		"@vocab": "http://ld.nice.org.uk/ns/bnf#",
		"bnf": "http://ld.nice.org.uk/ns/bnf/",
		"nicebnf": "http://ld.nice.org.uk/ns/bnf#",
		"route": "http://ld.nice.org.uk/ns/bnf/Route#",
		"patientGroup": "http://ld.nice.org.uk/ns/bnf/PatientGroup#",
		"indication": "http://ld.nice.org.uk/ns/bnf/Indication#",
		"sideEffect": "http://ld.nice.org.uk/ns/bnf/SideEffect#",
		"classification": "http://ld.nice.org.uk/ns/bnf/Classification#",
		"isLinkedFrom": {
			"@container": "@set"
		},
		"hasInteraction": {
			"@container": "@set"
		},
		"hasMessage": {
			"@container": "@set"
		},
		"hasInteractionList": {
			"@container": "@set"
		},
		"isInteractionListOf": {
			"@container": "@set"
		}
	},
	"@graph": [
		{
			"@id": "http://bnf.nice.org.uk/interaction/chlorpromazine",
			"@type": "InteractionList",
			"hasInteraction": [
				{
					"@id": "http://bnf.nice.org.uk/interaction/chlorpromazine#bnf_i1557280698372",
					"hasMessage": [
						{
							"@id": "http://bnf.nice.org.uk/interaction/chlorpromazine#bnf_i1557280698372_message_0",
							"hasDitaContent": {
								"@type": "rdf:XMLLiteral",
								"@value": "<p otherprops=\"Normal\" outputclass=\"int-message\">Both <ph otherprops=\"chlorpromazine\" outputclass=\"int-heading-drug\">chlorpromazine</ph> and <ph otherprops=\"acebutolol\" outputclass=\"int-drug\">acebutolol</ph> can increase the risk of hypotension.</p>"
							},
							"hasEvidence": "NotSet",
							"hasImportance": "NotSet",
							"hasOrder": "1",
							"hasTextContent": "Both  chlorpromazine  and  acebutolol  can increase the risk of hypotension. \n\n"
						}
					],
					"hasOrder": "1",
					"hasTitle": {
						"@type": "rdf:XMLLiteral",
						"@value": "<title>Acebutolol</title>"
					}
				},
				{
					"@id": "http://bnf.nice.org.uk/interaction/chlorpromazine#bnf_i1557280698373",
					"hasMessage": [
						{
							"@id": "http://bnf.nice.org.uk/interaction/chlorpromazine#bnf_i1557280698373_message_0",
							"hasDitaContent": {
								"@type": "rdf:XMLLiteral",
								"@value": "<p otherprops=\"Normal\" outputclass=\"int-message\">Both <ph otherprops=\"chlorpromazine\" outputclass=\"int-heading-drug\">chlorpromazine</ph> and <ph otherprops=\"aclidinium\" outputclass=\"int-drug\">aclidinium</ph> can cause antimuscarinic effects.</p>"
							},
							"hasEvidence": "NotSet",
							"hasImportance": "NotSet",
							"hasOrder": "1",
							"hasTextContent": "Both  chlorpromazine  and  aclidinium  can cause antimuscarinic effects. \n\n"
						}
					],
					"hasOrder": "2",
					"hasTitle": {
						"@type": "rdf:XMLLiteral",
						"@value": "<title>Aclidinium</title>"
					}
				},
				{
					"@id": "http://bnf.nice.org.uk/interaction/chlorpromazine#bnf_i1557280698374",
					"hasMessage": [
						{
							"@id": "http://bnf.nice.org.uk/interaction/chlorpromazine#bnf_i1557280698374_message_0",
							"hasDitaContent": {
								"@type": "rdf:XMLLiteral",
								"@value": "<p otherprops=\"Normal\" outputclass=\"int-message\">Both <ph otherprops=\"chlorpromazine\" outputclass=\"int-heading-drug\">chlorpromazine</ph> and <ph otherprops=\"agomelatine\" outputclass=\"int-drug\">agomelatine</ph> can have CNS depressant effects, which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in <xref format=\"dita\" href=\"guidance/guidance-on-prescribing.xml\" type=\"interaction\" rel=\"guidance\" bnfid=\"PHP97234\">Guidance on Prescribing</xref>).</p>"
							},
							"hasEvidence": "NotSet",
							"hasImportance": "NotSet",
							"hasOrder": "1",
							"hasTextContent": "Both  chlorpromazine  and  agomelatine  can have CNS depressant effects, which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in  Guidance on Prescribing ). \n\n"
						}
					],
					"hasOrder": "3",
					"hasTitle": {
						"@type": "rdf:XMLLiteral",
						"@value": "<title>Agomelatine</title>"
					}
				},
				{
					"@id": "http://bnf.nice.org.uk/interaction/chlorpromazine#bnf_i1557280698375",
					"hasMessage": [
						{
							"@id": "http://bnf.nice.org.uk/interaction/chlorpromazine#bnf_i1557280698375_message_0",
							"hasDitaContent": {
								"@type": "rdf:XMLLiteral",
								"@value": "<p otherprops=\"Normal\" outputclass=\"int-message\">Both <ph otherprops=\"chlorpromazine\" outputclass=\"int-heading-drug\">chlorpromazine</ph> and <ph otherprops=\"alcohol (beverage)\" outputclass=\"int-drug\">alcohol (beverage)</ph> can increase the risk of hypotension.</p>"
							},
							"hasEvidence": "NotSet",
							"hasImportance": "NotSet",
							"hasOrder": "1",
							"hasTextContent": "Both  chlorpromazine  and  alcohol (beverage)  can increase the risk of hypotension. \n\n"
						},
						{
							"@id": "http://bnf.nice.org.uk/interaction/chlorpromazine#bnf_i1557280698375_message_1",
							"hasDitaContent": {
								"@type": "rdf:XMLLiteral",
								"@value": "<p otherprops=\"Normal\" outputclass=\"int-message\">Both <ph otherprops=\"chlorpromazine\" outputclass=\"int-heading-drug\">chlorpromazine</ph> and <ph otherprops=\"alcohol (beverage)\" outputclass=\"int-drug\">alcohol (beverage)</ph> can have CNS depressant effects, which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in <xref format=\"dita\" href=\"guidance/guidance-on-prescribing.xml\" type=\"interaction\" rel=\"guidance\" bnfid=\"PHP97234\">Guidance on Prescribing</xref>).</p>"
							},
							"hasEvidence": "NotSet",
							"hasImportance": "NotSet",
							"hasOrder": "2",
							"hasTextContent": "Both  chlorpromazine  and  alcohol (beverage)  can have CNS depressant effects, which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in  Guidance on Prescribing ). \n\n"
						}
					],
					"hasOrder": "4",
					"hasTitle": {
						"@type": "rdf:XMLLiteral",
						"@value": "<title>Alcohol (beverage)</title>"
					}
				},
				{
					"@id": "http://bnf.nice.org.uk/interaction/chlorpromazine#bnf_i1557280698376",
					"hasMessage": [
						{
							"@id": "http://bnf.nice.org.uk/interaction/chlorpromazine#bnf_i1557280698376_message_0",
							"hasDitaContent": {
								"@type": "rdf:XMLLiteral",
								"@value": "<p otherprops=\"Normal\" outputclass=\"int-message\">Both <ph otherprops=\"chlorpromazine\" outputclass=\"int-heading-drug\">chlorpromazine</ph> and <ph otherprops=\"alfentanil\" outputclass=\"int-drug\">alfentanil</ph> can have CNS depressant effects, which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in <xref format=\"dita\" href=\"guidance/guidance-on-prescribing.xml\" type=\"interaction\" rel=\"guidance\" bnfid=\"PHP97234\">Guidance on Prescribing</xref>).</p>"
							},
							"hasEvidence": "NotSet",
							"hasImportance": "NotSet",
							"hasOrder": "1",
							"hasTextContent": "Both  chlorpromazine  and  alfentanil  can have CNS depressant effects, which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in  Guidance on Prescribing ). \n\n"
						}
					],
					"hasOrder": "5",
					"hasTitle": {
						"@type": "rdf:XMLLiteral",
						"@value": "<title>Alfentanil</title>"
					}
				},
				{
					"@id": "http://bnf.nice.org.uk/interaction/chlorpromazine#bnf_i1557280698377",
					"hasMessage": [
						{
							"@id": "http://bnf.nice.org.uk/interaction/chlorpromazine#bnf_i1557280698377_message_0",
							"hasDitaContent": {
								"@type": "rdf:XMLLiteral",
								"@value": "<p otherprops=\"Normal\" outputclass=\"int-message\">Both <ph otherprops=\"chlorpromazine\" outputclass=\"int-heading-drug\">chlorpromazine</ph> and <ph otherprops=\"alfuzosin\" outputclass=\"int-drug\">alfuzosin</ph> can increase the risk of hypotension.</p>"
							},
							"hasEvidence": "NotSet",
							"hasImportance": "NotSet",
							"hasOrder": "1",
							"hasTextContent": "Both  chlorpromazine  and  alfuzosin  can increase the risk of hypotension. \n\n"
						}
					],
					"hasOrder": "6",
					"hasTitle": {
						"@type": "rdf:XMLLiteral",
						"@value": "<title>Alfuzosin</title>"
					}
				},
				{
					"@id": "http://bnf.nice.org.uk/interaction/chlorpromazine#bnf_i1557280698378",
					"hasMessage": [
						{
							"@id": "http://bnf.nice.org.uk/interaction/chlorpromazine#bnf_i1557280698378_message_0",
							"hasDitaContent": {
								"@type": "rdf:XMLLiteral",
								"@value": "<p otherprops=\"Normal\" outputclass=\"int-message\">Both <ph otherprops=\"chlorpromazine\" outputclass=\"int-heading-drug\">chlorpromazine</ph> and <ph otherprops=\"alimemazine\" outputclass=\"int-drug\">alimemazine</ph> can have CNS depressant effects, which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in <xref format=\"dita\" href=\"guidance/guidance-on-prescribing.xml\" type=\"interaction\" rel=\"guidance\" bnfid=\"PHP97234\">Guidance on Prescribing</xref>).</p>"
							},
							"hasEvidence": "NotSet",
							"hasImportance": "NotSet",
							"hasOrder": "1",
							"hasTextContent": "Both  chlorpromazine  and  alimemazine  can have CNS depressant effects, which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in  Guidance on Prescribing ). \n\n"
						}
					],
					"hasOrder": "7",
					"hasTitle": {
						"@type": "rdf:XMLLiteral",
						"@value": "<title>Alimemazine</title>"
					}
				},
				{
					"@id": "http://bnf.nice.org.uk/interaction/chlorpromazine#bnf_i1557280698379",
					"hasMessage": [
						{
							"@id": "http://bnf.nice.org.uk/interaction/chlorpromazine#bnf_i1557280698379_message_0",
							"hasDitaContent": {
								"@type": "rdf:XMLLiteral",
								"@value": "<p otherprops=\"Normal\" outputclass=\"int-message\">Both <ph otherprops=\"chlorpromazine\" outputclass=\"int-heading-drug\">chlorpromazine</ph> and <ph otherprops=\"aliskiren\" outputclass=\"int-drug\">aliskiren</ph> can increase the risk of hypotension.</p>"
							},
							"hasEvidence": "NotSet",
							"hasImportance": "NotSet",
							"hasOrder": "1",
							"hasTextContent": "Both  chlorpromazine  and  aliskiren  can increase the risk of hypotension. \n\n"
						}
					],
					"hasOrder": "8",
					"hasTitle": {
						"@type": "rdf:XMLLiteral",
						"@value": "<title>Aliskiren</title>"
					}
				},
				{
					"@id": "http://bnf.nice.org.uk/interaction/chlorpromazine#bnf_i1557280698380",
					"hasMessage": [
						{
							"@id": "http://bnf.nice.org.uk/interaction/chlorpromazine#bnf_i1557280698380_message_0",
							"hasDitaContent": {
								"@type": "rdf:XMLLiteral",
								"@value": "<p otherprops=\"Normal\" outputclass=\"int-message\">Both <ph otherprops=\"chlorpromazine\" outputclass=\"int-heading-drug\">chlorpromazine</ph> and <ph otherprops=\"alprazolam\" outputclass=\"int-drug\">alprazolam</ph> can have CNS depressant effects, which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in <xref format=\"dita\" href=\"guidance/guidance-on-prescribing.xml\" type=\"interaction\" rel=\"guidance\" bnfid=\"PHP97234\">Guidance on Prescribing</xref>).</p>"
							},
							"hasEvidence": "NotSet",
							"hasImportance": "NotSet",
							"hasOrder": "1",
							"hasTextContent": "Both  chlorpromazine  and  alprazolam  can have CNS depressant effects, which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in  Guidance on Prescribing ). \n\n"
						}
					],
					"hasOrder": "9",
					"hasTitle": {
						"@type": "rdf:XMLLiteral",
						"@value": "<title>Alprazolam</title>"
					}
				},
				{
					"@id": "http://bnf.nice.org.uk/interaction/chlorpromazine#bnf_i1557280698381",
					"hasMessage": [
						{
							"@id": "http://bnf.nice.org.uk/interaction/chlorpromazine#bnf_i1557280698381_message_0",
							"hasDitaContent": {
								"@type": "rdf:XMLLiteral",
								"@value": "<p otherprops=\"Normal\" outputclass=\"int-message\">Both <ph otherprops=\"chlorpromazine\" outputclass=\"int-heading-drug\">chlorpromazine</ph> and <ph otherprops=\"alprostadil\" outputclass=\"int-drug\">alprostadil</ph> can increase the risk of hypotension.</p>"
							},
							"hasEvidence": "NotSet",
							"hasImportance": "NotSet",
							"hasOrder": "1",
							"hasTextContent": "Both  chlorpromazine  and  alprostadil  can increase the risk of hypotension. \n\n"
						}
					],
					"hasOrder": "10",
					"hasTitle": {
						"@type": "rdf:XMLLiteral",
						"@value": "<title>Alprostadil</title>"
					}
				},
				{
					"@id": "http://bnf.nice.org.uk/interaction/chlorpromazine#bnf_i1557280698382",
					"hasMessage": [
						{
							"@id": "http://bnf.nice.org.uk/interaction/chlorpromazine#bnf_i1557280698382_message_0",
							"hasDitaContent": {
								"@type": "rdf:XMLLiteral",
								"@value": "<p otherprops=\"Moderate\" outputclass=\"int-message\">\n  <ph otherprops=\"aluminium hydroxide\" outputclass=\"int-drug\">Aluminium hydroxide</ph> <ph outputclass=\"int-effect\">decreases</ph> <ph outputclass=\"int-parameter\">the absorption of</ph> <ph otherprops=\"chlorpromazine\" outputclass=\"int-heading-drug\">chlorpromazine</ph>. <ph outputclass=\"int-action\">Manufacturer makes no recommendation</ph>.  </p>"
							},
							"hasEvidence": "Anecdotal",
							"hasImportance": "Moderate",
							"hasOrder": "1",
							"hasTextContent": "Aluminium hydroxide   decreases   the absorption of   chlorpromazine .  Manufacturer makes no recommendation .    \n\n"
						}
					],
					"hasOrder": "11",
					"hasTitle": {
						"@type": "rdf:XMLLiteral",
						"@value": "<title>Aluminium hydroxide</title>"
					}
				},
				{
					"@id": "http://bnf.nice.org.uk/interaction/chlorpromazine#bnf_i1557280698383",
					"hasMessage": [
						{
							"@id": "http://bnf.nice.org.uk/interaction/chlorpromazine#bnf_i1557280698383_message_0",
							"hasDitaContent": {
								"@type": "rdf:XMLLiteral",
								"@value": "<p otherprops=\"Normal\" outputclass=\"int-message\">Both <ph otherprops=\"chlorpromazine\" outputclass=\"int-heading-drug\">chlorpromazine</ph> and <ph otherprops=\"amantadine\" outputclass=\"int-drug\">amantadine</ph> can increase the risk of hypotension.</p>"
							},
							"hasEvidence": "NotSet",
							"hasImportance": "NotSet",
							"hasOrder": "1",
							"hasTextContent": "Both  chlorpromazine  and  amantadine  can increase the risk of hypotension. \n\n"
						},
						{
							"@id": "http://bnf.nice.org.uk/interaction/chlorpromazine#bnf_i1557280698383_message_1",
							"hasDitaContent": {
								"@type": "rdf:XMLLiteral",
								"@value": "<p otherprops=\"Normal\" outputclass=\"int-message\">Both <ph otherprops=\"chlorpromazine\" outputclass=\"int-heading-drug\">chlorpromazine</ph> and <ph otherprops=\"amantadine\" outputclass=\"int-drug\">amantadine</ph> can cause antimuscarinic effects.</p>"
							},
							"hasEvidence": "NotSet",
							"hasImportance": "NotSet",
							"hasOrder": "2",
							"hasTextContent": "Both  chlorpromazine  and  amantadine  can cause antimuscarinic effects. \n\n"
						},
						{
							"@id": "http://bnf.nice.org.uk/interaction/chlorpromazine#bnf_i1557280698383_message_2",
							"hasDitaContent": {
								"@type": "rdf:XMLLiteral",
								"@value": "<p otherprops=\"Moderate\" outputclass=\"int-message\">\n  <ph otherprops=\"chlorpromazine\" outputclass=\"int-heading-drug\">Chlorpromazine</ph> <ph outputclass=\"int-effectQualifier\">is predicted to</ph> <ph outputclass=\"int-effect\">decrease</ph> <ph outputclass=\"int-parameter\">the effects of</ph> <ph otherprops=\"amantadine\" outputclass=\"int-drug\">amantadine</ph>. <ph outputclass=\"int-action\">Manufacturer advises avoid</ph>.  </p>"
							},
							"hasEvidence": "Theoretical",
							"hasImportance": "Moderate",
							"hasOrder": "3",
							"hasTextContent": "Chlorpromazine   is predicted to   decrease   the effects of   amantadine .  Manufacturer advises avoid .    \n\n"
						}
					],
					"hasOrder": "12",
					"hasTitle": {
						"@type": "rdf:XMLLiteral",
						"@value": "<title>Amantadine</title>"
					}
				},
				{
					"@id": "http://bnf.nice.org.uk/interaction/chlorpromazine#bnf_i1557280698384",
					"hasMessage": [
						{
							"@id": "http://bnf.nice.org.uk/interaction/chlorpromazine#bnf_i1557280698384_message_0",
							"hasDitaContent": {
								"@type": "rdf:XMLLiteral",
								"@value": "<p otherprops=\"Severe\" outputclass=\"int-message\">Both <ph otherprops=\"chlorpromazine\" outputclass=\"int-heading-drug\">chlorpromazine</ph> and <ph otherprops=\"amifampridine\" outputclass=\"int-drug\">amifampridine</ph> prolong the QT interval. Most manufacturers advise avoiding the use of two or more drugs that are associated with QT prolongation. Increasing age, female sex, cardiac disease, and some metabolic disturbances (notably hypokalaemia) predispose to QT prolongation. </p>"
							},
							"hasEvidence": "NotSet",
							"hasImportance": "Severe",
							"hasOrder": "1",
							"hasTextContent": "Both  chlorpromazine  and  amifampridine  prolong the QT interval. Most manufacturers advise avoiding the use of two or more drugs that are associated with QT prolongation. Increasing age, female sex, cardiac disease, and some metabolic disturbances (notably hypokalaemia) predispose to QT prolongation.  \n\n"
						}
					],
					"hasOrder": "13",
					"hasTitle": {
						"@type": "rdf:XMLLiteral",
						"@value": "<title>Amifampridine</title>"
					}
				},
				{
					"@id": "http://bnf.nice.org.uk/interaction/chlorpromazine#bnf_i1557280698385",
					"hasMessage": [
						{
							"@id": "http://bnf.nice.org.uk/interaction/chlorpromazine#bnf_i1557280698385_message_0",
							"hasDitaContent": {
								"@type": "rdf:XMLLiteral",
								"@value": "<p otherprops=\"Severe\" outputclass=\"int-message\">\n  <ph otherprops=\"aminophylline\" outputclass=\"int-drug\">Aminophylline</ph> <ph outputclass=\"int-effectQualifier\">is predicted to</ph> <ph outputclass=\"int-effect\">cause</ph> <ph outputclass=\"int-parameter\">hypokalaemia (potentially increasing the risk of torsade de pointes) when given with</ph> <ph otherprops=\"chlorpromazine\" outputclass=\"int-heading-drug\">chlorpromazine</ph>. <ph outputclass=\"int-action\">Manufacturer makes no recommendation</ph>.  </p>"
							},
							"hasEvidence": "Theoretical",
							"hasImportance": "Severe",
							"hasOrder": "1",
							"hasTextContent": "Aminophylline   is predicted to   cause   hypokalaemia (potentially increasing the risk of torsade de pointes) when given with   chlorpromazine .  Manufacturer makes no recommendation .    \n\n"
						}
					],
					"hasOrder": "14",
					"hasTitle": {
						"@type": "rdf:XMLLiteral",
						"@value": "<title>Aminophylline</title>"
					}
				},
				{
					"@id": "http://bnf.nice.org.uk/interaction/chlorpromazine#bnf_i1557280698386",
					"hasMessage": [
						{
							"@id": "http://bnf.nice.org.uk/interaction/chlorpromazine#bnf_i1557280698386_message_0",
							"hasDitaContent": {
								"@type": "rdf:XMLLiteral",
								"@value": "<p otherprops=\"Severe\" outputclass=\"int-message\">Both <ph otherprops=\"chlorpromazine\" outputclass=\"int-heading-drug\">chlorpromazine</ph> and <ph otherprops=\"amiodarone\" outputclass=\"int-drug\">amiodarone</ph> prolong the QT interval. Most manufacturers advise avoiding the use of two or more drugs that are associated with QT prolongation. Increasing age, female sex, cardiac disease, and some metabolic disturbances (notably hypokalaemia) predispose to QT prolongation. </p>"
							},
							"hasEvidence": "NotSet",
							"hasImportance": "Severe",
							"hasOrder": "1",
							"hasTextContent": "Both  chlorpromazine  and  amiodarone  prolong the QT interval. Most manufacturers advise avoiding the use of two or more drugs that are associated with QT prolongation. Increasing age, female sex, cardiac disease, and some metabolic disturbances (notably hypokalaemia) predispose to QT prolongation.  \n\n"
						}
					],
					"hasOrder": "15",
					"hasTitle": {
						"@type": "rdf:XMLLiteral",
						"@value": "<title>Amiodarone</title>"
					}
				},
				{
					"@id": "http://bnf.nice.org.uk/interaction/chlorpromazine#bnf_i1557280698387",
					"hasMessage": [
						{
							"@id": "http://bnf.nice.org.uk/interaction/chlorpromazine#bnf_i1557280698387_message_0",
							"hasDitaContent": {
								"@type": "rdf:XMLLiteral",
								"@value": "<p otherprops=\"Severe\" outputclass=\"int-message\">Both <ph otherprops=\"chlorpromazine\" outputclass=\"int-heading-drug\">chlorpromazine</ph> and <ph otherprops=\"amisulpride\" outputclass=\"int-drug\">amisulpride</ph> prolong the QT interval. Most manufacturers advise avoiding the use of two or more drugs that are associated with QT prolongation. Increasing age, female sex, cardiac disease, and some metabolic disturbances (notably hypokalaemia) predispose to QT prolongation. </p>"
							},
							"hasEvidence": "NotSet",
							"hasImportance": "Severe",
							"hasOrder": "1",
							"hasTextContent": "Both  chlorpromazine  and  amisulpride  prolong the QT interval. Most manufacturers advise avoiding the use of two or more drugs that are associated with QT prolongation. Increasing age, female sex, cardiac disease, and some metabolic disturbances (notably hypokalaemia) predispose to QT prolongation.  \n\n"
						},
						{
							"@id": "http://bnf.nice.org.uk/interaction/chlorpromazine#bnf_i1557280698387_message_1",
							"hasDitaContent": {
								"@type": "rdf:XMLLiteral",
								"@value": "<p otherprops=\"Normal\" outputclass=\"int-message\">Both <ph otherprops=\"chlorpromazine\" outputclass=\"int-heading-drug\">chlorpromazine</ph> and <ph otherprops=\"amisulpride\" outputclass=\"int-drug\">amisulpride</ph> can have CNS depressant effects, which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in <xref format=\"dita\" href=\"guidance/guidance-on-prescribing.xml\" type=\"interaction\" rel=\"guidance\" bnfid=\"PHP97234\">Guidance on Prescribing</xref>).</p>"
							},
							"hasEvidence": "NotSet",
							"hasImportance": "NotSet",
							"hasOrder": "2",
							"hasTextContent": "Both  chlorpromazine  and  amisulpride  can have CNS depressant effects, which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in  Guidance on Prescribing ). \n\n"
						}
					],
					"hasOrder": "16",
					"hasTitle": {
						"@type": "rdf:XMLLiteral",
						"@value": "<title>Amisulpride</title>"
					}
				},
				{
					"@id": "http://bnf.nice.org.uk/interaction/chlorpromazine#bnf_i1557280698388",
					"hasMessage": [
						{
							"@id": "http://bnf.nice.org.uk/interaction/chlorpromazine#bnf_i1557280698388_message_0",
							"hasDitaContent": {
								"@type": "rdf:XMLLiteral",
								"@value": "<p otherprops=\"Normal\" outputclass=\"int-message\">Both <ph otherprops=\"chlorpromazine\" outputclass=\"int-heading-drug\">chlorpromazine</ph> and <ph otherprops=\"amitriptyline\" outputclass=\"int-drug\">amitriptyline</ph> can increase the risk of hypotension.</p>"
							},
							"hasEvidence": "NotSet",
							"hasImportance": "NotSet",
							"hasOrder": "1",
							"hasTextContent": "Both  chlorpromazine  and  amitriptyline  can increase the risk of hypotension. \n\n"
						},
						{
							"@id": "http://bnf.nice.org.uk/interaction/chlorpromazine#bnf_i1557280698388_message_1",
							"hasDitaContent": {
								"@type": "rdf:XMLLiteral",
								"@value": "<p otherprops=\"Normal\" outputclass=\"int-message\">Both <ph otherprops=\"chlorpromazine\" outputclass=\"int-heading-drug\">chlorpromazine</ph> and <ph otherprops=\"amitriptyline\" outputclass=\"int-drug\">amitriptyline</ph> can cause antimuscarinic effects.</p>"
							},
							"hasEvidence": "NotSet",
							"hasImportance": "NotSet",
							"hasOrder": "2",
							"hasTextContent": "Both  chlorpromazine  and  amitriptyline  can cause antimuscarinic effects. \n\n"
						}
					],
					"hasOrder": "17",
					"hasTitle": {
						"@type": "rdf:XMLLiteral",
						"@value": "<title>Amitriptyline</title>"
					}
				},
				{
					"@id": "http://bnf.nice.org.uk/interaction/chlorpromazine#bnf_i1557280698389",
					"hasMessage": [
						{
							"@id": "http://bnf.nice.org.uk/interaction/chlorpromazine#bnf_i1557280698389_message_0",
							"hasDitaContent": {
								"@type": "rdf:XMLLiteral",
								"@value": "<p otherprops=\"Normal\" outputclass=\"int-message\">Both <ph otherprops=\"chlorpromazine\" outputclass=\"int-heading-drug\">chlorpromazine</ph> and <ph otherprops=\"amlodipine\" outputclass=\"int-drug\">amlodipine</ph> can increase the risk of hypotension.</p>"
							},
							"hasEvidence": "NotSet",
							"hasImportance": "NotSet",
							"hasOrder": "1",
							"hasTextContent": "Both  chlorpromazine  and  amlodipine  can increase the risk of hypotension. \n\n"
						}
					],
					"hasOrder": "18",
					"hasTitle": {
						"@type": "rdf:XMLLiteral",
						"@value": "<title>Amlodipine</title>"
					}
				},
				{
					"@id": "http://bnf.nice.org.uk/interaction/chlorpromazine#bnf_i1557280698390",
					"hasMessage": [
						{
							"@id": "http://bnf.nice.org.uk/interaction/chlorpromazine#bnf_i1557280698390_message_0",
							"hasDitaContent": {
								"@type": "rdf:XMLLiteral",
								"@value": "<p otherprops=\"Severe\" outputclass=\"int-message\">\n  <ph otherprops=\"amphotericin\" outputclass=\"int-drug\">Amphotericin</ph> <ph outputclass=\"int-effectQualifier\">is predicted to</ph> <ph outputclass=\"int-effect\">cause</ph> <ph outputclass=\"int-parameter\">hypokalaemia (potentially increasing the risk of torsade de pointes) when given with</ph> <ph otherprops=\"chlorpromazine\" outputclass=\"int-heading-drug\">chlorpromazine</ph>. <ph outputclass=\"int-action\">Manufacturer makes no recommendation</ph>.  </p>"
							},
							"hasEvidence": "Theoretical",
							"hasImportance": "Severe",
							"hasOrder": "1",
							"hasTextContent": "Amphotericin   is predicted to   cause   hypokalaemia (potentially increasing the risk of torsade de pointes) when given with   chlorpromazine .  Manufacturer makes no recommendation .    \n\n"
						}
					],
					"hasOrder": "19",
					"hasTitle": {
						"@type": "rdf:XMLLiteral",
						"@value": "<title>Amphotericin</title>"
					}
				},
				{
					"@id": "http://bnf.nice.org.uk/interaction/chlorpromazine#bnf_i1557280698391",
					"hasMessage": [
						{
							"@id": "http://bnf.nice.org.uk/interaction/chlorpromazine#bnf_i1557280698391_message_0",
							"hasDitaContent": {
								"@type": "rdf:XMLLiteral",
								"@value": "<p otherprops=\"Severe\" outputclass=\"int-message\">Both <ph otherprops=\"chlorpromazine\" outputclass=\"int-heading-drug\">chlorpromazine</ph> and <ph otherprops=\"anagrelide\" outputclass=\"int-drug\">anagrelide</ph> prolong the QT interval. Most manufacturers advise avoiding the use of two or more drugs that are associated with QT prolongation. Increasing age, female sex, cardiac disease, and some metabolic disturbances (notably hypokalaemia) predispose to QT prolongation. </p>"
							},
							"hasEvidence": "NotSet",
							"hasImportance": "Severe",
							"hasOrder": "1",
							"hasTextContent": "Both  chlorpromazine  and  anagrelide  prolong the QT interval. Most manufacturers advise avoiding the use of two or more drugs that are associated with QT prolongation. Increasing age, female sex, cardiac disease, and some metabolic disturbances (notably hypokalaemia) predispose to QT prolongation.  \n\n"
						}
					],
					"hasOrder": "20",
					"hasTitle": {
						"@type": "rdf:XMLLiteral",
						"@value": "<title>Anagrelide</title>"
					}
				},
				{
					"@id": "http://bnf.nice.org.uk/interaction/chlorpromazine#bnf_i1557280698392",
					"hasMessage": [
						{
							"@id": "http://bnf.nice.org.uk/interaction/chlorpromazine#bnf_i1557280698392_message_0",
							"hasDitaContent": {
								"@type": "rdf:XMLLiteral",
								"@value": "<p otherprops=\"Severe\" outputclass=\"int-message\">Both <ph otherprops=\"chlorpromazine\" outputclass=\"int-heading-drug\">chlorpromazine</ph> and <ph otherprops=\"apalutamide\" outputclass=\"int-drug\">apalutamide</ph> prolong the QT interval. Most manufacturers advise avoiding the use of two or more drugs that are associated with QT prolongation. Increasing age, female sex, cardiac disease, and some metabolic disturbances (notably hypokalaemia) predispose to QT prolongation. </p>"
							},
							"hasEvidence": "NotSet",
							"hasImportance": "Severe",
							"hasOrder": "1",
							"hasTextContent": "Both  chlorpromazine  and  apalutamide  prolong the QT interval. Most manufacturers advise avoiding the use of two or more drugs that are associated with QT prolongation. Increasing age, female sex, cardiac disease, and some metabolic disturbances (notably hypokalaemia) predispose to QT prolongation.  \n\n"
						}
					],
					"hasOrder": "21",
					"hasTitle": {
						"@type": "rdf:XMLLiteral",
						"@value": "<title>Apalutamide</title>"
					}
				},
				{
					"@id": "http://bnf.nice.org.uk/interaction/chlorpromazine#bnf_i1557280698393",
					"hasMessage": [
						{
							"@id": "http://bnf.nice.org.uk/interaction/chlorpromazine#bnf_i1557280698393_message_0",
							"hasDitaContent": {
								"@type": "rdf:XMLLiteral",
								"@value": "<p otherprops=\"Normal\" outputclass=\"int-message\">Both <ph otherprops=\"chlorpromazine\" outputclass=\"int-heading-drug\">chlorpromazine</ph> and <ph otherprops=\"apomorphine\" outputclass=\"int-drug\">apomorphine</ph> can increase the risk of hypotension.</p>"
							},
							"hasEvidence": "NotSet",
							"hasImportance": "NotSet",
							"hasOrder": "1",
							"hasTextContent": "Both  chlorpromazine  and  apomorphine  can increase the risk of hypotension. \n\n"
						},
						{
							"@id": "http://bnf.nice.org.uk/interaction/chlorpromazine#bnf_i1557280698393_message_1",
							"hasDitaContent": {
								"@type": "rdf:XMLLiteral",
								"@value": "<p otherprops=\"Severe\" outputclass=\"int-message\">Both <ph otherprops=\"chlorpromazine\" outputclass=\"int-heading-drug\">chlorpromazine</ph> and <ph otherprops=\"apomorphine\" outputclass=\"int-drug\">apomorphine</ph> prolong the QT interval. Most manufacturers advise avoiding the use of two or more drugs that are associated with QT prolongation. Increasing age, female sex, cardiac disease, and some metabolic disturbances (notably hypokalaemia) predispose to QT prolongation. </p>"
							},
							"hasEvidence": "NotSet",
							"hasImportance": "Severe",
							"hasOrder": "2",
							"hasTextContent": "Both  chlorpromazine  and  apomorphine  prolong the QT interval. Most manufacturers advise avoiding the use of two or more drugs that are associated with QT prolongation. Increasing age, female sex, cardiac disease, and some metabolic disturbances (notably hypokalaemia) predispose to QT prolongation.  \n\n"
						},
						{
							"@id": "http://bnf.nice.org.uk/interaction/chlorpromazine#bnf_i1557280698393_message_2",
							"hasDitaContent": {
								"@type": "rdf:XMLLiteral",
								"@value": "<p otherprops=\"Moderate\" outputclass=\"int-message\">\n  <ph otherprops=\"chlorpromazine\" outputclass=\"int-heading-drug\">Chlorpromazine</ph> <ph outputclass=\"int-effectQualifier\">is predicted to</ph> <ph outputclass=\"int-effect\">decrease</ph> <ph outputclass=\"int-parameter\">the effects of</ph> <ph otherprops=\"apomorphine\" outputclass=\"int-drug\">apomorphine</ph>. <ph outputclass=\"int-action\">Manufacturer advises avoid</ph>.  </p>"
							},
							"hasEvidence": "Theoretical",
							"hasImportance": "Moderate",
							"hasOrder": "3",
							"hasTextContent": "Chlorpromazine   is predicted to   decrease   the effects of   apomorphine .  Manufacturer advises avoid .    \n\n"
						}
					],
					"hasOrder": "22",
					"hasTitle": {
						"@type": "rdf:XMLLiteral",
						"@value": "<title>Apomorphine</title>"
					}
				},
				{
					"@id": "http://bnf.nice.org.uk/interaction/chlorpromazine#bnf_i1557280698394",
					"hasMessage": [
						{
							"@id": "http://bnf.nice.org.uk/interaction/chlorpromazine#bnf_i1557280698394_message_0",
							"hasDitaContent": {
								"@type": "rdf:XMLLiteral",
								"@value": "<p otherprops=\"Normal\" outputclass=\"int-message\">Both <ph otherprops=\"chlorpromazine\" outputclass=\"int-heading-drug\">chlorpromazine</ph> and <ph otherprops=\"apraclonidine\" outputclass=\"int-drug\">apraclonidine</ph> can increase the risk of hypotension.</p>"
							},
							"hasEvidence": "NotSet",
							"hasImportance": "NotSet",
							"hasOrder": "1",
							"hasTextContent": "Both  chlorpromazine  and  apraclonidine  can increase the risk of hypotension. \n\n"
						},
						{
							"@id": "http://bnf.nice.org.uk/interaction/chlorpromazine#bnf_i1557280698394_message_1",
							"hasDitaContent": {
								"@type": "rdf:XMLLiteral",
								"@value": "<p otherprops=\"Normal\" outputclass=\"int-message\">Both <ph otherprops=\"chlorpromazine\" outputclass=\"int-heading-drug\">chlorpromazine</ph> and <ph otherprops=\"apraclonidine\" outputclass=\"int-drug\">apraclonidine</ph> can have CNS depressant effects, which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in <xref format=\"dita\" href=\"guidance/guidance-on-prescribing.xml\" type=\"interaction\" rel=\"guidance\" bnfid=\"PHP97234\">Guidance on Prescribing</xref>).</p>"
							},
							"hasEvidence": "NotSet",
							"hasImportance": "NotSet",
							"hasOrder": "2",
							"hasTextContent": "Both  chlorpromazine  and  apraclonidine  can have CNS depressant effects, which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in  Guidance on Prescribing ). \n\n"
						}
					],
					"hasOrder": "23",
					"hasTitle": {
						"@type": "rdf:XMLLiteral",
						"@value": "<title>Apraclonidine</title>"
					}
				},
				{
					"@id": "http://bnf.nice.org.uk/interaction/chlorpromazine#bnf_i1557280698395",
					"hasMessage": [
						{
							"@id": "http://bnf.nice.org.uk/interaction/chlorpromazine#bnf_i1557280698395_message_0",
							"hasDitaContent": {
								"@type": "rdf:XMLLiteral",
								"@value": "<p otherprops=\"Normal\" outputclass=\"int-message\">Both <ph otherprops=\"chlorpromazine\" outputclass=\"int-heading-drug\">chlorpromazine</ph> and <ph otherprops=\"aripiprazole\" outputclass=\"int-drug\">aripiprazole</ph> can increase the risk of hypotension.</p>"
							},
							"hasEvidence": "NotSet",
							"hasImportance": "NotSet",
							"hasOrder": "1",
							"hasTextContent": "Both  chlorpromazine  and  aripiprazole  can increase the risk of hypotension. \n\n"
						},
						{
							"@id": "http://bnf.nice.org.uk/interaction/chlorpromazine#bnf_i1557280698395_message_1",
							"hasDitaContent": {
								"@type": "rdf:XMLLiteral",
								"@value": "<p otherprops=\"Normal\" outputclass=\"int-message\">Both <ph otherprops=\"chlorpromazine\" outputclass=\"int-heading-drug\">chlorpromazine</ph> and <ph otherprops=\"aripiprazole\" outputclass=\"int-drug\">aripiprazole</ph> can have CNS depressant effects, which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in <xref format=\"dita\" href=\"guidance/guidance-on-prescribing.xml\" type=\"interaction\" rel=\"guidance\" bnfid=\"PHP97234\">Guidance on Prescribing</xref>).</p>"
							},
							"hasEvidence": "NotSet",
							"hasImportance": "NotSet",
							"hasOrder": "2",
							"hasTextContent": "Both  chlorpromazine  and  aripiprazole  can have CNS depressant effects, which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in  Guidance on Prescribing ). \n\n"
						}
					],
					"hasOrder": "24",
					"hasTitle": {
						"@type": "rdf:XMLLiteral",
						"@value": "<title>Aripiprazole</title>"
					}
				},
				{
					"@id": "http://bnf.nice.org.uk/interaction/chlorpromazine#bnf_i1557280698396",
					"hasMessage": [
						{
							"@id": "http://bnf.nice.org.uk/interaction/chlorpromazine#bnf_i1557280698396_message_0",
							"hasDitaContent": {
								"@type": "rdf:XMLLiteral",
								"@value": "<p otherprops=\"Severe\" outputclass=\"int-message\">Both <ph otherprops=\"chlorpromazine\" outputclass=\"int-heading-drug\">chlorpromazine</ph> and <ph otherprops=\"arsenic trioxide\" outputclass=\"int-drug\">arsenic trioxide</ph> prolong the QT interval. Most manufacturers advise avoiding the use of two or more drugs that are associated with QT prolongation. Increasing age, female sex, cardiac disease, and some metabolic disturbances (notably hypokalaemia) predispose to QT prolongation. </p>"
							},
							"hasEvidence": "NotSet",
							"hasImportance": "Severe",
							"hasOrder": "1",
							"hasTextContent": "Both  chlorpromazine  and  arsenic trioxide  prolong the QT interval. Most manufacturers advise avoiding the use of two or more drugs that are associated with QT prolongation. Increasing age, female sex, cardiac disease, and some metabolic disturbances (notably hypokalaemia) predispose to QT prolongation.  \n\n"
						}
					],
					"hasOrder": "25",
					"hasTitle": {
						"@type": "rdf:XMLLiteral",
						"@value": "<title>Arsenic trioxide</title>"
					}
				},
				{
					"@id": "http://bnf.nice.org.uk/interaction/chlorpromazine#bnf_i1557280698397",
					"hasMessage": [
						{
							"@id": "http://bnf.nice.org.uk/interaction/chlorpromazine#bnf_i1557280698397_message_0",
							"hasDitaContent": {
								"@type": "rdf:XMLLiteral",
								"@value": "<p otherprops=\"Severe\" outputclass=\"int-message\">Both <ph otherprops=\"chlorpromazine\" outputclass=\"int-heading-drug\">chlorpromazine</ph> and <ph otherprops=\"artemether\" outputclass=\"int-drug\">artemether</ph> prolong the QT interval. Most manufacturers advise avoiding the use of two or more drugs that are associated with QT prolongation. Increasing age, female sex, cardiac disease, and some metabolic disturbances (notably hypokalaemia) predispose to QT prolongation. </p>"
							},
							"hasEvidence": "NotSet",
							"hasImportance": "Severe",
							"hasOrder": "1",
							"hasTextContent": "Both  chlorpromazine  and  artemether  prolong the QT interval. Most manufacturers advise avoiding the use of two or more drugs that are associated with QT prolongation. Increasing age, female sex, cardiac disease, and some metabolic disturbances (notably hypokalaemia) predispose to QT prolongation.  \n\n"
						}
					],
					"hasOrder": "26",
					"hasTitle": {
						"@type": "rdf:XMLLiteral",
						"@value": "<title>Artemether</title>"
					}
				},
				{
					"@id": "http://bnf.nice.org.uk/interaction/chlorpromazine#bnf_i1557280698398",
					"hasMessage": [
						{
							"@id": "http://bnf.nice.org.uk/interaction/chlorpromazine#bnf_i1557280698398_message_0",
							"hasDitaContent": {
								"@type": "rdf:XMLLiteral",
								"@value": "<p otherprops=\"Severe\" outputclass=\"int-message\">Both <ph otherprops=\"chlorpromazine\" outputclass=\"int-heading-drug\">chlorpromazine</ph> and <ph otherprops=\"artenimol\" outputclass=\"int-drug\">artenimol</ph> prolong the QT interval. Most manufacturers advise avoiding the use of two or more drugs that are associated with QT prolongation. Increasing age, female sex, cardiac disease, and some metabolic disturbances (notably hypokalaemia) predispose to QT prolongation. </p>"
							},
							"hasEvidence": "NotSet",
							"hasImportance": "Severe",
							"hasOrder": "1",
							"hasTextContent": "Both  chlorpromazine  and  artenimol  prolong the QT interval. Most manufacturers advise avoiding the use of two or more drugs that are associated with QT prolongation. Increasing age, female sex, cardiac disease, and some metabolic disturbances (notably hypokalaemia) predispose to QT prolongation.  \n\n"
						}
					],
					"hasOrder": "27",
					"hasTitle": {
						"@type": "rdf:XMLLiteral",
						"@value": "<title>Artenimol</title>"
					}
				},
				{
					"@id": "http://bnf.nice.org.uk/interaction/chlorpromazine#bnf_i1557280698399",
					"hasMessage": [
						{
							"@id": "http://bnf.nice.org.uk/interaction/chlorpromazine#bnf_i1557280698399_message_0",
							"hasDitaContent": {
								"@type": "rdf:XMLLiteral",
								"@value": "<p otherprops=\"Normal\" outputclass=\"int-message\">Both <ph otherprops=\"chlorpromazine\" outputclass=\"int-heading-drug\">chlorpromazine</ph> and <ph otherprops=\"articaine\" outputclass=\"int-drug\">articaine</ph> can have CNS depressant effects, which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in <xref format=\"dita\" href=\"guidance/guidance-on-prescribing.xml\" type=\"interaction\" rel=\"guidance\" bnfid=\"PHP97234\">Guidance on Prescribing</xref>).</p>"
							},
							"hasEvidence": "NotSet",
							"hasImportance": "NotSet",
							"hasOrder": "1",
							"hasTextContent": "Both  chlorpromazine  and  articaine  can have CNS depressant effects, which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in  Guidance on Prescribing ). \n\n"
						}
					],
					"hasOrder": "28",
					"hasTitle": {
						"@type": "rdf:XMLLiteral",
						"@value": "<title>Articaine</title>"
					}
				},
				{
					"@id": "http://bnf.nice.org.uk/interaction/chlorpromazine#bnf_i1557280698400",
					"hasMessage": [
						{
							"@id": "http://bnf.nice.org.uk/interaction/chlorpromazine#bnf_i1557280698400_message_0",
							"hasDitaContent": {
								"@type": "rdf:XMLLiteral",
								"@value": "<p otherprops=\"Normal\" outputclass=\"int-message\">Both <ph otherprops=\"chlorpromazine\" outputclass=\"int-heading-drug\">chlorpromazine</ph> and <ph otherprops=\"asenapine\" outputclass=\"int-drug\">asenapine</ph> can increase the risk of hypotension.</p>"
							},
							"hasEvidence": "NotSet",
							"hasImportance": "NotSet",
							"hasOrder": "1",
							"hasTextContent": "Both  chlorpromazine  and  asenapine  can increase the risk of hypotension. \n\n"
						},
						{
							"@id": "http://bnf.nice.org.uk/interaction/chlorpromazine#bnf_i1557280698400_message_1",
							"hasDitaContent": {
								"@type": "rdf:XMLLiteral",
								"@value": "<p otherprops=\"Normal\" outputclass=\"int-message\">Both <ph otherprops=\"chlorpromazine\" outputclass=\"int-heading-drug\">chlorpromazine</ph> and <ph otherprops=\"asenapine\" outputclass=\"int-drug\">asenapine</ph> can have CNS depressant effects, which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in <xref format=\"dita\" href=\"guidance/guidance-on-prescribing.xml\" type=\"interaction\" rel=\"guidance\" bnfid=\"PHP97234\">Guidance on Prescribing</xref>).</p>"
							},
							"hasEvidence": "NotSet",
							"hasImportance": "NotSet",
							"hasOrder": "2",
							"hasTextContent": "Both  chlorpromazine  and  asenapine  can have CNS depressant effects, which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in  Guidance on Prescribing ). \n\n"
						}
					],
					"hasOrder": "29",
					"hasTitle": {
						"@type": "rdf:XMLLiteral",
						"@value": "<title>Asenapine</title>"
					}
				},
				{
					"@id": "http://bnf.nice.org.uk/interaction/chlorpromazine#bnf_i1557280698401",
					"hasMessage": [
						{
							"@id": "http://bnf.nice.org.uk/interaction/chlorpromazine#bnf_i1557280698401_message_0",
							"hasDitaContent": {
								"@type": "rdf:XMLLiteral",
								"@value": "<p otherprops=\"Normal\" outputclass=\"int-message\">Both <ph otherprops=\"chlorpromazine\" outputclass=\"int-heading-drug\">chlorpromazine</ph> and <ph otherprops=\"atenolol\" outputclass=\"int-drug\">atenolol</ph> can increase the risk of hypotension.</p>"
							},
							"hasEvidence": "NotSet",
							"hasImportance": "NotSet",
							"hasOrder": "1",
							"hasTextContent": "Both  chlorpromazine  and  atenolol  can increase the risk of hypotension. \n\n"
						}
					],
					"hasOrder": "30",
					"hasTitle": {
						"@type": "rdf:XMLLiteral",
						"@value": "<title>Atenolol</title>"
					}
				},
				{
					"@id": "http://bnf.nice.org.uk/interaction/chlorpromazine#bnf_i1557280698402",
					"hasMessage": [
						{
							"@id": "http://bnf.nice.org.uk/interaction/chlorpromazine#bnf_i1557280698402_message_0",
							"hasDitaContent": {
								"@type": "rdf:XMLLiteral",
								"@value": "<p otherprops=\"Normal\" outputclass=\"int-message\">Both <ph otherprops=\"chlorpromazine\" outputclass=\"int-heading-drug\">chlorpromazine</ph> and <ph otherprops=\"atropine\" outputclass=\"int-drug\">atropine</ph> can cause antimuscarinic effects.</p>"
							},
							"hasEvidence": "NotSet",
							"hasImportance": "NotSet",
							"hasOrder": "1",
							"hasTextContent": "Both  chlorpromazine  and  atropine  can cause antimuscarinic effects. \n\n"
						}
					],
					"hasOrder": "31",
					"hasTitle": {
						"@type": "rdf:XMLLiteral",
						"@value": "<title>Atropine</title>"
					}
				},
				{
					"@id": "http://bnf.nice.org.uk/interaction/chlorpromazine#bnf_i1557280698403",
					"hasMessage": [
						{
							"@id": "http://bnf.nice.org.uk/interaction/chlorpromazine#bnf_i1557280698403_message_0",
							"hasDitaContent": {
								"@type": "rdf:XMLLiteral",
								"@value": "<p otherprops=\"Normal\" outputclass=\"int-message\">Both <ph otherprops=\"chlorpromazine\" outputclass=\"int-heading-drug\">chlorpromazine</ph> and <ph otherprops=\"avanafil\" outputclass=\"int-drug\">avanafil</ph> can increase the risk of hypotension.</p>"
							},
							"hasEvidence": "NotSet",
							"hasImportance": "NotSet",
							"hasOrder": "1",
							"hasTextContent": "Both  chlorpromazine  and  avanafil  can increase the risk of hypotension. \n\n"
						}
					],
					"hasOrder": "32",
					"hasTitle": {
						"@type": "rdf:XMLLiteral",
						"@value": "<title>Avanafil</title>"
					}
				},
				{
					"@id": "http://bnf.nice.org.uk/interaction/chlorpromazine#bnf_i1557280698404",
					"hasMessage": [
						{
							"@id": "http://bnf.nice.org.uk/interaction/chlorpromazine#bnf_i1557280698404_message_0",
							"hasDitaContent": {
								"@type": "rdf:XMLLiteral",
								"@value": "<p otherprops=\"Normal\" outputclass=\"int-message\">Both <ph otherprops=\"chlorpromazine\" outputclass=\"int-heading-drug\">chlorpromazine</ph> and <ph otherprops=\"azilsartan\" outputclass=\"int-drug\">azilsartan</ph> can increase the risk of hypotension.</p>"
							},
							"hasEvidence": "NotSet",
							"hasImportance": "NotSet",
							"hasOrder": "1",
							"hasTextContent": "Both  chlorpromazine  and  azilsartan  can increase the risk of hypotension. \n\n"
						}
					],
					"hasOrder": "33",
					"hasTitle": {
						"@type": "rdf:XMLLiteral",
						"@value": "<title>Azilsartan</title>"
					}
				},
				{
					"@id": "http://bnf.nice.org.uk/interaction/chlorpromazine#bnf_i1557280698405",
					"hasMessage": [
						{
							"@id": "http://bnf.nice.org.uk/interaction/chlorpromazine#bnf_i1557280698405_message_0",
							"hasDitaContent": {
								"@type": "rdf:XMLLiteral",
								"@value": "<p otherprops=\"Normal\" outputclass=\"int-message\">Both <ph otherprops=\"chlorpromazine\" outputclass=\"int-heading-drug\">chlorpromazine</ph> and <ph otherprops=\"baclofen\" outputclass=\"int-drug\">baclofen</ph> can increase the risk of hypotension.</p>"
							},
							"hasEvidence": "NotSet",
							"hasImportance": "NotSet",
							"hasOrder": "1",
							"hasTextContent": "Both  chlorpromazine  and  baclofen  can increase the risk of hypotension. \n\n"
						},
						{
							"@id": "http://bnf.nice.org.uk/interaction/chlorpromazine#bnf_i1557280698405_message_1",
							"hasDitaContent": {
								"@type": "rdf:XMLLiteral",
								"@value": "<p otherprops=\"Normal\" outputclass=\"int-message\">Both <ph otherprops=\"chlorpromazine\" outputclass=\"int-heading-drug\">chlorpromazine</ph> and <ph otherprops=\"baclofen\" outputclass=\"int-drug\">baclofen</ph> can have CNS depressant effects, which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in <xref format=\"dita\" href=\"guidance/guidance-on-prescribing.xml\" type=\"interaction\" rel=\"guidance\" bnfid=\"PHP97234\">Guidance on Prescribing</xref>).</p>"
							},
							"hasEvidence": "NotSet",
							"hasImportance": "NotSet",
							"hasOrder": "2",
							"hasTextContent": "Both  chlorpromazine  and  baclofen  can have CNS depressant effects, which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in  Guidance on Prescribing ). \n\n"
						},
						{
							"@id": "http://bnf.nice.org.uk/interaction/chlorpromazine#bnf_i1557280698405_message_2",
							"hasDitaContent": {
								"@type": "rdf:XMLLiteral",
								"@value": "<p otherprops=\"Normal\" outputclass=\"int-message\">Both <ph otherprops=\"chlorpromazine\" outputclass=\"int-heading-drug\">chlorpromazine</ph> and <ph otherprops=\"baclofen\" outputclass=\"int-drug\">baclofen</ph> can cause antimuscarinic effects.</p>"
							},
							"hasEvidence": "NotSet",
							"hasImportance": "NotSet",
							"hasOrder": "3",
							"hasTextContent": "Both  chlorpromazine  and  baclofen  can cause antimuscarinic effects. \n\n"
						}
					],
					"hasOrder": "34",
					"hasTitle": {
						"@type": "rdf:XMLLiteral",
						"@value": "<title>Baclofen</title>"
					}
				},
				{
					"@id": "http://bnf.nice.org.uk/interaction/chlorpromazine#bnf_i1557280698406",
					"hasMessage": [
						{
							"@id": "http://bnf.nice.org.uk/interaction/chlorpromazine#bnf_i1557280698406_message_0",
							"hasDitaContent": {
								"@type": "rdf:XMLLiteral",
								"@value": "<p otherprops=\"Severe\" outputclass=\"int-message\">\n  <ph otherprops=\"bambuterol\" outputclass=\"int-drug\">Bambuterol</ph> <ph outputclass=\"int-effectQualifier\">is predicted to</ph> <ph outputclass=\"int-effect\">cause</ph> <ph outputclass=\"int-parameter\">hypokalaemia (potentially increasing the risk of torsade de pointes) when given with</ph> <ph otherprops=\"chlorpromazine\" outputclass=\"int-heading-drug\">chlorpromazine</ph>. <ph outputclass=\"int-action\">Manufacturer makes no recommendation</ph>.  </p>"
							},
							"hasEvidence": "Theoretical",
							"hasImportance": "Severe",
							"hasOrder": "1",
							"hasTextContent": "Bambuterol   is predicted to   cause   hypokalaemia (potentially increasing the risk of torsade de pointes) when given with   chlorpromazine .  Manufacturer makes no recommendation .    \n\n"
						}
					],
					"hasOrder": "35",
					"hasTitle": {
						"@type": "rdf:XMLLiteral",
						"@value": "<title>Bambuterol</title>"
					}
				},
				{
					"@id": "http://bnf.nice.org.uk/interaction/chlorpromazine#bnf_i1557280698407",
					"hasMessage": [
						{
							"@id": "http://bnf.nice.org.uk/interaction/chlorpromazine#bnf_i1557280698407_message_0",
							"hasDitaContent": {
								"@type": "rdf:XMLLiteral",
								"@value": "<p otherprops=\"Severe\" outputclass=\"int-message\">\n  <ph otherprops=\"beclometasone\" outputclass=\"int-drug\">Beclometasone</ph> <ph outputclass=\"int-effectQualifier\">is predicted to</ph> <ph outputclass=\"int-effect\">cause</ph> <ph outputclass=\"int-parameter\">hypokalaemia (potentially increasing the risk of torsade de pointes) when given with</ph> <ph otherprops=\"chlorpromazine\" outputclass=\"int-heading-drug\">chlorpromazine</ph>. <ph outputclass=\"int-action\">Manufacturer makes no recommendation</ph>.  </p>"
							},
							"hasEvidence": "Theoretical",
							"hasImportance": "Severe",
							"hasOrder": "1",
							"hasTextContent": "Beclometasone   is predicted to   cause   hypokalaemia (potentially increasing the risk of torsade de pointes) when given with   chlorpromazine .  Manufacturer makes no recommendation .    \n\n"
						}
					],
					"hasOrder": "36",
					"hasTitle": {
						"@type": "rdf:XMLLiteral",
						"@value": "<title>Beclometasone</title>"
					}
				},
				{
					"@id": "http://bnf.nice.org.uk/interaction/chlorpromazine#bnf_i1557280698408",
					"hasMessage": [
						{
							"@id": "http://bnf.nice.org.uk/interaction/chlorpromazine#bnf_i1557280698408_message_0",
							"hasDitaContent": {
								"@type": "rdf:XMLLiteral",
								"@value": "<p otherprops=\"Severe\" outputclass=\"int-message\">Both <ph otherprops=\"chlorpromazine\" outputclass=\"int-heading-drug\">chlorpromazine</ph> and <ph otherprops=\"bedaquiline\" outputclass=\"int-drug\">bedaquiline</ph> prolong the QT interval. Most manufacturers advise avoiding the use of two or more drugs that are associated with QT prolongation. Increasing age, female sex, cardiac disease, and some metabolic disturbances (notably hypokalaemia) predispose to QT prolongation. </p>"
							},
							"hasEvidence": "NotSet",
							"hasImportance": "Severe",
							"hasOrder": "1",
							"hasTextContent": "Both  chlorpromazine  and  bedaquiline  prolong the QT interval. Most manufacturers advise avoiding the use of two or more drugs that are associated with QT prolongation. Increasing age, female sex, cardiac disease, and some metabolic disturbances (notably hypokalaemia) predispose to QT prolongation.  \n\n"
						}
					],
					"hasOrder": "37",
					"hasTitle": {
						"@type": "rdf:XMLLiteral",
						"@value": "<title>Bedaquiline</title>"
					}
				},
				{
					"@id": "http://bnf.nice.org.uk/interaction/chlorpromazine#bnf_i1557280698409",
					"hasMessage": [
						{
							"@id": "http://bnf.nice.org.uk/interaction/chlorpromazine#bnf_i1557280698409_message_0",
							"hasDitaContent": {
								"@type": "rdf:XMLLiteral",
								"@value": "<p otherprops=\"Normal\" outputclass=\"int-message\">Both <ph otherprops=\"chlorpromazine\" outputclass=\"int-heading-drug\">chlorpromazine</ph> and <ph otherprops=\"bendroflumethiazide\" outputclass=\"int-drug\">bendroflumethiazide</ph> can increase the risk of hypotension.</p>"
							},
							"hasEvidence": "NotSet",
							"hasImportance": "NotSet",
							"hasOrder": "1",
							"hasTextContent": "Both  chlorpromazine  and  bendroflumethiazide  can increase the risk of hypotension. \n\n"
						},
						{
							"@id": "http://bnf.nice.org.uk/interaction/chlorpromazine#bnf_i1557280698409_message_1",
							"hasDitaContent": {
								"@type": "rdf:XMLLiteral",
								"@value": "<p otherprops=\"Severe\" outputclass=\"int-message\">\n  <ph otherprops=\"bendroflumethiazide\" outputclass=\"int-drug\">Bendroflumethiazide</ph> <ph outputclass=\"int-effectQualifier\">is predicted to</ph> <ph outputclass=\"int-effect\">cause</ph> <ph outputclass=\"int-parameter\">hypokalaemia (potentially increasing the risk of torsade de pointes) when given with</ph> <ph otherprops=\"chlorpromazine\" outputclass=\"int-heading-drug\">chlorpromazine</ph>. <ph outputclass=\"int-action\">Manufacturer makes no recommendation</ph>.  </p>"
							},
							"hasEvidence": "Theoretical",
							"hasImportance": "Severe",
							"hasOrder": "2",
							"hasTextContent": "Bendroflumethiazide   is predicted to   cause   hypokalaemia (potentially increasing the risk of torsade de pointes) when given with   chlorpromazine .  Manufacturer makes no recommendation .    \n\n"
						}
					],
					"hasOrder": "38",
					"hasTitle": {
						"@type": "rdf:XMLLiteral",
						"@value": "<title>Bendroflumethiazide</title>"
					}
				},
				{
					"@id": "http://bnf.nice.org.uk/interaction/chlorpromazine#bnf_i1557280698410",
					"hasMessage": [
						{
							"@id": "http://bnf.nice.org.uk/interaction/chlorpromazine#bnf_i1557280698410_message_0",
							"hasDitaContent": {
								"@type": "rdf:XMLLiteral",
								"@value": "<p otherprops=\"Normal\" outputclass=\"int-message\">Both <ph otherprops=\"chlorpromazine\" outputclass=\"int-heading-drug\">chlorpromazine</ph> and <ph otherprops=\"benperidol\" outputclass=\"int-drug\">benperidol</ph> can increase the risk of hypotension.</p>"
							},
							"hasEvidence": "NotSet",
							"hasImportance": "NotSet",
							"hasOrder": "1",
							"hasTextContent": "Both  chlorpromazine  and  benperidol  can increase the risk of hypotension. \n\n"
						},
						{
							"@id": "http://bnf.nice.org.uk/interaction/chlorpromazine#bnf_i1557280698410_message_1",
							"hasDitaContent": {
								"@type": "rdf:XMLLiteral",
								"@value": "<p otherprops=\"Normal\" outputclass=\"int-message\">Both <ph otherprops=\"chlorpromazine\" outputclass=\"int-heading-drug\">chlorpromazine</ph> and <ph otherprops=\"benperidol\" outputclass=\"int-drug\">benperidol</ph> can have CNS depressant effects, which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in <xref format=\"dita\" href=\"guidance/guidance-on-prescribing.xml\" type=\"interaction\" rel=\"guidance\" bnfid=\"PHP97234\">Guidance on Prescribing</xref>).</p>"
							},
							"hasEvidence": "NotSet",
							"hasImportance": "NotSet",
							"hasOrder": "2",
							"hasTextContent": "Both  chlorpromazine  and  benperidol  can have CNS depressant effects, which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in  Guidance on Prescribing ). \n\n"
						}
					],
					"hasOrder": "39",
					"hasTitle": {
						"@type": "rdf:XMLLiteral",
						"@value": "<title>Benperidol</title>"
					}
				},
				{
					"@id": "http://bnf.nice.org.uk/interaction/chlorpromazine#bnf_i1557280698411",
					"hasMessage": [
						{
							"@id": "http://bnf.nice.org.uk/interaction/chlorpromazine#bnf_i1557280698411_message_0",
							"hasDitaContent": {
								"@type": "rdf:XMLLiteral",
								"@value": "<p otherprops=\"Severe\" outputclass=\"int-message\">\n  <ph otherprops=\"betamethasone\" outputclass=\"int-drug\">Betamethasone</ph> <ph outputclass=\"int-effectQualifier\">is predicted to</ph> <ph outputclass=\"int-effect\">cause</ph> <ph outputclass=\"int-parameter\">hypokalaemia (potentially increasing the risk of torsade de pointes) when given with</ph> <ph otherprops=\"chlorpromazine\" outputclass=\"int-heading-drug\">chlorpromazine</ph>. <ph outputclass=\"int-action\">Manufacturer makes no recommendation</ph>.  </p>"
							},
							"hasEvidence": "Theoretical",
							"hasImportance": "Severe",
							"hasOrder": "1",
							"hasTextContent": "Betamethasone   is predicted to   cause   hypokalaemia (potentially increasing the risk of torsade de pointes) when given with   chlorpromazine .  Manufacturer makes no recommendation .    \n\n"
						}
					],
					"hasOrder": "40",
					"hasTitle": {
						"@type": "rdf:XMLLiteral",
						"@value": "<title>Betamethasone</title>"
					}
				},
				{
					"@id": "http://bnf.nice.org.uk/interaction/chlorpromazine#bnf_i1557280698412",
					"hasMessage": [
						{
							"@id": "http://bnf.nice.org.uk/interaction/chlorpromazine#bnf_i1557280698412_message_0",
							"hasDitaContent": {
								"@type": "rdf:XMLLiteral",
								"@value": "<p otherprops=\"Normal\" outputclass=\"int-message\">Both <ph otherprops=\"chlorpromazine\" outputclass=\"int-heading-drug\">chlorpromazine</ph> and <ph otherprops=\"betaxolol\" outputclass=\"int-drug\">betaxolol</ph> can increase the risk of hypotension.</p>"
							},
							"hasEvidence": "NotSet",
							"hasImportance": "NotSet",
							"hasOrder": "1",
							"hasTextContent": "Both  chlorpromazine  and  betaxolol  can increase the risk of hypotension. \n\n"
						}
					],
					"hasOrder": "41",
					"hasTitle": {
						"@type": "rdf:XMLLiteral",
						"@value": "<title>Betaxolol</title>"
					}
				},
				{
					"@id": "http://bnf.nice.org.uk/interaction/chlorpromazine#bnf_i1557280698413",
					"hasMessage": [
						{
							"@id": "http://bnf.nice.org.uk/interaction/chlorpromazine#bnf_i1557280698413_message_0",
							"hasDitaContent": {
								"@type": "rdf:XMLLiteral",
								"@value": "<p otherprops=\"Normal\" outputclass=\"int-message\">Both <ph otherprops=\"chlorpromazine\" outputclass=\"int-heading-drug\">chlorpromazine</ph> and <ph otherprops=\"bisoprolol\" outputclass=\"int-drug\">bisoprolol</ph> can increase the risk of hypotension.</p>"
							},
							"hasEvidence": "NotSet",
							"hasImportance": "NotSet",
							"hasOrder": "1",
							"hasTextContent": "Both  chlorpromazine  and  bisoprolol  can increase the risk of hypotension. \n\n"
						}
					],
					"hasOrder": "42",
					"hasTitle": {
						"@type": "rdf:XMLLiteral",
						"@value": "<title>Bisoprolol</title>"
					}
				},
				{
					"@id": "http://bnf.nice.org.uk/interaction/chlorpromazine#bnf_i1557280698414",
					"hasMessage": [
						{
							"@id": "http://bnf.nice.org.uk/interaction/chlorpromazine#bnf_i1557280698414_message_0",
							"hasDitaContent": {
								"@type": "rdf:XMLLiteral",
								"@value": "<p otherprops=\"Normal\" outputclass=\"int-message\">Both <ph otherprops=\"chlorpromazine\" outputclass=\"int-heading-drug\">chlorpromazine</ph> and <ph otherprops=\"bortezomib\" outputclass=\"int-drug\">bortezomib</ph> can increase the risk of hypotension.</p>"
							},
							"hasEvidence": "NotSet",
							"hasImportance": "NotSet",
							"hasOrder": "1",
							"hasTextContent": "Both  chlorpromazine  and  bortezomib  can increase the risk of hypotension. \n\n"
						}
					],
					"hasOrder": "43",
					"hasTitle": {
						"@type": "rdf:XMLLiteral",
						"@value": "<title>Bortezomib</title>"
					}
				},
				{
					"@id": "http://bnf.nice.org.uk/interaction/chlorpromazine#bnf_i1557280698415",
					"hasMessage": [
						{
							"@id": "http://bnf.nice.org.uk/interaction/chlorpromazine#bnf_i1557280698415_message_0",
							"hasDitaContent": {
								"@type": "rdf:XMLLiteral",
								"@value": "<p otherprops=\"Severe\" outputclass=\"int-message\">Both <ph otherprops=\"chlorpromazine\" outputclass=\"int-heading-drug\">chlorpromazine</ph> and <ph otherprops=\"bosutinib\" outputclass=\"int-drug\">bosutinib</ph> prolong the QT interval. Most manufacturers advise avoiding the use of two or more drugs that are associated with QT prolongation. Increasing age, female sex, cardiac disease, and some metabolic disturbances (notably hypokalaemia) predispose to QT prolongation. </p>"
							},
							"hasEvidence": "NotSet",
							"hasImportance": "Severe",
							"hasOrder": "1",
							"hasTextContent": "Both  chlorpromazine  and  bosutinib  prolong the QT interval. Most manufacturers advise avoiding the use of two or more drugs that are associated with QT prolongation. Increasing age, female sex, cardiac disease, and some metabolic disturbances (notably hypokalaemia) predispose to QT prolongation.  \n\n"
						}
					],
					"hasOrder": "44",
					"hasTitle": {
						"@type": "rdf:XMLLiteral",
						"@value": "<title>Bosutinib</title>"
					}
				},
				{
					"@id": "http://bnf.nice.org.uk/interaction/chlorpromazine#bnf_i1557280698416",
					"hasMessage": [
						{
							"@id": "http://bnf.nice.org.uk/interaction/chlorpromazine#bnf_i1557280698416_message_0",
							"hasDitaContent": {
								"@type": "rdf:XMLLiteral",
								"@value": "<p otherprops=\"Normal\" outputclass=\"int-message\">Both <ph otherprops=\"chlorpromazine\" outputclass=\"int-heading-drug\">chlorpromazine</ph> and <ph otherprops=\"brimonidine\" outputclass=\"int-drug\">brimonidine</ph> can increase the risk of hypotension.</p>"
							},
							"hasEvidence": "NotSet",
							"hasImportance": "NotSet",
							"hasOrder": "1",
							"hasTextContent": "Both  chlorpromazine  and  brimonidine  can increase the risk of hypotension. \n\n"
						},
						{
							"@id": "http://bnf.nice.org.uk/interaction/chlorpromazine#bnf_i1557280698416_message_1",
							"hasDitaContent": {
								"@type": "rdf:XMLLiteral",
								"@value": "<p otherprops=\"Normal\" outputclass=\"int-message\">Both <ph otherprops=\"chlorpromazine\" outputclass=\"int-heading-drug\">chlorpromazine</ph> and <ph otherprops=\"brimonidine\" outputclass=\"int-drug\">brimonidine</ph> can have CNS depressant effects, which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in <xref format=\"dita\" href=\"guidance/guidance-on-prescribing.xml\" type=\"interaction\" rel=\"guidance\" bnfid=\"PHP97234\">Guidance on Prescribing</xref>).</p>"
							},
							"hasEvidence": "NotSet",
							"hasImportance": "NotSet",
							"hasOrder": "2",
							"hasTextContent": "Both  chlorpromazine  and  brimonidine  can have CNS depressant effects, which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in  Guidance on Prescribing ). \n\n"
						}
					],
					"hasOrder": "45",
					"hasTitle": {
						"@type": "rdf:XMLLiteral",
						"@value": "<title>Brimonidine</title>"
					}
				},
				{
					"@id": "http://bnf.nice.org.uk/interaction/chlorpromazine#bnf_i1557280698417",
					"hasMessage": [
						{
							"@id": "http://bnf.nice.org.uk/interaction/chlorpromazine#bnf_i1557280698417_message_0",
							"hasDitaContent": {
								"@type": "rdf:XMLLiteral",
								"@value": "<p otherprops=\"Normal\" outputclass=\"int-message\">Both <ph otherprops=\"chlorpromazine\" outputclass=\"int-heading-drug\">chlorpromazine</ph> and <ph otherprops=\"bromocriptine\" outputclass=\"int-drug\">bromocriptine</ph> can increase the risk of hypotension.</p>"
							},
							"hasEvidence": "NotSet",
							"hasImportance": "NotSet",
							"hasOrder": "1",
							"hasTextContent": "Both  chlorpromazine  and  bromocriptine  can increase the risk of hypotension. \n\n"
						},
						{
							"@id": "http://bnf.nice.org.uk/interaction/chlorpromazine#bnf_i1557280698417_message_1",
							"hasDitaContent": {
								"@type": "rdf:XMLLiteral",
								"@value": "<p otherprops=\"Moderate\" outputclass=\"int-message\">\n  <ph otherprops=\"chlorpromazine\" outputclass=\"int-heading-drug\">Chlorpromazine</ph> <ph outputclass=\"int-effectQualifier\">is predicted to</ph> <ph outputclass=\"int-effect\">decrease</ph> <ph outputclass=\"int-parameter\">the effects of</ph> <ph otherprops=\"bromocriptine\" outputclass=\"int-drug\">bromocriptine</ph>. <ph outputclass=\"int-action\">Manufacturer advises avoid</ph>.  </p>"
							},
							"hasEvidence": "Theoretical",
							"hasImportance": "Moderate",
							"hasOrder": "2",
							"hasTextContent": "Chlorpromazine   is predicted to   decrease   the effects of   bromocriptine .  Manufacturer advises avoid .    \n\n"
						}
					],
					"hasOrder": "46",
					"hasTitle": {
						"@type": "rdf:XMLLiteral",
						"@value": "<title>Bromocriptine</title>"
					}
				},
				{
					"@id": "http://bnf.nice.org.uk/interaction/chlorpromazine#bnf_i1557280698418",
					"hasMessage": [
						{
							"@id": "http://bnf.nice.org.uk/interaction/chlorpromazine#bnf_i1557280698418_message_0",
							"hasDitaContent": {
								"@type": "rdf:XMLLiteral",
								"@value": "<p otherprops=\"Normal\" outputclass=\"int-message\">Both <ph otherprops=\"chlorpromazine\" outputclass=\"int-heading-drug\">chlorpromazine</ph> and <ph otherprops=\"buclizine\" outputclass=\"int-drug\">buclizine</ph> can have CNS depressant effects, which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in <xref format=\"dita\" href=\"guidance/guidance-on-prescribing.xml\" type=\"interaction\" rel=\"guidance\" bnfid=\"PHP97234\">Guidance on Prescribing</xref>).</p>"
							},
							"hasEvidence": "NotSet",
							"hasImportance": "NotSet",
							"hasOrder": "1",
							"hasTextContent": "Both  chlorpromazine  and  buclizine  can have CNS depressant effects, which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in  Guidance on Prescribing ). \n\n"
						}
					],
					"hasOrder": "47",
					"hasTitle": {
						"@type": "rdf:XMLLiteral",
						"@value": "<title>Buclizine</title>"
					}
				},
				{
					"@id": "http://bnf.nice.org.uk/interaction/chlorpromazine#bnf_i1557280698419",
					"hasMessage": [
						{
							"@id": "http://bnf.nice.org.uk/interaction/chlorpromazine#bnf_i1557280698419_message_0",
							"hasDitaContent": {
								"@type": "rdf:XMLLiteral",
								"@value": "<p otherprops=\"Severe\" outputclass=\"int-message\">\n  <ph otherprops=\"budesonide\" outputclass=\"int-drug\">Budesonide</ph> <ph outputclass=\"int-effectQualifier\">is predicted to</ph> <ph outputclass=\"int-effect\">cause</ph> <ph outputclass=\"int-parameter\">hypokalaemia (potentially increasing the risk of torsade de pointes) when given with</ph> <ph otherprops=\"chlorpromazine\" outputclass=\"int-heading-drug\">chlorpromazine</ph>. <ph outputclass=\"int-action\">Manufacturer makes no recommendation</ph>.  </p>"
							},
							"hasEvidence": "Theoretical",
							"hasImportance": "Severe",
							"hasOrder": "1",
							"hasTextContent": "Budesonide   is predicted to   cause   hypokalaemia (potentially increasing the risk of torsade de pointes) when given with   chlorpromazine .  Manufacturer makes no recommendation .    \n\n"
						}
					],
					"hasOrder": "48",
					"hasTitle": {
						"@type": "rdf:XMLLiteral",
						"@value": "<title>Budesonide</title>"
					}
				},
				{
					"@id": "http://bnf.nice.org.uk/interaction/chlorpromazine#bnf_i1557280698420",
					"hasMessage": [
						{
							"@id": "http://bnf.nice.org.uk/interaction/chlorpromazine#bnf_i1557280698420_message_0",
							"hasDitaContent": {
								"@type": "rdf:XMLLiteral",
								"@value": "<p otherprops=\"Normal\" outputclass=\"int-message\">Both <ph otherprops=\"chlorpromazine\" outputclass=\"int-heading-drug\">chlorpromazine</ph> and <ph otherprops=\"bumetanide\" outputclass=\"int-drug\">bumetanide</ph> can increase the risk of hypotension.</p>"
							},
							"hasEvidence": "NotSet",
							"hasImportance": "NotSet",
							"hasOrder": "1",
							"hasTextContent": "Both  chlorpromazine  and  bumetanide  can increase the risk of hypotension. \n\n"
						},
						{
							"@id": "http://bnf.nice.org.uk/interaction/chlorpromazine#bnf_i1557280698420_message_1",
							"hasDitaContent": {
								"@type": "rdf:XMLLiteral",
								"@value": "<p otherprops=\"Severe\" outputclass=\"int-message\">\n  <ph otherprops=\"bumetanide\" outputclass=\"int-drug\">Bumetanide</ph> <ph outputclass=\"int-effectQualifier\">is predicted to</ph> <ph outputclass=\"int-effect\">cause</ph> <ph outputclass=\"int-parameter\">hypokalaemia (potentially increasing the risk of torsade de pointes) when given with</ph> <ph otherprops=\"chlorpromazine\" outputclass=\"int-heading-drug\">chlorpromazine</ph>. <ph outputclass=\"int-action\">Manufacturer makes no recommendation</ph>.  </p>"
							},
							"hasEvidence": "Theoretical",
							"hasImportance": "Severe",
							"hasOrder": "2",
							"hasTextContent": "Bumetanide   is predicted to   cause   hypokalaemia (potentially increasing the risk of torsade de pointes) when given with   chlorpromazine .  Manufacturer makes no recommendation .    \n\n"
						}
					],
					"hasOrder": "49",
					"hasTitle": {
						"@type": "rdf:XMLLiteral",
						"@value": "<title>Bumetanide</title>"
					}
				},
				{
					"@id": "http://bnf.nice.org.uk/interaction/chlorpromazine#bnf_i1557280698421",
					"hasMessage": [
						{
							"@id": "http://bnf.nice.org.uk/interaction/chlorpromazine#bnf_i1557280698421_message_0",
							"hasDitaContent": {
								"@type": "rdf:XMLLiteral",
								"@value": "<p otherprops=\"Normal\" outputclass=\"int-message\">Both <ph otherprops=\"chlorpromazine\" outputclass=\"int-heading-drug\">chlorpromazine</ph> and <ph otherprops=\"bupivacaine\" outputclass=\"int-drug\">bupivacaine</ph> can have CNS depressant effects, which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in <xref format=\"dita\" href=\"guidance/guidance-on-prescribing.xml\" type=\"interaction\" rel=\"guidance\" bnfid=\"PHP97234\">Guidance on Prescribing</xref>).</p>"
							},
							"hasEvidence": "NotSet",
							"hasImportance": "NotSet",
							"hasOrder": "1",
							"hasTextContent": "Both  chlorpromazine  and  bupivacaine  can have CNS depressant effects, which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in  Guidance on Prescribing ). \n\n"
						}
					],
					"hasOrder": "50",
					"hasTitle": {
						"@type": "rdf:XMLLiteral",
						"@value": "<title>Bupivacaine</title>"
					}
				},
				{
					"@id": "http://bnf.nice.org.uk/interaction/chlorpromazine#bnf_i1557280698422",
					"hasMessage": [
						{
							"@id": "http://bnf.nice.org.uk/interaction/chlorpromazine#bnf_i1557280698422_message_0",
							"hasDitaContent": {
								"@type": "rdf:XMLLiteral",
								"@value": "<p otherprops=\"Normal\" outputclass=\"int-message\">Both <ph otherprops=\"chlorpromazine\" outputclass=\"int-heading-drug\">chlorpromazine</ph> and <ph otherprops=\"buprenorphine\" outputclass=\"int-drug\">buprenorphine</ph> can have CNS depressant effects, which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in <xref format=\"dita\" href=\"guidance/guidance-on-prescribing.xml\" type=\"interaction\" rel=\"guidance\" bnfid=\"PHP97234\">Guidance on Prescribing</xref>).</p>"
							},
							"hasEvidence": "NotSet",
							"hasImportance": "NotSet",
							"hasOrder": "1",
							"hasTextContent": "Both  chlorpromazine  and  buprenorphine  can have CNS depressant effects, which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in  Guidance on Prescribing ). \n\n"
						}
					],
					"hasOrder": "51",
					"hasTitle": {
						"@type": "rdf:XMLLiteral",
						"@value": "<title>Buprenorphine</title>"
					}
				},
				{
					"@id": "http://bnf.nice.org.uk/interaction/chlorpromazine#bnf_i1557280698423",
					"hasMessage": [
						{
							"@id": "http://bnf.nice.org.uk/interaction/chlorpromazine#bnf_i1557280698423_message_0",
							"hasDitaContent": {
								"@type": "rdf:XMLLiteral",
								"@value": "<p otherprops=\"Normal\" outputclass=\"int-message\">Both <ph otherprops=\"chlorpromazine\" outputclass=\"int-heading-drug\">chlorpromazine</ph> and <ph otherprops=\"cabergoline\" outputclass=\"int-drug\">cabergoline</ph> can increase the risk of hypotension.</p>"
							},
							"hasEvidence": "NotSet",
							"hasImportance": "NotSet",
							"hasOrder": "1",
							"hasTextContent": "Both  chlorpromazine  and  cabergoline  can increase the risk of hypotension. \n\n"
						},
						{
							"@id": "http://bnf.nice.org.uk/interaction/chlorpromazine#bnf_i1557280698423_message_1",
							"hasDitaContent": {
								"@type": "rdf:XMLLiteral",
								"@value": "<p otherprops=\"Moderate\" outputclass=\"int-message\">\n  <ph otherprops=\"chlorpromazine\" outputclass=\"int-heading-drug\">Chlorpromazine</ph> <ph outputclass=\"int-effectQualifier\">is predicted to</ph> <ph outputclass=\"int-effect\">decrease</ph> <ph outputclass=\"int-parameter\">the effects of</ph> <ph otherprops=\"cabergoline\" outputclass=\"int-drug\">cabergoline</ph>. <ph outputclass=\"int-action\">Manufacturer advises avoid</ph>.  </p>"
							},
							"hasEvidence": "Theoretical",
							"hasImportance": "Moderate",
							"hasOrder": "2",
							"hasTextContent": "Chlorpromazine   is predicted to   decrease   the effects of   cabergoline .  Manufacturer advises avoid .    \n\n"
						}
					],
					"hasOrder": "52",
					"hasTitle": {
						"@type": "rdf:XMLLiteral",
						"@value": "<title>Cabergoline</title>"
					}
				},
				{
					"@id": "http://bnf.nice.org.uk/interaction/chlorpromazine#bnf_i1557280698424",
					"hasMessage": [
						{
							"@id": "http://bnf.nice.org.uk/interaction/chlorpromazine#bnf_i1557280698424_message_0",
							"hasDitaContent": {
								"@type": "rdf:XMLLiteral",
								"@value": "<p otherprops=\"Severe\" outputclass=\"int-message\">Both <ph otherprops=\"chlorpromazine\" outputclass=\"int-heading-drug\">chlorpromazine</ph> and <ph otherprops=\"cabozantinib\" outputclass=\"int-drug\">cabozantinib</ph> prolong the QT interval. Most manufacturers advise avoiding the use of two or more drugs that are associated with QT prolongation. Increasing age, female sex, cardiac disease, and some metabolic disturbances (notably hypokalaemia) predispose to QT prolongation. </p>"
							},
							"hasEvidence": "NotSet",
							"hasImportance": "Severe",
							"hasOrder": "1",
							"hasTextContent": "Both  chlorpromazine  and  cabozantinib  prolong the QT interval. Most manufacturers advise avoiding the use of two or more drugs that are associated with QT prolongation. Increasing age, female sex, cardiac disease, and some metabolic disturbances (notably hypokalaemia) predispose to QT prolongation.  \n\n"
						}
					],
					"hasOrder": "53",
					"hasTitle": {
						"@type": "rdf:XMLLiteral",
						"@value": "<title>Cabozantinib</title>"
					}
				},
				{
					"@id": "http://bnf.nice.org.uk/interaction/chlorpromazine#bnf_i1557280698425",
					"hasMessage": [
						{
							"@id": "http://bnf.nice.org.uk/interaction/chlorpromazine#bnf_i1557280698425_message_0",
							"hasDitaContent": {
								"@type": "rdf:XMLLiteral",
								"@value": "<p otherprops=\"Normal\" outputclass=\"int-message\">Both <ph otherprops=\"chlorpromazine\" outputclass=\"int-heading-drug\">chlorpromazine</ph> and <ph otherprops=\"canagliflozin\" outputclass=\"int-drug\">canagliflozin</ph> can increase the risk of hypotension.</p>"
							},
							"hasEvidence": "NotSet",
							"hasImportance": "NotSet",
							"hasOrder": "1",
							"hasTextContent": "Both  chlorpromazine  and  canagliflozin  can increase the risk of hypotension. \n\n"
						}
					],
					"hasOrder": "54",
					"hasTitle": {
						"@type": "rdf:XMLLiteral",
						"@value": "<title>Canagliflozin</title>"
					}
				},
				{
					"@id": "http://bnf.nice.org.uk/interaction/chlorpromazine#bnf_i1557280698426",
					"hasMessage": [
						{
							"@id": "http://bnf.nice.org.uk/interaction/chlorpromazine#bnf_i1557280698426_message_0",
							"hasDitaContent": {
								"@type": "rdf:XMLLiteral",
								"@value": "<p otherprops=\"Normal\" outputclass=\"int-message\">Both <ph otherprops=\"chlorpromazine\" outputclass=\"int-heading-drug\">chlorpromazine</ph> and <ph otherprops=\"candesartan\" outputclass=\"int-drug\">candesartan</ph> can increase the risk of hypotension.</p>"
							},
							"hasEvidence": "NotSet",
							"hasImportance": "NotSet",
							"hasOrder": "1",
							"hasTextContent": "Both  chlorpromazine  and  candesartan  can increase the risk of hypotension. \n\n"
						}
					],
					"hasOrder": "55",
					"hasTitle": {
						"@type": "rdf:XMLLiteral",
						"@value": "<title>Candesartan</title>"
					}
				},
				{
					"@id": "http://bnf.nice.org.uk/interaction/chlorpromazine#bnf_i1557280698427",
					"hasMessage": [
						{
							"@id": "http://bnf.nice.org.uk/interaction/chlorpromazine#bnf_i1557280698427_message_0",
							"hasDitaContent": {
								"@type": "rdf:XMLLiteral",
								"@value": "<p otherprops=\"Normal\" outputclass=\"int-message\">Both <ph otherprops=\"chlorpromazine\" outputclass=\"int-heading-drug\">chlorpromazine</ph> and <ph otherprops=\"cannabis extract\" outputclass=\"int-drug\">cannabis extract</ph> can have CNS depressant effects, which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in <xref format=\"dita\" href=\"guidance/guidance-on-prescribing.xml\" type=\"interaction\" rel=\"guidance\" bnfid=\"PHP97234\">Guidance on Prescribing</xref>).</p>"
							},
							"hasEvidence": "NotSet",
							"hasImportance": "NotSet",
							"hasOrder": "1",
							"hasTextContent": "Both  chlorpromazine  and  cannabis extract  can have CNS depressant effects, which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in  Guidance on Prescribing ). \n\n"
						}
					],
					"hasOrder": "56",
					"hasTitle": {
						"@type": "rdf:XMLLiteral",
						"@value": "<title>Cannabis extract</title>"
					}
				},
				{
					"@id": "http://bnf.nice.org.uk/interaction/chlorpromazine#bnf_i1557280698428",
					"hasMessage": [
						{
							"@id": "http://bnf.nice.org.uk/interaction/chlorpromazine#bnf_i1557280698428_message_0",
							"hasDitaContent": {
								"@type": "rdf:XMLLiteral",
								"@value": "<p otherprops=\"Normal\" outputclass=\"int-message\">Both <ph otherprops=\"chlorpromazine\" outputclass=\"int-heading-drug\">chlorpromazine</ph> and <ph otherprops=\"captopril\" outputclass=\"int-drug\">captopril</ph> can increase the risk of hypotension.</p>"
							},
							"hasEvidence": "NotSet",
							"hasImportance": "NotSet",
							"hasOrder": "1",
							"hasTextContent": "Both  chlorpromazine  and  captopril  can increase the risk of hypotension. \n\n"
						}
					],
					"hasOrder": "57",
					"hasTitle": {
						"@type": "rdf:XMLLiteral",
						"@value": "<title>Captopril</title>"
					}
				},
				{
					"@id": "http://bnf.nice.org.uk/interaction/chlorpromazine#bnf_i1557280698429",
					"hasMessage": [
						{
							"@id": "http://bnf.nice.org.uk/interaction/chlorpromazine#bnf_i1557280698429_message_0",
							"hasDitaContent": {
								"@type": "rdf:XMLLiteral",
								"@value": "<p otherprops=\"Normal\" outputclass=\"int-message\">Both <ph otherprops=\"chlorpromazine\" outputclass=\"int-heading-drug\">chlorpromazine</ph> and <ph otherprops=\"cariprazine\" outputclass=\"int-drug\">cariprazine</ph> can increase the risk of hypotension.</p>"
							},
							"hasEvidence": "NotSet",
							"hasImportance": "NotSet",
							"hasOrder": "1",
							"hasTextContent": "Both  chlorpromazine  and  cariprazine  can increase the risk of hypotension. \n\n"
						},
						{
							"@id": "http://bnf.nice.org.uk/interaction/chlorpromazine#bnf_i1557280698429_message_1",
							"hasDitaContent": {
								"@type": "rdf:XMLLiteral",
								"@value": "<p otherprops=\"Normal\" outputclass=\"int-message\">Both <ph otherprops=\"chlorpromazine\" outputclass=\"int-heading-drug\">chlorpromazine</ph> and <ph otherprops=\"cariprazine\" outputclass=\"int-drug\">cariprazine</ph> can have CNS depressant effects, which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in <xref format=\"dita\" href=\"guidance/guidance-on-prescribing.xml\" type=\"interaction\" rel=\"guidance\" bnfid=\"PHP97234\">Guidance on Prescribing</xref>).</p>"
							},
							"hasEvidence": "NotSet",
							"hasImportance": "NotSet",
							"hasOrder": "2",
							"hasTextContent": "Both  chlorpromazine  and  cariprazine  can have CNS depressant effects, which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in  Guidance on Prescribing ). \n\n"
						}
					],
					"hasOrder": "58",
					"hasTitle": {
						"@type": "rdf:XMLLiteral",
						"@value": "<title>Cariprazine</title>"
					}
				},
				{
					"@id": "http://bnf.nice.org.uk/interaction/chlorpromazine#bnf_i1557280698430",
					"hasMessage": [
						{
							"@id": "http://bnf.nice.org.uk/interaction/chlorpromazine#bnf_i1557280698430_message_0",
							"hasDitaContent": {
								"@type": "rdf:XMLLiteral",
								"@value": "<p otherprops=\"Normal\" outputclass=\"int-message\">Both <ph otherprops=\"chlorpromazine\" outputclass=\"int-heading-drug\">chlorpromazine</ph> and <ph otherprops=\"carvedilol\" outputclass=\"int-drug\">carvedilol</ph> can increase the risk of hypotension.</p>"
							},
							"hasEvidence": "NotSet",
							"hasImportance": "NotSet",
							"hasOrder": "1",
							"hasTextContent": "Both  chlorpromazine  and  carvedilol  can increase the risk of hypotension. \n\n"
						}
					],
					"hasOrder": "59",
					"hasTitle": {
						"@type": "rdf:XMLLiteral",
						"@value": "<title>Carvedilol</title>"
					}
				},
				{
					"@id": "http://bnf.nice.org.uk/interaction/chlorpromazine#bnf_i1557280698431",
					"hasMessage": [
						{
							"@id": "http://bnf.nice.org.uk/interaction/chlorpromazine#bnf_i1557280698431_message_0",
							"hasDitaContent": {
								"@type": "rdf:XMLLiteral",
								"@value": "<p otherprops=\"Normal\" outputclass=\"int-message\">Both <ph otherprops=\"chlorpromazine\" outputclass=\"int-heading-drug\">chlorpromazine</ph> and <ph otherprops=\"celiprolol\" outputclass=\"int-drug\">celiprolol</ph> can increase the risk of hypotension.</p>"
							},
							"hasEvidence": "NotSet",
							"hasImportance": "NotSet",
							"hasOrder": "1",
							"hasTextContent": "Both  chlorpromazine  and  celiprolol  can increase the risk of hypotension. \n\n"
						}
					],
					"hasOrder": "60",
					"hasTitle": {
						"@type": "rdf:XMLLiteral",
						"@value": "<title>Celiprolol</title>"
					}
				},
				{
					"@id": "http://bnf.nice.org.uk/interaction/chlorpromazine#bnf_i1557280698432",
					"hasMessage": [
						{
							"@id": "http://bnf.nice.org.uk/interaction/chlorpromazine#bnf_i1557280698432_message_0",
							"hasDitaContent": {
								"@type": "rdf:XMLLiteral",
								"@value": "<p otherprops=\"Severe\" outputclass=\"int-message\">Both <ph otherprops=\"chlorpromazine\" outputclass=\"int-heading-drug\">chlorpromazine</ph> and <ph otherprops=\"ceritinib\" outputclass=\"int-drug\">ceritinib</ph> prolong the QT interval. Most manufacturers advise avoiding the use of two or more drugs that are associated with QT prolongation. Increasing age, female sex, cardiac disease, and some metabolic disturbances (notably hypokalaemia) predispose to QT prolongation. </p>"
							},
							"hasEvidence": "NotSet",
							"hasImportance": "Severe",
							"hasOrder": "1",
							"hasTextContent": "Both  chlorpromazine  and  ceritinib  prolong the QT interval. Most manufacturers advise avoiding the use of two or more drugs that are associated with QT prolongation. Increasing age, female sex, cardiac disease, and some metabolic disturbances (notably hypokalaemia) predispose to QT prolongation.  \n\n"
						}
					],
					"hasOrder": "61",
					"hasTitle": {
						"@type": "rdf:XMLLiteral",
						"@value": "<title>Ceritinib</title>"
					}
				},
				{
					"@id": "http://bnf.nice.org.uk/interaction/chlorpromazine#bnf_i1557280698433",
					"hasMessage": [
						{
							"@id": "http://bnf.nice.org.uk/interaction/chlorpromazine#bnf_i1557280698433_message_0",
							"hasDitaContent": {
								"@type": "rdf:XMLLiteral",
								"@value": "<p otherprops=\"Normal\" outputclass=\"int-message\">Both <ph otherprops=\"chlorpromazine\" outputclass=\"int-heading-drug\">chlorpromazine</ph> and <ph otherprops=\"chloral hydrate\" outputclass=\"int-drug\">chloral hydrate</ph> can have CNS depressant effects, which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in <xref format=\"dita\" href=\"guidance/guidance-on-prescribing.xml\" type=\"interaction\" rel=\"guidance\" bnfid=\"PHP97234\">Guidance on Prescribing</xref>).</p>"
							},
							"hasEvidence": "NotSet",
							"hasImportance": "NotSet",
							"hasOrder": "1",
							"hasTextContent": "Both  chlorpromazine  and  chloral hydrate  can have CNS depressant effects, which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in  Guidance on Prescribing ). \n\n"
						}
					],
					"hasOrder": "62",
					"hasTitle": {
						"@type": "rdf:XMLLiteral",
						"@value": "<title>Chloral hydrate</title>"
					}
				},
				{
					"@id": "http://bnf.nice.org.uk/interaction/chlorpromazine#bnf_i1557280698434",
					"hasMessage": [
						{
							"@id": "http://bnf.nice.org.uk/interaction/chlorpromazine#bnf_i1557280698434_message_0",
							"hasDitaContent": {
								"@type": "rdf:XMLLiteral",
								"@value": "<p otherprops=\"Normal\" outputclass=\"int-message\">Both <ph otherprops=\"chlorpromazine\" outputclass=\"int-heading-drug\">chlorpromazine</ph> and <ph otherprops=\"chlordiazepoxide\" outputclass=\"int-drug\">chlordiazepoxide</ph> can have CNS depressant effects, which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in <xref format=\"dita\" href=\"guidance/guidance-on-prescribing.xml\" type=\"interaction\" rel=\"guidance\" bnfid=\"PHP97234\">Guidance on Prescribing</xref>).</p>"
							},
							"hasEvidence": "NotSet",
							"hasImportance": "NotSet",
							"hasOrder": "1",
							"hasTextContent": "Both  chlorpromazine  and  chlordiazepoxide  can have CNS depressant effects, which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in  Guidance on Prescribing ). \n\n"
						}
					],
					"hasOrder": "63",
					"hasTitle": {
						"@type": "rdf:XMLLiteral",
						"@value": "<title>Chlordiazepoxide</title>"
					}
				},
				{
					"@id": "http://bnf.nice.org.uk/interaction/chlorpromazine#bnf_i1557280698435",
					"hasMessage": [
						{
							"@id": "http://bnf.nice.org.uk/interaction/chlorpromazine#bnf_i1557280698435_message_0",
							"hasDitaContent": {
								"@type": "rdf:XMLLiteral",
								"@value": "<p otherprops=\"Normal\" outputclass=\"int-message\">Both <ph otherprops=\"chlorpromazine\" outputclass=\"int-heading-drug\">chlorpromazine</ph> and <ph otherprops=\"chlorothiazide\" outputclass=\"int-drug\">chlorothiazide</ph> can increase the risk of hypotension.</p>"
							},
							"hasEvidence": "NotSet",
							"hasImportance": "NotSet",
							"hasOrder": "1",
							"hasTextContent": "Both  chlorpromazine  and  chlorothiazide  can increase the risk of hypotension. \n\n"
						},
						{
							"@id": "http://bnf.nice.org.uk/interaction/chlorpromazine#bnf_i1557280698435_message_1",
							"hasDitaContent": {
								"@type": "rdf:XMLLiteral",
								"@value": "<p otherprops=\"Severe\" outputclass=\"int-message\">\n  <ph otherprops=\"chlorothiazide\" outputclass=\"int-drug\">Chlorothiazide</ph> <ph outputclass=\"int-effectQualifier\">is predicted to</ph> <ph outputclass=\"int-effect\">cause</ph> <ph outputclass=\"int-parameter\">hypokalaemia (potentially increasing the risk of torsade de pointes) when given with</ph> <ph otherprops=\"chlorpromazine\" outputclass=\"int-heading-drug\">chlorpromazine</ph>. <ph outputclass=\"int-action\">Manufacturer makes no recommendation</ph>.  </p>"
							},
							"hasEvidence": "Theoretical",
							"hasImportance": "Severe",
							"hasOrder": "2",
							"hasTextContent": "Chlorothiazide   is predicted to   cause   hypokalaemia (potentially increasing the risk of torsade de pointes) when given with   chlorpromazine .  Manufacturer makes no recommendation .    \n\n"
						}
					],
					"hasOrder": "64",
					"hasTitle": {
						"@type": "rdf:XMLLiteral",
						"@value": "<title>Chlorothiazide</title>"
					}
				},
				{
					"@id": "http://bnf.nice.org.uk/interaction/chlorpromazine#bnf_i1557280698436",
					"hasMessage": [
						{
							"@id": "http://bnf.nice.org.uk/interaction/chlorpromazine#bnf_i1557280698436_message_0",
							"hasDitaContent": {
								"@type": "rdf:XMLLiteral",
								"@value": "<p otherprops=\"Normal\" outputclass=\"int-message\">Both <ph otherprops=\"chlorpromazine\" outputclass=\"int-heading-drug\">chlorpromazine</ph> and <ph otherprops=\"chlorphenamine\" outputclass=\"int-drug\">chlorphenamine</ph> can have CNS depressant effects, which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in <xref format=\"dita\" href=\"guidance/guidance-on-prescribing.xml\" type=\"interaction\" rel=\"guidance\" bnfid=\"PHP97234\">Guidance on Prescribing</xref>).</p>"
							},
							"hasEvidence": "NotSet",
							"hasImportance": "NotSet",
							"hasOrder": "1",
							"hasTextContent": "Both  chlorpromazine  and  chlorphenamine  can have CNS depressant effects, which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in  Guidance on Prescribing ). \n\n"
						},
						{
							"@id": "http://bnf.nice.org.uk/interaction/chlorpromazine#bnf_i1557280698436_message_1",
							"hasDitaContent": {
								"@type": "rdf:XMLLiteral",
								"@value": "<p otherprops=\"Normal\" outputclass=\"int-message\">Both <ph otherprops=\"chlorpromazine\" outputclass=\"int-heading-drug\">chlorpromazine</ph> and <ph otherprops=\"chlorphenamine\" outputclass=\"int-drug\">chlorphenamine</ph> can cause antimuscarinic effects.</p>"
							},
							"hasEvidence": "NotSet",
							"hasImportance": "NotSet",
							"hasOrder": "2",
							"hasTextContent": "Both  chlorpromazine  and  chlorphenamine  can cause antimuscarinic effects. \n\n"
						}
					],
					"hasOrder": "65",
					"hasTitle": {
						"@type": "rdf:XMLLiteral",
						"@value": "<title>Chlorphenamine</title>"
					}
				},
				{
					"@id": "http://bnf.nice.org.uk/interaction/chlorpromazine#bnf_i1557280698437",
					"hasMessage": [
						{
							"@id": "http://bnf.nice.org.uk/interaction/chlorpromazine#bnf_i1557280698437_message_0",
							"hasDitaContent": {
								"@type": "rdf:XMLLiteral",
								"@value": "<p otherprops=\"Normal\" outputclass=\"int-message\">Both <ph otherprops=\"chlorpromazine\" outputclass=\"int-heading-drug\">chlorpromazine</ph> and <ph otherprops=\"chlortalidone\" outputclass=\"int-drug\">chlortalidone</ph> can increase the risk of hypotension.</p>"
							},
							"hasEvidence": "NotSet",
							"hasImportance": "NotSet",
							"hasOrder": "1",
							"hasTextContent": "Both  chlorpromazine  and  chlortalidone  can increase the risk of hypotension. \n\n"
						},
						{
							"@id": "http://bnf.nice.org.uk/interaction/chlorpromazine#bnf_i1557280698437_message_1",
							"hasDitaContent": {
								"@type": "rdf:XMLLiteral",
								"@value": "<p otherprops=\"Severe\" outputclass=\"int-message\">\n  <ph otherprops=\"chlortalidone\" outputclass=\"int-drug\">Chlortalidone</ph> <ph outputclass=\"int-effectQualifier\">is predicted to</ph> <ph outputclass=\"int-effect\">cause</ph> <ph outputclass=\"int-parameter\">hypokalaemia (potentially increasing the risk of torsade de pointes) when given with</ph> <ph otherprops=\"chlorpromazine\" outputclass=\"int-heading-drug\">chlorpromazine</ph>. <ph outputclass=\"int-action\">Manufacturer makes no recommendation</ph>.  </p>"
							},
							"hasEvidence": "Theoretical",
							"hasImportance": "Severe",
							"hasOrder": "2",
							"hasTextContent": "Chlortalidone   is predicted to   cause   hypokalaemia (potentially increasing the risk of torsade de pointes) when given with   chlorpromazine .  Manufacturer makes no recommendation .    \n\n"
						}
					],
					"hasOrder": "66",
					"hasTitle": {
						"@type": "rdf:XMLLiteral",
						"@value": "<title>Chlortalidone</title>"
					}
				},
				{
					"@id": "http://bnf.nice.org.uk/interaction/chlorpromazine#bnf_i1557280698438",
					"hasMessage": [
						{
							"@id": "http://bnf.nice.org.uk/interaction/chlorpromazine#bnf_i1557280698438_message_0",
							"hasDitaContent": {
								"@type": "rdf:XMLLiteral",
								"@value": "<p otherprops=\"Normal\" outputclass=\"int-message\">Both <ph otherprops=\"chlorpromazine\" outputclass=\"int-heading-drug\">chlorpromazine</ph> and <ph otherprops=\"cinnarizine\" outputclass=\"int-drug\">cinnarizine</ph> can have CNS depressant effects, which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in <xref format=\"dita\" href=\"guidance/guidance-on-prescribing.xml\" type=\"interaction\" rel=\"guidance\" bnfid=\"PHP97234\">Guidance on Prescribing</xref>).</p>"
							},
							"hasEvidence": "NotSet",
							"hasImportance": "NotSet",
							"hasOrder": "1",
							"hasTextContent": "Both  chlorpromazine  and  cinnarizine  can have CNS depressant effects, which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in  Guidance on Prescribing ). \n\n"
						}
					],
					"hasOrder": "67",
					"hasTitle": {
						"@type": "rdf:XMLLiteral",
						"@value": "<title>Cinnarizine</title>"
					}
				},
				{
					"@id": "http://bnf.nice.org.uk/interaction/chlorpromazine#bnf_i1557280698439",
					"hasMessage": [
						{
							"@id": "http://bnf.nice.org.uk/interaction/chlorpromazine#bnf_i1557280698439_message_0",
							"hasDitaContent": {
								"@type": "rdf:XMLLiteral",
								"@value": "<p otherprops=\"Severe\" outputclass=\"int-message\">Both <ph otherprops=\"chlorpromazine\" outputclass=\"int-heading-drug\">chlorpromazine</ph> and <ph otherprops=\"citalopram\" outputclass=\"int-drug\">citalopram</ph> prolong the QT interval. Most manufacturers advise avoiding the use of two or more drugs that are associated with QT prolongation. Increasing age, female sex, cardiac disease, and some metabolic disturbances (notably hypokalaemia) predispose to QT prolongation. </p>"
							},
							"hasEvidence": "NotSet",
							"hasImportance": "Severe",
							"hasOrder": "1",
							"hasTextContent": "Both  chlorpromazine  and  citalopram  prolong the QT interval. Most manufacturers advise avoiding the use of two or more drugs that are associated with QT prolongation. Increasing age, female sex, cardiac disease, and some metabolic disturbances (notably hypokalaemia) predispose to QT prolongation.  \n\n"
						}
					],
					"hasOrder": "68",
					"hasTitle": {
						"@type": "rdf:XMLLiteral",
						"@value": "<title>Citalopram</title>"
					}
				},
				{
					"@id": "http://bnf.nice.org.uk/interaction/chlorpromazine#bnf_i1557280698440",
					"hasMessage": [
						{
							"@id": "http://bnf.nice.org.uk/interaction/chlorpromazine#bnf_i1557280698440_message_0",
							"hasDitaContent": {
								"@type": "rdf:XMLLiteral",
								"@value": "<p otherprops=\"Severe\" outputclass=\"int-message\">Both <ph otherprops=\"chlorpromazine\" outputclass=\"int-heading-drug\">chlorpromazine</ph> and <ph otherprops=\"clarithromycin\" outputclass=\"int-drug\">clarithromycin</ph> prolong the QT interval. Most manufacturers advise avoiding the use of two or more drugs that are associated with QT prolongation. Increasing age, female sex, cardiac disease, and some metabolic disturbances (notably hypokalaemia) predispose to QT prolongation. </p>"
							},
							"hasEvidence": "NotSet",
							"hasImportance": "Severe",
							"hasOrder": "1",
							"hasTextContent": "Both  chlorpromazine  and  clarithromycin  prolong the QT interval. Most manufacturers advise avoiding the use of two or more drugs that are associated with QT prolongation. Increasing age, female sex, cardiac disease, and some metabolic disturbances (notably hypokalaemia) predispose to QT prolongation.  \n\n"
						}
					],
					"hasOrder": "69",
					"hasTitle": {
						"@type": "rdf:XMLLiteral",
						"@value": "<title>Clarithromycin</title>"
					}
				},
				{
					"@id": "http://bnf.nice.org.uk/interaction/chlorpromazine#bnf_i1557280698441",
					"hasMessage": [
						{
							"@id": "http://bnf.nice.org.uk/interaction/chlorpromazine#bnf_i1557280698441_message_0",
							"hasDitaContent": {
								"@type": "rdf:XMLLiteral",
								"@value": "<p otherprops=\"Normal\" outputclass=\"int-message\">Both <ph otherprops=\"chlorpromazine\" outputclass=\"int-heading-drug\">chlorpromazine</ph> and <ph otherprops=\"clemastine\" outputclass=\"int-drug\">clemastine</ph> can have CNS depressant effects, which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in <xref format=\"dita\" href=\"guidance/guidance-on-prescribing.xml\" type=\"interaction\" rel=\"guidance\" bnfid=\"PHP97234\">Guidance on Prescribing</xref>).</p>"
							},
							"hasEvidence": "NotSet",
							"hasImportance": "NotSet",
							"hasOrder": "1",
							"hasTextContent": "Both  chlorpromazine  and  clemastine  can have CNS depressant effects, which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in  Guidance on Prescribing ). \n\n"
						},
						{
							"@id": "http://bnf.nice.org.uk/interaction/chlorpromazine#bnf_i1557280698441_message_1",
							"hasDitaContent": {
								"@type": "rdf:XMLLiteral",
								"@value": "<p otherprops=\"Normal\" outputclass=\"int-message\">Both <ph otherprops=\"chlorpromazine\" outputclass=\"int-heading-drug\">chlorpromazine</ph> and <ph otherprops=\"clemastine\" outputclass=\"int-drug\">clemastine</ph> can cause antimuscarinic effects.</p>"
							},
							"hasEvidence": "NotSet",
							"hasImportance": "NotSet",
							"hasOrder": "2",
							"hasTextContent": "Both  chlorpromazine  and  clemastine  can cause antimuscarinic effects. \n\n"
						}
					],
					"hasOrder": "70",
					"hasTitle": {
						"@type": "rdf:XMLLiteral",
						"@value": "<title>Clemastine</title>"
					}
				},
				{
					"@id": "http://bnf.nice.org.uk/interaction/chlorpromazine#bnf_i1557280698442",
					"hasMessage": [
						{
							"@id": "http://bnf.nice.org.uk/interaction/chlorpromazine#bnf_i1557280698442_message_0",
							"hasDitaContent": {
								"@type": "rdf:XMLLiteral",
								"@value": "<p otherprops=\"Normal\" outputclass=\"int-message\">Both <ph otherprops=\"chlorpromazine\" outputclass=\"int-heading-drug\">chlorpromazine</ph> and <ph otherprops=\"clevidipine\" outputclass=\"int-drug\">clevidipine</ph> can increase the risk of hypotension.</p>"
							},
							"hasEvidence": "NotSet",
							"hasImportance": "NotSet",
							"hasOrder": "1",
							"hasTextContent": "Both  chlorpromazine  and  clevidipine  can increase the risk of hypotension. \n\n"
						}
					],
					"hasOrder": "71",
					"hasTitle": {
						"@type": "rdf:XMLLiteral",
						"@value": "<title>Clevidipine</title>"
					}
				},
				{
					"@id": "http://bnf.nice.org.uk/interaction/chlorpromazine#bnf_i1557280698443",
					"hasMessage": [
						{
							"@id": "http://bnf.nice.org.uk/interaction/chlorpromazine#bnf_i1557280698443_message_0",
							"hasDitaContent": {
								"@type": "rdf:XMLLiteral",
								"@value": "<p otherprops=\"Normal\" outputclass=\"int-message\">Both <ph otherprops=\"chlorpromazine\" outputclass=\"int-heading-drug\">chlorpromazine</ph> and <ph otherprops=\"clobazam\" outputclass=\"int-drug\">clobazam</ph> can have CNS depressant effects, which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in <xref format=\"dita\" href=\"guidance/guidance-on-prescribing.xml\" type=\"interaction\" rel=\"guidance\" bnfid=\"PHP97234\">Guidance on Prescribing</xref>).</p>"
							},
							"hasEvidence": "NotSet",
							"hasImportance": "NotSet",
							"hasOrder": "1",
							"hasTextContent": "Both  chlorpromazine  and  clobazam  can have CNS depressant effects, which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in  Guidance on Prescribing ). \n\n"
						}
					],
					"hasOrder": "72",
					"hasTitle": {
						"@type": "rdf:XMLLiteral",
						"@value": "<title>Clobazam</title>"
					}
				},
				{
					"@id": "http://bnf.nice.org.uk/interaction/chlorpromazine#bnf_i1557280698444",
					"hasMessage": [
						{
							"@id": "http://bnf.nice.org.uk/interaction/chlorpromazine#bnf_i1557280698444_message_0",
							"hasDitaContent": {
								"@type": "rdf:XMLLiteral",
								"@value": "<p otherprops=\"Normal\" outputclass=\"int-message\">Both <ph otherprops=\"chlorpromazine\" outputclass=\"int-heading-drug\">chlorpromazine</ph> and <ph otherprops=\"clomethiazole\" outputclass=\"int-drug\">clomethiazole</ph> can have CNS depressant effects, which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in <xref format=\"dita\" href=\"guidance/guidance-on-prescribing.xml\" type=\"interaction\" rel=\"guidance\" bnfid=\"PHP97234\">Guidance on Prescribing</xref>).</p>"
							},
							"hasEvidence": "NotSet",
							"hasImportance": "NotSet",
							"hasOrder": "1",
							"hasTextContent": "Both  chlorpromazine  and  clomethiazole  can have CNS depressant effects, which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in  Guidance on Prescribing ). \n\n"
						}
					],
					"hasOrder": "73",
					"hasTitle": {
						"@type": "rdf:XMLLiteral",
						"@value": "<title>Clomethiazole</title>"
					}
				},
				{
					"@id": "http://bnf.nice.org.uk/interaction/chlorpromazine#bnf_i1557280698445",
					"hasMessage": [
						{
							"@id": "http://bnf.nice.org.uk/interaction/chlorpromazine#bnf_i1557280698445_message_0",
							"hasDitaContent": {
								"@type": "rdf:XMLLiteral",
								"@value": "<p otherprops=\"Normal\" outputclass=\"int-message\">Both <ph otherprops=\"chlorpromazine\" outputclass=\"int-heading-drug\">chlorpromazine</ph> and <ph otherprops=\"clomipramine\" outputclass=\"int-drug\">clomipramine</ph> can increase the risk of hypotension.</p>"
							},
							"hasEvidence": "NotSet",
							"hasImportance": "NotSet",
							"hasOrder": "1",
							"hasTextContent": "Both  chlorpromazine  and  clomipramine  can increase the risk of hypotension. \n\n"
						},
						{
							"@id": "http://bnf.nice.org.uk/interaction/chlorpromazine#bnf_i1557280698445_message_1",
							"hasDitaContent": {
								"@type": "rdf:XMLLiteral",
								"@value": "<p otherprops=\"Severe\" outputclass=\"int-message\">Both <ph otherprops=\"chlorpromazine\" outputclass=\"int-heading-drug\">chlorpromazine</ph> and <ph otherprops=\"clomipramine\" outputclass=\"int-drug\">clomipramine</ph> prolong the QT interval. Most manufacturers advise avoiding the use of two or more drugs that are associated with QT prolongation. Increasing age, female sex, cardiac disease, and some metabolic disturbances (notably hypokalaemia) predispose to QT prolongation. </p>"
							},
							"hasEvidence": "NotSet",
							"hasImportance": "Severe",
							"hasOrder": "2",
							"hasTextContent": "Both  chlorpromazine  and  clomipramine  prolong the QT interval. Most manufacturers advise avoiding the use of two or more drugs that are associated with QT prolongation. Increasing age, female sex, cardiac disease, and some metabolic disturbances (notably hypokalaemia) predispose to QT prolongation.  \n\n"
						},
						{
							"@id": "http://bnf.nice.org.uk/interaction/chlorpromazine#bnf_i1557280698445_message_2",
							"hasDitaContent": {
								"@type": "rdf:XMLLiteral",
								"@value": "<p otherprops=\"Normal\" outputclass=\"int-message\">Both <ph otherprops=\"chlorpromazine\" outputclass=\"int-heading-drug\">chlorpromazine</ph> and <ph otherprops=\"clomipramine\" outputclass=\"int-drug\">clomipramine</ph> can cause antimuscarinic effects.</p>"
							},
							"hasEvidence": "NotSet",
							"hasImportance": "NotSet",
							"hasOrder": "3",
							"hasTextContent": "Both  chlorpromazine  and  clomipramine  can cause antimuscarinic effects. \n\n"
						}
					],
					"hasOrder": "74",
					"hasTitle": {
						"@type": "rdf:XMLLiteral",
						"@value": "<title>Clomipramine</title>"
					}
				},
				{
					"@id": "http://bnf.nice.org.uk/interaction/chlorpromazine#bnf_i1557280698446",
					"hasMessage": [
						{
							"@id": "http://bnf.nice.org.uk/interaction/chlorpromazine#bnf_i1557280698446_message_0",
							"hasDitaContent": {
								"@type": "rdf:XMLLiteral",
								"@value": "<p otherprops=\"Normal\" outputclass=\"int-message\">Both <ph otherprops=\"chlorpromazine\" outputclass=\"int-heading-drug\">chlorpromazine</ph> and <ph otherprops=\"clonazepam\" outputclass=\"int-drug\">clonazepam</ph> can have CNS depressant effects, which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in <xref format=\"dita\" href=\"guidance/guidance-on-prescribing.xml\" type=\"interaction\" rel=\"guidance\" bnfid=\"PHP97234\">Guidance on Prescribing</xref>).</p>"
							},
							"hasEvidence": "NotSet",
							"hasImportance": "NotSet",
							"hasOrder": "1",
							"hasTextContent": "Both  chlorpromazine  and  clonazepam  can have CNS depressant effects, which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in  Guidance on Prescribing ). \n\n"
						}
					],
					"hasOrder": "75",
					"hasTitle": {
						"@type": "rdf:XMLLiteral",
						"@value": "<title>Clonazepam</title>"
					}
				},
				{
					"@id": "http://bnf.nice.org.uk/interaction/chlorpromazine#bnf_i1557280698447",
					"hasMessage": [
						{
							"@id": "http://bnf.nice.org.uk/interaction/chlorpromazine#bnf_i1557280698447_message_0",
							"hasDitaContent": {
								"@type": "rdf:XMLLiteral",
								"@value": "<p otherprops=\"Normal\" outputclass=\"int-message\">Both <ph otherprops=\"chlorpromazine\" outputclass=\"int-heading-drug\">chlorpromazine</ph> and <ph otherprops=\"clonidine\" outputclass=\"int-drug\">clonidine</ph> can increase the risk of hypotension.</p>"
							},
							"hasEvidence": "NotSet",
							"hasImportance": "NotSet",
							"hasOrder": "1",
							"hasTextContent": "Both  chlorpromazine  and  clonidine  can increase the risk of hypotension. \n\n"
						},
						{
							"@id": "http://bnf.nice.org.uk/interaction/chlorpromazine#bnf_i1557280698447_message_1",
							"hasDitaContent": {
								"@type": "rdf:XMLLiteral",
								"@value": "<p otherprops=\"Normal\" outputclass=\"int-message\">Both <ph otherprops=\"chlorpromazine\" outputclass=\"int-heading-drug\">chlorpromazine</ph> and <ph otherprops=\"clonidine\" outputclass=\"int-drug\">clonidine</ph> can have CNS depressant effects, which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in <xref format=\"dita\" href=\"guidance/guidance-on-prescribing.xml\" type=\"interaction\" rel=\"guidance\" bnfid=\"PHP97234\">Guidance on Prescribing</xref>).</p>"
							},
							"hasEvidence": "NotSet",
							"hasImportance": "NotSet",
							"hasOrder": "2",
							"hasTextContent": "Both  chlorpromazine  and  clonidine  can have CNS depressant effects, which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in  Guidance on Prescribing ). \n\n"
						}
					],
					"hasOrder": "76",
					"hasTitle": {
						"@type": "rdf:XMLLiteral",
						"@value": "<title>Clonidine</title>"
					}
				},
				{
					"@id": "http://bnf.nice.org.uk/interaction/chlorpromazine#bnf_i1557280698448",
					"hasMessage": [
						{
							"@id": "http://bnf.nice.org.uk/interaction/chlorpromazine#bnf_i1557280698448_message_0",
							"hasDitaContent": {
								"@type": "rdf:XMLLiteral",
								"@value": "<p otherprops=\"Normal\" outputclass=\"int-message\">Both <ph otherprops=\"chlorpromazine\" outputclass=\"int-heading-drug\">chlorpromazine</ph> and <ph otherprops=\"clozapine\" outputclass=\"int-drug\">clozapine</ph> can increase the risk of hypotension.</p>"
							},
							"hasEvidence": "NotSet",
							"hasImportance": "NotSet",
							"hasOrder": "1",
							"hasTextContent": "Both  chlorpromazine  and  clozapine  can increase the risk of hypotension. \n\n"
						},
						{
							"@id": "http://bnf.nice.org.uk/interaction/chlorpromazine#bnf_i1557280698448_message_1",
							"hasDitaContent": {
								"@type": "rdf:XMLLiteral",
								"@value": "<p otherprops=\"Normal\" outputclass=\"int-message\">Both <ph otherprops=\"chlorpromazine\" outputclass=\"int-heading-drug\">chlorpromazine</ph> and <ph otherprops=\"clozapine\" outputclass=\"int-drug\">clozapine</ph> can have CNS depressant effects, which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in <xref format=\"dita\" href=\"guidance/guidance-on-prescribing.xml\" type=\"interaction\" rel=\"guidance\" bnfid=\"PHP97234\">Guidance on Prescribing</xref>).</p>"
							},
							"hasEvidence": "NotSet",
							"hasImportance": "NotSet",
							"hasOrder": "2",
							"hasTextContent": "Both  chlorpromazine  and  clozapine  can have CNS depressant effects, which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in  Guidance on Prescribing ). \n\n"
						},
						{
							"@id": "http://bnf.nice.org.uk/interaction/chlorpromazine#bnf_i1557280698448_message_2",
							"hasDitaContent": {
								"@type": "rdf:XMLLiteral",
								"@value": "<p otherprops=\"Normal\" outputclass=\"int-message\">Both <ph otherprops=\"chlorpromazine\" outputclass=\"int-heading-drug\">chlorpromazine</ph> and <ph otherprops=\"clozapine\" outputclass=\"int-drug\">clozapine</ph> can cause antimuscarinic effects.</p>"
							},
							"hasEvidence": "NotSet",
							"hasImportance": "NotSet",
							"hasOrder": "3",
							"hasTextContent": "Both  chlorpromazine  and  clozapine  can cause antimuscarinic effects. \n\n"
						}
					],
					"hasOrder": "77",
					"hasTitle": {
						"@type": "rdf:XMLLiteral",
						"@value": "<title>Clozapine</title>"
					}
				},
				{
					"@id": "http://bnf.nice.org.uk/interaction/chlorpromazine#bnf_i1557280698449",
					"hasMessage": [
						{
							"@id": "http://bnf.nice.org.uk/interaction/chlorpromazine#bnf_i1557280698449_message_0",
							"hasDitaContent": {
								"@type": "rdf:XMLLiteral",
								"@value": "<p otherprops=\"Normal\" outputclass=\"int-message\">Both <ph otherprops=\"chlorpromazine\" outputclass=\"int-heading-drug\">chlorpromazine</ph> and <ph otherprops=\"codeine\" outputclass=\"int-drug\">codeine</ph> can have CNS depressant effects, which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in <xref format=\"dita\" href=\"guidance/guidance-on-prescribing.xml\" type=\"interaction\" rel=\"guidance\" bnfid=\"PHP97234\">Guidance on Prescribing</xref>).</p>"
							},
							"hasEvidence": "NotSet",
							"hasImportance": "NotSet",
							"hasOrder": "1",
							"hasTextContent": "Both  chlorpromazine  and  codeine  can have CNS depressant effects, which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in  Guidance on Prescribing ). \n\n"
						}
					],
					"hasOrder": "78",
					"hasTitle": {
						"@type": "rdf:XMLLiteral",
						"@value": "<title>Codeine</title>"
					}
				},
				{
					"@id": "http://bnf.nice.org.uk/interaction/chlorpromazine#bnf_i1557280698450",
					"hasMessage": [
						{
							"@id": "http://bnf.nice.org.uk/interaction/chlorpromazine#bnf_i1557280698450_message_0",
							"hasDitaContent": {
								"@type": "rdf:XMLLiteral",
								"@value": "<p otherprops=\"Severe\" outputclass=\"int-message\">Both <ph otherprops=\"chlorpromazine\" outputclass=\"int-heading-drug\">chlorpromazine</ph> and <ph otherprops=\"crizotinib\" outputclass=\"int-drug\">crizotinib</ph> prolong the QT interval. Most manufacturers advise avoiding the use of two or more drugs that are associated with QT prolongation. Increasing age, female sex, cardiac disease, and some metabolic disturbances (notably hypokalaemia) predispose to QT prolongation. </p>"
							},
							"hasEvidence": "NotSet",
							"hasImportance": "Severe",
							"hasOrder": "1",
							"hasTextContent": "Both  chlorpromazine  and  crizotinib  prolong the QT interval. Most manufacturers advise avoiding the use of two or more drugs that are associated with QT prolongation. Increasing age, female sex, cardiac disease, and some metabolic disturbances (notably hypokalaemia) predispose to QT prolongation.  \n\n"
						}
					],
					"hasOrder": "79",
					"hasTitle": {
						"@type": "rdf:XMLLiteral",
						"@value": "<title>Crizotinib</title>"
					}
				},
				{
					"@id": "http://bnf.nice.org.uk/interaction/chlorpromazine#bnf_i1557280698451",
					"hasMessage": [
						{
							"@id": "http://bnf.nice.org.uk/interaction/chlorpromazine#bnf_i1557280698451_message_0",
							"hasDitaContent": {
								"@type": "rdf:XMLLiteral",
								"@value": "<p otherprops=\"Normal\" outputclass=\"int-message\">Both <ph otherprops=\"chlorpromazine\" outputclass=\"int-heading-drug\">chlorpromazine</ph> and <ph otherprops=\"cyclizine\" outputclass=\"int-drug\">cyclizine</ph> can have CNS depressant effects, which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in <xref format=\"dita\" href=\"guidance/guidance-on-prescribing.xml\" type=\"interaction\" rel=\"guidance\" bnfid=\"PHP97234\">Guidance on Prescribing</xref>).</p>"
							},
							"hasEvidence": "NotSet",
							"hasImportance": "NotSet",
							"hasOrder": "1",
							"hasTextContent": "Both  chlorpromazine  and  cyclizine  can have CNS depressant effects, which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in  Guidance on Prescribing ). \n\n"
						},
						{
							"@id": "http://bnf.nice.org.uk/interaction/chlorpromazine#bnf_i1557280698451_message_1",
							"hasDitaContent": {
								"@type": "rdf:XMLLiteral",
								"@value": "<p otherprops=\"Normal\" outputclass=\"int-message\">Both <ph otherprops=\"chlorpromazine\" outputclass=\"int-heading-drug\">chlorpromazine</ph> and <ph otherprops=\"cyclizine\" outputclass=\"int-drug\">cyclizine</ph> can cause antimuscarinic effects.</p>"
							},
							"hasEvidence": "NotSet",
							"hasImportance": "NotSet",
							"hasOrder": "2",
							"hasTextContent": "Both  chlorpromazine  and  cyclizine  can cause antimuscarinic effects. \n\n"
						}
					],
					"hasOrder": "80",
					"hasTitle": {
						"@type": "rdf:XMLLiteral",
						"@value": "<title>Cyclizine</title>"
					}
				},
				{
					"@id": "http://bnf.nice.org.uk/interaction/chlorpromazine#bnf_i1557280698452",
					"hasMessage": [
						{
							"@id": "http://bnf.nice.org.uk/interaction/chlorpromazine#bnf_i1557280698452_message_0",
							"hasDitaContent": {
								"@type": "rdf:XMLLiteral",
								"@value": "<p otherprops=\"Normal\" outputclass=\"int-message\">Both <ph otherprops=\"chlorpromazine\" outputclass=\"int-heading-drug\">chlorpromazine</ph> and <ph otherprops=\"cyclopentolate\" outputclass=\"int-drug\">cyclopentolate</ph> can cause antimuscarinic effects.</p>"
							},
							"hasEvidence": "NotSet",
							"hasImportance": "NotSet",
							"hasOrder": "1",
							"hasTextContent": "Both  chlorpromazine  and  cyclopentolate  can cause antimuscarinic effects. \n\n"
						}
					],
					"hasOrder": "81",
					"hasTitle": {
						"@type": "rdf:XMLLiteral",
						"@value": "<title>Cyclopentolate</title>"
					}
				},
				{
					"@id": "http://bnf.nice.org.uk/interaction/chlorpromazine#bnf_i1557280698453",
					"hasMessage": [
						{
							"@id": "http://bnf.nice.org.uk/interaction/chlorpromazine#bnf_i1557280698453_message_0",
							"hasDitaContent": {
								"@type": "rdf:XMLLiteral",
								"@value": "<p otherprops=\"Normal\" outputclass=\"int-message\">Both <ph otherprops=\"chlorpromazine\" outputclass=\"int-heading-drug\">chlorpromazine</ph> and <ph otherprops=\"cyproheptadine\" outputclass=\"int-drug\">cyproheptadine</ph> can have CNS depressant effects, which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in <xref format=\"dita\" href=\"guidance/guidance-on-prescribing.xml\" type=\"interaction\" rel=\"guidance\" bnfid=\"PHP97234\">Guidance on Prescribing</xref>).</p>"
							},
							"hasEvidence": "NotSet",
							"hasImportance": "NotSet",
							"hasOrder": "1",
							"hasTextContent": "Both  chlorpromazine  and  cyproheptadine  can have CNS depressant effects, which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in  Guidance on Prescribing ). \n\n"
						},
						{
							"@id": "http://bnf.nice.org.uk/interaction/chlorpromazine#bnf_i1557280698453_message_1",
							"hasDitaContent": {
								"@type": "rdf:XMLLiteral",
								"@value": "<p otherprops=\"Normal\" outputclass=\"int-message\">Both <ph otherprops=\"chlorpromazine\" outputclass=\"int-heading-drug\">chlorpromazine</ph> and <ph otherprops=\"cyproheptadine\" outputclass=\"int-drug\">cyproheptadine</ph> can cause antimuscarinic effects.</p>"
							},
							"hasEvidence": "NotSet",
							"hasImportance": "NotSet",
							"hasOrder": "2",
							"hasTextContent": "Both  chlorpromazine  and  cyproheptadine  can cause antimuscarinic effects. \n\n"
						}
					],
					"hasOrder": "82",
					"hasTitle": {
						"@type": "rdf:XMLLiteral",
						"@value": "<title>Cyproheptadine</title>"
					}
				},
				{
					"@id": "http://bnf.nice.org.uk/interaction/chlorpromazine#bnf_i1557280698454",
					"hasMessage": [
						{
							"@id": "http://bnf.nice.org.uk/interaction/chlorpromazine#bnf_i1557280698454_message_0",
							"hasDitaContent": {
								"@type": "rdf:XMLLiteral",
								"@value": "<p otherprops=\"Normal\" outputclass=\"int-message\">Both <ph otherprops=\"chlorpromazine\" outputclass=\"int-heading-drug\">chlorpromazine</ph> and <ph otherprops=\"dapagliflozin\" outputclass=\"int-drug\">dapagliflozin</ph> can increase the risk of hypotension.</p>"
							},
							"hasEvidence": "NotSet",
							"hasImportance": "NotSet",
							"hasOrder": "1",
							"hasTextContent": "Both  chlorpromazine  and  dapagliflozin  can increase the risk of hypotension. \n\n"
						}
					],
					"hasOrder": "83",
					"hasTitle": {
						"@type": "rdf:XMLLiteral",
						"@value": "<title>Dapagliflozin</title>"
					}
				},
				{
					"@id": "http://bnf.nice.org.uk/interaction/chlorpromazine#bnf_i1557280698455",
					"hasMessage": [
						{
							"@id": "http://bnf.nice.org.uk/interaction/chlorpromazine#bnf_i1557280698455_message_0",
							"hasDitaContent": {
								"@type": "rdf:XMLLiteral",
								"@value": "<p otherprops=\"Normal\" outputclass=\"int-message\">Both <ph otherprops=\"chlorpromazine\" outputclass=\"int-heading-drug\">chlorpromazine</ph> and <ph otherprops=\"darifenacin\" outputclass=\"int-drug\">darifenacin</ph> can cause antimuscarinic effects.</p>"
							},
							"hasEvidence": "NotSet",
							"hasImportance": "NotSet",
							"hasOrder": "1",
							"hasTextContent": "Both  chlorpromazine  and  darifenacin  can cause antimuscarinic effects. \n\n"
						}
					],
					"hasOrder": "84",
					"hasTitle": {
						"@type": "rdf:XMLLiteral",
						"@value": "<title>Darifenacin</title>"
					}
				},
				{
					"@id": "http://bnf.nice.org.uk/interaction/chlorpromazine#bnf_i1557280698456",
					"hasMessage": [
						{
							"@id": "http://bnf.nice.org.uk/interaction/chlorpromazine#bnf_i1557280698456_message_0",
							"hasDitaContent": {
								"@type": "rdf:XMLLiteral",
								"@value": "<p otherprops=\"Severe\" outputclass=\"int-message\">Both <ph otherprops=\"chlorpromazine\" outputclass=\"int-heading-drug\">chlorpromazine</ph> and <ph otherprops=\"dasatinib\" outputclass=\"int-drug\">dasatinib</ph> prolong the QT interval. Most manufacturers advise avoiding the use of two or more drugs that are associated with QT prolongation. Increasing age, female sex, cardiac disease, and some metabolic disturbances (notably hypokalaemia) predispose to QT prolongation. </p>"
							},
							"hasEvidence": "NotSet",
							"hasImportance": "Severe",
							"hasOrder": "1",
							"hasTextContent": "Both  chlorpromazine  and  dasatinib  prolong the QT interval. Most manufacturers advise avoiding the use of two or more drugs that are associated with QT prolongation. Increasing age, female sex, cardiac disease, and some metabolic disturbances (notably hypokalaemia) predispose to QT prolongation.  \n\n"
						}
					],
					"hasOrder": "85",
					"hasTitle": {
						"@type": "rdf:XMLLiteral",
						"@value": "<title>Dasatinib</title>"
					}
				},
				{
					"@id": "http://bnf.nice.org.uk/interaction/chlorpromazine#bnf_i1557280698457",
					"hasMessage": [
						{
							"@id": "http://bnf.nice.org.uk/interaction/chlorpromazine#bnf_i1557280698457_message_0",
							"hasDitaContent": {
								"@type": "rdf:XMLLiteral",
								"@value": "<p otherprops=\"Severe\" outputclass=\"int-message\">\n  <ph otherprops=\"deflazacort\" outputclass=\"int-drug\">Deflazacort</ph> <ph outputclass=\"int-effectQualifier\">is predicted to</ph> <ph outputclass=\"int-effect\">cause</ph> <ph outputclass=\"int-parameter\">hypokalaemia (potentially increasing the risk of torsade de pointes) when given with</ph> <ph otherprops=\"chlorpromazine\" outputclass=\"int-heading-drug\">chlorpromazine</ph>. <ph outputclass=\"int-action\">Manufacturer makes no recommendation</ph>.  </p>"
							},
							"hasEvidence": "Theoretical",
							"hasImportance": "Severe",
							"hasOrder": "1",
							"hasTextContent": "Deflazacort   is predicted to   cause   hypokalaemia (potentially increasing the risk of torsade de pointes) when given with   chlorpromazine .  Manufacturer makes no recommendation .    \n\n"
						}
					],
					"hasOrder": "86",
					"hasTitle": {
						"@type": "rdf:XMLLiteral",
						"@value": "<title>Deflazacort</title>"
					}
				},
				{
					"@id": "http://bnf.nice.org.uk/interaction/chlorpromazine#bnf_i1557280698458",
					"hasMessage": [
						{
							"@id": "http://bnf.nice.org.uk/interaction/chlorpromazine#bnf_i1557280698458_message_0",
							"hasDitaContent": {
								"@type": "rdf:XMLLiteral",
								"@value": "<p otherprops=\"Severe\" outputclass=\"int-message\">Both <ph otherprops=\"chlorpromazine\" outputclass=\"int-heading-drug\">chlorpromazine</ph> and <ph otherprops=\"delamanid\" outputclass=\"int-drug\">delamanid</ph> prolong the QT interval. Most manufacturers advise avoiding the use of two or more drugs that are associated with QT prolongation. Increasing age, female sex, cardiac disease, and some metabolic disturbances (notably hypokalaemia) predispose to QT prolongation. </p>"
							},
							"hasEvidence": "NotSet",
							"hasImportance": "Severe",
							"hasOrder": "1",
							"hasTextContent": "Both  chlorpromazine  and  delamanid  prolong the QT interval. Most manufacturers advise avoiding the use of two or more drugs that are associated with QT prolongation. Increasing age, female sex, cardiac disease, and some metabolic disturbances (notably hypokalaemia) predispose to QT prolongation.  \n\n"
						}
					],
					"hasOrder": "87",
					"hasTitle": {
						"@type": "rdf:XMLLiteral",
						"@value": "<title>Delamanid</title>"
					}
				},
				{
					"@id": "http://bnf.nice.org.uk/interaction/chlorpromazine#bnf_i1557280698459",
					"hasMessage": [
						{
							"@id": "http://bnf.nice.org.uk/interaction/chlorpromazine#bnf_i1557280698459_message_0",
							"hasDitaContent": {
								"@type": "rdf:XMLLiteral",
								"@value": "<p otherprops=\"Normal\" outputclass=\"int-message\">Both <ph otherprops=\"chlorpromazine\" outputclass=\"int-heading-drug\">chlorpromazine</ph> and <ph otherprops=\"desflurane\" outputclass=\"int-drug\">desflurane</ph> can increase the risk of hypotension.</p>"
							},
							"hasEvidence": "NotSet",
							"hasImportance": "NotSet",
							"hasOrder": "1",
							"hasTextContent": "Both  chlorpromazine  and  desflurane  can increase the risk of hypotension. \n\n"
						},
						{
							"@id": "http://bnf.nice.org.uk/interaction/chlorpromazine#bnf_i1557280698459_message_1",
							"hasDitaContent": {
								"@type": "rdf:XMLLiteral",
								"@value": "<p otherprops=\"Normal\" outputclass=\"int-message\">Both <ph otherprops=\"chlorpromazine\" outputclass=\"int-heading-drug\">chlorpromazine</ph> and <ph otherprops=\"desflurane\" outputclass=\"int-drug\">desflurane</ph> can have CNS depressant effects, which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in <xref format=\"dita\" href=\"guidance/guidance-on-prescribing.xml\" type=\"interaction\" rel=\"guidance\" bnfid=\"PHP97234\">Guidance on Prescribing</xref>).</p>"
							},
							"hasEvidence": "NotSet",
							"hasImportance": "NotSet",
							"hasOrder": "2",
							"hasTextContent": "Both  chlorpromazine  and  desflurane  can have CNS depressant effects, which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in  Guidance on Prescribing ). \n\n"
						}
					],
					"hasOrder": "88",
					"hasTitle": {
						"@type": "rdf:XMLLiteral",
						"@value": "<title>Desflurane</title>"
					}
				},
				{
					"@id": "http://bnf.nice.org.uk/interaction/chlorpromazine#bnf_i1557280698460",
					"hasMessage": [
						{
							"@id": "http://bnf.nice.org.uk/interaction/chlorpromazine#bnf_i1557280698460_message_0",
							"hasDitaContent": {
								"@type": "rdf:XMLLiteral",
								"@value": "<p otherprops=\"Severe\" outputclass=\"int-message\">\n  <ph otherprops=\"chlorpromazine\" outputclass=\"int-heading-drug\">Chlorpromazine</ph> <ph outputclass=\"int-effectQualifier\">is predicted to</ph> <ph outputclass=\"int-effect\">increase</ph> <ph outputclass=\"int-parameter\">the risk of hyponatraemia when given with</ph> <ph otherprops=\"desmopressin\" outputclass=\"int-drug\">desmopressin</ph>. <ph outputclass=\"int-action\">Manufacturer advises monitor serum sodium</ph>.  </p>"
							},
							"hasEvidence": "Theoretical",
							"hasImportance": "Severe",
							"hasOrder": "1",
							"hasTextContent": "Chlorpromazine   is predicted to   increase   the risk of hyponatraemia when given with   desmopressin .  Manufacturer advises monitor serum sodium .    \n\n"
						}
					],
					"hasOrder": "89",
					"hasTitle": {
						"@type": "rdf:XMLLiteral",
						"@value": "<title>Desmopressin</title>"
					}
				},
				{
					"@id": "http://bnf.nice.org.uk/interaction/chlorpromazine#bnf_i1557280698461",
					"hasMessage": [
						{
							"@id": "http://bnf.nice.org.uk/interaction/chlorpromazine#bnf_i1557280698461_message_0",
							"hasDitaContent": {
								"@type": "rdf:XMLLiteral",
								"@value": "<p otherprops=\"Severe\" outputclass=\"int-message\">\n  <ph otherprops=\"dexamethasone\" outputclass=\"int-drug\">Dexamethasone</ph> <ph outputclass=\"int-effectQualifier\">is predicted to</ph> <ph outputclass=\"int-effect\">cause</ph> <ph outputclass=\"int-parameter\">hypokalaemia (potentially increasing the risk of torsade de pointes) when given with</ph> <ph otherprops=\"chlorpromazine\" outputclass=\"int-heading-drug\">chlorpromazine</ph>. <ph outputclass=\"int-action\">Manufacturer makes no recommendation</ph>.  </p>"
							},
							"hasEvidence": "Theoretical",
							"hasImportance": "Severe",
							"hasOrder": "1",
							"hasTextContent": "Dexamethasone   is predicted to   cause   hypokalaemia (potentially increasing the risk of torsade de pointes) when given with   chlorpromazine .  Manufacturer makes no recommendation .    \n\n"
						}
					],
					"hasOrder": "90",
					"hasTitle": {
						"@type": "rdf:XMLLiteral",
						"@value": "<title>Dexamethasone</title>"
					}
				},
				{
					"@id": "http://bnf.nice.org.uk/interaction/chlorpromazine#bnf_i1557280698462",
					"hasMessage": [
						{
							"@id": "http://bnf.nice.org.uk/interaction/chlorpromazine#bnf_i1557280698462_message_0",
							"hasDitaContent": {
								"@type": "rdf:XMLLiteral",
								"@value": "<p otherprops=\"Moderate\" outputclass=\"int-message\">\n  <ph otherprops=\"chlorpromazine\" outputclass=\"int-heading-drug\">Chlorpromazine</ph> <ph outputclass=\"int-effectQualifier\">is predicted to</ph> <ph outputclass=\"int-effect\">decrease</ph> <ph outputclass=\"int-parameter\">the effects of</ph> <ph otherprops=\"dexamfetamine\" outputclass=\"int-drug\">dexamfetamine</ph> and <ph otherprops=\"dexamfetamine\" outputclass=\"int-drug\">dexamfetamine</ph> <ph outputclass=\"int-effectQualifier\">is predicted to</ph> <ph outputclass=\"int-effect\">decrease</ph> <ph outputclass=\"int-parameter\">the effects of</ph> <ph otherprops=\"chlorpromazine\" outputclass=\"int-heading-drug\">chlorpromazine</ph>. <ph outputclass=\"int-action\">Manufacturer makes no recommendation</ph>.  </p>"
							},
							"hasEvidence": "Study",
							"hasImportance": "Moderate",
							"hasOrder": "1",
							"hasTextContent": "Chlorpromazine   is predicted to   decrease   the effects of   dexamfetamine  and  dexamfetamine   is predicted to   decrease   the effects of   chlorpromazine .  Manufacturer makes no recommendation .    \n\n"
						}
					],
					"hasOrder": "91",
					"hasTitle": {
						"@type": "rdf:XMLLiteral",
						"@value": "<title>Dexamfetamine</title>"
					}
				},
				{
					"@id": "http://bnf.nice.org.uk/interaction/chlorpromazine#bnf_i1557280698463",
					"hasMessage": [
						{
							"@id": "http://bnf.nice.org.uk/interaction/chlorpromazine#bnf_i1557280698463_message_0",
							"hasDitaContent": {
								"@type": "rdf:XMLLiteral",
								"@value": "<p otherprops=\"Normal\" outputclass=\"int-message\">Both <ph otherprops=\"chlorpromazine\" outputclass=\"int-heading-drug\">chlorpromazine</ph> and <ph otherprops=\"dexmedetomidine\" outputclass=\"int-drug\">dexmedetomidine</ph> can have CNS depressant effects, which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in <xref format=\"dita\" href=\"guidance/guidance-on-prescribing.xml\" type=\"interaction\" rel=\"guidance\" bnfid=\"PHP97234\">Guidance on Prescribing</xref>).</p>"
							},
							"hasEvidence": "NotSet",
							"hasImportance": "NotSet",
							"hasOrder": "1",
							"hasTextContent": "Both  chlorpromazine  and  dexmedetomidine  can have CNS depressant effects, which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in  Guidance on Prescribing ). \n\n"
						}
					],
					"hasOrder": "92",
					"hasTitle": {
						"@type": "rdf:XMLLiteral",
						"@value": "<title>Dexmedetomidine</title>"
					}
				},
				{
					"@id": "http://bnf.nice.org.uk/interaction/chlorpromazine#bnf_i1557280698464",
					"hasMessage": [
						{
							"@id": "http://bnf.nice.org.uk/interaction/chlorpromazine#bnf_i1557280698464_message_0",
							"hasDitaContent": {
								"@type": "rdf:XMLLiteral",
								"@value": "<p otherprops=\"Normal\" outputclass=\"int-message\">Both <ph otherprops=\"chlorpromazine\" outputclass=\"int-heading-drug\">chlorpromazine</ph> and <ph otherprops=\"diamorphine\" outputclass=\"int-drug\">diamorphine</ph> can have CNS depressant effects, which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in <xref format=\"dita\" href=\"guidance/guidance-on-prescribing.xml\" type=\"interaction\" rel=\"guidance\" bnfid=\"PHP97234\">Guidance on Prescribing</xref>).</p>"
							},
							"hasEvidence": "NotSet",
							"hasImportance": "NotSet",
							"hasOrder": "1",
							"hasTextContent": "Both  chlorpromazine  and  diamorphine  can have CNS depressant effects, which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in  Guidance on Prescribing ). \n\n"
						}
					],
					"hasOrder": "93",
					"hasTitle": {
						"@type": "rdf:XMLLiteral",
						"@value": "<title>Diamorphine</title>"
					}
				},
				{
					"@id": "http://bnf.nice.org.uk/interaction/chlorpromazine#bnf_i1557280698465",
					"hasMessage": [
						{
							"@id": "http://bnf.nice.org.uk/interaction/chlorpromazine#bnf_i1557280698465_message_0",
							"hasDitaContent": {
								"@type": "rdf:XMLLiteral",
								"@value": "<p otherprops=\"Normal\" outputclass=\"int-message\">Both <ph otherprops=\"chlorpromazine\" outputclass=\"int-heading-drug\">chlorpromazine</ph> and <ph otherprops=\"diazepam\" outputclass=\"int-drug\">diazepam</ph> can have CNS depressant effects, which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in <xref format=\"dita\" href=\"guidance/guidance-on-prescribing.xml\" type=\"interaction\" rel=\"guidance\" bnfid=\"PHP97234\">Guidance on Prescribing</xref>).</p>"
							},
							"hasEvidence": "NotSet",
							"hasImportance": "NotSet",
							"hasOrder": "1",
							"hasTextContent": "Both  chlorpromazine  and  diazepam  can have CNS depressant effects, which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in  Guidance on Prescribing ). \n\n"
						}
					],
					"hasOrder": "94",
					"hasTitle": {
						"@type": "rdf:XMLLiteral",
						"@value": "<title>Diazepam</title>"
					}
				},
				{
					"@id": "http://bnf.nice.org.uk/interaction/chlorpromazine#bnf_i1557280698466",
					"hasMessage": [
						{
							"@id": "http://bnf.nice.org.uk/interaction/chlorpromazine#bnf_i1557280698466_message_0",
							"hasDitaContent": {
								"@type": "rdf:XMLLiteral",
								"@value": "<p otherprops=\"Normal\" outputclass=\"int-message\">Both <ph otherprops=\"chlorpromazine\" outputclass=\"int-heading-drug\">chlorpromazine</ph> and <ph otherprops=\"diazoxide\" outputclass=\"int-drug\">diazoxide</ph> can increase the risk of hypotension.</p>"
							},
							"hasEvidence": "NotSet",
							"hasImportance": "NotSet",
							"hasOrder": "1",
							"hasTextContent": "Both  chlorpromazine  and  diazoxide  can increase the risk of hypotension. \n\n"
						}
					],
					"hasOrder": "95",
					"hasTitle": {
						"@type": "rdf:XMLLiteral",
						"@value": "<title>Diazoxide</title>"
					}
				},
				{
					"@id": "http://bnf.nice.org.uk/interaction/chlorpromazine#bnf_i1557280698467",
					"hasMessage": [
						{
							"@id": "http://bnf.nice.org.uk/interaction/chlorpromazine#bnf_i1557280698467_message_0",
							"hasDitaContent": {
								"@type": "rdf:XMLLiteral",
								"@value": "<p otherprops=\"Normal\" outputclass=\"int-message\">Both <ph otherprops=\"chlorpromazine\" outputclass=\"int-heading-drug\">chlorpromazine</ph> and <ph otherprops=\"dicycloverine\" outputclass=\"int-drug\">dicycloverine</ph> can cause antimuscarinic effects.</p>"
							},
							"hasEvidence": "NotSet",
							"hasImportance": "NotSet",
							"hasOrder": "1",
							"hasTextContent": "Both  chlorpromazine  and  dicycloverine  can cause antimuscarinic effects. \n\n"
						}
					],
					"hasOrder": "96",
					"hasTitle": {
						"@type": "rdf:XMLLiteral",
						"@value": "<title>Dicycloverine</title>"
					}
				},
				{
					"@id": "http://bnf.nice.org.uk/interaction/chlorpromazine#bnf_i1557280698468",
					"hasMessage": [
						{
							"@id": "http://bnf.nice.org.uk/interaction/chlorpromazine#bnf_i1557280698468_message_0",
							"hasDitaContent": {
								"@type": "rdf:XMLLiteral",
								"@value": "<p otherprops=\"Normal\" outputclass=\"int-message\">Both <ph otherprops=\"chlorpromazine\" outputclass=\"int-heading-drug\">chlorpromazine</ph> and <ph otherprops=\"dihydrocodeine\" outputclass=\"int-drug\">dihydrocodeine</ph> can have CNS depressant effects, which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in <xref format=\"dita\" href=\"guidance/guidance-on-prescribing.xml\" type=\"interaction\" rel=\"guidance\" bnfid=\"PHP97234\">Guidance on Prescribing</xref>).</p>"
							},
							"hasEvidence": "NotSet",
							"hasImportance": "NotSet",
							"hasOrder": "1",
							"hasTextContent": "Both  chlorpromazine  and  dihydrocodeine  can have CNS depressant effects, which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in  Guidance on Prescribing ). \n\n"
						}
					],
					"hasOrder": "97",
					"hasTitle": {
						"@type": "rdf:XMLLiteral",
						"@value": "<title>Dihydrocodeine</title>"
					}
				},
				{
					"@id": "http://bnf.nice.org.uk/interaction/chlorpromazine#bnf_i1557280698469",
					"hasMessage": [
						{
							"@id": "http://bnf.nice.org.uk/interaction/chlorpromazine#bnf_i1557280698469_message_0",
							"hasDitaContent": {
								"@type": "rdf:XMLLiteral",
								"@value": "<p otherprops=\"Normal\" outputclass=\"int-message\">Both <ph otherprops=\"chlorpromazine\" outputclass=\"int-heading-drug\">chlorpromazine</ph> and <ph otherprops=\"diltiazem\" outputclass=\"int-drug\">diltiazem</ph> can increase the risk of hypotension.</p>"
							},
							"hasEvidence": "NotSet",
							"hasImportance": "NotSet",
							"hasOrder": "1",
							"hasTextContent": "Both  chlorpromazine  and  diltiazem  can increase the risk of hypotension. \n\n"
						}
					],
					"hasOrder": "98",
					"hasTitle": {
						"@type": "rdf:XMLLiteral",
						"@value": "<title>Diltiazem</title>"
					}
				},
				{
					"@id": "http://bnf.nice.org.uk/interaction/chlorpromazine#bnf_i1557280698470",
					"hasMessage": [
						{
							"@id": "http://bnf.nice.org.uk/interaction/chlorpromazine#bnf_i1557280698470_message_0",
							"hasDitaContent": {
								"@type": "rdf:XMLLiteral",
								"@value": "<p otherprops=\"Normal\" outputclass=\"int-message\">Both <ph otherprops=\"chlorpromazine\" outputclass=\"int-heading-drug\">chlorpromazine</ph> and <ph otherprops=\"dimenhydrinate\" outputclass=\"int-drug\">dimenhydrinate</ph> can cause antimuscarinic effects.</p>"
							},
							"hasEvidence": "NotSet",
							"hasImportance": "NotSet",
							"hasOrder": "1",
							"hasTextContent": "Both  chlorpromazine  and  dimenhydrinate  can cause antimuscarinic effects. \n\n"
						}
					],
					"hasOrder": "99",
					"hasTitle": {
						"@type": "rdf:XMLLiteral",
						"@value": "<title>Dimenhydrinate</title>"
					}
				},
				{
					"@id": "http://bnf.nice.org.uk/interaction/chlorpromazine#bnf_i1557280698471",
					"hasMessage": [
						{
							"@id": "http://bnf.nice.org.uk/interaction/chlorpromazine#bnf_i1557280698471_message_0",
							"hasDitaContent": {
								"@type": "rdf:XMLLiteral",
								"@value": "<p otherprops=\"Normal\" outputclass=\"int-message\">Both <ph otherprops=\"chlorpromazine\" outputclass=\"int-heading-drug\">chlorpromazine</ph> and <ph otherprops=\"dipipanone\" outputclass=\"int-drug\">dipipanone</ph> can have CNS depressant effects, which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in <xref format=\"dita\" href=\"guidance/guidance-on-prescribing.xml\" type=\"interaction\" rel=\"guidance\" bnfid=\"PHP97234\">Guidance on Prescribing</xref>).</p>"
							},
							"hasEvidence": "NotSet",
							"hasImportance": "NotSet",
							"hasOrder": "1",
							"hasTextContent": "Both  chlorpromazine  and  dipipanone  can have CNS depressant effects, which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in  Guidance on Prescribing ). \n\n"
						}
					],
					"hasOrder": "100",
					"hasTitle": {
						"@type": "rdf:XMLLiteral",
						"@value": "<title>Dipipanone</title>"
					}
				},
				{
					"@id": "http://bnf.nice.org.uk/interaction/chlorpromazine#bnf_i1557280698472",
					"hasMessage": [
						{
							"@id": "http://bnf.nice.org.uk/interaction/chlorpromazine#bnf_i1557280698472_message_0",
							"hasDitaContent": {
								"@type": "rdf:XMLLiteral",
								"@value": "<p otherprops=\"Normal\" outputclass=\"int-message\">Both <ph otherprops=\"chlorpromazine\" outputclass=\"int-heading-drug\">chlorpromazine</ph> and <ph otherprops=\"dipyridamole\" outputclass=\"int-drug\">dipyridamole</ph> can increase the risk of hypotension.</p>"
							},
							"hasEvidence": "NotSet",
							"hasImportance": "NotSet",
							"hasOrder": "1",
							"hasTextContent": "Both  chlorpromazine  and  dipyridamole  can increase the risk of hypotension. \n\n"
						}
					],
					"hasOrder": "101",
					"hasTitle": {
						"@type": "rdf:XMLLiteral",
						"@value": "<title>Dipyridamole</title>"
					}
				},
				{
					"@id": "http://bnf.nice.org.uk/interaction/chlorpromazine#bnf_i1557280698473",
					"hasMessage": [
						{
							"@id": "http://bnf.nice.org.uk/interaction/chlorpromazine#bnf_i1557280698473_message_0",
							"hasDitaContent": {
								"@type": "rdf:XMLLiteral",
								"@value": "<p otherprops=\"Severe\" outputclass=\"int-message\">Both <ph otherprops=\"chlorpromazine\" outputclass=\"int-heading-drug\">chlorpromazine</ph> and <ph otherprops=\"disopyramide\" outputclass=\"int-drug\">disopyramide</ph> prolong the QT interval. Most manufacturers advise avoiding the use of two or more drugs that are associated with QT prolongation. Increasing age, female sex, cardiac disease, and some metabolic disturbances (notably hypokalaemia) predispose to QT prolongation. </p>"
							},
							"hasEvidence": "NotSet",
							"hasImportance": "Severe",
							"hasOrder": "1",
							"hasTextContent": "Both  chlorpromazine  and  disopyramide  prolong the QT interval. Most manufacturers advise avoiding the use of two or more drugs that are associated with QT prolongation. Increasing age, female sex, cardiac disease, and some metabolic disturbances (notably hypokalaemia) predispose to QT prolongation.  \n\n"
						},
						{
							"@id": "http://bnf.nice.org.uk/interaction/chlorpromazine#bnf_i1557280698473_message_1",
							"hasDitaContent": {
								"@type": "rdf:XMLLiteral",
								"@value": "<p otherprops=\"Normal\" outputclass=\"int-message\">Both <ph otherprops=\"chlorpromazine\" outputclass=\"int-heading-drug\">chlorpromazine</ph> and <ph otherprops=\"disopyramide\" outputclass=\"int-drug\">disopyramide</ph> can cause antimuscarinic effects.</p>"
							},
							"hasEvidence": "NotSet",
							"hasImportance": "NotSet",
							"hasOrder": "2",
							"hasTextContent": "Both  chlorpromazine  and  disopyramide  can cause antimuscarinic effects. \n\n"
						}
					],
					"hasOrder": "102",
					"hasTitle": {
						"@type": "rdf:XMLLiteral",
						"@value": "<title>Disopyramide</title>"
					}
				},
				{
					"@id": "http://bnf.nice.org.uk/interaction/chlorpromazine#bnf_i1557280698474",
					"hasMessage": [
						{
							"@id": "http://bnf.nice.org.uk/interaction/chlorpromazine#bnf_i1557280698474_message_0",
							"hasDitaContent": {
								"@type": "rdf:XMLLiteral",
								"@value": "<p otherprops=\"Severe\" outputclass=\"int-message\">\n  <ph otherprops=\"domperidone\" outputclass=\"int-drug\">Domperidone</ph> <ph outputclass=\"int-effect\">increases</ph> <ph outputclass=\"int-parameter\">the risk of QT-prolongation when given with</ph> <ph otherprops=\"chlorpromazine\" outputclass=\"int-heading-drug\">chlorpromazine</ph>. <ph outputclass=\"int-action\">Manufacturer advises avoid</ph>.  </p>"
							},
							"hasEvidence": "Theoretical",
							"hasImportance": "Severe",
							"hasOrder": "1",
							"hasTextContent": "Domperidone   increases   the risk of QT-prolongation when given with   chlorpromazine .  Manufacturer advises avoid .    \n\n"
						}
					],
					"hasOrder": "103",
					"hasTitle": {
						"@type": "rdf:XMLLiteral",
						"@value": "<title>Domperidone</title>"
					}
				},
				{
					"@id": "http://bnf.nice.org.uk/interaction/chlorpromazine#bnf_i1557280698475",
					"hasMessage": [
						{
							"@id": "http://bnf.nice.org.uk/interaction/chlorpromazine#bnf_i1557280698475_message_0",
							"hasDitaContent": {
								"@type": "rdf:XMLLiteral",
								"@value": "<p otherprops=\"Normal\" outputclass=\"int-message\">Both <ph otherprops=\"chlorpromazine\" outputclass=\"int-heading-drug\">chlorpromazine</ph> and <ph otherprops=\"dosulepin\" outputclass=\"int-drug\">dosulepin</ph> can increase the risk of hypotension.</p>"
							},
							"hasEvidence": "NotSet",
							"hasImportance": "NotSet",
							"hasOrder": "1",
							"hasTextContent": "Both  chlorpromazine  and  dosulepin  can increase the risk of hypotension. \n\n"
						},
						{
							"@id": "http://bnf.nice.org.uk/interaction/chlorpromazine#bnf_i1557280698475_message_1",
							"hasDitaContent": {
								"@type": "rdf:XMLLiteral",
								"@value": "<p otherprops=\"Normal\" outputclass=\"int-message\">Both <ph otherprops=\"chlorpromazine\" outputclass=\"int-heading-drug\">chlorpromazine</ph> and <ph otherprops=\"dosulepin\" outputclass=\"int-drug\">dosulepin</ph> can cause antimuscarinic effects.</p>"
							},
							"hasEvidence": "NotSet",
							"hasImportance": "NotSet",
							"hasOrder": "2",
							"hasTextContent": "Both  chlorpromazine  and  dosulepin  can cause antimuscarinic effects. \n\n"
						}
					],
					"hasOrder": "104",
					"hasTitle": {
						"@type": "rdf:XMLLiteral",
						"@value": "<title>Dosulepin</title>"
					}
				},
				{
					"@id": "http://bnf.nice.org.uk/interaction/chlorpromazine#bnf_i1557280698476",
					"hasMessage": [
						{
							"@id": "http://bnf.nice.org.uk/interaction/chlorpromazine#bnf_i1557280698476_message_0",
							"hasDitaContent": {
								"@type": "rdf:XMLLiteral",
								"@value": "<p otherprops=\"Normal\" outputclass=\"int-message\">Both <ph otherprops=\"chlorpromazine\" outputclass=\"int-heading-drug\">chlorpromazine</ph> and <ph otherprops=\"doxazosin\" outputclass=\"int-drug\">doxazosin</ph> can increase the risk of hypotension.</p>"
							},
							"hasEvidence": "NotSet",
							"hasImportance": "NotSet",
							"hasOrder": "1",
							"hasTextContent": "Both  chlorpromazine  and  doxazosin  can increase the risk of hypotension. \n\n"
						}
					],
					"hasOrder": "105",
					"hasTitle": {
						"@type": "rdf:XMLLiteral",
						"@value": "<title>Doxazosin</title>"
					}
				},
				{
					"@id": "http://bnf.nice.org.uk/interaction/chlorpromazine#bnf_i1557280698477",
					"hasMessage": [
						{
							"@id": "http://bnf.nice.org.uk/interaction/chlorpromazine#bnf_i1557280698477_message_0",
							"hasDitaContent": {
								"@type": "rdf:XMLLiteral",
								"@value": "<p otherprops=\"Normal\" outputclass=\"int-message\">Both <ph otherprops=\"chlorpromazine\" outputclass=\"int-heading-drug\">chlorpromazine</ph> and <ph otherprops=\"doxepin\" outputclass=\"int-drug\">doxepin</ph> can increase the risk of hypotension.</p>"
							},
							"hasEvidence": "NotSet",
							"hasImportance": "NotSet",
							"hasOrder": "1",
							"hasTextContent": "Both  chlorpromazine  and  doxepin  can increase the risk of hypotension. \n\n"
						},
						{
							"@id": "http://bnf.nice.org.uk/interaction/chlorpromazine#bnf_i1557280698477_message_1",
							"hasDitaContent": {
								"@type": "rdf:XMLLiteral",
								"@value": "<p otherprops=\"Normal\" outputclass=\"int-message\">Both <ph otherprops=\"chlorpromazine\" outputclass=\"int-heading-drug\">chlorpromazine</ph> and <ph otherprops=\"doxepin\" outputclass=\"int-drug\">doxepin</ph> can cause antimuscarinic effects.</p>"
							},
							"hasEvidence": "NotSet",
							"hasImportance": "NotSet",
							"hasOrder": "2",
							"hasTextContent": "Both  chlorpromazine  and  doxepin  can cause antimuscarinic effects. \n\n"
						}
					],
					"hasOrder": "106",
					"hasTitle": {
						"@type": "rdf:XMLLiteral",
						"@value": "<title>Doxepin</title>"
					}
				},
				{
					"@id": "http://bnf.nice.org.uk/interaction/chlorpromazine#bnf_i1557280698478",
					"hasMessage": [
						{
							"@id": "http://bnf.nice.org.uk/interaction/chlorpromazine#bnf_i1557280698478_message_0",
							"hasDitaContent": {
								"@type": "rdf:XMLLiteral",
								"@value": "<p otherprops=\"Severe\" outputclass=\"int-message\">Both <ph otherprops=\"chlorpromazine\" outputclass=\"int-heading-drug\">chlorpromazine</ph> and <ph otherprops=\"dronedarone\" outputclass=\"int-drug\">dronedarone</ph> prolong the QT interval. Most manufacturers advise avoiding the use of two or more drugs that are associated with QT prolongation. Increasing age, female sex, cardiac disease, and some metabolic disturbances (notably hypokalaemia) predispose to QT prolongation. </p>"
							},
							"hasEvidence": "NotSet",
							"hasImportance": "Severe",
							"hasOrder": "1",
							"hasTextContent": "Both  chlorpromazine  and  dronedarone  prolong the QT interval. Most manufacturers advise avoiding the use of two or more drugs that are associated with QT prolongation. Increasing age, female sex, cardiac disease, and some metabolic disturbances (notably hypokalaemia) predispose to QT prolongation.  \n\n"
						}
					],
					"hasOrder": "107",
					"hasTitle": {
						"@type": "rdf:XMLLiteral",
						"@value": "<title>Dronedarone</title>"
					}
				},
				{
					"@id": "http://bnf.nice.org.uk/interaction/chlorpromazine#bnf_i1557280698479",
					"hasMessage": [
						{
							"@id": "http://bnf.nice.org.uk/interaction/chlorpromazine#bnf_i1557280698479_message_0",
							"hasDitaContent": {
								"@type": "rdf:XMLLiteral",
								"@value": "<p otherprops=\"Normal\" outputclass=\"int-message\">Both <ph otherprops=\"chlorpromazine\" outputclass=\"int-heading-drug\">chlorpromazine</ph> and <ph otherprops=\"droperidol\" outputclass=\"int-drug\">droperidol</ph> can increase the risk of hypotension.</p>"
							},
							"hasEvidence": "NotSet",
							"hasImportance": "NotSet",
							"hasOrder": "1",
							"hasTextContent": "Both  chlorpromazine  and  droperidol  can increase the risk of hypotension. \n\n"
						},
						{
							"@id": "http://bnf.nice.org.uk/interaction/chlorpromazine#bnf_i1557280698479_message_1",
							"hasDitaContent": {
								"@type": "rdf:XMLLiteral",
								"@value": "<p otherprops=\"Severe\" outputclass=\"int-message\">Both <ph otherprops=\"chlorpromazine\" outputclass=\"int-heading-drug\">chlorpromazine</ph> and <ph otherprops=\"droperidol\" outputclass=\"int-drug\">droperidol</ph> prolong the QT interval. Most manufacturers advise avoiding the use of two or more drugs that are associated with QT prolongation. Increasing age, female sex, cardiac disease, and some metabolic disturbances (notably hypokalaemia) predispose to QT prolongation. </p>"
							},
							"hasEvidence": "NotSet",
							"hasImportance": "Severe",
							"hasOrder": "2",
							"hasTextContent": "Both  chlorpromazine  and  droperidol  prolong the QT interval. Most manufacturers advise avoiding the use of two or more drugs that are associated with QT prolongation. Increasing age, female sex, cardiac disease, and some metabolic disturbances (notably hypokalaemia) predispose to QT prolongation.  \n\n"
						},
						{
							"@id": "http://bnf.nice.org.uk/interaction/chlorpromazine#bnf_i1557280698479_message_2",
							"hasDitaContent": {
								"@type": "rdf:XMLLiteral",
								"@value": "<p otherprops=\"Normal\" outputclass=\"int-message\">Both <ph otherprops=\"chlorpromazine\" outputclass=\"int-heading-drug\">chlorpromazine</ph> and <ph otherprops=\"droperidol\" outputclass=\"int-drug\">droperidol</ph> can have CNS depressant effects, which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in <xref format=\"dita\" href=\"guidance/guidance-on-prescribing.xml\" type=\"interaction\" rel=\"guidance\" bnfid=\"PHP97234\">Guidance on Prescribing</xref>).</p>"
							},
							"hasEvidence": "NotSet",
							"hasImportance": "NotSet",
							"hasOrder": "3",
							"hasTextContent": "Both  chlorpromazine  and  droperidol  can have CNS depressant effects, which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in  Guidance on Prescribing ). \n\n"
						}
					],
					"hasOrder": "108",
					"hasTitle": {
						"@type": "rdf:XMLLiteral",
						"@value": "<title>Droperidol</title>"
					}
				},
				{
					"@id": "http://bnf.nice.org.uk/interaction/chlorpromazine#bnf_i1557280698480",
					"hasMessage": [
						{
							"@id": "http://bnf.nice.org.uk/interaction/chlorpromazine#bnf_i1557280698480_message_0",
							"hasDitaContent": {
								"@type": "rdf:XMLLiteral",
								"@value": "<p otherprops=\"Severe\" outputclass=\"int-message\">Both <ph otherprops=\"chlorpromazine\" outputclass=\"int-heading-drug\">chlorpromazine</ph> and <ph otherprops=\"efavirenz\" outputclass=\"int-drug\">efavirenz</ph> prolong the QT interval. Most manufacturers advise avoiding the use of two or more drugs that are associated with QT prolongation. Increasing age, female sex, cardiac disease, and some metabolic disturbances (notably hypokalaemia) predispose to QT prolongation. </p>"
							},
							"hasEvidence": "NotSet",
							"hasImportance": "Severe",
							"hasOrder": "1",
							"hasTextContent": "Both  chlorpromazine  and  efavirenz  prolong the QT interval. Most manufacturers advise avoiding the use of two or more drugs that are associated with QT prolongation. Increasing age, female sex, cardiac disease, and some metabolic disturbances (notably hypokalaemia) predispose to QT prolongation.  \n\n"
						}
					],
					"hasOrder": "109",
					"hasTitle": {
						"@type": "rdf:XMLLiteral",
						"@value": "<title>Efavirenz</title>"
					}
				},
				{
					"@id": "http://bnf.nice.org.uk/interaction/chlorpromazine#bnf_i1557280698481",
					"hasMessage": [
						{
							"@id": "http://bnf.nice.org.uk/interaction/chlorpromazine#bnf_i1557280698481_message_0",
							"hasDitaContent": {
								"@type": "rdf:XMLLiteral",
								"@value": "<p otherprops=\"Normal\" outputclass=\"int-message\">Both <ph otherprops=\"chlorpromazine\" outputclass=\"int-heading-drug\">chlorpromazine</ph> and <ph otherprops=\"empagliflozin\" outputclass=\"int-drug\">empagliflozin</ph> can increase the risk of hypotension.</p>"
							},
							"hasEvidence": "NotSet",
							"hasImportance": "NotSet",
							"hasOrder": "1",
							"hasTextContent": "Both  chlorpromazine  and  empagliflozin  can increase the risk of hypotension. \n\n"
						}
					],
					"hasOrder": "110",
					"hasTitle": {
						"@type": "rdf:XMLLiteral",
						"@value": "<title>Empagliflozin</title>"
					}
				},
				{
					"@id": "http://bnf.nice.org.uk/interaction/chlorpromazine#bnf_i1557280698482",
					"hasMessage": [
						{
							"@id": "http://bnf.nice.org.uk/interaction/chlorpromazine#bnf_i1557280698482_message_0",
							"hasDitaContent": {
								"@type": "rdf:XMLLiteral",
								"@value": "<p otherprops=\"Normal\" outputclass=\"int-message\">Both <ph otherprops=\"chlorpromazine\" outputclass=\"int-heading-drug\">chlorpromazine</ph> and <ph otherprops=\"enalapril\" outputclass=\"int-drug\">enalapril</ph> can increase the risk of hypotension.</p>"
							},
							"hasEvidence": "NotSet",
							"hasImportance": "NotSet",
							"hasOrder": "1",
							"hasTextContent": "Both  chlorpromazine  and  enalapril  can increase the risk of hypotension. \n\n"
						}
					],
					"hasOrder": "111",
					"hasTitle": {
						"@type": "rdf:XMLLiteral",
						"@value": "<title>Enalapril</title>"
					}
				},
				{
					"@id": "http://bnf.nice.org.uk/interaction/chlorpromazine#bnf_i1557280698483",
					"hasMessage": [
						{
							"@id": "http://bnf.nice.org.uk/interaction/chlorpromazine#bnf_i1557280698483_message_0",
							"hasDitaContent": {
								"@type": "rdf:XMLLiteral",
								"@value": "<p otherprops=\"Severe\" outputclass=\"int-message\">Both <ph otherprops=\"chlorpromazine\" outputclass=\"int-heading-drug\">chlorpromazine</ph> and <ph otherprops=\"encorafenib\" outputclass=\"int-drug\">encorafenib</ph> prolong the QT interval. Most manufacturers advise avoiding the use of two or more drugs that are associated with QT prolongation. Increasing age, female sex, cardiac disease, and some metabolic disturbances (notably hypokalaemia) predispose to QT prolongation. </p>"
							},
							"hasEvidence": "NotSet",
							"hasImportance": "Severe",
							"hasOrder": "1",
							"hasTextContent": "Both  chlorpromazine  and  encorafenib  prolong the QT interval. Most manufacturers advise avoiding the use of two or more drugs that are associated with QT prolongation. Increasing age, female sex, cardiac disease, and some metabolic disturbances (notably hypokalaemia) predispose to QT prolongation.  \n\n"
						}
					],
					"hasOrder": "112",
					"hasTitle": {
						"@type": "rdf:XMLLiteral",
						"@value": "<title>Encorafenib</title>"
					}
				},
				{
					"@id": "http://bnf.nice.org.uk/interaction/chlorpromazine#bnf_i1557280698484",
					"hasMessage": [
						{
							"@id": "http://bnf.nice.org.uk/interaction/chlorpromazine#bnf_i1557280698484_message_0",
							"hasDitaContent": {
								"@type": "rdf:XMLLiteral",
								"@value": "<p otherprops=\"Normal\" outputclass=\"int-message\">Both <ph otherprops=\"chlorpromazine\" outputclass=\"int-heading-drug\">chlorpromazine</ph> and <ph otherprops=\"eplerenone\" outputclass=\"int-drug\">eplerenone</ph> can increase the risk of hypotension.</p>"
							},
							"hasEvidence": "NotSet",
							"hasImportance": "NotSet",
							"hasOrder": "1",
							"hasTextContent": "Both  chlorpromazine  and  eplerenone  can increase the risk of hypotension. \n\n"
						}
					],
					"hasOrder": "113",
					"hasTitle": {
						"@type": "rdf:XMLLiteral",
						"@value": "<title>Eplerenone</title>"
					}
				},
				{
					"@id": "http://bnf.nice.org.uk/interaction/chlorpromazine#bnf_i1557280698485",
					"hasMessage": [
						{
							"@id": "http://bnf.nice.org.uk/interaction/chlorpromazine#bnf_i1557280698485_message_0",
							"hasDitaContent": {
								"@type": "rdf:XMLLiteral",
								"@value": "<p otherprops=\"Normal\" outputclass=\"int-message\">Both <ph otherprops=\"chlorpromazine\" outputclass=\"int-heading-drug\">chlorpromazine</ph> and <ph otherprops=\"eprosartan\" outputclass=\"int-drug\">eprosartan</ph> can increase the risk of hypotension.</p>"
							},
							"hasEvidence": "NotSet",
							"hasImportance": "NotSet",
							"hasOrder": "1",
							"hasTextContent": "Both  chlorpromazine  and  eprosartan  can increase the risk of hypotension. \n\n"
						}
					],
					"hasOrder": "114",
					"hasTitle": {
						"@type": "rdf:XMLLiteral",
						"@value": "<title>Eprosartan</title>"
					}
				},
				{
					"@id": "http://bnf.nice.org.uk/interaction/chlorpromazine#bnf_i1557280698486",
					"hasMessage": [
						{
							"@id": "http://bnf.nice.org.uk/interaction/chlorpromazine#bnf_i1557280698486_message_0",
							"hasDitaContent": {
								"@type": "rdf:XMLLiteral",
								"@value": "<p otherprops=\"Severe\" outputclass=\"int-message\">Both <ph otherprops=\"chlorpromazine\" outputclass=\"int-heading-drug\">chlorpromazine</ph> and <ph otherprops=\"eribulin\" outputclass=\"int-drug\">eribulin</ph> prolong the QT interval. Most manufacturers advise avoiding the use of two or more drugs that are associated with QT prolongation. Increasing age, female sex, cardiac disease, and some metabolic disturbances (notably hypokalaemia) predispose to QT prolongation. </p>"
							},
							"hasEvidence": "NotSet",
							"hasImportance": "Severe",
							"hasOrder": "1",
							"hasTextContent": "Both  chlorpromazine  and  eribulin  prolong the QT interval. Most manufacturers advise avoiding the use of two or more drugs that are associated with QT prolongation. Increasing age, female sex, cardiac disease, and some metabolic disturbances (notably hypokalaemia) predispose to QT prolongation.  \n\n"
						}
					],
					"hasOrder": "115",
					"hasTitle": {
						"@type": "rdf:XMLLiteral",
						"@value": "<title>Eribulin</title>"
					}
				},
				{
					"@id": "http://bnf.nice.org.uk/interaction/chlorpromazine#bnf_i1557280698487",
					"hasMessage": [
						{
							"@id": "http://bnf.nice.org.uk/interaction/chlorpromazine#bnf_i1557280698487_message_0",
							"hasDitaContent": {
								"@type": "rdf:XMLLiteral",
								"@value": "<p otherprops=\"Normal\" outputclass=\"int-message\">Both <ph otherprops=\"chlorpromazine\" outputclass=\"int-heading-drug\">chlorpromazine</ph> and <ph otherprops=\"ertugliflozin\" outputclass=\"int-drug\">ertugliflozin</ph> can increase the risk of hypotension.</p>"
							},
							"hasEvidence": "NotSet",
							"hasImportance": "NotSet",
							"hasOrder": "1",
							"hasTextContent": "Both  chlorpromazine  and  ertugliflozin  can increase the risk of hypotension. \n\n"
						}
					],
					"hasOrder": "116",
					"hasTitle": {
						"@type": "rdf:XMLLiteral",
						"@value": "<title>Ertugliflozin</title>"
					}
				},
				{
					"@id": "http://bnf.nice.org.uk/interaction/chlorpromazine#bnf_i1557280698488",
					"hasMessage": [
						{
							"@id": "http://bnf.nice.org.uk/interaction/chlorpromazine#bnf_i1557280698488_message_0",
							"hasDitaContent": {
								"@type": "rdf:XMLLiteral",
								"@value": "<p otherprops=\"Severe\" outputclass=\"int-message\">Both <ph otherprops=\"chlorpromazine\" outputclass=\"int-heading-drug\">chlorpromazine</ph> and <ph otherprops=\"erythromycin\" outputclass=\"int-drug\">erythromycin</ph> prolong the QT interval. Most manufacturers advise avoiding the use of two or more drugs that are associated with QT prolongation. Increasing age, female sex, cardiac disease, and some metabolic disturbances (notably hypokalaemia) predispose to QT prolongation. </p>"
							},
							"hasEvidence": "NotSet",
							"hasImportance": "Severe",
							"hasOrder": "1",
							"hasTextContent": "Both  chlorpromazine  and  erythromycin  prolong the QT interval. Most manufacturers advise avoiding the use of two or more drugs that are associated with QT prolongation. Increasing age, female sex, cardiac disease, and some metabolic disturbances (notably hypokalaemia) predispose to QT prolongation.  \n\n"
						}
					],
					"hasOrder": "117",
					"hasTitle": {
						"@type": "rdf:XMLLiteral",
						"@value": "<title>Erythromycin</title>"
					}
				},
				{
					"@id": "http://bnf.nice.org.uk/interaction/chlorpromazine#bnf_i1557280698489",
					"hasMessage": [
						{
							"@id": "http://bnf.nice.org.uk/interaction/chlorpromazine#bnf_i1557280698489_message_0",
							"hasDitaContent": {
								"@type": "rdf:XMLLiteral",
								"@value": "<p otherprops=\"Severe\" outputclass=\"int-message\">Both <ph otherprops=\"chlorpromazine\" outputclass=\"int-heading-drug\">chlorpromazine</ph> and <ph otherprops=\"escitalopram\" outputclass=\"int-drug\">escitalopram</ph> prolong the QT interval. Most manufacturers advise avoiding the use of two or more drugs that are associated with QT prolongation. Increasing age, female sex, cardiac disease, and some metabolic disturbances (notably hypokalaemia) predispose to QT prolongation. </p>"
							},
							"hasEvidence": "NotSet",
							"hasImportance": "Severe",
							"hasOrder": "1",
							"hasTextContent": "Both  chlorpromazine  and  escitalopram  prolong the QT interval. Most manufacturers advise avoiding the use of two or more drugs that are associated with QT prolongation. Increasing age, female sex, cardiac disease, and some metabolic disturbances (notably hypokalaemia) predispose to QT prolongation.  \n\n"
						}
					],
					"hasOrder": "118",
					"hasTitle": {
						"@type": "rdf:XMLLiteral",
						"@value": "<title>Escitalopram</title>"
					}
				},
				{
					"@id": "http://bnf.nice.org.uk/interaction/chlorpromazine#bnf_i1557280698490",
					"hasMessage": [
						{
							"@id": "http://bnf.nice.org.uk/interaction/chlorpromazine#bnf_i1557280698490_message_0",
							"hasDitaContent": {
								"@type": "rdf:XMLLiteral",
								"@value": "<p otherprops=\"Normal\" outputclass=\"int-message\">Both <ph otherprops=\"chlorpromazine\" outputclass=\"int-heading-drug\">chlorpromazine</ph> and <ph otherprops=\"esketamine\" outputclass=\"int-drug\">esketamine</ph> can increase the risk of hypotension.</p>"
							},
							"hasEvidence": "NotSet",
							"hasImportance": "NotSet",
							"hasOrder": "1",
							"hasTextContent": "Both  chlorpromazine  and  esketamine  can increase the risk of hypotension. \n\n"
						},
						{
							"@id": "http://bnf.nice.org.uk/interaction/chlorpromazine#bnf_i1557280698490_message_1",
							"hasDitaContent": {
								"@type": "rdf:XMLLiteral",
								"@value": "<p otherprops=\"Normal\" outputclass=\"int-message\">Both <ph otherprops=\"chlorpromazine\" outputclass=\"int-heading-drug\">chlorpromazine</ph> and <ph otherprops=\"esketamine\" outputclass=\"int-drug\">esketamine</ph> can have CNS depressant effects, which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in <xref format=\"dita\" href=\"guidance/guidance-on-prescribing.xml\" type=\"interaction\" rel=\"guidance\" bnfid=\"PHP97234\">Guidance on Prescribing</xref>).</p>"
							},
							"hasEvidence": "NotSet",
							"hasImportance": "NotSet",
							"hasOrder": "2",
							"hasTextContent": "Both  chlorpromazine  and  esketamine  can have CNS depressant effects, which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in  Guidance on Prescribing ). \n\n"
						}
					],
					"hasOrder": "119",
					"hasTitle": {
						"@type": "rdf:XMLLiteral",
						"@value": "<title>Esketamine</title>"
					}
				},
				{
					"@id": "http://bnf.nice.org.uk/interaction/chlorpromazine#bnf_i1557280698491",
					"hasMessage": [
						{
							"@id": "http://bnf.nice.org.uk/interaction/chlorpromazine#bnf_i1557280698491_message_0",
							"hasDitaContent": {
								"@type": "rdf:XMLLiteral",
								"@value": "<p otherprops=\"Normal\" outputclass=\"int-message\">Both <ph otherprops=\"chlorpromazine\" outputclass=\"int-heading-drug\">chlorpromazine</ph> and <ph otherprops=\"esmolol\" outputclass=\"int-drug\">esmolol</ph> can increase the risk of hypotension.</p>"
							},
							"hasEvidence": "NotSet",
							"hasImportance": "NotSet",
							"hasOrder": "1",
							"hasTextContent": "Both  chlorpromazine  and  esmolol  can increase the risk of hypotension. \n\n"
						}
					],
					"hasOrder": "120",
					"hasTitle": {
						"@type": "rdf:XMLLiteral",
						"@value": "<title>Esmolol</title>"
					}
				},
				{
					"@id": "http://bnf.nice.org.uk/interaction/chlorpromazine#bnf_i1557280698492",
					"hasMessage": [
						{
							"@id": "http://bnf.nice.org.uk/interaction/chlorpromazine#bnf_i1557280698492_message_0",
							"hasDitaContent": {
								"@type": "rdf:XMLLiteral",
								"@value": "<p otherprops=\"Normal\" outputclass=\"int-message\">Both <ph otherprops=\"chlorpromazine\" outputclass=\"int-heading-drug\">chlorpromazine</ph> and <ph otherprops=\"etomidate\" outputclass=\"int-drug\">etomidate</ph> can increase the risk of hypotension.</p>"
							},
							"hasEvidence": "NotSet",
							"hasImportance": "NotSet",
							"hasOrder": "1",
							"hasTextContent": "Both  chlorpromazine  and  etomidate  can increase the risk of hypotension. \n\n"
						},
						{
							"@id": "http://bnf.nice.org.uk/interaction/chlorpromazine#bnf_i1557280698492_message_1",
							"hasDitaContent": {
								"@type": "rdf:XMLLiteral",
								"@value": "<p otherprops=\"Normal\" outputclass=\"int-message\">Both <ph otherprops=\"chlorpromazine\" outputclass=\"int-heading-drug\">chlorpromazine</ph> and <ph otherprops=\"etomidate\" outputclass=\"int-drug\">etomidate</ph> can have CNS depressant effects, which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in <xref format=\"dita\" href=\"guidance/guidance-on-prescribing.xml\" type=\"interaction\" rel=\"guidance\" bnfid=\"PHP97234\">Guidance on Prescribing</xref>).</p>"
							},
							"hasEvidence": "NotSet",
							"hasImportance": "NotSet",
							"hasOrder": "2",
							"hasTextContent": "Both  chlorpromazine  and  etomidate  can have CNS depressant effects, which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in  Guidance on Prescribing ). \n\n"
						}
					],
					"hasOrder": "121",
					"hasTitle": {
						"@type": "rdf:XMLLiteral",
						"@value": "<title>Etomidate</title>"
					}
				},
				{
					"@id": "http://bnf.nice.org.uk/interaction/chlorpromazine#bnf_i1557280698493",
					"hasMessage": [
						{
							"@id": "http://bnf.nice.org.uk/interaction/chlorpromazine#bnf_i1557280698493_message_0",
							"hasDitaContent": {
								"@type": "rdf:XMLLiteral",
								"@value": "<p otherprops=\"Normal\" outputclass=\"int-message\">Both <ph otherprops=\"chlorpromazine\" outputclass=\"int-heading-drug\">chlorpromazine</ph> and <ph otherprops=\"felodipine\" outputclass=\"int-drug\">felodipine</ph> can increase the risk of hypotension.</p>"
							},
							"hasEvidence": "NotSet",
							"hasImportance": "NotSet",
							"hasOrder": "1",
							"hasTextContent": "Both  chlorpromazine  and  felodipine  can increase the risk of hypotension. \n\n"
						}
					],
					"hasOrder": "122",
					"hasTitle": {
						"@type": "rdf:XMLLiteral",
						"@value": "<title>Felodipine</title>"
					}
				},
				{
					"@id": "http://bnf.nice.org.uk/interaction/chlorpromazine#bnf_i1557280698494",
					"hasMessage": [
						{
							"@id": "http://bnf.nice.org.uk/interaction/chlorpromazine#bnf_i1557280698494_message_0",
							"hasDitaContent": {
								"@type": "rdf:XMLLiteral",
								"@value": "<p otherprops=\"Normal\" outputclass=\"int-message\">Both <ph otherprops=\"chlorpromazine\" outputclass=\"int-heading-drug\">chlorpromazine</ph> and <ph otherprops=\"fentanyl\" outputclass=\"int-drug\">fentanyl</ph> can have CNS depressant effects, which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in <xref format=\"dita\" href=\"guidance/guidance-on-prescribing.xml\" type=\"interaction\" rel=\"guidance\" bnfid=\"PHP97234\">Guidance on Prescribing</xref>).</p>"
							},
							"hasEvidence": "NotSet",
							"hasImportance": "NotSet",
							"hasOrder": "1",
							"hasTextContent": "Both  chlorpromazine  and  fentanyl  can have CNS depressant effects, which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in  Guidance on Prescribing ). \n\n"
						}
					],
					"hasOrder": "123",
					"hasTitle": {
						"@type": "rdf:XMLLiteral",
						"@value": "<title>Fentanyl</title>"
					}
				},
				{
					"@id": "http://bnf.nice.org.uk/interaction/chlorpromazine#bnf_i1557280698495",
					"hasMessage": [
						{
							"@id": "http://bnf.nice.org.uk/interaction/chlorpromazine#bnf_i1557280698495_message_0",
							"hasDitaContent": {
								"@type": "rdf:XMLLiteral",
								"@value": "<p otherprops=\"Normal\" outputclass=\"int-message\">Both <ph otherprops=\"chlorpromazine\" outputclass=\"int-heading-drug\">chlorpromazine</ph> and <ph otherprops=\"fesoterodine\" outputclass=\"int-drug\">fesoterodine</ph> can cause antimuscarinic effects.</p>"
							},
							"hasEvidence": "NotSet",
							"hasImportance": "NotSet",
							"hasOrder": "1",
							"hasTextContent": "Both  chlorpromazine  and  fesoterodine  can cause antimuscarinic effects. \n\n"
						}
					],
					"hasOrder": "124",
					"hasTitle": {
						"@type": "rdf:XMLLiteral",
						"@value": "<title>Fesoterodine</title>"
					}
				},
				{
					"@id": "http://bnf.nice.org.uk/interaction/chlorpromazine#bnf_i1557280698496",
					"hasMessage": [
						{
							"@id": "http://bnf.nice.org.uk/interaction/chlorpromazine#bnf_i1557280698496_message_0",
							"hasDitaContent": {
								"@type": "rdf:XMLLiteral",
								"@value": "<p otherprops=\"Severe\" outputclass=\"int-message\">\n  <ph otherprops=\"fingolimod\" outputclass=\"int-drug\">Fingolimod</ph> <ph outputclass=\"int-effect\">increases</ph> <ph outputclass=\"int-parameter\">the risk of QT-prolongation when given with</ph> <ph otherprops=\"chlorpromazine\" outputclass=\"int-heading-drug\">chlorpromazine</ph>. <ph outputclass=\"int-action\">Manufacturer advises avoid</ph>.  </p>"
							},
							"hasEvidence": "Theoretical",
							"hasImportance": "Severe",
							"hasOrder": "1",
							"hasTextContent": "Fingolimod   increases   the risk of QT-prolongation when given with   chlorpromazine .  Manufacturer advises avoid .    \n\n"
						}
					],
					"hasOrder": "125",
					"hasTitle": {
						"@type": "rdf:XMLLiteral",
						"@value": "<title>Fingolimod</title>"
					}
				},
				{
					"@id": "http://bnf.nice.org.uk/interaction/chlorpromazine#bnf_i1557280698497",
					"hasMessage": [
						{
							"@id": "http://bnf.nice.org.uk/interaction/chlorpromazine#bnf_i1557280698497_message_0",
							"hasDitaContent": {
								"@type": "rdf:XMLLiteral",
								"@value": "<p otherprops=\"Normal\" outputclass=\"int-message\">Both <ph otherprops=\"chlorpromazine\" outputclass=\"int-heading-drug\">chlorpromazine</ph> and <ph otherprops=\"flavoxate\" outputclass=\"int-drug\">flavoxate</ph> can cause antimuscarinic effects.</p>"
							},
							"hasEvidence": "NotSet",
							"hasImportance": "NotSet",
							"hasOrder": "1",
							"hasTextContent": "Both  chlorpromazine  and  flavoxate  can cause antimuscarinic effects. \n\n"
						}
					],
					"hasOrder": "126",
					"hasTitle": {
						"@type": "rdf:XMLLiteral",
						"@value": "<title>Flavoxate</title>"
					}
				},
				{
					"@id": "http://bnf.nice.org.uk/interaction/chlorpromazine#bnf_i1557280698498",
					"hasMessage": [
						{
							"@id": "http://bnf.nice.org.uk/interaction/chlorpromazine#bnf_i1557280698498_message_0",
							"hasDitaContent": {
								"@type": "rdf:XMLLiteral",
								"@value": "<p otherprops=\"Severe\" outputclass=\"int-message\">Both <ph otherprops=\"chlorpromazine\" outputclass=\"int-heading-drug\">chlorpromazine</ph> and <ph otherprops=\"flecainide\" outputclass=\"int-drug\">flecainide</ph> prolong the QT interval. Most manufacturers advise avoiding the use of two or more drugs that are associated with QT prolongation. Increasing age, female sex, cardiac disease, and some metabolic disturbances (notably hypokalaemia) predispose to QT prolongation. </p>"
							},
							"hasEvidence": "NotSet",
							"hasImportance": "Severe",
							"hasOrder": "1",
							"hasTextContent": "Both  chlorpromazine  and  flecainide  prolong the QT interval. Most manufacturers advise avoiding the use of two or more drugs that are associated with QT prolongation. Increasing age, female sex, cardiac disease, and some metabolic disturbances (notably hypokalaemia) predispose to QT prolongation.  \n\n"
						}
					],
					"hasOrder": "127",
					"hasTitle": {
						"@type": "rdf:XMLLiteral",
						"@value": "<title>Flecainide</title>"
					}
				},
				{
					"@id": "http://bnf.nice.org.uk/interaction/chlorpromazine#bnf_i1557280698499",
					"hasMessage": [
						{
							"@id": "http://bnf.nice.org.uk/interaction/chlorpromazine#bnf_i1557280698499_message_0",
							"hasDitaContent": {
								"@type": "rdf:XMLLiteral",
								"@value": "<p otherprops=\"Severe\" outputclass=\"int-message\">Both <ph otherprops=\"chlorpromazine\" outputclass=\"int-heading-drug\">chlorpromazine</ph> and <ph otherprops=\"fluconazole\" outputclass=\"int-drug\">fluconazole</ph> prolong the QT interval. Most manufacturers advise avoiding the use of two or more drugs that are associated with QT prolongation. Increasing age, female sex, cardiac disease, and some metabolic disturbances (notably hypokalaemia) predispose to QT prolongation. </p>"
							},
							"hasEvidence": "NotSet",
							"hasImportance": "Severe",
							"hasOrder": "1",
							"hasTextContent": "Both  chlorpromazine  and  fluconazole  prolong the QT interval. Most manufacturers advise avoiding the use of two or more drugs that are associated with QT prolongation. Increasing age, female sex, cardiac disease, and some metabolic disturbances (notably hypokalaemia) predispose to QT prolongation.  \n\n"
						}
					],
					"hasOrder": "128",
					"hasTitle": {
						"@type": "rdf:XMLLiteral",
						"@value": "<title>Fluconazole</title>"
					}
				},
				{
					"@id": "http://bnf.nice.org.uk/interaction/chlorpromazine#bnf_i1557280698500",
					"hasMessage": [
						{
							"@id": "http://bnf.nice.org.uk/interaction/chlorpromazine#bnf_i1557280698500_message_0",
							"hasDitaContent": {
								"@type": "rdf:XMLLiteral",
								"@value": "<p otherprops=\"Severe\" outputclass=\"int-message\">\n  <ph otherprops=\"fludrocortisone\" outputclass=\"int-drug\">Fludrocortisone</ph> <ph outputclass=\"int-effectQualifier\">is predicted to</ph> <ph outputclass=\"int-effect\">cause</ph> <ph outputclass=\"int-parameter\">hypokalaemia (potentially increasing the risk of torsade de pointes) when given with</ph> <ph otherprops=\"chlorpromazine\" outputclass=\"int-heading-drug\">chlorpromazine</ph>. <ph outputclass=\"int-action\">Manufacturer makes no recommendation</ph>.  </p>"
							},
							"hasEvidence": "Theoretical",
							"hasImportance": "Severe",
							"hasOrder": "1",
							"hasTextContent": "Fludrocortisone   is predicted to   cause   hypokalaemia (potentially increasing the risk of torsade de pointes) when given with   chlorpromazine .  Manufacturer makes no recommendation .    \n\n"
						}
					],
					"hasOrder": "129",
					"hasTitle": {
						"@type": "rdf:XMLLiteral",
						"@value": "<title>Fludrocortisone</title>"
					}
				},
				{
					"@id": "http://bnf.nice.org.uk/interaction/chlorpromazine#bnf_i1557280698501",
					"hasMessage": [
						{
							"@id": "http://bnf.nice.org.uk/interaction/chlorpromazine#bnf_i1557280698501_message_0",
							"hasDitaContent": {
								"@type": "rdf:XMLLiteral",
								"@value": "<p otherprops=\"Normal\" outputclass=\"int-message\">Both <ph otherprops=\"chlorpromazine\" outputclass=\"int-heading-drug\">chlorpromazine</ph> and <ph otherprops=\"flupentixol\" outputclass=\"int-drug\">flupentixol</ph> can increase the risk of hypotension.</p>"
							},
							"hasEvidence": "NotSet",
							"hasImportance": "NotSet",
							"hasOrder": "1",
							"hasTextContent": "Both  chlorpromazine  and  flupentixol  can increase the risk of hypotension. \n\n"
						},
						{
							"@id": "http://bnf.nice.org.uk/interaction/chlorpromazine#bnf_i1557280698501_message_1",
							"hasDitaContent": {
								"@type": "rdf:XMLLiteral",
								"@value": "<p otherprops=\"Normal\" outputclass=\"int-message\">Both <ph otherprops=\"chlorpromazine\" outputclass=\"int-heading-drug\">chlorpromazine</ph> and <ph otherprops=\"flupentixol\" outputclass=\"int-drug\">flupentixol</ph> can have CNS depressant effects, which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in <xref format=\"dita\" href=\"guidance/guidance-on-prescribing.xml\" type=\"interaction\" rel=\"guidance\" bnfid=\"PHP97234\">Guidance on Prescribing</xref>).</p>"
							},
							"hasEvidence": "NotSet",
							"hasImportance": "NotSet",
							"hasOrder": "2",
							"hasTextContent": "Both  chlorpromazine  and  flupentixol  can have CNS depressant effects, which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in  Guidance on Prescribing ). \n\n"
						}
					],
					"hasOrder": "130",
					"hasTitle": {
						"@type": "rdf:XMLLiteral",
						"@value": "<title>Flupentixol</title>"
					}
				},
				{
					"@id": "http://bnf.nice.org.uk/interaction/chlorpromazine#bnf_i1557280698502",
					"hasMessage": [
						{
							"@id": "http://bnf.nice.org.uk/interaction/chlorpromazine#bnf_i1557280698502_message_0",
							"hasDitaContent": {
								"@type": "rdf:XMLLiteral",
								"@value": "<p otherprops=\"Normal\" outputclass=\"int-message\">Both <ph otherprops=\"chlorpromazine\" outputclass=\"int-heading-drug\">chlorpromazine</ph> and <ph otherprops=\"flurazepam\" outputclass=\"int-drug\">flurazepam</ph> can have CNS depressant effects, which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in <xref format=\"dita\" href=\"guidance/guidance-on-prescribing.xml\" type=\"interaction\" rel=\"guidance\" bnfid=\"PHP97234\">Guidance on Prescribing</xref>).</p>"
							},
							"hasEvidence": "NotSet",
							"hasImportance": "NotSet",
							"hasOrder": "1",
							"hasTextContent": "Both  chlorpromazine  and  flurazepam  can have CNS depressant effects, which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in  Guidance on Prescribing ). \n\n"
						}
					],
					"hasOrder": "131",
					"hasTitle": {
						"@type": "rdf:XMLLiteral",
						"@value": "<title>Flurazepam</title>"
					}
				},
				{
					"@id": "http://bnf.nice.org.uk/interaction/chlorpromazine#bnf_i1557280698503",
					"hasMessage": [
						{
							"@id": "http://bnf.nice.org.uk/interaction/chlorpromazine#bnf_i1557280698503_message_0",
							"hasDitaContent": {
								"@type": "rdf:XMLLiteral",
								"@value": "<p otherprops=\"Severe\" outputclass=\"int-message\">\n  <ph otherprops=\"formoterol\" outputclass=\"int-drug\">Formoterol</ph> <ph outputclass=\"int-effectQualifier\">is predicted to</ph> <ph outputclass=\"int-effect\">cause</ph> <ph outputclass=\"int-parameter\">hypokalaemia (potentially increasing the risk of torsade de pointes) when given with</ph> <ph otherprops=\"chlorpromazine\" outputclass=\"int-heading-drug\">chlorpromazine</ph>. <ph outputclass=\"int-action\">Manufacturer makes no recommendation</ph>.  </p>"
							},
							"hasEvidence": "Theoretical",
							"hasImportance": "Severe",
							"hasOrder": "1",
							"hasTextContent": "Formoterol   is predicted to   cause   hypokalaemia (potentially increasing the risk of torsade de pointes) when given with   chlorpromazine .  Manufacturer makes no recommendation .    \n\n"
						}
					],
					"hasOrder": "132",
					"hasTitle": {
						"@type": "rdf:XMLLiteral",
						"@value": "<title>Formoterol</title>"
					}
				},
				{
					"@id": "http://bnf.nice.org.uk/interaction/chlorpromazine#bnf_i1557280698504",
					"hasMessage": [
						{
							"@id": "http://bnf.nice.org.uk/interaction/chlorpromazine#bnf_i1557280698504_message_0",
							"hasDitaContent": {
								"@type": "rdf:XMLLiteral",
								"@value": "<p otherprops=\"Normal\" outputclass=\"int-message\">Both <ph otherprops=\"chlorpromazine\" outputclass=\"int-heading-drug\">chlorpromazine</ph> and <ph otherprops=\"fosinopril\" outputclass=\"int-drug\">fosinopril</ph> can increase the risk of hypotension.</p>"
							},
							"hasEvidence": "NotSet",
							"hasImportance": "NotSet",
							"hasOrder": "1",
							"hasTextContent": "Both  chlorpromazine  and  fosinopril  can increase the risk of hypotension. \n\n"
						}
					],
					"hasOrder": "133",
					"hasTitle": {
						"@type": "rdf:XMLLiteral",
						"@value": "<title>Fosinopril</title>"
					}
				},
				{
					"@id": "http://bnf.nice.org.uk/interaction/chlorpromazine#bnf_i1557280698505",
					"hasMessage": [
						{
							"@id": "http://bnf.nice.org.uk/interaction/chlorpromazine#bnf_i1557280698505_message_0",
							"hasDitaContent": {
								"@type": "rdf:XMLLiteral",
								"@value": "<p otherprops=\"Normal\" outputclass=\"int-message\">Both <ph otherprops=\"chlorpromazine\" outputclass=\"int-heading-drug\">chlorpromazine</ph> and <ph otherprops=\"furosemide\" outputclass=\"int-drug\">furosemide</ph> can increase the risk of hypotension.</p>"
							},
							"hasEvidence": "NotSet",
							"hasImportance": "NotSet",
							"hasOrder": "1",
							"hasTextContent": "Both  chlorpromazine  and  furosemide  can increase the risk of hypotension. \n\n"
						},
						{
							"@id": "http://bnf.nice.org.uk/interaction/chlorpromazine#bnf_i1557280698505_message_1",
							"hasDitaContent": {
								"@type": "rdf:XMLLiteral",
								"@value": "<p otherprops=\"Severe\" outputclass=\"int-message\">\n  <ph otherprops=\"furosemide\" outputclass=\"int-drug\">Furosemide</ph> <ph outputclass=\"int-effectQualifier\">is predicted to</ph> <ph outputclass=\"int-effect\">cause</ph> <ph outputclass=\"int-parameter\">hypokalaemia (potentially increasing the risk of torsade de pointes) when given with</ph> <ph otherprops=\"chlorpromazine\" outputclass=\"int-heading-drug\">chlorpromazine</ph>. <ph outputclass=\"int-action\">Manufacturer makes no recommendation</ph>.  </p>"
							},
							"hasEvidence": "Theoretical",
							"hasImportance": "Severe",
							"hasOrder": "2",
							"hasTextContent": "Furosemide   is predicted to   cause   hypokalaemia (potentially increasing the risk of torsade de pointes) when given with   chlorpromazine .  Manufacturer makes no recommendation .    \n\n"
						}
					],
					"hasOrder": "134",
					"hasTitle": {
						"@type": "rdf:XMLLiteral",
						"@value": "<title>Furosemide</title>"
					}
				},
				{
					"@id": "http://bnf.nice.org.uk/interaction/chlorpromazine#bnf_i1557280698506",
					"hasMessage": [
						{
							"@id": "http://bnf.nice.org.uk/interaction/chlorpromazine#bnf_i1557280698506_message_0",
							"hasDitaContent": {
								"@type": "rdf:XMLLiteral",
								"@value": "<p otherprops=\"Normal\" outputclass=\"int-message\">Both <ph otherprops=\"chlorpromazine\" outputclass=\"int-heading-drug\">chlorpromazine</ph> and <ph otherprops=\"gabapentin\" outputclass=\"int-drug\">gabapentin</ph> can have CNS depressant effects, which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in <xref format=\"dita\" href=\"guidance/guidance-on-prescribing.xml\" type=\"interaction\" rel=\"guidance\" bnfid=\"PHP97234\">Guidance on Prescribing</xref>).</p>"
							},
							"hasEvidence": "NotSet",
							"hasImportance": "NotSet",
							"hasOrder": "1",
							"hasTextContent": "Both  chlorpromazine  and  gabapentin  can have CNS depressant effects, which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in  Guidance on Prescribing ). \n\n"
						}
					],
					"hasOrder": "135",
					"hasTitle": {
						"@type": "rdf:XMLLiteral",
						"@value": "<title>Gabapentin</title>"
					}
				},
				{
					"@id": "http://bnf.nice.org.uk/interaction/chlorpromazine#bnf_i1557280698507",
					"hasMessage": [
						{
							"@id": "http://bnf.nice.org.uk/interaction/chlorpromazine#bnf_i1557280698507_message_0",
							"hasDitaContent": {
								"@type": "rdf:XMLLiteral",
								"@value": "<p otherprops=\"Normal\" outputclass=\"int-message\">Both <ph otherprops=\"chlorpromazine\" outputclass=\"int-heading-drug\">chlorpromazine</ph> and <ph otherprops=\"glyceryl trinitrate\" outputclass=\"int-drug\">glyceryl trinitrate</ph> can increase the risk of hypotension.</p>"
							},
							"hasEvidence": "NotSet",
							"hasImportance": "NotSet",
							"hasOrder": "1",
							"hasTextContent": "Both  chlorpromazine  and  glyceryl trinitrate  can increase the risk of hypotension. \n\n"
						}
					],
					"hasOrder": "136",
					"hasTitle": {
						"@type": "rdf:XMLLiteral",
						"@value": "<title>Glyceryl trinitrate</title>"
					}
				},
				{
					"@id": "http://bnf.nice.org.uk/interaction/chlorpromazine#bnf_i1557280698508",
					"hasMessage": [
						{
							"@id": "http://bnf.nice.org.uk/interaction/chlorpromazine#bnf_i1557280698508_message_0",
							"hasDitaContent": {
								"@type": "rdf:XMLLiteral",
								"@value": "<p otherprops=\"Normal\" outputclass=\"int-message\">Both <ph otherprops=\"chlorpromazine\" outputclass=\"int-heading-drug\">chlorpromazine</ph> and <ph otherprops=\"glycopyrronium\" outputclass=\"int-drug\">glycopyrronium</ph> can cause antimuscarinic effects.</p>"
							},
							"hasEvidence": "NotSet",
							"hasImportance": "NotSet",
							"hasOrder": "1",
							"hasTextContent": "Both  chlorpromazine  and  glycopyrronium  can cause antimuscarinic effects. \n\n"
						}
					],
					"hasOrder": "137",
					"hasTitle": {
						"@type": "rdf:XMLLiteral",
						"@value": "<title>Glycopyrronium</title>"
					}
				},
				{
					"@id": "http://bnf.nice.org.uk/interaction/chlorpromazine#bnf_i1557280698509",
					"hasMessage": [
						{
							"@id": "http://bnf.nice.org.uk/interaction/chlorpromazine#bnf_i1557280698509_message_0",
							"hasDitaContent": {
								"@type": "rdf:XMLLiteral",
								"@value": "<p otherprops=\"Severe\" outputclass=\"int-message\">\n  <ph otherprops=\"granisetron\" outputclass=\"int-drug\">Granisetron</ph> <ph outputclass=\"int-effectQualifier\">is predicted to</ph> <ph outputclass=\"int-effect\">increase</ph> <ph outputclass=\"int-parameter\">the risk of QT-prolongation when given with</ph> <ph otherprops=\"chlorpromazine\" outputclass=\"int-heading-drug\">chlorpromazine</ph>. <ph outputclass=\"int-action\">Manufacturer advises caution</ph>.  </p>"
							},
							"hasEvidence": "Theoretical",
							"hasImportance": "Severe",
							"hasOrder": "1",
							"hasTextContent": "Granisetron   is predicted to   increase   the risk of QT-prolongation when given with   chlorpromazine .  Manufacturer advises caution .    \n\n"
						}
					],
					"hasOrder": "138",
					"hasTitle": {
						"@type": "rdf:XMLLiteral",
						"@value": "<title>Granisetron</title>"
					}
				},
				{
					"@id": "http://bnf.nice.org.uk/interaction/chlorpromazine#bnf_i1557280698510",
					"hasMessage": [
						{
							"@id": "http://bnf.nice.org.uk/interaction/chlorpromazine#bnf_i1557280698510_message_0",
							"hasDitaContent": {
								"@type": "rdf:XMLLiteral",
								"@value": "<p otherprops=\"Normal\" outputclass=\"int-message\">Both <ph otherprops=\"chlorpromazine\" outputclass=\"int-heading-drug\">chlorpromazine</ph> and <ph otherprops=\"guanethidine\" outputclass=\"int-drug\">guanethidine</ph> can increase the risk of hypotension.</p>"
							},
							"hasEvidence": "NotSet",
							"hasImportance": "NotSet",
							"hasOrder": "1",
							"hasTextContent": "Both  chlorpromazine  and  guanethidine  can increase the risk of hypotension. \n\n"
						},
						{
							"@id": "http://bnf.nice.org.uk/interaction/chlorpromazine#bnf_i1557280698510_message_1",
							"hasDitaContent": {
								"@type": "rdf:XMLLiteral",
								"@value": "<p otherprops=\"Moderate\" outputclass=\"int-message\">\n  <ph otherprops=\"chlorpromazine\" outputclass=\"int-heading-drug\">Chlorpromazine</ph> <ph outputclass=\"int-effectQualifier\">is predicted to</ph> <ph outputclass=\"int-effect\">decrease</ph> <ph outputclass=\"int-parameter\">the antihypertensive effects of</ph> <ph otherprops=\"guanethidine\" outputclass=\"int-drug\">guanethidine</ph>. <ph outputclass=\"int-action\">Manufacturer advises caution</ph>.  </p>"
							},
							"hasEvidence": "Theoretical",
							"hasImportance": "Moderate",
							"hasOrder": "2",
							"hasTextContent": "Chlorpromazine   is predicted to   decrease   the antihypertensive effects of   guanethidine .  Manufacturer advises caution .    \n\n"
						}
					],
					"hasOrder": "139",
					"hasTitle": {
						"@type": "rdf:XMLLiteral",
						"@value": "<title>Guanethidine</title>"
					}
				},
				{
					"@id": "http://bnf.nice.org.uk/interaction/chlorpromazine#bnf_i1557280698511",
					"hasMessage": [
						{
							"@id": "http://bnf.nice.org.uk/interaction/chlorpromazine#bnf_i1557280698511_message_0",
							"hasDitaContent": {
								"@type": "rdf:XMLLiteral",
								"@value": "<p otherprops=\"Normal\" outputclass=\"int-message\">Both <ph otherprops=\"chlorpromazine\" outputclass=\"int-heading-drug\">chlorpromazine</ph> and <ph otherprops=\"guanfacine\" outputclass=\"int-drug\">guanfacine</ph> can increase the risk of hypotension.</p>"
							},
							"hasEvidence": "NotSet",
							"hasImportance": "NotSet",
							"hasOrder": "1",
							"hasTextContent": "Both  chlorpromazine  and  guanfacine  can increase the risk of hypotension. \n\n"
						},
						{
							"@id": "http://bnf.nice.org.uk/interaction/chlorpromazine#bnf_i1557280698511_message_1",
							"hasDitaContent": {
								"@type": "rdf:XMLLiteral",
								"@value": "<p otherprops=\"Normal\" outputclass=\"int-message\">Both <ph otherprops=\"chlorpromazine\" outputclass=\"int-heading-drug\">chlorpromazine</ph> and <ph otherprops=\"guanfacine\" outputclass=\"int-drug\">guanfacine</ph> can have CNS depressant effects, which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in <xref format=\"dita\" href=\"guidance/guidance-on-prescribing.xml\" type=\"interaction\" rel=\"guidance\" bnfid=\"PHP97234\">Guidance on Prescribing</xref>).</p>"
							},
							"hasEvidence": "NotSet",
							"hasImportance": "NotSet",
							"hasOrder": "2",
							"hasTextContent": "Both  chlorpromazine  and  guanfacine  can have CNS depressant effects, which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in  Guidance on Prescribing ). \n\n"
						}
					],
					"hasOrder": "140",
					"hasTitle": {
						"@type": "rdf:XMLLiteral",
						"@value": "<title>Guanfacine</title>"
					}
				},
				{
					"@id": "http://bnf.nice.org.uk/interaction/chlorpromazine#bnf_i1557280698512",
					"hasMessage": [
						{
							"@id": "http://bnf.nice.org.uk/interaction/chlorpromazine#bnf_i1557280698512_message_0",
							"hasDitaContent": {
								"@type": "rdf:XMLLiteral",
								"@value": "<p otherprops=\"Normal\" outputclass=\"int-message\">Both <ph otherprops=\"chlorpromazine\" outputclass=\"int-heading-drug\">chlorpromazine</ph> and <ph otherprops=\"haloperidol\" outputclass=\"int-drug\">haloperidol</ph> can increase the risk of hypotension.</p>"
							},
							"hasEvidence": "NotSet",
							"hasImportance": "NotSet",
							"hasOrder": "1",
							"hasTextContent": "Both  chlorpromazine  and  haloperidol  can increase the risk of hypotension. \n\n"
						},
						{
							"@id": "http://bnf.nice.org.uk/interaction/chlorpromazine#bnf_i1557280698512_message_1",
							"hasDitaContent": {
								"@type": "rdf:XMLLiteral",
								"@value": "<p otherprops=\"Severe\" outputclass=\"int-message\">Both <ph otherprops=\"chlorpromazine\" outputclass=\"int-heading-drug\">chlorpromazine</ph> and <ph otherprops=\"haloperidol\" outputclass=\"int-drug\">haloperidol</ph> prolong the QT interval. Most manufacturers advise avoiding the use of two or more drugs that are associated with QT prolongation. Increasing age, female sex, cardiac disease, and some metabolic disturbances (notably hypokalaemia) predispose to QT prolongation. </p>"
							},
							"hasEvidence": "NotSet",
							"hasImportance": "Severe",
							"hasOrder": "2",
							"hasTextContent": "Both  chlorpromazine  and  haloperidol  prolong the QT interval. Most manufacturers advise avoiding the use of two or more drugs that are associated with QT prolongation. Increasing age, female sex, cardiac disease, and some metabolic disturbances (notably hypokalaemia) predispose to QT prolongation.  \n\n"
						},
						{
							"@id": "http://bnf.nice.org.uk/interaction/chlorpromazine#bnf_i1557280698512_message_2",
							"hasDitaContent": {
								"@type": "rdf:XMLLiteral",
								"@value": "<p otherprops=\"Normal\" outputclass=\"int-message\">Both <ph otherprops=\"chlorpromazine\" outputclass=\"int-heading-drug\">chlorpromazine</ph> and <ph otherprops=\"haloperidol\" outputclass=\"int-drug\">haloperidol</ph> can have CNS depressant effects, which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in <xref format=\"dita\" href=\"guidance/guidance-on-prescribing.xml\" type=\"interaction\" rel=\"guidance\" bnfid=\"PHP97234\">Guidance on Prescribing</xref>).</p>"
							},
							"hasEvidence": "NotSet",
							"hasImportance": "NotSet",
							"hasOrder": "3",
							"hasTextContent": "Both  chlorpromazine  and  haloperidol  can have CNS depressant effects, which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in  Guidance on Prescribing ). \n\n"
						},
						{
							"@id": "http://bnf.nice.org.uk/interaction/chlorpromazine#bnf_i1557280698512_message_3",
							"hasDitaContent": {
								"@type": "rdf:XMLLiteral",
								"@value": "<p otherprops=\"Normal\" outputclass=\"int-message\">Both <ph otherprops=\"chlorpromazine\" outputclass=\"int-heading-drug\">chlorpromazine</ph> and <ph otherprops=\"haloperidol\" outputclass=\"int-drug\">haloperidol</ph> can cause antimuscarinic effects.</p>"
							},
							"hasEvidence": "NotSet",
							"hasImportance": "NotSet",
							"hasOrder": "4",
							"hasTextContent": "Both  chlorpromazine  and  haloperidol  can cause antimuscarinic effects. \n\n"
						}
					],
					"hasOrder": "141",
					"hasTitle": {
						"@type": "rdf:XMLLiteral",
						"@value": "<title>Haloperidol</title>"
					}
				},
				{
					"@id": "http://bnf.nice.org.uk/interaction/chlorpromazine#bnf_i1557280698513",
					"hasMessage": [
						{
							"@id": "http://bnf.nice.org.uk/interaction/chlorpromazine#bnf_i1557280698513_message_0",
							"hasDitaContent": {
								"@type": "rdf:XMLLiteral",
								"@value": "<p otherprops=\"Normal\" outputclass=\"int-message\">Both <ph otherprops=\"chlorpromazine\" outputclass=\"int-heading-drug\">chlorpromazine</ph> and <ph otherprops=\"homatropine\" outputclass=\"int-drug\">homatropine</ph> can cause antimuscarinic effects.</p>"
							},
							"hasEvidence": "NotSet",
							"hasImportance": "NotSet",
							"hasOrder": "1",
							"hasTextContent": "Both  chlorpromazine  and  homatropine  can cause antimuscarinic effects. \n\n"
						}
					],
					"hasOrder": "142",
					"hasTitle": {
						"@type": "rdf:XMLLiteral",
						"@value": "<title>Homatropine</title>"
					}
				},
				{
					"@id": "http://bnf.nice.org.uk/interaction/chlorpromazine#bnf_i1557280698514",
					"hasMessage": [
						{
							"@id": "http://bnf.nice.org.uk/interaction/chlorpromazine#bnf_i1557280698514_message_0",
							"hasDitaContent": {
								"@type": "rdf:XMLLiteral",
								"@value": "<p otherprops=\"Normal\" outputclass=\"int-message\">Both <ph otherprops=\"chlorpromazine\" outputclass=\"int-heading-drug\">chlorpromazine</ph> and <ph otherprops=\"hydralazine\" outputclass=\"int-drug\">hydralazine</ph> can increase the risk of hypotension.</p>"
							},
							"hasEvidence": "NotSet",
							"hasImportance": "NotSet",
							"hasOrder": "1",
							"hasTextContent": "Both  chlorpromazine  and  hydralazine  can increase the risk of hypotension. \n\n"
						}
					],
					"hasOrder": "143",
					"hasTitle": {
						"@type": "rdf:XMLLiteral",
						"@value": "<title>Hydralazine</title>"
					}
				},
				{
					"@id": "http://bnf.nice.org.uk/interaction/chlorpromazine#bnf_i1557280698515",
					"hasMessage": [
						{
							"@id": "http://bnf.nice.org.uk/interaction/chlorpromazine#bnf_i1557280698515_message_0",
							"hasDitaContent": {
								"@type": "rdf:XMLLiteral",
								"@value": "<p otherprops=\"Normal\" outputclass=\"int-message\">Both <ph otherprops=\"chlorpromazine\" outputclass=\"int-heading-drug\">chlorpromazine</ph> and <ph otherprops=\"hydrochlorothiazide\" outputclass=\"int-drug\">hydrochlorothiazide</ph> can increase the risk of hypotension.</p>"
							},
							"hasEvidence": "NotSet",
							"hasImportance": "NotSet",
							"hasOrder": "1",
							"hasTextContent": "Both  chlorpromazine  and  hydrochlorothiazide  can increase the risk of hypotension. \n\n"
						},
						{
							"@id": "http://bnf.nice.org.uk/interaction/chlorpromazine#bnf_i1557280698515_message_1",
							"hasDitaContent": {
								"@type": "rdf:XMLLiteral",
								"@value": "<p otherprops=\"Severe\" outputclass=\"int-message\">\n  <ph otherprops=\"hydrochlorothiazide\" outputclass=\"int-drug\">Hydrochlorothiazide</ph> <ph outputclass=\"int-effectQualifier\">is predicted to</ph> <ph outputclass=\"int-effect\">cause</ph> <ph outputclass=\"int-parameter\">hypokalaemia (potentially increasing the risk of torsade de pointes) when given with</ph> <ph otherprops=\"chlorpromazine\" outputclass=\"int-heading-drug\">chlorpromazine</ph>. <ph outputclass=\"int-action\">Manufacturer makes no recommendation</ph>.  </p>"
							},
							"hasEvidence": "Theoretical",
							"hasImportance": "Severe",
							"hasOrder": "2",
							"hasTextContent": "Hydrochlorothiazide   is predicted to   cause   hypokalaemia (potentially increasing the risk of torsade de pointes) when given with   chlorpromazine .  Manufacturer makes no recommendation .    \n\n"
						}
					],
					"hasOrder": "144",
					"hasTitle": {
						"@type": "rdf:XMLLiteral",
						"@value": "<title>Hydrochlorothiazide</title>"
					}
				},
				{
					"@id": "http://bnf.nice.org.uk/interaction/chlorpromazine#bnf_i1557280698516",
					"hasMessage": [
						{
							"@id": "http://bnf.nice.org.uk/interaction/chlorpromazine#bnf_i1557280698516_message_0",
							"hasDitaContent": {
								"@type": "rdf:XMLLiteral",
								"@value": "<p otherprops=\"Severe\" outputclass=\"int-message\">\n  <ph otherprops=\"hydrocortisone\" outputclass=\"int-drug\">Hydrocortisone</ph> <ph outputclass=\"int-effectQualifier\">is predicted to</ph> <ph outputclass=\"int-effect\">cause</ph> <ph outputclass=\"int-parameter\">hypokalaemia (potentially increasing the risk of torsade de pointes) when given with</ph> <ph otherprops=\"chlorpromazine\" outputclass=\"int-heading-drug\">chlorpromazine</ph>. <ph outputclass=\"int-action\">Manufacturer makes no recommendation</ph>.  </p>"
							},
							"hasEvidence": "Theoretical",
							"hasImportance": "Severe",
							"hasOrder": "1",
							"hasTextContent": "Hydrocortisone   is predicted to   cause   hypokalaemia (potentially increasing the risk of torsade de pointes) when given with   chlorpromazine .  Manufacturer makes no recommendation .    \n\n"
						}
					],
					"hasOrder": "145",
					"hasTitle": {
						"@type": "rdf:XMLLiteral",
						"@value": "<title>Hydrocortisone</title>"
					}
				},
				{
					"@id": "http://bnf.nice.org.uk/interaction/chlorpromazine#bnf_i1557280698517",
					"hasMessage": [
						{
							"@id": "http://bnf.nice.org.uk/interaction/chlorpromazine#bnf_i1557280698517_message_0",
							"hasDitaContent": {
								"@type": "rdf:XMLLiteral",
								"@value": "<p otherprops=\"Normal\" outputclass=\"int-message\">Both <ph otherprops=\"chlorpromazine\" outputclass=\"int-heading-drug\">chlorpromazine</ph> and <ph otherprops=\"hydroflumethiazide\" outputclass=\"int-drug\">hydroflumethiazide</ph> can increase the risk of hypotension.</p>"
							},
							"hasEvidence": "NotSet",
							"hasImportance": "NotSet",
							"hasOrder": "1",
							"hasTextContent": "Both  chlorpromazine  and  hydroflumethiazide  can increase the risk of hypotension. \n\n"
						},
						{
							"@id": "http://bnf.nice.org.uk/interaction/chlorpromazine#bnf_i1557280698517_message_1",
							"hasDitaContent": {
								"@type": "rdf:XMLLiteral",
								"@value": "<p otherprops=\"Severe\" outputclass=\"int-message\">\n  <ph otherprops=\"hydroflumethiazide\" outputclass=\"int-drug\">Hydroflumethiazide</ph> <ph outputclass=\"int-effectQualifier\">is predicted to</ph> <ph outputclass=\"int-effect\">cause</ph> <ph outputclass=\"int-parameter\">hypokalaemia (potentially increasing the risk of torsade de pointes) when given with</ph> <ph otherprops=\"chlorpromazine\" outputclass=\"int-heading-drug\">chlorpromazine</ph>. <ph outputclass=\"int-action\">Manufacturer makes no recommendation</ph>.  </p>"
							},
							"hasEvidence": "Theoretical",
							"hasImportance": "Severe",
							"hasOrder": "2",
							"hasTextContent": "Hydroflumethiazide   is predicted to   cause   hypokalaemia (potentially increasing the risk of torsade de pointes) when given with   chlorpromazine .  Manufacturer makes no recommendation .    \n\n"
						}
					],
					"hasOrder": "146",
					"hasTitle": {
						"@type": "rdf:XMLLiteral",
						"@value": "<title>Hydroflumethiazide</title>"
					}
				},
				{
					"@id": "http://bnf.nice.org.uk/interaction/chlorpromazine#bnf_i1557280698518",
					"hasMessage": [
						{
							"@id": "http://bnf.nice.org.uk/interaction/chlorpromazine#bnf_i1557280698518_message_0",
							"hasDitaContent": {
								"@type": "rdf:XMLLiteral",
								"@value": "<p otherprops=\"Normal\" outputclass=\"int-message\">Both <ph otherprops=\"chlorpromazine\" outputclass=\"int-heading-drug\">chlorpromazine</ph> and <ph otherprops=\"hydromorphone\" outputclass=\"int-drug\">hydromorphone</ph> can have CNS depressant effects, which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in <xref format=\"dita\" href=\"guidance/guidance-on-prescribing.xml\" type=\"interaction\" rel=\"guidance\" bnfid=\"PHP97234\">Guidance on Prescribing</xref>).</p>"
							},
							"hasEvidence": "NotSet",
							"hasImportance": "NotSet",
							"hasOrder": "1",
							"hasTextContent": "Both  chlorpromazine  and  hydromorphone  can have CNS depressant effects, which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in  Guidance on Prescribing ). \n\n"
						}
					],
					"hasOrder": "147",
					"hasTitle": {
						"@type": "rdf:XMLLiteral",
						"@value": "<title>Hydromorphone</title>"
					}
				},
				{
					"@id": "http://bnf.nice.org.uk/interaction/chlorpromazine#bnf_i1557280698519",
					"hasMessage": [
						{
							"@id": "http://bnf.nice.org.uk/interaction/chlorpromazine#bnf_i1557280698519_message_0",
							"hasDitaContent": {
								"@type": "rdf:XMLLiteral",
								"@value": "<p otherprops=\"Severe\" outputclass=\"int-message\">Both <ph otherprops=\"chlorpromazine\" outputclass=\"int-heading-drug\">chlorpromazine</ph> and <ph otherprops=\"hydroxyzine\" outputclass=\"int-drug\">hydroxyzine</ph> prolong the QT interval. Most manufacturers advise avoiding the use of two or more drugs that are associated with QT prolongation. Increasing age, female sex, cardiac disease, and some metabolic disturbances (notably hypokalaemia) predispose to QT prolongation. </p>"
							},
							"hasEvidence": "NotSet",
							"hasImportance": "Severe",
							"hasOrder": "1",
							"hasTextContent": "Both  chlorpromazine  and  hydroxyzine  prolong the QT interval. Most manufacturers advise avoiding the use of two or more drugs that are associated with QT prolongation. Increasing age, female sex, cardiac disease, and some metabolic disturbances (notably hypokalaemia) predispose to QT prolongation.  \n\n"
						},
						{
							"@id": "http://bnf.nice.org.uk/interaction/chlorpromazine#bnf_i1557280698519_message_1",
							"hasDitaContent": {
								"@type": "rdf:XMLLiteral",
								"@value": "<p otherprops=\"Normal\" outputclass=\"int-message\">Both <ph otherprops=\"chlorpromazine\" outputclass=\"int-heading-drug\">chlorpromazine</ph> and <ph otherprops=\"hydroxyzine\" outputclass=\"int-drug\">hydroxyzine</ph> can have CNS depressant effects, which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in <xref format=\"dita\" href=\"guidance/guidance-on-prescribing.xml\" type=\"interaction\" rel=\"guidance\" bnfid=\"PHP97234\">Guidance on Prescribing</xref>).</p>"
							},
							"hasEvidence": "NotSet",
							"hasImportance": "NotSet",
							"hasOrder": "2",
							"hasTextContent": "Both  chlorpromazine  and  hydroxyzine  can have CNS depressant effects, which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in  Guidance on Prescribing ). \n\n"
						},
						{
							"@id": "http://bnf.nice.org.uk/interaction/chlorpromazine#bnf_i1557280698519_message_2",
							"hasDitaContent": {
								"@type": "rdf:XMLLiteral",
								"@value": "<p otherprops=\"Normal\" outputclass=\"int-message\">Both <ph otherprops=\"chlorpromazine\" outputclass=\"int-heading-drug\">chlorpromazine</ph> and <ph otherprops=\"hydroxyzine\" outputclass=\"int-drug\">hydroxyzine</ph> can cause antimuscarinic effects.</p>"
							},
							"hasEvidence": "NotSet",
							"hasImportance": "NotSet",
							"hasOrder": "3",
							"hasTextContent": "Both  chlorpromazine  and  hydroxyzine  can cause antimuscarinic effects. \n\n"
						}
					],
					"hasOrder": "148",
					"hasTitle": {
						"@type": "rdf:XMLLiteral",
						"@value": "<title>Hydroxyzine</title>"
					}
				},
				{
					"@id": "http://bnf.nice.org.uk/interaction/chlorpromazine#bnf_i1557280698520",
					"hasMessage": [
						{
							"@id": "http://bnf.nice.org.uk/interaction/chlorpromazine#bnf_i1557280698520_message_0",
							"hasDitaContent": {
								"@type": "rdf:XMLLiteral",
								"@value": "<p otherprops=\"Normal\" outputclass=\"int-message\">Both <ph otherprops=\"chlorpromazine\" outputclass=\"int-heading-drug\">chlorpromazine</ph> and <ph otherprops=\"hyoscine\" outputclass=\"int-drug\">hyoscine</ph> can cause antimuscarinic effects.</p>"
							},
							"hasEvidence": "NotSet",
							"hasImportance": "NotSet",
							"hasOrder": "1",
							"hasTextContent": "Both  chlorpromazine  and  hyoscine  can cause antimuscarinic effects. \n\n"
						}
					],
					"hasOrder": "149",
					"hasTitle": {
						"@type": "rdf:XMLLiteral",
						"@value": "<title>Hyoscine</title>"
					}
				},
				{
					"@id": "http://bnf.nice.org.uk/interaction/chlorpromazine#bnf_i1557280698521",
					"hasMessage": [
						{
							"@id": "http://bnf.nice.org.uk/interaction/chlorpromazine#bnf_i1557280698521_message_0",
							"hasDitaContent": {
								"@type": "rdf:XMLLiteral",
								"@value": "<p otherprops=\"Normal\" outputclass=\"int-message\">Both <ph otherprops=\"chlorpromazine\" outputclass=\"int-heading-drug\">chlorpromazine</ph> and <ph otherprops=\"imidapril\" outputclass=\"int-drug\">imidapril</ph> can increase the risk of hypotension.</p>"
							},
							"hasEvidence": "NotSet",
							"hasImportance": "NotSet",
							"hasOrder": "1",
							"hasTextContent": "Both  chlorpromazine  and  imidapril  can increase the risk of hypotension. \n\n"
						}
					],
					"hasOrder": "150",
					"hasTitle": {
						"@type": "rdf:XMLLiteral",
						"@value": "<title>Imidapril</title>"
					}
				},
				{
					"@id": "http://bnf.nice.org.uk/interaction/chlorpromazine#bnf_i1557280698522",
					"hasMessage": [
						{
							"@id": "http://bnf.nice.org.uk/interaction/chlorpromazine#bnf_i1557280698522_message_0",
							"hasDitaContent": {
								"@type": "rdf:XMLLiteral",
								"@value": "<p otherprops=\"Normal\" outputclass=\"int-message\">Both <ph otherprops=\"chlorpromazine\" outputclass=\"int-heading-drug\">chlorpromazine</ph> and <ph otherprops=\"imipramine\" outputclass=\"int-drug\">imipramine</ph> can increase the risk of hypotension.</p>"
							},
							"hasEvidence": "NotSet",
							"hasImportance": "NotSet",
							"hasOrder": "1",
							"hasTextContent": "Both  chlorpromazine  and  imipramine  can increase the risk of hypotension. \n\n"
						},
						{
							"@id": "http://bnf.nice.org.uk/interaction/chlorpromazine#bnf_i1557280698522_message_1",
							"hasDitaContent": {
								"@type": "rdf:XMLLiteral",
								"@value": "<p otherprops=\"Normal\" outputclass=\"int-message\">Both <ph otherprops=\"chlorpromazine\" outputclass=\"int-heading-drug\">chlorpromazine</ph> and <ph otherprops=\"imipramine\" outputclass=\"int-drug\">imipramine</ph> can cause antimuscarinic effects.</p>"
							},
							"hasEvidence": "NotSet",
							"hasImportance": "NotSet",
							"hasOrder": "2",
							"hasTextContent": "Both  chlorpromazine  and  imipramine  can cause antimuscarinic effects. \n\n"
						}
					],
					"hasOrder": "151",
					"hasTitle": {
						"@type": "rdf:XMLLiteral",
						"@value": "<title>Imipramine</title>"
					}
				},
				{
					"@id": "http://bnf.nice.org.uk/interaction/chlorpromazine#bnf_i1557280698523",
					"hasMessage": [
						{
							"@id": "http://bnf.nice.org.uk/interaction/chlorpromazine#bnf_i1557280698523_message_0",
							"hasDitaContent": {
								"@type": "rdf:XMLLiteral",
								"@value": "<p otherprops=\"Severe\" outputclass=\"int-message\">\n  <ph otherprops=\"indacaterol\" outputclass=\"int-drug\">Indacaterol</ph> <ph outputclass=\"int-effectQualifier\">is predicted to</ph> <ph outputclass=\"int-effect\">cause</ph> <ph outputclass=\"int-parameter\">hypokalaemia (potentially increasing the risk of torsade de pointes) when given with</ph> <ph otherprops=\"chlorpromazine\" outputclass=\"int-heading-drug\">chlorpromazine</ph>. <ph outputclass=\"int-action\">Manufacturer makes no recommendation</ph>.  </p>"
							},
							"hasEvidence": "Theoretical",
							"hasImportance": "Severe",
							"hasOrder": "1",
							"hasTextContent": "Indacaterol   is predicted to   cause   hypokalaemia (potentially increasing the risk of torsade de pointes) when given with   chlorpromazine .  Manufacturer makes no recommendation .    \n\n"
						}
					],
					"hasOrder": "152",
					"hasTitle": {
						"@type": "rdf:XMLLiteral",
						"@value": "<title>Indacaterol</title>"
					}
				},
				{
					"@id": "http://bnf.nice.org.uk/interaction/chlorpromazine#bnf_i1557280698524",
					"hasMessage": [
						{
							"@id": "http://bnf.nice.org.uk/interaction/chlorpromazine#bnf_i1557280698524_message_0",
							"hasDitaContent": {
								"@type": "rdf:XMLLiteral",
								"@value": "<p otherprops=\"Normal\" outputclass=\"int-message\">Both <ph otherprops=\"chlorpromazine\" outputclass=\"int-heading-drug\">chlorpromazine</ph> and <ph otherprops=\"indapamide\" outputclass=\"int-drug\">indapamide</ph> can increase the risk of hypotension.</p>"
							},
							"hasEvidence": "NotSet",
							"hasImportance": "NotSet",
							"hasOrder": "1",
							"hasTextContent": "Both  chlorpromazine  and  indapamide  can increase the risk of hypotension. \n\n"
						},
						{
							"@id": "http://bnf.nice.org.uk/interaction/chlorpromazine#bnf_i1557280698524_message_1",
							"hasDitaContent": {
								"@type": "rdf:XMLLiteral",
								"@value": "<p otherprops=\"Severe\" outputclass=\"int-message\">\n  <ph otherprops=\"indapamide\" outputclass=\"int-drug\">Indapamide</ph> <ph outputclass=\"int-effectQualifier\">is predicted to</ph> <ph outputclass=\"int-effect\">cause</ph> <ph outputclass=\"int-parameter\">hypokalaemia (potentially increasing the risk of torsade de pointes) when given with</ph> <ph otherprops=\"chlorpromazine\" outputclass=\"int-heading-drug\">chlorpromazine</ph>. <ph outputclass=\"int-action\">Manufacturer makes no recommendation</ph>.  </p>"
							},
							"hasEvidence": "Theoretical",
							"hasImportance": "Severe",
							"hasOrder": "2",
							"hasTextContent": "Indapamide   is predicted to   cause   hypokalaemia (potentially increasing the risk of torsade de pointes) when given with   chlorpromazine .  Manufacturer makes no recommendation .    \n\n"
						}
					],
					"hasOrder": "153",
					"hasTitle": {
						"@type": "rdf:XMLLiteral",
						"@value": "<title>Indapamide</title>"
					}
				},
				{
					"@id": "http://bnf.nice.org.uk/interaction/chlorpromazine#bnf_i1557280698525",
					"hasMessage": [
						{
							"@id": "http://bnf.nice.org.uk/interaction/chlorpromazine#bnf_i1557280698525_message_0",
							"hasDitaContent": {
								"@type": "rdf:XMLLiteral",
								"@value": "<p otherprops=\"Normal\" outputclass=\"int-message\">Both <ph otherprops=\"chlorpromazine\" outputclass=\"int-heading-drug\">chlorpromazine</ph> and <ph otherprops=\"indoramin\" outputclass=\"int-drug\">indoramin</ph> can increase the risk of hypotension.</p>"
							},
							"hasEvidence": "NotSet",
							"hasImportance": "NotSet",
							"hasOrder": "1",
							"hasTextContent": "Both  chlorpromazine  and  indoramin  can increase the risk of hypotension. \n\n"
						}
					],
					"hasOrder": "154",
					"hasTitle": {
						"@type": "rdf:XMLLiteral",
						"@value": "<title>Indoramin</title>"
					}
				},
				{
					"@id": "http://bnf.nice.org.uk/interaction/chlorpromazine#bnf_i1557280698526",
					"hasMessage": [
						{
							"@id": "http://bnf.nice.org.uk/interaction/chlorpromazine#bnf_i1557280698526_message_0",
							"hasDitaContent": {
								"@type": "rdf:XMLLiteral",
								"@value": "<p otherprops=\"Severe\" outputclass=\"int-message\">Both <ph otherprops=\"chlorpromazine\" outputclass=\"int-heading-drug\">chlorpromazine</ph> and <ph otherprops=\"inotuzumab ozogamicin\" outputclass=\"int-drug\">inotuzumab ozogamicin</ph> prolong the QT interval. Most manufacturers advise avoiding the use of two or more drugs that are associated with QT prolongation. Increasing age, female sex, cardiac disease, and some metabolic disturbances (notably hypokalaemia) predispose to QT prolongation. </p>"
							},
							"hasEvidence": "NotSet",
							"hasImportance": "Severe",
							"hasOrder": "1",
							"hasTextContent": "Both  chlorpromazine  and  inotuzumab ozogamicin  prolong the QT interval. Most manufacturers advise avoiding the use of two or more drugs that are associated with QT prolongation. Increasing age, female sex, cardiac disease, and some metabolic disturbances (notably hypokalaemia) predispose to QT prolongation.  \n\n"
						}
					],
					"hasOrder": "155",
					"hasTitle": {
						"@type": "rdf:XMLLiteral",
						"@value": "<title>Inotuzumab ozogamicin</title>"
					}
				},
				{
					"@id": "http://bnf.nice.org.uk/interaction/chlorpromazine#bnf_i1557280698527",
					"hasMessage": [
						{
							"@id": "http://bnf.nice.org.uk/interaction/chlorpromazine#bnf_i1557280698527_message_0",
							"hasDitaContent": {
								"@type": "rdf:XMLLiteral",
								"@value": "<p otherprops=\"Normal\" outputclass=\"int-message\">Both <ph otherprops=\"chlorpromazine\" outputclass=\"int-heading-drug\">chlorpromazine</ph> and <ph otherprops=\"ipratropium\" outputclass=\"int-drug\">ipratropium</ph> can cause antimuscarinic effects.</p>"
							},
							"hasEvidence": "NotSet",
							"hasImportance": "NotSet",
							"hasOrder": "1",
							"hasTextContent": "Both  chlorpromazine  and  ipratropium  can cause antimuscarinic effects. \n\n"
						}
					],
					"hasOrder": "156",
					"hasTitle": {
						"@type": "rdf:XMLLiteral",
						"@value": "<title>Ipratropium</title>"
					}
				},
				{
					"@id": "http://bnf.nice.org.uk/interaction/chlorpromazine#bnf_i1557280698528",
					"hasMessage": [
						{
							"@id": "http://bnf.nice.org.uk/interaction/chlorpromazine#bnf_i1557280698528_message_0",
							"hasDitaContent": {
								"@type": "rdf:XMLLiteral",
								"@value": "<p otherprops=\"Normal\" outputclass=\"int-message\">Both <ph otherprops=\"chlorpromazine\" outputclass=\"int-heading-drug\">chlorpromazine</ph> and <ph otherprops=\"irbesartan\" outputclass=\"int-drug\">irbesartan</ph> can increase the risk of hypotension.</p>"
							},
							"hasEvidence": "NotSet",
							"hasImportance": "NotSet",
							"hasOrder": "1",
							"hasTextContent": "Both  chlorpromazine  and  irbesartan  can increase the risk of hypotension. \n\n"
						}
					],
					"hasOrder": "157",
					"hasTitle": {
						"@type": "rdf:XMLLiteral",
						"@value": "<title>Irbesartan</title>"
					}
				},
				{
					"@id": "http://bnf.nice.org.uk/interaction/chlorpromazine#bnf_i1557280698529",
					"hasMessage": [
						{
							"@id": "http://bnf.nice.org.uk/interaction/chlorpromazine#bnf_i1557280698529_message_0",
							"hasDitaContent": {
								"@type": "rdf:XMLLiteral",
								"@value": "<p otherprops=\"Normal\" outputclass=\"int-message\">Both <ph otherprops=\"chlorpromazine\" outputclass=\"int-heading-drug\">chlorpromazine</ph> and <ph otherprops=\"isocarboxazid\" outputclass=\"int-drug\">isocarboxazid</ph> can increase the risk of hypotension.</p>"
							},
							"hasEvidence": "NotSet",
							"hasImportance": "NotSet",
							"hasOrder": "1",
							"hasTextContent": "Both  chlorpromazine  and  isocarboxazid  can increase the risk of hypotension. \n\n"
						},
						{
							"@id": "http://bnf.nice.org.uk/interaction/chlorpromazine#bnf_i1557280698529_message_1",
							"hasDitaContent": {
								"@type": "rdf:XMLLiteral",
								"@value": "<p otherprops=\"Severe\" outputclass=\"int-message\">\n  <ph otherprops=\"isocarboxazid\" outputclass=\"int-drug\">Isocarboxazid</ph> <ph outputclass=\"int-effectQualifier\">is predicted to</ph> <ph outputclass=\"int-effect\">increase</ph> <ph outputclass=\"int-parameter\">the risk of neuroleptic malignant syndrome when given with</ph> <ph otherprops=\"chlorpromazine\" outputclass=\"int-heading-drug\">chlorpromazine</ph>. <ph outputclass=\"int-action\">Manufacturer makes no recommendation</ph>.  </p>"
							},
							"hasEvidence": "Theoretical",
							"hasImportance": "Severe",
							"hasOrder": "2",
							"hasTextContent": "Isocarboxazid   is predicted to   increase   the risk of neuroleptic malignant syndrome when given with   chlorpromazine .  Manufacturer makes no recommendation .    \n\n"
						}
					],
					"hasOrder": "158",
					"hasTitle": {
						"@type": "rdf:XMLLiteral",
						"@value": "<title>Isocarboxazid</title>"
					}
				},
				{
					"@id": "http://bnf.nice.org.uk/interaction/chlorpromazine#bnf_i1557280698530",
					"hasMessage": [
						{
							"@id": "http://bnf.nice.org.uk/interaction/chlorpromazine#bnf_i1557280698530_message_0",
							"hasDitaContent": {
								"@type": "rdf:XMLLiteral",
								"@value": "<p otherprops=\"Normal\" outputclass=\"int-message\">Both <ph otherprops=\"chlorpromazine\" outputclass=\"int-heading-drug\">chlorpromazine</ph> and <ph otherprops=\"isoflurane\" outputclass=\"int-drug\">isoflurane</ph> can increase the risk of hypotension.</p>"
							},
							"hasEvidence": "NotSet",
							"hasImportance": "NotSet",
							"hasOrder": "1",
							"hasTextContent": "Both  chlorpromazine  and  isoflurane  can increase the risk of hypotension. \n\n"
						},
						{
							"@id": "http://bnf.nice.org.uk/interaction/chlorpromazine#bnf_i1557280698530_message_1",
							"hasDitaContent": {
								"@type": "rdf:XMLLiteral",
								"@value": "<p otherprops=\"Normal\" outputclass=\"int-message\">Both <ph otherprops=\"chlorpromazine\" outputclass=\"int-heading-drug\">chlorpromazine</ph> and <ph otherprops=\"isoflurane\" outputclass=\"int-drug\">isoflurane</ph> can have CNS depressant effects, which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in <xref format=\"dita\" href=\"guidance/guidance-on-prescribing.xml\" type=\"interaction\" rel=\"guidance\" bnfid=\"PHP97234\">Guidance on Prescribing</xref>).</p>"
							},
							"hasEvidence": "NotSet",
							"hasImportance": "NotSet",
							"hasOrder": "2",
							"hasTextContent": "Both  chlorpromazine  and  isoflurane  can have CNS depressant effects, which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in  Guidance on Prescribing ). \n\n"
						}
					],
					"hasOrder": "159",
					"hasTitle": {
						"@type": "rdf:XMLLiteral",
						"@value": "<title>Isoflurane</title>"
					}
				},
				{
					"@id": "http://bnf.nice.org.uk/interaction/chlorpromazine#bnf_i1557280698531",
					"hasMessage": [
						{
							"@id": "http://bnf.nice.org.uk/interaction/chlorpromazine#bnf_i1557280698531_message_0",
							"hasDitaContent": {
								"@type": "rdf:XMLLiteral",
								"@value": "<p otherprops=\"Normal\" outputclass=\"int-message\">Both <ph otherprops=\"chlorpromazine\" outputclass=\"int-heading-drug\">chlorpromazine</ph> and <ph otherprops=\"isosorbide dinitrate\" outputclass=\"int-drug\">isosorbide dinitrate</ph> can increase the risk of hypotension.</p>"
							},
							"hasEvidence": "NotSet",
							"hasImportance": "NotSet",
							"hasOrder": "1",
							"hasTextContent": "Both  chlorpromazine  and  isosorbide dinitrate  can increase the risk of hypotension. \n\n"
						}
					],
					"hasOrder": "160",
					"hasTitle": {
						"@type": "rdf:XMLLiteral",
						"@value": "<title>Isosorbide dinitrate</title>"
					}
				},
				{
					"@id": "http://bnf.nice.org.uk/interaction/chlorpromazine#bnf_i1557280698532",
					"hasMessage": [
						{
							"@id": "http://bnf.nice.org.uk/interaction/chlorpromazine#bnf_i1557280698532_message_0",
							"hasDitaContent": {
								"@type": "rdf:XMLLiteral",
								"@value": "<p otherprops=\"Normal\" outputclass=\"int-message\">Both <ph otherprops=\"chlorpromazine\" outputclass=\"int-heading-drug\">chlorpromazine</ph> and <ph otherprops=\"isosorbide mononitrate\" outputclass=\"int-drug\">isosorbide mononitrate</ph> can increase the risk of hypotension.</p>"
							},
							"hasEvidence": "NotSet",
							"hasImportance": "NotSet",
							"hasOrder": "1",
							"hasTextContent": "Both  chlorpromazine  and  isosorbide mononitrate  can increase the risk of hypotension. \n\n"
						}
					],
					"hasOrder": "161",
					"hasTitle": {
						"@type": "rdf:XMLLiteral",
						"@value": "<title>Isosorbide mononitrate</title>"
					}
				},
				{
					"@id": "http://bnf.nice.org.uk/interaction/chlorpromazine#bnf_i1557280698533",
					"hasMessage": [
						{
							"@id": "http://bnf.nice.org.uk/interaction/chlorpromazine#bnf_i1557280698533_message_0",
							"hasDitaContent": {
								"@type": "rdf:XMLLiteral",
								"@value": "<p otherprops=\"Severe\" outputclass=\"int-message\">\n  <ph otherprops=\"ivabradine\" outputclass=\"int-drug\">Ivabradine</ph> <ph outputclass=\"int-effectQualifier\">is predicted to</ph> <ph outputclass=\"int-effect\">increase</ph> <ph outputclass=\"int-parameter\">the risk of torsade de pointes when given with</ph> <ph otherprops=\"chlorpromazine\" outputclass=\"int-heading-drug\">chlorpromazine</ph>. <ph outputclass=\"int-action\">Manufacturer advises avoid</ph>.  </p>"
							},
							"hasEvidence": "Theoretical",
							"hasImportance": "Severe",
							"hasOrder": "1",
							"hasTextContent": "Ivabradine   is predicted to   increase   the risk of torsade de pointes when given with   chlorpromazine .  Manufacturer advises avoid .    \n\n"
						}
					],
					"hasOrder": "162",
					"hasTitle": {
						"@type": "rdf:XMLLiteral",
						"@value": "<title>Ivabradine</title>"
					}
				},
				{
					"@id": "http://bnf.nice.org.uk/interaction/chlorpromazine#bnf_i1557280698534",
					"hasMessage": [
						{
							"@id": "http://bnf.nice.org.uk/interaction/chlorpromazine#bnf_i1557280698534_message_0",
							"hasDitaContent": {
								"@type": "rdf:XMLLiteral",
								"@value": "<p otherprops=\"Normal\" outputclass=\"int-message\">Both <ph otherprops=\"chlorpromazine\" outputclass=\"int-heading-drug\">chlorpromazine</ph> and <ph otherprops=\"ketamine\" outputclass=\"int-drug\">ketamine</ph> can increase the risk of hypotension.</p>"
							},
							"hasEvidence": "NotSet",
							"hasImportance": "NotSet",
							"hasOrder": "1",
							"hasTextContent": "Both  chlorpromazine  and  ketamine  can increase the risk of hypotension. \n\n"
						},
						{
							"@id": "http://bnf.nice.org.uk/interaction/chlorpromazine#bnf_i1557280698534_message_1",
							"hasDitaContent": {
								"@type": "rdf:XMLLiteral",
								"@value": "<p otherprops=\"Normal\" outputclass=\"int-message\">Both <ph otherprops=\"chlorpromazine\" outputclass=\"int-heading-drug\">chlorpromazine</ph> and <ph otherprops=\"ketamine\" outputclass=\"int-drug\">ketamine</ph> can have CNS depressant effects, which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in <xref format=\"dita\" href=\"guidance/guidance-on-prescribing.xml\" type=\"interaction\" rel=\"guidance\" bnfid=\"PHP97234\">Guidance on Prescribing</xref>).</p>"
							},
							"hasEvidence": "NotSet",
							"hasImportance": "NotSet",
							"hasOrder": "2",
							"hasTextContent": "Both  chlorpromazine  and  ketamine  can have CNS depressant effects, which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in  Guidance on Prescribing ). \n\n"
						}
					],
					"hasOrder": "163",
					"hasTitle": {
						"@type": "rdf:XMLLiteral",
						"@value": "<title>Ketamine</title>"
					}
				},
				{
					"@id": "http://bnf.nice.org.uk/interaction/chlorpromazine#bnf_i1557280698535",
					"hasMessage": [
						{
							"@id": "http://bnf.nice.org.uk/interaction/chlorpromazine#bnf_i1557280698535_message_0",
							"hasDitaContent": {
								"@type": "rdf:XMLLiteral",
								"@value": "<p otherprops=\"Normal\" outputclass=\"int-message\">Both <ph otherprops=\"chlorpromazine\" outputclass=\"int-heading-drug\">chlorpromazine</ph> and <ph otherprops=\"ketotifen\" outputclass=\"int-drug\">ketotifen</ph> can have CNS depressant effects, which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in <xref format=\"dita\" href=\"guidance/guidance-on-prescribing.xml\" type=\"interaction\" rel=\"guidance\" bnfid=\"PHP97234\">Guidance on Prescribing</xref>).</p>"
							},
							"hasEvidence": "NotSet",
							"hasImportance": "NotSet",
							"hasOrder": "1",
							"hasTextContent": "Both  chlorpromazine  and  ketotifen  can have CNS depressant effects, which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in  Guidance on Prescribing ). \n\n"
						}
					],
					"hasOrder": "164",
					"hasTitle": {
						"@type": "rdf:XMLLiteral",
						"@value": "<title>Ketotifen</title>"
					}
				},
				{
					"@id": "http://bnf.nice.org.uk/interaction/chlorpromazine#bnf_i1557280698536",
					"hasMessage": [
						{
							"@id": "http://bnf.nice.org.uk/interaction/chlorpromazine#bnf_i1557280698536_message_0",
							"hasDitaContent": {
								"@type": "rdf:XMLLiteral",
								"@value": "<p otherprops=\"Normal\" outputclass=\"int-message\">Both <ph otherprops=\"chlorpromazine\" outputclass=\"int-heading-drug\">chlorpromazine</ph> and <ph otherprops=\"labetalol\" outputclass=\"int-drug\">labetalol</ph> can increase the risk of hypotension.</p>"
							},
							"hasEvidence": "NotSet",
							"hasImportance": "NotSet",
							"hasOrder": "1",
							"hasTextContent": "Both  chlorpromazine  and  labetalol  can increase the risk of hypotension. \n\n"
						}
					],
					"hasOrder": "165",
					"hasTitle": {
						"@type": "rdf:XMLLiteral",
						"@value": "<title>Labetalol</title>"
					}
				},
				{
					"@id": "http://bnf.nice.org.uk/interaction/chlorpromazine#bnf_i1557280698537",
					"hasMessage": [
						{
							"@id": "http://bnf.nice.org.uk/interaction/chlorpromazine#bnf_i1557280698537_message_0",
							"hasDitaContent": {
								"@type": "rdf:XMLLiteral",
								"@value": "<p otherprops=\"Normal\" outputclass=\"int-message\">Both <ph otherprops=\"chlorpromazine\" outputclass=\"int-heading-drug\">chlorpromazine</ph> and <ph otherprops=\"lacidipine\" outputclass=\"int-drug\">lacidipine</ph> can increase the risk of hypotension.</p>"
							},
							"hasEvidence": "NotSet",
							"hasImportance": "NotSet",
							"hasOrder": "1",
							"hasTextContent": "Both  chlorpromazine  and  lacidipine  can increase the risk of hypotension. \n\n"
						}
					],
					"hasOrder": "166",
					"hasTitle": {
						"@type": "rdf:XMLLiteral",
						"@value": "<title>Lacidipine</title>"
					}
				},
				{
					"@id": "http://bnf.nice.org.uk/interaction/chlorpromazine#bnf_i1557280698538",
					"hasMessage": [
						{
							"@id": "http://bnf.nice.org.uk/interaction/chlorpromazine#bnf_i1557280698538_message_0",
							"hasDitaContent": {
								"@type": "rdf:XMLLiteral",
								"@value": "<p otherprops=\"Normal\" outputclass=\"int-message\">Both <ph otherprops=\"chlorpromazine\" outputclass=\"int-heading-drug\">chlorpromazine</ph> and <ph otherprops=\"lamotrigine\" outputclass=\"int-drug\">lamotrigine</ph> can have CNS depressant effects, which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in <xref format=\"dita\" href=\"guidance/guidance-on-prescribing.xml\" type=\"interaction\" rel=\"guidance\" bnfid=\"PHP97234\">Guidance on Prescribing</xref>).</p>"
							},
							"hasEvidence": "NotSet",
							"hasImportance": "NotSet",
							"hasOrder": "1",
							"hasTextContent": "Both  chlorpromazine  and  lamotrigine  can have CNS depressant effects, which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in  Guidance on Prescribing ). \n\n"
						}
					],
					"hasOrder": "167",
					"hasTitle": {
						"@type": "rdf:XMLLiteral",
						"@value": "<title>Lamotrigine</title>"
					}
				},
				{
					"@id": "http://bnf.nice.org.uk/interaction/chlorpromazine#bnf_i1557280698539",
					"hasMessage": [
						{
							"@id": "http://bnf.nice.org.uk/interaction/chlorpromazine#bnf_i1557280698539_message_0",
							"hasDitaContent": {
								"@type": "rdf:XMLLiteral",
								"@value": "<p otherprops=\"Severe\" outputclass=\"int-message\">Both <ph otherprops=\"chlorpromazine\" outputclass=\"int-heading-drug\">chlorpromazine</ph> and <ph otherprops=\"lapatinib\" outputclass=\"int-drug\">lapatinib</ph> prolong the QT interval. Most manufacturers advise avoiding the use of two or more drugs that are associated with QT prolongation. Increasing age, female sex, cardiac disease, and some metabolic disturbances (notably hypokalaemia) predispose to QT prolongation. </p>"
							},
							"hasEvidence": "NotSet",
							"hasImportance": "Severe",
							"hasOrder": "1",
							"hasTextContent": "Both  chlorpromazine  and  lapatinib  prolong the QT interval. Most manufacturers advise avoiding the use of two or more drugs that are associated with QT prolongation. Increasing age, female sex, cardiac disease, and some metabolic disturbances (notably hypokalaemia) predispose to QT prolongation.  \n\n"
						}
					],
					"hasOrder": "168",
					"hasTitle": {
						"@type": "rdf:XMLLiteral",
						"@value": "<title>Lapatinib</title>"
					}
				},
				{
					"@id": "http://bnf.nice.org.uk/interaction/chlorpromazine#bnf_i1557280698540",
					"hasMessage": [
						{
							"@id": "http://bnf.nice.org.uk/interaction/chlorpromazine#bnf_i1557280698540_message_0",
							"hasDitaContent": {
								"@type": "rdf:XMLLiteral",
								"@value": "<p otherprops=\"Severe\" outputclass=\"int-message\">Both <ph otherprops=\"chlorpromazine\" outputclass=\"int-heading-drug\">chlorpromazine</ph> and <ph otherprops=\"lenvatinib\" outputclass=\"int-drug\">lenvatinib</ph> prolong the QT interval. Most manufacturers advise avoiding the use of two or more drugs that are associated with QT prolongation. Increasing age, female sex, cardiac disease, and some metabolic disturbances (notably hypokalaemia) predispose to QT prolongation. </p>"
							},
							"hasEvidence": "NotSet",
							"hasImportance": "Severe",
							"hasOrder": "1",
							"hasTextContent": "Both  chlorpromazine  and  lenvatinib  prolong the QT interval. Most manufacturers advise avoiding the use of two or more drugs that are associated with QT prolongation. Increasing age, female sex, cardiac disease, and some metabolic disturbances (notably hypokalaemia) predispose to QT prolongation.  \n\n"
						}
					],
					"hasOrder": "169",
					"hasTitle": {
						"@type": "rdf:XMLLiteral",
						"@value": "<title>Lenvatinib</title>"
					}
				},
				{
					"@id": "http://bnf.nice.org.uk/interaction/chlorpromazine#bnf_i1557280698541",
					"hasMessage": [
						{
							"@id": "http://bnf.nice.org.uk/interaction/chlorpromazine#bnf_i1557280698541_message_0",
							"hasDitaContent": {
								"@type": "rdf:XMLLiteral",
								"@value": "<p otherprops=\"Normal\" outputclass=\"int-message\">Both <ph otherprops=\"chlorpromazine\" outputclass=\"int-heading-drug\">chlorpromazine</ph> and <ph otherprops=\"lercanidipine\" outputclass=\"int-drug\">lercanidipine</ph> can increase the risk of hypotension.</p>"
							},
							"hasEvidence": "NotSet",
							"hasImportance": "NotSet",
							"hasOrder": "1",
							"hasTextContent": "Both  chlorpromazine  and  lercanidipine  can increase the risk of hypotension. \n\n"
						}
					],
					"hasOrder": "170",
					"hasTitle": {
						"@type": "rdf:XMLLiteral",
						"@value": "<title>Lercanidipine</title>"
					}
				},
				{
					"@id": "http://bnf.nice.org.uk/interaction/chlorpromazine#bnf_i1557280698542",
					"hasMessage": [
						{
							"@id": "http://bnf.nice.org.uk/interaction/chlorpromazine#bnf_i1557280698542_message_0",
							"hasDitaContent": {
								"@type": "rdf:XMLLiteral",
								"@value": "<p otherprops=\"Normal\" outputclass=\"int-message\">Both <ph otherprops=\"chlorpromazine\" outputclass=\"int-heading-drug\">chlorpromazine</ph> and <ph otherprops=\"levetiracetam\" outputclass=\"int-drug\">levetiracetam</ph> can have CNS depressant effects, which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in <xref format=\"dita\" href=\"guidance/guidance-on-prescribing.xml\" type=\"interaction\" rel=\"guidance\" bnfid=\"PHP97234\">Guidance on Prescribing</xref>).</p>"
							},
							"hasEvidence": "NotSet",
							"hasImportance": "NotSet",
							"hasOrder": "1",
							"hasTextContent": "Both  chlorpromazine  and  levetiracetam  can have CNS depressant effects, which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in  Guidance on Prescribing ). \n\n"
						}
					],
					"hasOrder": "171",
					"hasTitle": {
						"@type": "rdf:XMLLiteral",
						"@value": "<title>Levetiracetam</title>"
					}
				},
				{
					"@id": "http://bnf.nice.org.uk/interaction/chlorpromazine#bnf_i1557280698543",
					"hasMessage": [
						{
							"@id": "http://bnf.nice.org.uk/interaction/chlorpromazine#bnf_i1557280698543_message_0",
							"hasDitaContent": {
								"@type": "rdf:XMLLiteral",
								"@value": "<p otherprops=\"Normal\" outputclass=\"int-message\">Both <ph otherprops=\"chlorpromazine\" outputclass=\"int-heading-drug\">chlorpromazine</ph> and <ph otherprops=\"levobunolol\" outputclass=\"int-drug\">levobunolol</ph> can increase the risk of hypotension.</p>"
							},
							"hasEvidence": "NotSet",
							"hasImportance": "NotSet",
							"hasOrder": "1",
							"hasTextContent": "Both  chlorpromazine  and  levobunolol  can increase the risk of hypotension. \n\n"
						}
					],
					"hasOrder": "172",
					"hasTitle": {
						"@type": "rdf:XMLLiteral",
						"@value": "<title>Levobunolol</title>"
					}
				},
				{
					"@id": "http://bnf.nice.org.uk/interaction/chlorpromazine#bnf_i1557280698544",
					"hasMessage": [
						{
							"@id": "http://bnf.nice.org.uk/interaction/chlorpromazine#bnf_i1557280698544_message_0",
							"hasDitaContent": {
								"@type": "rdf:XMLLiteral",
								"@value": "<p otherprops=\"Normal\" outputclass=\"int-message\">Both <ph otherprops=\"chlorpromazine\" outputclass=\"int-heading-drug\">chlorpromazine</ph> and <ph otherprops=\"levodopa\" outputclass=\"int-drug\">levodopa</ph> can increase the risk of hypotension.</p>"
							},
							"hasEvidence": "NotSet",
							"hasImportance": "NotSet",
							"hasOrder": "1",
							"hasTextContent": "Both  chlorpromazine  and  levodopa  can increase the risk of hypotension. \n\n"
						},
						{
							"@id": "http://bnf.nice.org.uk/interaction/chlorpromazine#bnf_i1557280698544_message_1",
							"hasDitaContent": {
								"@type": "rdf:XMLLiteral",
								"@value": "<p otherprops=\"Severe\" outputclass=\"int-message\">\n  <ph otherprops=\"chlorpromazine\" outputclass=\"int-heading-drug\">Chlorpromazine</ph> <ph outputclass=\"int-effect\">decreases</ph> <ph outputclass=\"int-parameter\">the effects of</ph> <ph otherprops=\"levodopa\" outputclass=\"int-drug\">levodopa</ph>. <ph outputclass=\"int-action\">Manufacturer advises avoid or monitor worsening parkinsonian symptoms</ph>.  </p>"
							},
							"hasEvidence": "Study",
							"hasImportance": "Severe",
							"hasOrder": "2",
							"hasTextContent": "Chlorpromazine   decreases   the effects of   levodopa .  Manufacturer advises avoid or monitor worsening parkinsonian symptoms .    \n\n"
						},
						{
							"@id": "http://bnf.nice.org.uk/interaction/chlorpromazine#bnf_i1557280698544_message_2",
							"hasDitaContent": {
								"@type": "rdf:XMLLiteral",
								"@value": "<p otherprops=\"Moderate\" outputclass=\"int-message\">\n  <ph otherprops=\"chlorpromazine\" outputclass=\"int-heading-drug\">Chlorpromazine</ph> <ph outputclass=\"int-effect\">decreases</ph> <ph outputclass=\"int-parameter\">the absorption of</ph> <ph otherprops=\"levodopa\" outputclass=\"int-drug\">levodopa</ph>. <ph outputclass=\"int-action\">Manufacturer makes no recommendation</ph>.  </p>"
							},
							"hasEvidence": "Theoretical",
							"hasImportance": "Moderate",
							"hasOrder": "3",
							"hasTextContent": "Chlorpromazine   decreases   the absorption of   levodopa .  Manufacturer makes no recommendation .    \n\n"
						}
					],
					"hasOrder": "173",
					"hasTitle": {
						"@type": "rdf:XMLLiteral",
						"@value": "<title>Levodopa</title>"
					}
				},
				{
					"@id": "http://bnf.nice.org.uk/interaction/chlorpromazine#bnf_i1557280698545",
					"hasMessage": [
						{
							"@id": "http://bnf.nice.org.uk/interaction/chlorpromazine#bnf_i1557280698545_message_0",
							"hasDitaContent": {
								"@type": "rdf:XMLLiteral",
								"@value": "<p otherprops=\"Normal\" outputclass=\"int-message\">Both <ph otherprops=\"chlorpromazine\" outputclass=\"int-heading-drug\">chlorpromazine</ph> and <ph otherprops=\"lidocaine\" outputclass=\"int-drug\">lidocaine</ph> can have CNS depressant effects, which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in <xref format=\"dita\" href=\"guidance/guidance-on-prescribing.xml\" type=\"interaction\" rel=\"guidance\" bnfid=\"PHP97234\">Guidance on Prescribing</xref>).</p>"
							},
							"hasEvidence": "NotSet",
							"hasImportance": "NotSet",
							"hasOrder": "1",
							"hasTextContent": "Both  chlorpromazine  and  lidocaine  can have CNS depressant effects, which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in  Guidance on Prescribing ). \n\n"
						}
					],
					"hasOrder": "174",
					"hasTitle": {
						"@type": "rdf:XMLLiteral",
						"@value": "<title>Lidocaine</title>"
					}
				},
				{
					"@id": "http://bnf.nice.org.uk/interaction/chlorpromazine#bnf_i1557280698546",
					"hasMessage": [
						{
							"@id": "http://bnf.nice.org.uk/interaction/chlorpromazine#bnf_i1557280698546_message_0",
							"hasDitaContent": {
								"@type": "rdf:XMLLiteral",
								"@value": "<p otherprops=\"Moderate\" outputclass=\"int-message\">\n  <ph otherprops=\"chlorpromazine\" outputclass=\"int-heading-drug\">Chlorpromazine</ph> <ph outputclass=\"int-effectQualifier\">is predicted to</ph> <ph outputclass=\"int-effect\">decrease</ph> <ph outputclass=\"int-parameter\">the effects of</ph> <ph otherprops=\"lisdexamfetamine\" outputclass=\"int-drug\">lisdexamfetamine</ph> and <ph otherprops=\"lisdexamfetamine\" outputclass=\"int-drug\">lisdexamfetamine</ph> <ph outputclass=\"int-effectQualifier\">is predicted to</ph> <ph outputclass=\"int-effect\">decrease</ph> <ph outputclass=\"int-parameter\">the effects of</ph> <ph otherprops=\"chlorpromazine\" outputclass=\"int-heading-drug\">chlorpromazine</ph>. <ph outputclass=\"int-action\">Manufacturer makes no recommendation</ph>.  </p>"
							},
							"hasEvidence": "Study",
							"hasImportance": "Moderate",
							"hasOrder": "1",
							"hasTextContent": "Chlorpromazine   is predicted to   decrease   the effects of   lisdexamfetamine  and  lisdexamfetamine   is predicted to   decrease   the effects of   chlorpromazine .  Manufacturer makes no recommendation .    \n\n"
						}
					],
					"hasOrder": "175",
					"hasTitle": {
						"@type": "rdf:XMLLiteral",
						"@value": "<title>Lisdexamfetamine</title>"
					}
				},
				{
					"@id": "http://bnf.nice.org.uk/interaction/chlorpromazine#bnf_i1557280698547",
					"hasMessage": [
						{
							"@id": "http://bnf.nice.org.uk/interaction/chlorpromazine#bnf_i1557280698547_message_0",
							"hasDitaContent": {
								"@type": "rdf:XMLLiteral",
								"@value": "<p otherprops=\"Normal\" outputclass=\"int-message\">Both <ph otherprops=\"chlorpromazine\" outputclass=\"int-heading-drug\">chlorpromazine</ph> and <ph otherprops=\"lisinopril\" outputclass=\"int-drug\">lisinopril</ph> can increase the risk of hypotension.</p>"
							},
							"hasEvidence": "NotSet",
							"hasImportance": "NotSet",
							"hasOrder": "1",
							"hasTextContent": "Both  chlorpromazine  and  lisinopril  can increase the risk of hypotension. \n\n"
						}
					],
					"hasOrder": "176",
					"hasTitle": {
						"@type": "rdf:XMLLiteral",
						"@value": "<title>Lisinopril</title>"
					}
				},
				{
					"@id": "http://bnf.nice.org.uk/interaction/chlorpromazine#bnf_i1557280698548",
					"hasMessage": [
						{
							"@id": "http://bnf.nice.org.uk/interaction/chlorpromazine#bnf_i1557280698548_message_0",
							"hasDitaContent": {
								"@type": "rdf:XMLLiteral",
								"@value": "<p otherprops=\"Severe\" outputclass=\"int-message\">Both <ph otherprops=\"chlorpromazine\" outputclass=\"int-heading-drug\">chlorpromazine</ph> and <ph otherprops=\"lithium\" outputclass=\"int-drug\">lithium</ph> prolong the QT interval. Most manufacturers advise avoiding the use of two or more drugs that are associated with QT prolongation. Increasing age, female sex, cardiac disease, and some metabolic disturbances (notably hypokalaemia) predispose to QT prolongation. </p>"
							},
							"hasEvidence": "NotSet",
							"hasImportance": "Severe",
							"hasOrder": "1",
							"hasTextContent": "Both  chlorpromazine  and  lithium  prolong the QT interval. Most manufacturers advise avoiding the use of two or more drugs that are associated with QT prolongation. Increasing age, female sex, cardiac disease, and some metabolic disturbances (notably hypokalaemia) predispose to QT prolongation.  \n\n"
						},
						{
							"@id": "http://bnf.nice.org.uk/interaction/chlorpromazine#bnf_i1557280698548_message_1",
							"hasDitaContent": {
								"@type": "rdf:XMLLiteral",
								"@value": "<p otherprops=\"Severe\" outputclass=\"int-message\">\n  <ph otherprops=\"chlorpromazine\" outputclass=\"int-heading-drug\">Chlorpromazine</ph> <ph outputclass=\"int-effectQualifier\">potentially</ph> <ph outputclass=\"int-effect\">increases</ph> <ph outputclass=\"int-parameter\">the risk of neurotoxicity when given with</ph> <ph otherprops=\"lithium\" outputclass=\"int-drug\">lithium</ph>. <ph outputclass=\"int-action\">Manufacturer advises discontinue if neurotoxicity develops</ph>.  </p>"
							},
							"hasEvidence": "Anecdotal",
							"hasImportance": "Severe",
							"hasOrder": "2",
							"hasTextContent": "Chlorpromazine   potentially   increases   the risk of neurotoxicity when given with   lithium .  Manufacturer advises discontinue if neurotoxicity develops .    \n\n"
						}
					],
					"hasOrder": "177",
					"hasTitle": {
						"@type": "rdf:XMLLiteral",
						"@value": "<title>Lithium</title>"
					}
				},
				{
					"@id": "http://bnf.nice.org.uk/interaction/chlorpromazine#bnf_i1557280698549",
					"hasMessage": [
						{
							"@id": "http://bnf.nice.org.uk/interaction/chlorpromazine#bnf_i1557280698549_message_0",
							"hasDitaContent": {
								"@type": "rdf:XMLLiteral",
								"@value": "<p otherprops=\"Normal\" outputclass=\"int-message\">Both <ph otherprops=\"chlorpromazine\" outputclass=\"int-heading-drug\">chlorpromazine</ph> and <ph otherprops=\"lofepramine\" outputclass=\"int-drug\">lofepramine</ph> can increase the risk of hypotension.</p>"
							},
							"hasEvidence": "NotSet",
							"hasImportance": "NotSet",
							"hasOrder": "1",
							"hasTextContent": "Both  chlorpromazine  and  lofepramine  can increase the risk of hypotension. \n\n"
						},
						{
							"@id": "http://bnf.nice.org.uk/interaction/chlorpromazine#bnf_i1557280698549_message_1",
							"hasDitaContent": {
								"@type": "rdf:XMLLiteral",
								"@value": "<p otherprops=\"Normal\" outputclass=\"int-message\">Both <ph otherprops=\"chlorpromazine\" outputclass=\"int-heading-drug\">chlorpromazine</ph> and <ph otherprops=\"lofepramine\" outputclass=\"int-drug\">lofepramine</ph> can cause antimuscarinic effects.</p>"
							},
							"hasEvidence": "NotSet",
							"hasImportance": "NotSet",
							"hasOrder": "2",
							"hasTextContent": "Both  chlorpromazine  and  lofepramine  can cause antimuscarinic effects. \n\n"
						}
					],
					"hasOrder": "178",
					"hasTitle": {
						"@type": "rdf:XMLLiteral",
						"@value": "<title>Lofepramine</title>"
					}
				},
				{
					"@id": "http://bnf.nice.org.uk/interaction/chlorpromazine#bnf_i1557280698550",
					"hasMessage": [
						{
							"@id": "http://bnf.nice.org.uk/interaction/chlorpromazine#bnf_i1557280698550_message_0",
							"hasDitaContent": {
								"@type": "rdf:XMLLiteral",
								"@value": "<p otherprops=\"Normal\" outputclass=\"int-message\">Both <ph otherprops=\"chlorpromazine\" outputclass=\"int-heading-drug\">chlorpromazine</ph> and <ph otherprops=\"lofexidine\" outputclass=\"int-drug\">lofexidine</ph> can increase the risk of hypotension.</p>"
							},
							"hasEvidence": "NotSet",
							"hasImportance": "NotSet",
							"hasOrder": "1",
							"hasTextContent": "Both  chlorpromazine  and  lofexidine  can increase the risk of hypotension. \n\n"
						},
						{
							"@id": "http://bnf.nice.org.uk/interaction/chlorpromazine#bnf_i1557280698550_message_1",
							"hasDitaContent": {
								"@type": "rdf:XMLLiteral",
								"@value": "<p otherprops=\"Severe\" outputclass=\"int-message\">Both <ph otherprops=\"chlorpromazine\" outputclass=\"int-heading-drug\">chlorpromazine</ph> and <ph otherprops=\"lofexidine\" outputclass=\"int-drug\">lofexidine</ph> prolong the QT interval. Most manufacturers advise avoiding the use of two or more drugs that are associated with QT prolongation. Increasing age, female sex, cardiac disease, and some metabolic disturbances (notably hypokalaemia) predispose to QT prolongation. </p>"
							},
							"hasEvidence": "NotSet",
							"hasImportance": "Severe",
							"hasOrder": "2",
							"hasTextContent": "Both  chlorpromazine  and  lofexidine  prolong the QT interval. Most manufacturers advise avoiding the use of two or more drugs that are associated with QT prolongation. Increasing age, female sex, cardiac disease, and some metabolic disturbances (notably hypokalaemia) predispose to QT prolongation.  \n\n"
						},
						{
							"@id": "http://bnf.nice.org.uk/interaction/chlorpromazine#bnf_i1557280698550_message_2",
							"hasDitaContent": {
								"@type": "rdf:XMLLiteral",
								"@value": "<p otherprops=\"Normal\" outputclass=\"int-message\">Both <ph otherprops=\"chlorpromazine\" outputclass=\"int-heading-drug\">chlorpromazine</ph> and <ph otherprops=\"lofexidine\" outputclass=\"int-drug\">lofexidine</ph> can have CNS depressant effects, which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in <xref format=\"dita\" href=\"guidance/guidance-on-prescribing.xml\" type=\"interaction\" rel=\"guidance\" bnfid=\"PHP97234\">Guidance on Prescribing</xref>).</p>"
							},
							"hasEvidence": "NotSet",
							"hasImportance": "NotSet",
							"hasOrder": "3",
							"hasTextContent": "Both  chlorpromazine  and  lofexidine  can have CNS depressant effects, which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in  Guidance on Prescribing ). \n\n"
						}
					],
					"hasOrder": "179",
					"hasTitle": {
						"@type": "rdf:XMLLiteral",
						"@value": "<title>Lofexidine</title>"
					}
				},
				{
					"@id": "http://bnf.nice.org.uk/interaction/chlorpromazine#bnf_i1557280698551",
					"hasMessage": [
						{
							"@id": "http://bnf.nice.org.uk/interaction/chlorpromazine#bnf_i1557280698551_message_0",
							"hasDitaContent": {
								"@type": "rdf:XMLLiteral",
								"@value": "<p otherprops=\"Normal\" outputclass=\"int-message\">Both <ph otherprops=\"chlorpromazine\" outputclass=\"int-heading-drug\">chlorpromazine</ph> and <ph otherprops=\"loprazolam\" outputclass=\"int-drug\">loprazolam</ph> can have CNS depressant effects, which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in <xref format=\"dita\" href=\"guidance/guidance-on-prescribing.xml\" type=\"interaction\" rel=\"guidance\" bnfid=\"PHP97234\">Guidance on Prescribing</xref>).</p>"
							},
							"hasEvidence": "NotSet",
							"hasImportance": "NotSet",
							"hasOrder": "1",
							"hasTextContent": "Both  chlorpromazine  and  loprazolam  can have CNS depressant effects, which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in  Guidance on Prescribing ). \n\n"
						}
					],
					"hasOrder": "180",
					"hasTitle": {
						"@type": "rdf:XMLLiteral",
						"@value": "<title>Loprazolam</title>"
					}
				},
				{
					"@id": "http://bnf.nice.org.uk/interaction/chlorpromazine#bnf_i1557280698552",
					"hasMessage": [
						{
							"@id": "http://bnf.nice.org.uk/interaction/chlorpromazine#bnf_i1557280698552_message_0",
							"hasDitaContent": {
								"@type": "rdf:XMLLiteral",
								"@value": "<p otherprops=\"Normal\" outputclass=\"int-message\">Both <ph otherprops=\"chlorpromazine\" outputclass=\"int-heading-drug\">chlorpromazine</ph> and <ph otherprops=\"lorazepam\" outputclass=\"int-drug\">lorazepam</ph> can have CNS depressant effects, which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in <xref format=\"dita\" href=\"guidance/guidance-on-prescribing.xml\" type=\"interaction\" rel=\"guidance\" bnfid=\"PHP97234\">Guidance on Prescribing</xref>).</p>"
							},
							"hasEvidence": "NotSet",
							"hasImportance": "NotSet",
							"hasOrder": "1",
							"hasTextContent": "Both  chlorpromazine  and  lorazepam  can have CNS depressant effects, which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in  Guidance on Prescribing ). \n\n"
						}
					],
					"hasOrder": "181",
					"hasTitle": {
						"@type": "rdf:XMLLiteral",
						"@value": "<title>Lorazepam</title>"
					}
				},
				{
					"@id": "http://bnf.nice.org.uk/interaction/chlorpromazine#bnf_i1557280698553",
					"hasMessage": [
						{
							"@id": "http://bnf.nice.org.uk/interaction/chlorpromazine#bnf_i1557280698553_message_0",
							"hasDitaContent": {
								"@type": "rdf:XMLLiteral",
								"@value": "<p otherprops=\"Normal\" outputclass=\"int-message\">Both <ph otherprops=\"chlorpromazine\" outputclass=\"int-heading-drug\">chlorpromazine</ph> and <ph otherprops=\"lormetazepam\" outputclass=\"int-drug\">lormetazepam</ph> can have CNS depressant effects, which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in <xref format=\"dita\" href=\"guidance/guidance-on-prescribing.xml\" type=\"interaction\" rel=\"guidance\" bnfid=\"PHP97234\">Guidance on Prescribing</xref>).</p>"
							},
							"hasEvidence": "NotSet",
							"hasImportance": "NotSet",
							"hasOrder": "1",
							"hasTextContent": "Both  chlorpromazine  and  lormetazepam  can have CNS depressant effects, which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in  Guidance on Prescribing ). \n\n"
						}
					],
					"hasOrder": "182",
					"hasTitle": {
						"@type": "rdf:XMLLiteral",
						"@value": "<title>Lormetazepam</title>"
					}
				},
				{
					"@id": "http://bnf.nice.org.uk/interaction/chlorpromazine#bnf_i1557280698554",
					"hasMessage": [
						{
							"@id": "http://bnf.nice.org.uk/interaction/chlorpromazine#bnf_i1557280698554_message_0",
							"hasDitaContent": {
								"@type": "rdf:XMLLiteral",
								"@value": "<p otherprops=\"Normal\" outputclass=\"int-message\">Both <ph otherprops=\"chlorpromazine\" outputclass=\"int-heading-drug\">chlorpromazine</ph> and <ph otherprops=\"losartan\" outputclass=\"int-drug\">losartan</ph> can increase the risk of hypotension.</p>"
							},
							"hasEvidence": "NotSet",
							"hasImportance": "NotSet",
							"hasOrder": "1",
							"hasTextContent": "Both  chlorpromazine  and  losartan  can increase the risk of hypotension. \n\n"
						}
					],
					"hasOrder": "183",
					"hasTitle": {
						"@type": "rdf:XMLLiteral",
						"@value": "<title>Losartan</title>"
					}
				},
				{
					"@id": "http://bnf.nice.org.uk/interaction/chlorpromazine#bnf_i1557280698555",
					"hasMessage": [
						{
							"@id": "http://bnf.nice.org.uk/interaction/chlorpromazine#bnf_i1557280698555_message_0",
							"hasDitaContent": {
								"@type": "rdf:XMLLiteral",
								"@value": "<p otherprops=\"Normal\" outputclass=\"int-message\">Both <ph otherprops=\"chlorpromazine\" outputclass=\"int-heading-drug\">chlorpromazine</ph> and <ph otherprops=\"loxapine\" outputclass=\"int-drug\">loxapine</ph> can increase the risk of hypotension.</p>"
							},
							"hasEvidence": "NotSet",
							"hasImportance": "NotSet",
							"hasOrder": "1",
							"hasTextContent": "Both  chlorpromazine  and  loxapine  can increase the risk of hypotension. \n\n"
						},
						{
							"@id": "http://bnf.nice.org.uk/interaction/chlorpromazine#bnf_i1557280698555_message_1",
							"hasDitaContent": {
								"@type": "rdf:XMLLiteral",
								"@value": "<p otherprops=\"Normal\" outputclass=\"int-message\">Both <ph otherprops=\"chlorpromazine\" outputclass=\"int-heading-drug\">chlorpromazine</ph> and <ph otherprops=\"loxapine\" outputclass=\"int-drug\">loxapine</ph> can have CNS depressant effects, which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in <xref format=\"dita\" href=\"guidance/guidance-on-prescribing.xml\" type=\"interaction\" rel=\"guidance\" bnfid=\"PHP97234\">Guidance on Prescribing</xref>).</p>"
							},
							"hasEvidence": "NotSet",
							"hasImportance": "NotSet",
							"hasOrder": "2",
							"hasTextContent": "Both  chlorpromazine  and  loxapine  can have CNS depressant effects, which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in  Guidance on Prescribing ). \n\n"
						},
						{
							"@id": "http://bnf.nice.org.uk/interaction/chlorpromazine#bnf_i1557280698555_message_2",
							"hasDitaContent": {
								"@type": "rdf:XMLLiteral",
								"@value": "<p otherprops=\"Normal\" outputclass=\"int-message\">Both <ph otherprops=\"chlorpromazine\" outputclass=\"int-heading-drug\">chlorpromazine</ph> and <ph otherprops=\"loxapine\" outputclass=\"int-drug\">loxapine</ph> can cause antimuscarinic effects.</p>"
							},
							"hasEvidence": "NotSet",
							"hasImportance": "NotSet",
							"hasOrder": "3",
							"hasTextContent": "Both  chlorpromazine  and  loxapine  can cause antimuscarinic effects. \n\n"
						}
					],
					"hasOrder": "184",
					"hasTitle": {
						"@type": "rdf:XMLLiteral",
						"@value": "<title>Loxapine</title>"
					}
				},
				{
					"@id": "http://bnf.nice.org.uk/interaction/chlorpromazine#bnf_i1557280698556",
					"hasMessage": [
						{
							"@id": "http://bnf.nice.org.uk/interaction/chlorpromazine#bnf_i1557280698556_message_0",
							"hasDitaContent": {
								"@type": "rdf:XMLLiteral",
								"@value": "<p otherprops=\"Normal\" outputclass=\"int-message\">Both <ph otherprops=\"chlorpromazine\" outputclass=\"int-heading-drug\">chlorpromazine</ph> and <ph otherprops=\"lurasidone\" outputclass=\"int-drug\">lurasidone</ph> can increase the risk of hypotension.</p>"
							},
							"hasEvidence": "NotSet",
							"hasImportance": "NotSet",
							"hasOrder": "1",
							"hasTextContent": "Both  chlorpromazine  and  lurasidone  can increase the risk of hypotension. \n\n"
						},
						{
							"@id": "http://bnf.nice.org.uk/interaction/chlorpromazine#bnf_i1557280698556_message_1",
							"hasDitaContent": {
								"@type": "rdf:XMLLiteral",
								"@value": "<p otherprops=\"Normal\" outputclass=\"int-message\">Both <ph otherprops=\"chlorpromazine\" outputclass=\"int-heading-drug\">chlorpromazine</ph> and <ph otherprops=\"lurasidone\" outputclass=\"int-drug\">lurasidone</ph> can have CNS depressant effects, which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in <xref format=\"dita\" href=\"guidance/guidance-on-prescribing.xml\" type=\"interaction\" rel=\"guidance\" bnfid=\"PHP97234\">Guidance on Prescribing</xref>).</p>"
							},
							"hasEvidence": "NotSet",
							"hasImportance": "NotSet",
							"hasOrder": "2",
							"hasTextContent": "Both  chlorpromazine  and  lurasidone  can have CNS depressant effects, which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in  Guidance on Prescribing ). \n\n"
						}
					],
					"hasOrder": "185",
					"hasTitle": {
						"@type": "rdf:XMLLiteral",
						"@value": "<title>Lurasidone</title>"
					}
				},
				{
					"@id": "http://bnf.nice.org.uk/interaction/chlorpromazine#bnf_i1557280698557",
					"hasMessage": [
						{
							"@id": "http://bnf.nice.org.uk/interaction/chlorpromazine#bnf_i1557280698557_message_0",
							"hasDitaContent": {
								"@type": "rdf:XMLLiteral",
								"@value": "<p otherprops=\"Moderate\" outputclass=\"int-message\">\n  <ph otherprops=\"magnesium carbonate\" outputclass=\"int-drug\">Magnesium carbonate</ph> <ph outputclass=\"int-effect\">decreases</ph> <ph outputclass=\"int-parameter\">the absorption of</ph> <ph otherprops=\"chlorpromazine\" outputclass=\"int-heading-drug\">chlorpromazine</ph>. <ph outputclass=\"int-action\">Manufacturer makes no recommendation</ph>.  </p>"
							},
							"hasEvidence": "Anecdotal",
							"hasImportance": "Moderate",
							"hasOrder": "1",
							"hasTextContent": "Magnesium carbonate   decreases   the absorption of   chlorpromazine .  Manufacturer makes no recommendation .    \n\n"
						}
					],
					"hasOrder": "186",
					"hasTitle": {
						"@type": "rdf:XMLLiteral",
						"@value": "<title>Magnesium carbonate</title>"
					}
				},
				{
					"@id": "http://bnf.nice.org.uk/interaction/chlorpromazine#bnf_i1557280698558",
					"hasMessage": [
						{
							"@id": "http://bnf.nice.org.uk/interaction/chlorpromazine#bnf_i1557280698558_message_0",
							"hasDitaContent": {
								"@type": "rdf:XMLLiteral",
								"@value": "<p otherprops=\"Moderate\" outputclass=\"int-message\">\n  <ph otherprops=\"magnesium trisilicate\" outputclass=\"int-drug\">Magnesium trisilicate</ph> <ph outputclass=\"int-effect\">decreases</ph> <ph outputclass=\"int-parameter\">the absorption of</ph> <ph otherprops=\"chlorpromazine\" outputclass=\"int-heading-drug\">chlorpromazine</ph>. <ph outputclass=\"int-action\">Manufacturer makes no recommendation</ph>.  </p>"
							},
							"hasEvidence": "Anecdotal",
							"hasImportance": "Moderate",
							"hasOrder": "1",
							"hasTextContent": "Magnesium trisilicate   decreases   the absorption of   chlorpromazine .  Manufacturer makes no recommendation .    \n\n"
						}
					],
					"hasOrder": "187",
					"hasTitle": {
						"@type": "rdf:XMLLiteral",
						"@value": "<title>Magnesium trisilicate</title>"
					}
				},
				{
					"@id": "http://bnf.nice.org.uk/interaction/chlorpromazine#bnf_i1557280698559",
					"hasMessage": [
						{
							"@id": "http://bnf.nice.org.uk/interaction/chlorpromazine#bnf_i1557280698559_message_0",
							"hasDitaContent": {
								"@type": "rdf:XMLLiteral",
								"@value": "<p otherprops=\"Severe\" outputclass=\"int-message\">\n  <ph otherprops=\"mefloquine\" outputclass=\"int-drug\">Mefloquine</ph> <ph outputclass=\"int-effectQualifier\">is predicted to</ph> <ph outputclass=\"int-effect\">increase</ph> <ph outputclass=\"int-parameter\">the risk of QT-prolongation when given with</ph> <ph otherprops=\"chlorpromazine\" outputclass=\"int-heading-drug\">chlorpromazine</ph>. <ph outputclass=\"int-action\">Manufacturer makes no recommendation</ph>.  </p>"
							},
							"hasEvidence": "Theoretical",
							"hasImportance": "Severe",
							"hasOrder": "1",
							"hasTextContent": "Mefloquine   is predicted to   increase   the risk of QT-prolongation when given with   chlorpromazine .  Manufacturer makes no recommendation .    \n\n"
						}
					],
					"hasOrder": "188",
					"hasTitle": {
						"@type": "rdf:XMLLiteral",
						"@value": "<title>Mefloquine</title>"
					}
				},
				{
					"@id": "http://bnf.nice.org.uk/interaction/chlorpromazine#bnf_i1557280698560",
					"hasMessage": [
						{
							"@id": "http://bnf.nice.org.uk/interaction/chlorpromazine#bnf_i1557280698560_message_0",
							"hasDitaContent": {
								"@type": "rdf:XMLLiteral",
								"@value": "<p otherprops=\"Normal\" outputclass=\"int-message\">Both <ph otherprops=\"chlorpromazine\" outputclass=\"int-heading-drug\">chlorpromazine</ph> and <ph otherprops=\"melatonin\" outputclass=\"int-drug\">melatonin</ph> can have CNS depressant effects, which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in <xref format=\"dita\" href=\"guidance/guidance-on-prescribing.xml\" type=\"interaction\" rel=\"guidance\" bnfid=\"PHP97234\">Guidance on Prescribing</xref>).</p>"
							},
							"hasEvidence": "NotSet",
							"hasImportance": "NotSet",
							"hasOrder": "1",
							"hasTextContent": "Both  chlorpromazine  and  melatonin  can have CNS depressant effects, which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in  Guidance on Prescribing ). \n\n"
						}
					],
					"hasOrder": "189",
					"hasTitle": {
						"@type": "rdf:XMLLiteral",
						"@value": "<title>Melatonin</title>"
					}
				},
				{
					"@id": "http://bnf.nice.org.uk/interaction/chlorpromazine#bnf_i1557280698561",
					"hasMessage": [
						{
							"@id": "http://bnf.nice.org.uk/interaction/chlorpromazine#bnf_i1557280698561_message_0",
							"hasDitaContent": {
								"@type": "rdf:XMLLiteral",
								"@value": "<p otherprops=\"Normal\" outputclass=\"int-message\">Both <ph otherprops=\"chlorpromazine\" outputclass=\"int-heading-drug\">chlorpromazine</ph> and <ph otherprops=\"mepivacaine\" outputclass=\"int-drug\">mepivacaine</ph> can have CNS depressant effects, which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in <xref format=\"dita\" href=\"guidance/guidance-on-prescribing.xml\" type=\"interaction\" rel=\"guidance\" bnfid=\"PHP97234\">Guidance on Prescribing</xref>).</p>"
							},
							"hasEvidence": "NotSet",
							"hasImportance": "NotSet",
							"hasOrder": "1",
							"hasTextContent": "Both  chlorpromazine  and  mepivacaine  can have CNS depressant effects, which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in  Guidance on Prescribing ). \n\n"
						}
					],
					"hasOrder": "190",
					"hasTitle": {
						"@type": "rdf:XMLLiteral",
						"@value": "<title>Mepivacaine</title>"
					}
				},
				{
					"@id": "http://bnf.nice.org.uk/interaction/chlorpromazine#bnf_i1557280698562",
					"hasMessage": [
						{
							"@id": "http://bnf.nice.org.uk/interaction/chlorpromazine#bnf_i1557280698562_message_0",
							"hasDitaContent": {
								"@type": "rdf:XMLLiteral",
								"@value": "<p otherprops=\"Normal\" outputclass=\"int-message\">Both <ph otherprops=\"chlorpromazine\" outputclass=\"int-heading-drug\">chlorpromazine</ph> and <ph otherprops=\"meprobamate\" outputclass=\"int-drug\">meprobamate</ph> can have CNS depressant effects, which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in <xref format=\"dita\" href=\"guidance/guidance-on-prescribing.xml\" type=\"interaction\" rel=\"guidance\" bnfid=\"PHP97234\">Guidance on Prescribing</xref>).</p>"
							},
							"hasEvidence": "NotSet",
							"hasImportance": "NotSet",
							"hasOrder": "1",
							"hasTextContent": "Both  chlorpromazine  and  meprobamate  can have CNS depressant effects, which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in  Guidance on Prescribing ). \n\n"
						}
					],
					"hasOrder": "191",
					"hasTitle": {
						"@type": "rdf:XMLLiteral",
						"@value": "<title>Meprobamate</title>"
					}
				},
				{
					"@id": "http://bnf.nice.org.uk/interaction/chlorpromazine#bnf_i1557280698563",
					"hasMessage": [
						{
							"@id": "http://bnf.nice.org.uk/interaction/chlorpromazine#bnf_i1557280698563_message_0",
							"hasDitaContent": {
								"@type": "rdf:XMLLiteral",
								"@value": "<p otherprops=\"Normal\" outputclass=\"int-message\">Both <ph otherprops=\"chlorpromazine\" outputclass=\"int-heading-drug\">chlorpromazine</ph> and <ph otherprops=\"meptazinol\" outputclass=\"int-drug\">meptazinol</ph> can have CNS depressant effects, which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in <xref format=\"dita\" href=\"guidance/guidance-on-prescribing.xml\" type=\"interaction\" rel=\"guidance\" bnfid=\"PHP97234\">Guidance on Prescribing</xref>).</p>"
							},
							"hasEvidence": "NotSet",
							"hasImportance": "NotSet",
							"hasOrder": "1",
							"hasTextContent": "Both  chlorpromazine  and  meptazinol  can have CNS depressant effects, which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in  Guidance on Prescribing ). \n\n"
						}
					],
					"hasOrder": "192",
					"hasTitle": {
						"@type": "rdf:XMLLiteral",
						"@value": "<title>Meptazinol</title>"
					}
				},
				{
					"@id": "http://bnf.nice.org.uk/interaction/chlorpromazine#bnf_i1557280698564",
					"hasMessage": [
						{
							"@id": "http://bnf.nice.org.uk/interaction/chlorpromazine#bnf_i1557280698564_message_0",
							"hasDitaContent": {
								"@type": "rdf:XMLLiteral",
								"@value": "<p otherprops=\"Severe\" outputclass=\"int-message\">Both <ph otherprops=\"chlorpromazine\" outputclass=\"int-heading-drug\">chlorpromazine</ph> and <ph otherprops=\"methadone\" outputclass=\"int-drug\">methadone</ph> prolong the QT interval. Most manufacturers advise avoiding the use of two or more drugs that are associated with QT prolongation. Increasing age, female sex, cardiac disease, and some metabolic disturbances (notably hypokalaemia) predispose to QT prolongation. </p>"
							},
							"hasEvidence": "NotSet",
							"hasImportance": "Severe",
							"hasOrder": "1",
							"hasTextContent": "Both  chlorpromazine  and  methadone  prolong the QT interval. Most manufacturers advise avoiding the use of two or more drugs that are associated with QT prolongation. Increasing age, female sex, cardiac disease, and some metabolic disturbances (notably hypokalaemia) predispose to QT prolongation.  \n\n"
						},
						{
							"@id": "http://bnf.nice.org.uk/interaction/chlorpromazine#bnf_i1557280698564_message_1",
							"hasDitaContent": {
								"@type": "rdf:XMLLiteral",
								"@value": "<p otherprops=\"Normal\" outputclass=\"int-message\">Both <ph otherprops=\"chlorpromazine\" outputclass=\"int-heading-drug\">chlorpromazine</ph> and <ph otherprops=\"methadone\" outputclass=\"int-drug\">methadone</ph> can have CNS depressant effects, which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in <xref format=\"dita\" href=\"guidance/guidance-on-prescribing.xml\" type=\"interaction\" rel=\"guidance\" bnfid=\"PHP97234\">Guidance on Prescribing</xref>).</p>"
							},
							"hasEvidence": "NotSet",
							"hasImportance": "NotSet",
							"hasOrder": "2",
							"hasTextContent": "Both  chlorpromazine  and  methadone  can have CNS depressant effects, which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in  Guidance on Prescribing ). \n\n"
						}
					],
					"hasOrder": "193",
					"hasTitle": {
						"@type": "rdf:XMLLiteral",
						"@value": "<title>Methadone</title>"
					}
				},
				{
					"@id": "http://bnf.nice.org.uk/interaction/chlorpromazine#bnf_i1557280698565",
					"hasMessage": [
						{
							"@id": "http://bnf.nice.org.uk/interaction/chlorpromazine#bnf_i1557280698565_message_0",
							"hasDitaContent": {
								"@type": "rdf:XMLLiteral",
								"@value": "<p otherprops=\"Normal\" outputclass=\"int-message\">Both <ph otherprops=\"chlorpromazine\" outputclass=\"int-heading-drug\">chlorpromazine</ph> and <ph otherprops=\"methocarbamol\" outputclass=\"int-drug\">methocarbamol</ph> can have CNS depressant effects, which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in <xref format=\"dita\" href=\"guidance/guidance-on-prescribing.xml\" type=\"interaction\" rel=\"guidance\" bnfid=\"PHP97234\">Guidance on Prescribing</xref>).</p>"
							},
							"hasEvidence": "NotSet",
							"hasImportance": "NotSet",
							"hasOrder": "1",
							"hasTextContent": "Both  chlorpromazine  and  methocarbamol  can have CNS depressant effects, which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in  Guidance on Prescribing ). \n\n"
						}
					],
					"hasOrder": "194",
					"hasTitle": {
						"@type": "rdf:XMLLiteral",
						"@value": "<title>Methocarbamol</title>"
					}
				},
				{
					"@id": "http://bnf.nice.org.uk/interaction/chlorpromazine#bnf_i1557280698566",
					"hasMessage": [
						{
							"@id": "http://bnf.nice.org.uk/interaction/chlorpromazine#bnf_i1557280698566_message_0",
							"hasDitaContent": {
								"@type": "rdf:XMLLiteral",
								"@value": "<p otherprops=\"Normal\" outputclass=\"int-message\">Both <ph otherprops=\"chlorpromazine\" outputclass=\"int-heading-drug\">chlorpromazine</ph> and <ph otherprops=\"methoxyflurane\" outputclass=\"int-drug\">methoxyflurane</ph> can increase the risk of hypotension.</p>"
							},
							"hasEvidence": "NotSet",
							"hasImportance": "NotSet",
							"hasOrder": "1",
							"hasTextContent": "Both  chlorpromazine  and  methoxyflurane  can increase the risk of hypotension. \n\n"
						},
						{
							"@id": "http://bnf.nice.org.uk/interaction/chlorpromazine#bnf_i1557280698566_message_1",
							"hasDitaContent": {
								"@type": "rdf:XMLLiteral",
								"@value": "<p otherprops=\"Normal\" outputclass=\"int-message\">Both <ph otherprops=\"chlorpromazine\" outputclass=\"int-heading-drug\">chlorpromazine</ph> and <ph otherprops=\"methoxyflurane\" outputclass=\"int-drug\">methoxyflurane</ph> can have CNS depressant effects, which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in <xref format=\"dita\" href=\"guidance/guidance-on-prescribing.xml\" type=\"interaction\" rel=\"guidance\" bnfid=\"PHP97234\">Guidance on Prescribing</xref>).</p>"
							},
							"hasEvidence": "NotSet",
							"hasImportance": "NotSet",
							"hasOrder": "2",
							"hasTextContent": "Both  chlorpromazine  and  methoxyflurane  can have CNS depressant effects, which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in  Guidance on Prescribing ). \n\n"
						}
					],
					"hasOrder": "195",
					"hasTitle": {
						"@type": "rdf:XMLLiteral",
						"@value": "<title>Methoxyflurane</title>"
					}
				},
				{
					"@id": "http://bnf.nice.org.uk/interaction/chlorpromazine#bnf_i1557280698567",
					"hasMessage": [
						{
							"@id": "http://bnf.nice.org.uk/interaction/chlorpromazine#bnf_i1557280698567_message_0",
							"hasDitaContent": {
								"@type": "rdf:XMLLiteral",
								"@value": "<p otherprops=\"Normal\" outputclass=\"int-message\">Both <ph otherprops=\"chlorpromazine\" outputclass=\"int-heading-drug\">chlorpromazine</ph> and <ph otherprops=\"methyldopa\" outputclass=\"int-drug\">methyldopa</ph> can increase the risk of hypotension.</p>"
							},
							"hasEvidence": "NotSet",
							"hasImportance": "NotSet",
							"hasOrder": "1",
							"hasTextContent": "Both  chlorpromazine  and  methyldopa  can increase the risk of hypotension. \n\n"
						}
					],
					"hasOrder": "196",
					"hasTitle": {
						"@type": "rdf:XMLLiteral",
						"@value": "<title>Methyldopa</title>"
					}
				},
				{
					"@id": "http://bnf.nice.org.uk/interaction/chlorpromazine#bnf_i1557280698568",
					"hasMessage": [
						{
							"@id": "http://bnf.nice.org.uk/interaction/chlorpromazine#bnf_i1557280698568_message_0",
							"hasDitaContent": {
								"@type": "rdf:XMLLiteral",
								"@value": "<p otherprops=\"Severe\" outputclass=\"int-message\">\n  <ph otherprops=\"methylprednisolone\" outputclass=\"int-drug\">Methylprednisolone</ph> <ph outputclass=\"int-effectQualifier\">is predicted to</ph> <ph outputclass=\"int-effect\">cause</ph> <ph outputclass=\"int-parameter\">hypokalaemia (potentially increasing the risk of torsade de pointes) when given with</ph> <ph otherprops=\"chlorpromazine\" outputclass=\"int-heading-drug\">chlorpromazine</ph>. <ph outputclass=\"int-action\">Manufacturer makes no recommendation</ph>.  </p>"
							},
							"hasEvidence": "Theoretical",
							"hasImportance": "Severe",
							"hasOrder": "1",
							"hasTextContent": "Methylprednisolone   is predicted to   cause   hypokalaemia (potentially increasing the risk of torsade de pointes) when given with   chlorpromazine .  Manufacturer makes no recommendation .    \n\n"
						}
					],
					"hasOrder": "197",
					"hasTitle": {
						"@type": "rdf:XMLLiteral",
						"@value": "<title>Methylprednisolone</title>"
					}
				},
				{
					"@id": "http://bnf.nice.org.uk/interaction/chlorpromazine#bnf_i1557280698569",
					"hasMessage": [
						{
							"@id": "http://bnf.nice.org.uk/interaction/chlorpromazine#bnf_i1557280698569_message_0",
							"hasDitaContent": {
								"@type": "rdf:XMLLiteral",
								"@value": "<p otherprops=\"Normal\" outputclass=\"int-message\">Both <ph otherprops=\"chlorpromazine\" outputclass=\"int-heading-drug\">chlorpromazine</ph> and <ph otherprops=\"metolazone\" outputclass=\"int-drug\">metolazone</ph> can increase the risk of hypotension.</p>"
							},
							"hasEvidence": "NotSet",
							"hasImportance": "NotSet",
							"hasOrder": "1",
							"hasTextContent": "Both  chlorpromazine  and  metolazone  can increase the risk of hypotension. \n\n"
						},
						{
							"@id": "http://bnf.nice.org.uk/interaction/chlorpromazine#bnf_i1557280698569_message_1",
							"hasDitaContent": {
								"@type": "rdf:XMLLiteral",
								"@value": "<p otherprops=\"Severe\" outputclass=\"int-message\">\n  <ph otherprops=\"metolazone\" outputclass=\"int-drug\">Metolazone</ph> <ph outputclass=\"int-effectQualifier\">is predicted to</ph> <ph outputclass=\"int-effect\">cause</ph> <ph outputclass=\"int-parameter\">hypokalaemia (potentially increasing the risk of torsade de pointes) when given with</ph> <ph otherprops=\"chlorpromazine\" outputclass=\"int-heading-drug\">chlorpromazine</ph>. <ph outputclass=\"int-action\">Manufacturer makes no recommendation</ph>.  </p>"
							},
							"hasEvidence": "Theoretical",
							"hasImportance": "Severe",
							"hasOrder": "2",
							"hasTextContent": "Metolazone   is predicted to   cause   hypokalaemia (potentially increasing the risk of torsade de pointes) when given with   chlorpromazine .  Manufacturer makes no recommendation .    \n\n"
						}
					],
					"hasOrder": "198",
					"hasTitle": {
						"@type": "rdf:XMLLiteral",
						"@value": "<title>Metolazone</title>"
					}
				},
				{
					"@id": "http://bnf.nice.org.uk/interaction/chlorpromazine#bnf_i1557280698570",
					"hasMessage": [
						{
							"@id": "http://bnf.nice.org.uk/interaction/chlorpromazine#bnf_i1557280698570_message_0",
							"hasDitaContent": {
								"@type": "rdf:XMLLiteral",
								"@value": "<p otherprops=\"Normal\" outputclass=\"int-message\">Both <ph otherprops=\"chlorpromazine\" outputclass=\"int-heading-drug\">chlorpromazine</ph> and <ph otherprops=\"metoprolol\" outputclass=\"int-drug\">metoprolol</ph> can increase the risk of hypotension.</p>"
							},
							"hasEvidence": "NotSet",
							"hasImportance": "NotSet",
							"hasOrder": "1",
							"hasTextContent": "Both  chlorpromazine  and  metoprolol  can increase the risk of hypotension. \n\n"
						}
					],
					"hasOrder": "199",
					"hasTitle": {
						"@type": "rdf:XMLLiteral",
						"@value": "<title>Metoprolol</title>"
					}
				},
				{
					"@id": "http://bnf.nice.org.uk/interaction/chlorpromazine#bnf_i1557280698571",
					"hasMessage": [
						{
							"@id": "http://bnf.nice.org.uk/interaction/chlorpromazine#bnf_i1557280698571_message_0",
							"hasDitaContent": {
								"@type": "rdf:XMLLiteral",
								"@value": "<p otherprops=\"Moderate\" outputclass=\"int-message\">\n  <ph otherprops=\"chlorpromazine\" outputclass=\"int-heading-drug\">Chlorpromazine</ph> <ph outputclass=\"int-effect\">decreases</ph> <ph outputclass=\"int-parameter\">the effects of</ph> <ph otherprops=\"metyrapone\" outputclass=\"int-drug\">metyrapone</ph>. <ph outputclass=\"int-action\">Manufacturer advises avoid</ph>.  </p>"
							},
							"hasEvidence": "Theoretical",
							"hasImportance": "Moderate",
							"hasOrder": "1",
							"hasTextContent": "Chlorpromazine   decreases   the effects of   metyrapone .  Manufacturer advises avoid .    \n\n"
						}
					],
					"hasOrder": "200",
					"hasTitle": {
						"@type": "rdf:XMLLiteral",
						"@value": "<title>Metyrapone</title>"
					}
				},
				{
					"@id": "http://bnf.nice.org.uk/interaction/chlorpromazine#bnf_i1557280698572",
					"hasMessage": [
						{
							"@id": "http://bnf.nice.org.uk/interaction/chlorpromazine#bnf_i1557280698572_message_0",
							"hasDitaContent": {
								"@type": "rdf:XMLLiteral",
								"@value": "<p otherprops=\"Normal\" outputclass=\"int-message\">Both <ph otherprops=\"chlorpromazine\" outputclass=\"int-heading-drug\">chlorpromazine</ph> and <ph otherprops=\"mianserin\" outputclass=\"int-drug\">mianserin</ph> can have CNS depressant effects, which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in <xref format=\"dita\" href=\"guidance/guidance-on-prescribing.xml\" type=\"interaction\" rel=\"guidance\" bnfid=\"PHP97234\">Guidance on Prescribing</xref>).</p>"
							},
							"hasEvidence": "NotSet",
							"hasImportance": "NotSet",
							"hasOrder": "1",
							"hasTextContent": "Both  chlorpromazine  and  mianserin  can have CNS depressant effects, which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in  Guidance on Prescribing ). \n\n"
						}
					],
					"hasOrder": "201",
					"hasTitle": {
						"@type": "rdf:XMLLiteral",
						"@value": "<title>Mianserin</title>"
					}
				},
				{
					"@id": "http://bnf.nice.org.uk/interaction/chlorpromazine#bnf_i1557280698573",
					"hasMessage": [
						{
							"@id": "http://bnf.nice.org.uk/interaction/chlorpromazine#bnf_i1557280698573_message_0",
							"hasDitaContent": {
								"@type": "rdf:XMLLiteral",
								"@value": "<p otherprops=\"Normal\" outputclass=\"int-message\">Both <ph otherprops=\"chlorpromazine\" outputclass=\"int-heading-drug\">chlorpromazine</ph> and <ph otherprops=\"midazolam\" outputclass=\"int-drug\">midazolam</ph> can have CNS depressant effects, which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in <xref format=\"dita\" href=\"guidance/guidance-on-prescribing.xml\" type=\"interaction\" rel=\"guidance\" bnfid=\"PHP97234\">Guidance on Prescribing</xref>).</p>"
							},
							"hasEvidence": "NotSet",
							"hasImportance": "NotSet",
							"hasOrder": "1",
							"hasTextContent": "Both  chlorpromazine  and  midazolam  can have CNS depressant effects, which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in  Guidance on Prescribing ). \n\n"
						}
					],
					"hasOrder": "202",
					"hasTitle": {
						"@type": "rdf:XMLLiteral",
						"@value": "<title>Midazolam</title>"
					}
				},
				{
					"@id": "http://bnf.nice.org.uk/interaction/chlorpromazine#bnf_i1557280698574",
					"hasMessage": [
						{
							"@id": "http://bnf.nice.org.uk/interaction/chlorpromazine#bnf_i1557280698574_message_0",
							"hasDitaContent": {
								"@type": "rdf:XMLLiteral",
								"@value": "<p otherprops=\"Normal\" outputclass=\"int-message\">Both <ph otherprops=\"chlorpromazine\" outputclass=\"int-heading-drug\">chlorpromazine</ph> and <ph otherprops=\"minoxidil\" outputclass=\"int-drug\">minoxidil</ph> can increase the risk of hypotension.</p>"
							},
							"hasEvidence": "NotSet",
							"hasImportance": "NotSet",
							"hasOrder": "1",
							"hasTextContent": "Both  chlorpromazine  and  minoxidil  can increase the risk of hypotension. \n\n"
						}
					],
					"hasOrder": "203",
					"hasTitle": {
						"@type": "rdf:XMLLiteral",
						"@value": "<title>Minoxidil</title>"
					}
				},
				{
					"@id": "http://bnf.nice.org.uk/interaction/chlorpromazine#bnf_i1557280698575",
					"hasMessage": [
						{
							"@id": "http://bnf.nice.org.uk/interaction/chlorpromazine#bnf_i1557280698575_message_0",
							"hasDitaContent": {
								"@type": "rdf:XMLLiteral",
								"@value": "<p otherprops=\"Normal\" outputclass=\"int-message\">Both <ph otherprops=\"chlorpromazine\" outputclass=\"int-heading-drug\">chlorpromazine</ph> and <ph otherprops=\"mirtazapine\" outputclass=\"int-drug\">mirtazapine</ph> can have CNS depressant effects, which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in <xref format=\"dita\" href=\"guidance/guidance-on-prescribing.xml\" type=\"interaction\" rel=\"guidance\" bnfid=\"PHP97234\">Guidance on Prescribing</xref>).</p>"
							},
							"hasEvidence": "NotSet",
							"hasImportance": "NotSet",
							"hasOrder": "1",
							"hasTextContent": "Both  chlorpromazine  and  mirtazapine  can have CNS depressant effects, which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in  Guidance on Prescribing ). \n\n"
						}
					],
					"hasOrder": "204",
					"hasTitle": {
						"@type": "rdf:XMLLiteral",
						"@value": "<title>Mirtazapine</title>"
					}
				},
				{
					"@id": "http://bnf.nice.org.uk/interaction/chlorpromazine#bnf_i1557280698576",
					"hasMessage": [
						{
							"@id": "http://bnf.nice.org.uk/interaction/chlorpromazine#bnf_i1557280698576_message_0",
							"hasDitaContent": {
								"@type": "rdf:XMLLiteral",
								"@value": "<p otherprops=\"Severe\" outputclass=\"int-message\">\n  <ph otherprops=\"mizolastine\" outputclass=\"int-drug\">Mizolastine</ph> <ph outputclass=\"int-effectQualifier\">is predicted to</ph> <ph outputclass=\"int-effect\">increase</ph> <ph outputclass=\"int-parameter\">the risk of QT-prolongation when given with</ph> <ph otherprops=\"chlorpromazine\" outputclass=\"int-heading-drug\">chlorpromazine</ph>. <ph outputclass=\"int-action\">Manufacturer advises avoid</ph>.  </p>"
							},
							"hasEvidence": "Theoretical",
							"hasImportance": "Severe",
							"hasOrder": "1",
							"hasTextContent": "Mizolastine   is predicted to   increase   the risk of QT-prolongation when given with   chlorpromazine .  Manufacturer advises avoid .    \n\n"
						}
					],
					"hasOrder": "205",
					"hasTitle": {
						"@type": "rdf:XMLLiteral",
						"@value": "<title>Mizolastine</title>"
					}
				},
				{
					"@id": "http://bnf.nice.org.uk/interaction/chlorpromazine#bnf_i1557280698577",
					"hasMessage": [
						{
							"@id": "http://bnf.nice.org.uk/interaction/chlorpromazine#bnf_i1557280698577_message_0",
							"hasDitaContent": {
								"@type": "rdf:XMLLiteral",
								"@value": "<p otherprops=\"Normal\" outputclass=\"int-message\">Both <ph otherprops=\"chlorpromazine\" outputclass=\"int-heading-drug\">chlorpromazine</ph> and <ph otherprops=\"morphine\" outputclass=\"int-drug\">morphine</ph> can have CNS depressant effects, which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in <xref format=\"dita\" href=\"guidance/guidance-on-prescribing.xml\" type=\"interaction\" rel=\"guidance\" bnfid=\"PHP97234\">Guidance on Prescribing</xref>).</p>"
							},
							"hasEvidence": "NotSet",
							"hasImportance": "NotSet",
							"hasOrder": "1",
							"hasTextContent": "Both  chlorpromazine  and  morphine  can have CNS depressant effects, which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in  Guidance on Prescribing ). \n\n"
						}
					],
					"hasOrder": "206",
					"hasTitle": {
						"@type": "rdf:XMLLiteral",
						"@value": "<title>Morphine</title>"
					}
				},
				{
					"@id": "http://bnf.nice.org.uk/interaction/chlorpromazine#bnf_i1557280698578",
					"hasMessage": [
						{
							"@id": "http://bnf.nice.org.uk/interaction/chlorpromazine#bnf_i1557280698578_message_0",
							"hasDitaContent": {
								"@type": "rdf:XMLLiteral",
								"@value": "<p otherprops=\"Severe\" outputclass=\"int-message\">Both <ph otherprops=\"chlorpromazine\" outputclass=\"int-heading-drug\">chlorpromazine</ph> and <ph otherprops=\"moxifloxacin\" outputclass=\"int-drug\">moxifloxacin</ph> prolong the QT interval. Most manufacturers advise avoiding the use of two or more drugs that are associated with QT prolongation. Increasing age, female sex, cardiac disease, and some metabolic disturbances (notably hypokalaemia) predispose to QT prolongation. </p>"
							},
							"hasEvidence": "NotSet",
							"hasImportance": "Severe",
							"hasOrder": "1",
							"hasTextContent": "Both  chlorpromazine  and  moxifloxacin  prolong the QT interval. Most manufacturers advise avoiding the use of two or more drugs that are associated with QT prolongation. Increasing age, female sex, cardiac disease, and some metabolic disturbances (notably hypokalaemia) predispose to QT prolongation.  \n\n"
						}
					],
					"hasOrder": "207",
					"hasTitle": {
						"@type": "rdf:XMLLiteral",
						"@value": "<title>Moxifloxacin</title>"
					}
				},
				{
					"@id": "http://bnf.nice.org.uk/interaction/chlorpromazine#bnf_i1557280698579",
					"hasMessage": [
						{
							"@id": "http://bnf.nice.org.uk/interaction/chlorpromazine#bnf_i1557280698579_message_0",
							"hasDitaContent": {
								"@type": "rdf:XMLLiteral",
								"@value": "<p otherprops=\"Normal\" outputclass=\"int-message\">Both <ph otherprops=\"chlorpromazine\" outputclass=\"int-heading-drug\">chlorpromazine</ph> and <ph otherprops=\"moxisylyte\" outputclass=\"int-drug\">moxisylyte</ph> can increase the risk of hypotension.</p>"
							},
							"hasEvidence": "NotSet",
							"hasImportance": "NotSet",
							"hasOrder": "1",
							"hasTextContent": "Both  chlorpromazine  and  moxisylyte  can increase the risk of hypotension. \n\n"
						}
					],
					"hasOrder": "208",
					"hasTitle": {
						"@type": "rdf:XMLLiteral",
						"@value": "<title>Moxisylyte</title>"
					}
				},
				{
					"@id": "http://bnf.nice.org.uk/interaction/chlorpromazine#bnf_i1557280698580",
					"hasMessage": [
						{
							"@id": "http://bnf.nice.org.uk/interaction/chlorpromazine#bnf_i1557280698580_message_0",
							"hasDitaContent": {
								"@type": "rdf:XMLLiteral",
								"@value": "<p otherprops=\"Normal\" outputclass=\"int-message\">Both <ph otherprops=\"chlorpromazine\" outputclass=\"int-heading-drug\">chlorpromazine</ph> and <ph otherprops=\"moxonidine\" outputclass=\"int-drug\">moxonidine</ph> can increase the risk of hypotension.</p>"
							},
							"hasEvidence": "NotSet",
							"hasImportance": "NotSet",
							"hasOrder": "1",
							"hasTextContent": "Both  chlorpromazine  and  moxonidine  can increase the risk of hypotension. \n\n"
						},
						{
							"@id": "http://bnf.nice.org.uk/interaction/chlorpromazine#bnf_i1557280698580_message_1",
							"hasDitaContent": {
								"@type": "rdf:XMLLiteral",
								"@value": "<p otherprops=\"Normal\" outputclass=\"int-message\">Both <ph otherprops=\"chlorpromazine\" outputclass=\"int-heading-drug\">chlorpromazine</ph> and <ph otherprops=\"moxonidine\" outputclass=\"int-drug\">moxonidine</ph> can have CNS depressant effects, which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in <xref format=\"dita\" href=\"guidance/guidance-on-prescribing.xml\" type=\"interaction\" rel=\"guidance\" bnfid=\"PHP97234\">Guidance on Prescribing</xref>).</p>"
							},
							"hasEvidence": "NotSet",
							"hasImportance": "NotSet",
							"hasOrder": "2",
							"hasTextContent": "Both  chlorpromazine  and  moxonidine  can have CNS depressant effects, which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in  Guidance on Prescribing ). \n\n"
						}
					],
					"hasOrder": "209",
					"hasTitle": {
						"@type": "rdf:XMLLiteral",
						"@value": "<title>Moxonidine</title>"
					}
				},
				{
					"@id": "http://bnf.nice.org.uk/interaction/chlorpromazine#bnf_i1557280698581",
					"hasMessage": [
						{
							"@id": "http://bnf.nice.org.uk/interaction/chlorpromazine#bnf_i1557280698581_message_0",
							"hasDitaContent": {
								"@type": "rdf:XMLLiteral",
								"@value": "<p otherprops=\"Normal\" outputclass=\"int-message\">Both <ph otherprops=\"chlorpromazine\" outputclass=\"int-heading-drug\">chlorpromazine</ph> and <ph otherprops=\"nabilone\" outputclass=\"int-drug\">nabilone</ph> can have CNS depressant effects, which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in <xref format=\"dita\" href=\"guidance/guidance-on-prescribing.xml\" type=\"interaction\" rel=\"guidance\" bnfid=\"PHP97234\">Guidance on Prescribing</xref>).</p>"
							},
							"hasEvidence": "NotSet",
							"hasImportance": "NotSet",
							"hasOrder": "1",
							"hasTextContent": "Both  chlorpromazine  and  nabilone  can have CNS depressant effects, which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in  Guidance on Prescribing ). \n\n"
						}
					],
					"hasOrder": "210",
					"hasTitle": {
						"@type": "rdf:XMLLiteral",
						"@value": "<title>Nabilone</title>"
					}
				},
				{
					"@id": "http://bnf.nice.org.uk/interaction/chlorpromazine#bnf_i1557280698582",
					"hasMessage": [
						{
							"@id": "http://bnf.nice.org.uk/interaction/chlorpromazine#bnf_i1557280698582_message_0",
							"hasDitaContent": {
								"@type": "rdf:XMLLiteral",
								"@value": "<p otherprops=\"Normal\" outputclass=\"int-message\">Both <ph otherprops=\"chlorpromazine\" outputclass=\"int-heading-drug\">chlorpromazine</ph> and <ph otherprops=\"nadolol\" outputclass=\"int-drug\">nadolol</ph> can increase the risk of hypotension.</p>"
							},
							"hasEvidence": "NotSet",
							"hasImportance": "NotSet",
							"hasOrder": "1",
							"hasTextContent": "Both  chlorpromazine  and  nadolol  can increase the risk of hypotension. \n\n"
						}
					],
					"hasOrder": "211",
					"hasTitle": {
						"@type": "rdf:XMLLiteral",
						"@value": "<title>Nadolol</title>"
					}
				},
				{
					"@id": "http://bnf.nice.org.uk/interaction/chlorpromazine#bnf_i1557280698583",
					"hasMessage": [
						{
							"@id": "http://bnf.nice.org.uk/interaction/chlorpromazine#bnf_i1557280698583_message_0",
							"hasDitaContent": {
								"@type": "rdf:XMLLiteral",
								"@value": "<p otherprops=\"Normal\" outputclass=\"int-message\">Both <ph otherprops=\"chlorpromazine\" outputclass=\"int-heading-drug\">chlorpromazine</ph> and <ph otherprops=\"nebivolol\" outputclass=\"int-drug\">nebivolol</ph> can increase the risk of hypotension.</p>"
							},
							"hasEvidence": "NotSet",
							"hasImportance": "NotSet",
							"hasOrder": "1",
							"hasTextContent": "Both  chlorpromazine  and  nebivolol  can increase the risk of hypotension. \n\n"
						}
					],
					"hasOrder": "212",
					"hasTitle": {
						"@type": "rdf:XMLLiteral",
						"@value": "<title>Nebivolol</title>"
					}
				},
				{
					"@id": "http://bnf.nice.org.uk/interaction/chlorpromazine#bnf_i1557280698584",
					"hasMessage": [
						{
							"@id": "http://bnf.nice.org.uk/interaction/chlorpromazine#bnf_i1557280698584_message_0",
							"hasDitaContent": {
								"@type": "rdf:XMLLiteral",
								"@value": "<p otherprops=\"Normal\" outputclass=\"int-message\">Both <ph otherprops=\"chlorpromazine\" outputclass=\"int-heading-drug\">chlorpromazine</ph> and <ph otherprops=\"nefopam\" outputclass=\"int-drug\">nefopam</ph> can cause antimuscarinic effects.</p>"
							},
							"hasEvidence": "NotSet",
							"hasImportance": "NotSet",
							"hasOrder": "1",
							"hasTextContent": "Both  chlorpromazine  and  nefopam  can cause antimuscarinic effects. \n\n"
						}
					],
					"hasOrder": "213",
					"hasTitle": {
						"@type": "rdf:XMLLiteral",
						"@value": "<title>Nefopam</title>"
					}
				},
				{
					"@id": "http://bnf.nice.org.uk/interaction/chlorpromazine#bnf_i1557280698585",
					"hasMessage": [
						{
							"@id": "http://bnf.nice.org.uk/interaction/chlorpromazine#bnf_i1557280698585_message_0",
							"hasDitaContent": {
								"@type": "rdf:XMLLiteral",
								"@value": "<p otherprops=\"Normal\" outputclass=\"int-message\">Both <ph otherprops=\"chlorpromazine\" outputclass=\"int-heading-drug\">chlorpromazine</ph> and <ph otherprops=\"nicardipine\" outputclass=\"int-drug\">nicardipine</ph> can increase the risk of hypotension.</p>"
							},
							"hasEvidence": "NotSet",
							"hasImportance": "NotSet",
							"hasOrder": "1",
							"hasTextContent": "Both  chlorpromazine  and  nicardipine  can increase the risk of hypotension. \n\n"
						}
					],
					"hasOrder": "214",
					"hasTitle": {
						"@type": "rdf:XMLLiteral",
						"@value": "<title>Nicardipine</title>"
					}
				},
				{
					"@id": "http://bnf.nice.org.uk/interaction/chlorpromazine#bnf_i1557280698586",
					"hasMessage": [
						{
							"@id": "http://bnf.nice.org.uk/interaction/chlorpromazine#bnf_i1557280698586_message_0",
							"hasDitaContent": {
								"@type": "rdf:XMLLiteral",
								"@value": "<p otherprops=\"Normal\" outputclass=\"int-message\">Both <ph otherprops=\"chlorpromazine\" outputclass=\"int-heading-drug\">chlorpromazine</ph> and <ph otherprops=\"nicorandil\" outputclass=\"int-drug\">nicorandil</ph> can increase the risk of hypotension.</p>"
							},
							"hasEvidence": "NotSet",
							"hasImportance": "NotSet",
							"hasOrder": "1",
							"hasTextContent": "Both  chlorpromazine  and  nicorandil  can increase the risk of hypotension. \n\n"
						}
					],
					"hasOrder": "215",
					"hasTitle": {
						"@type": "rdf:XMLLiteral",
						"@value": "<title>Nicorandil</title>"
					}
				},
				{
					"@id": "http://bnf.nice.org.uk/interaction/chlorpromazine#bnf_i1557280698587",
					"hasMessage": [
						{
							"@id": "http://bnf.nice.org.uk/interaction/chlorpromazine#bnf_i1557280698587_message_0",
							"hasDitaContent": {
								"@type": "rdf:XMLLiteral",
								"@value": "<p otherprops=\"Normal\" outputclass=\"int-message\">Both <ph otherprops=\"chlorpromazine\" outputclass=\"int-heading-drug\">chlorpromazine</ph> and <ph otherprops=\"nifedipine\" outputclass=\"int-drug\">nifedipine</ph> can increase the risk of hypotension.</p>"
							},
							"hasEvidence": "NotSet",
							"hasImportance": "NotSet",
							"hasOrder": "1",
							"hasTextContent": "Both  chlorpromazine  and  nifedipine  can increase the risk of hypotension. \n\n"
						}
					],
					"hasOrder": "216",
					"hasTitle": {
						"@type": "rdf:XMLLiteral",
						"@value": "<title>Nifedipine</title>"
					}
				},
				{
					"@id": "http://bnf.nice.org.uk/interaction/chlorpromazine#bnf_i1557280698588",
					"hasMessage": [
						{
							"@id": "http://bnf.nice.org.uk/interaction/chlorpromazine#bnf_i1557280698588_message_0",
							"hasDitaContent": {
								"@type": "rdf:XMLLiteral",
								"@value": "<p otherprops=\"Severe\" outputclass=\"int-message\">Both <ph otherprops=\"chlorpromazine\" outputclass=\"int-heading-drug\">chlorpromazine</ph> and <ph otherprops=\"nilotinib\" outputclass=\"int-drug\">nilotinib</ph> prolong the QT interval. Most manufacturers advise avoiding the use of two or more drugs that are associated with QT prolongation. Increasing age, female sex, cardiac disease, and some metabolic disturbances (notably hypokalaemia) predispose to QT prolongation. </p>"
							},
							"hasEvidence": "NotSet",
							"hasImportance": "Severe",
							"hasOrder": "1",
							"hasTextContent": "Both  chlorpromazine  and  nilotinib  prolong the QT interval. Most manufacturers advise avoiding the use of two or more drugs that are associated with QT prolongation. Increasing age, female sex, cardiac disease, and some metabolic disturbances (notably hypokalaemia) predispose to QT prolongation.  \n\n"
						}
					],
					"hasOrder": "217",
					"hasTitle": {
						"@type": "rdf:XMLLiteral",
						"@value": "<title>Nilotinib</title>"
					}
				},
				{
					"@id": "http://bnf.nice.org.uk/interaction/chlorpromazine#bnf_i1557280698589",
					"hasMessage": [
						{
							"@id": "http://bnf.nice.org.uk/interaction/chlorpromazine#bnf_i1557280698589_message_0",
							"hasDitaContent": {
								"@type": "rdf:XMLLiteral",
								"@value": "<p otherprops=\"Normal\" outputclass=\"int-message\">Both <ph otherprops=\"chlorpromazine\" outputclass=\"int-heading-drug\">chlorpromazine</ph> and <ph otherprops=\"nimodipine\" outputclass=\"int-drug\">nimodipine</ph> can increase the risk of hypotension.</p>"
							},
							"hasEvidence": "NotSet",
							"hasImportance": "NotSet",
							"hasOrder": "1",
							"hasTextContent": "Both  chlorpromazine  and  nimodipine  can increase the risk of hypotension. \n\n"
						}
					],
					"hasOrder": "218",
					"hasTitle": {
						"@type": "rdf:XMLLiteral",
						"@value": "<title>Nimodipine</title>"
					}
				},
				{
					"@id": "http://bnf.nice.org.uk/interaction/chlorpromazine#bnf_i1557280698590",
					"hasMessage": [
						{
							"@id": "http://bnf.nice.org.uk/interaction/chlorpromazine#bnf_i1557280698590_message_0",
							"hasDitaContent": {
								"@type": "rdf:XMLLiteral",
								"@value": "<p otherprops=\"Normal\" outputclass=\"int-message\">Both <ph otherprops=\"chlorpromazine\" outputclass=\"int-heading-drug\">chlorpromazine</ph> and <ph otherprops=\"nitrazepam\" outputclass=\"int-drug\">nitrazepam</ph> can have CNS depressant effects, which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in <xref format=\"dita\" href=\"guidance/guidance-on-prescribing.xml\" type=\"interaction\" rel=\"guidance\" bnfid=\"PHP97234\">Guidance on Prescribing</xref>).</p>"
							},
							"hasEvidence": "NotSet",
							"hasImportance": "NotSet",
							"hasOrder": "1",
							"hasTextContent": "Both  chlorpromazine  and  nitrazepam  can have CNS depressant effects, which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in  Guidance on Prescribing ). \n\n"
						}
					],
					"hasOrder": "219",
					"hasTitle": {
						"@type": "rdf:XMLLiteral",
						"@value": "<title>Nitrazepam</title>"
					}
				},
				{
					"@id": "http://bnf.nice.org.uk/interaction/chlorpromazine#bnf_i1557280698591",
					"hasMessage": [
						{
							"@id": "http://bnf.nice.org.uk/interaction/chlorpromazine#bnf_i1557280698591_message_0",
							"hasDitaContent": {
								"@type": "rdf:XMLLiteral",
								"@value": "<p otherprops=\"Normal\" outputclass=\"int-message\">Both <ph otherprops=\"chlorpromazine\" outputclass=\"int-heading-drug\">chlorpromazine</ph> and <ph otherprops=\"nitrous oxide\" outputclass=\"int-drug\">nitrous oxide</ph> can increase the risk of hypotension.</p>"
							},
							"hasEvidence": "NotSet",
							"hasImportance": "NotSet",
							"hasOrder": "1",
							"hasTextContent": "Both  chlorpromazine  and  nitrous oxide  can increase the risk of hypotension. \n\n"
						},
						{
							"@id": "http://bnf.nice.org.uk/interaction/chlorpromazine#bnf_i1557280698591_message_1",
							"hasDitaContent": {
								"@type": "rdf:XMLLiteral",
								"@value": "<p otherprops=\"Normal\" outputclass=\"int-message\">Both <ph otherprops=\"chlorpromazine\" outputclass=\"int-heading-drug\">chlorpromazine</ph> and <ph otherprops=\"nitrous oxide\" outputclass=\"int-drug\">nitrous oxide</ph> can have CNS depressant effects, which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in <xref format=\"dita\" href=\"guidance/guidance-on-prescribing.xml\" type=\"interaction\" rel=\"guidance\" bnfid=\"PHP97234\">Guidance on Prescribing</xref>).</p>"
							},
							"hasEvidence": "NotSet",
							"hasImportance": "NotSet",
							"hasOrder": "2",
							"hasTextContent": "Both  chlorpromazine  and  nitrous oxide  can have CNS depressant effects, which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in  Guidance on Prescribing ). \n\n"
						}
					],
					"hasOrder": "220",
					"hasTitle": {
						"@type": "rdf:XMLLiteral",
						"@value": "<title>Nitrous oxide</title>"
					}
				},
				{
					"@id": "http://bnf.nice.org.uk/interaction/chlorpromazine#bnf_i1557280698592",
					"hasMessage": [
						{
							"@id": "http://bnf.nice.org.uk/interaction/chlorpromazine#bnf_i1557280698592_message_0",
							"hasDitaContent": {
								"@type": "rdf:XMLLiteral",
								"@value": "<p otherprops=\"Normal\" outputclass=\"int-message\">Both <ph otherprops=\"chlorpromazine\" outputclass=\"int-heading-drug\">chlorpromazine</ph> and <ph otherprops=\"nortriptyline\" outputclass=\"int-drug\">nortriptyline</ph> can increase the risk of hypotension.</p>"
							},
							"hasEvidence": "NotSet",
							"hasImportance": "NotSet",
							"hasOrder": "1",
							"hasTextContent": "Both  chlorpromazine  and  nortriptyline  can increase the risk of hypotension. \n\n"
						},
						{
							"@id": "http://bnf.nice.org.uk/interaction/chlorpromazine#bnf_i1557280698592_message_1",
							"hasDitaContent": {
								"@type": "rdf:XMLLiteral",
								"@value": "<p otherprops=\"Normal\" outputclass=\"int-message\">Both <ph otherprops=\"chlorpromazine\" outputclass=\"int-heading-drug\">chlorpromazine</ph> and <ph otherprops=\"nortriptyline\" outputclass=\"int-drug\">nortriptyline</ph> can cause antimuscarinic effects.</p>"
							},
							"hasEvidence": "NotSet",
							"hasImportance": "NotSet",
							"hasOrder": "2",
							"hasTextContent": "Both  chlorpromazine  and  nortriptyline  can cause antimuscarinic effects. \n\n"
						}
					],
					"hasOrder": "221",
					"hasTitle": {
						"@type": "rdf:XMLLiteral",
						"@value": "<title>Nortriptyline</title>"
					}
				},
				{
					"@id": "http://bnf.nice.org.uk/interaction/chlorpromazine#bnf_i1557280698593",
					"hasMessage": [
						{
							"@id": "http://bnf.nice.org.uk/interaction/chlorpromazine#bnf_i1557280698593_message_0",
							"hasDitaContent": {
								"@type": "rdf:XMLLiteral",
								"@value": "<p otherprops=\"Normal\" outputclass=\"int-message\">Both <ph otherprops=\"chlorpromazine\" outputclass=\"int-heading-drug\">chlorpromazine</ph> and <ph otherprops=\"olanzapine\" outputclass=\"int-drug\">olanzapine</ph> can increase the risk of hypotension.</p>"
							},
							"hasEvidence": "NotSet",
							"hasImportance": "NotSet",
							"hasOrder": "1",
							"hasTextContent": "Both  chlorpromazine  and  olanzapine  can increase the risk of hypotension. \n\n"
						},
						{
							"@id": "http://bnf.nice.org.uk/interaction/chlorpromazine#bnf_i1557280698593_message_1",
							"hasDitaContent": {
								"@type": "rdf:XMLLiteral",
								"@value": "<p otherprops=\"Normal\" outputclass=\"int-message\">Both <ph otherprops=\"chlorpromazine\" outputclass=\"int-heading-drug\">chlorpromazine</ph> and <ph otherprops=\"olanzapine\" outputclass=\"int-drug\">olanzapine</ph> can have CNS depressant effects, which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in <xref format=\"dita\" href=\"guidance/guidance-on-prescribing.xml\" type=\"interaction\" rel=\"guidance\" bnfid=\"PHP97234\">Guidance on Prescribing</xref>).</p>"
							},
							"hasEvidence": "NotSet",
							"hasImportance": "NotSet",
							"hasOrder": "2",
							"hasTextContent": "Both  chlorpromazine  and  olanzapine  can have CNS depressant effects, which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in  Guidance on Prescribing ). \n\n"
						}
					],
					"hasOrder": "222",
					"hasTitle": {
						"@type": "rdf:XMLLiteral",
						"@value": "<title>Olanzapine</title>"
					}
				},
				{
					"@id": "http://bnf.nice.org.uk/interaction/chlorpromazine#bnf_i1557280698594",
					"hasMessage": [
						{
							"@id": "http://bnf.nice.org.uk/interaction/chlorpromazine#bnf_i1557280698594_message_0",
							"hasDitaContent": {
								"@type": "rdf:XMLLiteral",
								"@value": "<p otherprops=\"Normal\" outputclass=\"int-message\">Both <ph otherprops=\"chlorpromazine\" outputclass=\"int-heading-drug\">chlorpromazine</ph> and <ph otherprops=\"olmesartan\" outputclass=\"int-drug\">olmesartan</ph> can increase the risk of hypotension.</p>"
							},
							"hasEvidence": "NotSet",
							"hasImportance": "NotSet",
							"hasOrder": "1",
							"hasTextContent": "Both  chlorpromazine  and  olmesartan  can increase the risk of hypotension. \n\n"
						}
					],
					"hasOrder": "223",
					"hasTitle": {
						"@type": "rdf:XMLLiteral",
						"@value": "<title>Olmesartan</title>"
					}
				},
				{
					"@id": "http://bnf.nice.org.uk/interaction/chlorpromazine#bnf_i1557280698595",
					"hasMessage": [
						{
							"@id": "http://bnf.nice.org.uk/interaction/chlorpromazine#bnf_i1557280698595_message_0",
							"hasDitaContent": {
								"@type": "rdf:XMLLiteral",
								"@value": "<p otherprops=\"Severe\" outputclass=\"int-message\">\n  <ph otherprops=\"olodaterol\" outputclass=\"int-drug\">Olodaterol</ph> <ph outputclass=\"int-effectQualifier\">is predicted to</ph> <ph outputclass=\"int-effect\">cause</ph> <ph outputclass=\"int-parameter\">hypokalaemia (potentially increasing the risk of torsade de pointes) when given with</ph> <ph otherprops=\"chlorpromazine\" outputclass=\"int-heading-drug\">chlorpromazine</ph>. <ph outputclass=\"int-action\">Manufacturer makes no recommendation</ph>.  </p>"
							},
							"hasEvidence": "Theoretical",
							"hasImportance": "Severe",
							"hasOrder": "1",
							"hasTextContent": "Olodaterol   is predicted to   cause   hypokalaemia (potentially increasing the risk of torsade de pointes) when given with   chlorpromazine .  Manufacturer makes no recommendation .    \n\n"
						}
					],
					"hasOrder": "224",
					"hasTitle": {
						"@type": "rdf:XMLLiteral",
						"@value": "<title>Olodaterol</title>"
					}
				},
				{
					"@id": "http://bnf.nice.org.uk/interaction/chlorpromazine#bnf_i1557280698596",
					"hasMessage": [
						{
							"@id": "http://bnf.nice.org.uk/interaction/chlorpromazine#bnf_i1557280698596_message_0",
							"hasDitaContent": {
								"@type": "rdf:XMLLiteral",
								"@value": "<p otherprops=\"Severe\" outputclass=\"int-message\">Both <ph otherprops=\"chlorpromazine\" outputclass=\"int-heading-drug\">chlorpromazine</ph> and <ph otherprops=\"ondansetron\" outputclass=\"int-drug\">ondansetron</ph> prolong the QT interval. Most manufacturers advise avoiding the use of two or more drugs that are associated with QT prolongation. Increasing age, female sex, cardiac disease, and some metabolic disturbances (notably hypokalaemia) predispose to QT prolongation. </p>"
							},
							"hasEvidence": "NotSet",
							"hasImportance": "Severe",
							"hasOrder": "1",
							"hasTextContent": "Both  chlorpromazine  and  ondansetron  prolong the QT interval. Most manufacturers advise avoiding the use of two or more drugs that are associated with QT prolongation. Increasing age, female sex, cardiac disease, and some metabolic disturbances (notably hypokalaemia) predispose to QT prolongation.  \n\n"
						}
					],
					"hasOrder": "225",
					"hasTitle": {
						"@type": "rdf:XMLLiteral",
						"@value": "<title>Ondansetron</title>"
					}
				},
				{
					"@id": "http://bnf.nice.org.uk/interaction/chlorpromazine#bnf_i1557280698597",
					"hasMessage": [
						{
							"@id": "http://bnf.nice.org.uk/interaction/chlorpromazine#bnf_i1557280698597_message_0",
							"hasDitaContent": {
								"@type": "rdf:XMLLiteral",
								"@value": "<p otherprops=\"Normal\" outputclass=\"int-message\">Both <ph otherprops=\"chlorpromazine\" outputclass=\"int-heading-drug\">chlorpromazine</ph> and <ph otherprops=\"orphenadrine\" outputclass=\"int-drug\">orphenadrine</ph> can cause antimuscarinic effects.</p>"
							},
							"hasEvidence": "NotSet",
							"hasImportance": "NotSet",
							"hasOrder": "1",
							"hasTextContent": "Both  chlorpromazine  and  orphenadrine  can cause antimuscarinic effects. \n\n"
						}
					],
					"hasOrder": "226",
					"hasTitle": {
						"@type": "rdf:XMLLiteral",
						"@value": "<title>Orphenadrine</title>"
					}
				},
				{
					"@id": "http://bnf.nice.org.uk/interaction/chlorpromazine#bnf_i1557280698598",
					"hasMessage": [
						{
							"@id": "http://bnf.nice.org.uk/interaction/chlorpromazine#bnf_i1557280698598_message_0",
							"hasDitaContent": {
								"@type": "rdf:XMLLiteral",
								"@value": "<p otherprops=\"Severe\" outputclass=\"int-message\">Both <ph otherprops=\"chlorpromazine\" outputclass=\"int-heading-drug\">chlorpromazine</ph> and <ph otherprops=\"osimertinib\" outputclass=\"int-drug\">osimertinib</ph> prolong the QT interval. Most manufacturers advise avoiding the use of two or more drugs that are associated with QT prolongation. Increasing age, female sex, cardiac disease, and some metabolic disturbances (notably hypokalaemia) predispose to QT prolongation. </p>"
							},
							"hasEvidence": "NotSet",
							"hasImportance": "Severe",
							"hasOrder": "1",
							"hasTextContent": "Both  chlorpromazine  and  osimertinib  prolong the QT interval. Most manufacturers advise avoiding the use of two or more drugs that are associated with QT prolongation. Increasing age, female sex, cardiac disease, and some metabolic disturbances (notably hypokalaemia) predispose to QT prolongation.  \n\n"
						}
					],
					"hasOrder": "227",
					"hasTitle": {
						"@type": "rdf:XMLLiteral",
						"@value": "<title>Osimertinib</title>"
					}
				},
				{
					"@id": "http://bnf.nice.org.uk/interaction/chlorpromazine#bnf_i1557280698599",
					"hasMessage": [
						{
							"@id": "http://bnf.nice.org.uk/interaction/chlorpromazine#bnf_i1557280698599_message_0",
							"hasDitaContent": {
								"@type": "rdf:XMLLiteral",
								"@value": "<p otherprops=\"Normal\" outputclass=\"int-message\">Both <ph otherprops=\"chlorpromazine\" outputclass=\"int-heading-drug\">chlorpromazine</ph> and <ph otherprops=\"oxazepam\" outputclass=\"int-drug\">oxazepam</ph> can have CNS depressant effects, which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in <xref format=\"dita\" href=\"guidance/guidance-on-prescribing.xml\" type=\"interaction\" rel=\"guidance\" bnfid=\"PHP97234\">Guidance on Prescribing</xref>).</p>"
							},
							"hasEvidence": "NotSet",
							"hasImportance": "NotSet",
							"hasOrder": "1",
							"hasTextContent": "Both  chlorpromazine  and  oxazepam  can have CNS depressant effects, which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in  Guidance on Prescribing ). \n\n"
						}
					],
					"hasOrder": "228",
					"hasTitle": {
						"@type": "rdf:XMLLiteral",
						"@value": "<title>Oxazepam</title>"
					}
				},
				{
					"@id": "http://bnf.nice.org.uk/interaction/chlorpromazine#bnf_i1557280698600",
					"hasMessage": [
						{
							"@id": "http://bnf.nice.org.uk/interaction/chlorpromazine#bnf_i1557280698600_message_0",
							"hasDitaContent": {
								"@type": "rdf:XMLLiteral",
								"@value": "<p otherprops=\"Normal\" outputclass=\"int-message\">Both <ph otherprops=\"chlorpromazine\" outputclass=\"int-heading-drug\">chlorpromazine</ph> and <ph otherprops=\"oxprenolol\" outputclass=\"int-drug\">oxprenolol</ph> can increase the risk of hypotension.</p>"
							},
							"hasEvidence": "NotSet",
							"hasImportance": "NotSet",
							"hasOrder": "1",
							"hasTextContent": "Both  chlorpromazine  and  oxprenolol  can increase the risk of hypotension. \n\n"
						}
					],
					"hasOrder": "229",
					"hasTitle": {
						"@type": "rdf:XMLLiteral",
						"@value": "<title>Oxprenolol</title>"
					}
				},
				{
					"@id": "http://bnf.nice.org.uk/interaction/chlorpromazine#bnf_i1557280698601",
					"hasMessage": [
						{
							"@id": "http://bnf.nice.org.uk/interaction/chlorpromazine#bnf_i1557280698601_message_0",
							"hasDitaContent": {
								"@type": "rdf:XMLLiteral",
								"@value": "<p otherprops=\"Normal\" outputclass=\"int-message\">Both <ph otherprops=\"chlorpromazine\" outputclass=\"int-heading-drug\">chlorpromazine</ph> and <ph otherprops=\"oxybutynin\" outputclass=\"int-drug\">oxybutynin</ph> can cause antimuscarinic effects.</p>"
							},
							"hasEvidence": "NotSet",
							"hasImportance": "NotSet",
							"hasOrder": "1",
							"hasTextContent": "Both  chlorpromazine  and  oxybutynin  can cause antimuscarinic effects. \n\n"
						}
					],
					"hasOrder": "230",
					"hasTitle": {
						"@type": "rdf:XMLLiteral",
						"@value": "<title>Oxybutynin</title>"
					}
				},
				{
					"@id": "http://bnf.nice.org.uk/interaction/chlorpromazine#bnf_i1557280698602",
					"hasMessage": [
						{
							"@id": "http://bnf.nice.org.uk/interaction/chlorpromazine#bnf_i1557280698602_message_0",
							"hasDitaContent": {
								"@type": "rdf:XMLLiteral",
								"@value": "<p otherprops=\"Normal\" outputclass=\"int-message\">Both <ph otherprops=\"chlorpromazine\" outputclass=\"int-heading-drug\">chlorpromazine</ph> and <ph otherprops=\"oxycodone\" outputclass=\"int-drug\">oxycodone</ph> can have CNS depressant effects, which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in <xref format=\"dita\" href=\"guidance/guidance-on-prescribing.xml\" type=\"interaction\" rel=\"guidance\" bnfid=\"PHP97234\">Guidance on Prescribing</xref>).</p>"
							},
							"hasEvidence": "NotSet",
							"hasImportance": "NotSet",
							"hasOrder": "1",
							"hasTextContent": "Both  chlorpromazine  and  oxycodone  can have CNS depressant effects, which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in  Guidance on Prescribing ). \n\n"
						}
					],
					"hasOrder": "231",
					"hasTitle": {
						"@type": "rdf:XMLLiteral",
						"@value": "<title>Oxycodone</title>"
					}
				},
				{
					"@id": "http://bnf.nice.org.uk/interaction/chlorpromazine#bnf_i1557280698603",
					"hasMessage": [
						{
							"@id": "http://bnf.nice.org.uk/interaction/chlorpromazine#bnf_i1557280698603_message_0",
							"hasDitaContent": {
								"@type": "rdf:XMLLiteral",
								"@value": "<p otherprops=\"Normal\" outputclass=\"int-message\">Both <ph otherprops=\"chlorpromazine\" outputclass=\"int-heading-drug\">chlorpromazine</ph> and <ph otherprops=\"paliperidone\" outputclass=\"int-drug\">paliperidone</ph> can increase the risk of hypotension.</p>"
							},
							"hasEvidence": "NotSet",
							"hasImportance": "NotSet",
							"hasOrder": "1",
							"hasTextContent": "Both  chlorpromazine  and  paliperidone  can increase the risk of hypotension. \n\n"
						},
						{
							"@id": "http://bnf.nice.org.uk/interaction/chlorpromazine#bnf_i1557280698603_message_1",
							"hasDitaContent": {
								"@type": "rdf:XMLLiteral",
								"@value": "<p otherprops=\"Severe\" outputclass=\"int-message\">Both <ph otherprops=\"chlorpromazine\" outputclass=\"int-heading-drug\">chlorpromazine</ph> and <ph otherprops=\"paliperidone\" outputclass=\"int-drug\">paliperidone</ph> prolong the QT interval. Most manufacturers advise avoiding the use of two or more drugs that are associated with QT prolongation. Increasing age, female sex, cardiac disease, and some metabolic disturbances (notably hypokalaemia) predispose to QT prolongation. </p>"
							},
							"hasEvidence": "NotSet",
							"hasImportance": "Severe",
							"hasOrder": "2",
							"hasTextContent": "Both  chlorpromazine  and  paliperidone  prolong the QT interval. Most manufacturers advise avoiding the use of two or more drugs that are associated with QT prolongation. Increasing age, female sex, cardiac disease, and some metabolic disturbances (notably hypokalaemia) predispose to QT prolongation.  \n\n"
						},
						{
							"@id": "http://bnf.nice.org.uk/interaction/chlorpromazine#bnf_i1557280698603_message_2",
							"hasDitaContent": {
								"@type": "rdf:XMLLiteral",
								"@value": "<p otherprops=\"Normal\" outputclass=\"int-message\">Both <ph otherprops=\"chlorpromazine\" outputclass=\"int-heading-drug\">chlorpromazine</ph> and <ph otherprops=\"paliperidone\" outputclass=\"int-drug\">paliperidone</ph> can have CNS depressant effects, which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in <xref format=\"dita\" href=\"guidance/guidance-on-prescribing.xml\" type=\"interaction\" rel=\"guidance\" bnfid=\"PHP97234\">Guidance on Prescribing</xref>).</p>"
							},
							"hasEvidence": "NotSet",
							"hasImportance": "NotSet",
							"hasOrder": "3",
							"hasTextContent": "Both  chlorpromazine  and  paliperidone  can have CNS depressant effects, which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in  Guidance on Prescribing ). \n\n"
						}
					],
					"hasOrder": "232",
					"hasTitle": {
						"@type": "rdf:XMLLiteral",
						"@value": "<title>Paliperidone</title>"
					}
				},
				{
					"@id": "http://bnf.nice.org.uk/interaction/chlorpromazine#bnf_i1557280698604",
					"hasMessage": [
						{
							"@id": "http://bnf.nice.org.uk/interaction/chlorpromazine#bnf_i1557280698604_message_0",
							"hasDitaContent": {
								"@type": "rdf:XMLLiteral",
								"@value": "<p otherprops=\"Severe\" outputclass=\"int-message\">\n  <ph otherprops=\"palonosetron\" outputclass=\"int-drug\">Palonosetron</ph> <ph outputclass=\"int-effectQualifier\">is predicted to</ph> <ph outputclass=\"int-effect\">increase</ph> <ph outputclass=\"int-parameter\">the risk of QT-prolongation when given with</ph> <ph otherprops=\"chlorpromazine\" outputclass=\"int-heading-drug\">chlorpromazine</ph>. <ph outputclass=\"int-action\">Manufacturer advises caution</ph>.  </p>"
							},
							"hasEvidence": "Theoretical",
							"hasImportance": "Severe",
							"hasOrder": "1",
							"hasTextContent": "Palonosetron   is predicted to   increase   the risk of QT-prolongation when given with   chlorpromazine .  Manufacturer advises caution .    \n\n"
						}
					],
					"hasOrder": "233",
					"hasTitle": {
						"@type": "rdf:XMLLiteral",
						"@value": "<title>Palonosetron</title>"
					}
				},
				{
					"@id": "http://bnf.nice.org.uk/interaction/chlorpromazine#bnf_i1557280698605",
					"hasMessage": [
						{
							"@id": "http://bnf.nice.org.uk/interaction/chlorpromazine#bnf_i1557280698605_message_0",
							"hasDitaContent": {
								"@type": "rdf:XMLLiteral",
								"@value": "<p otherprops=\"Severe\" outputclass=\"int-message\">Both <ph otherprops=\"chlorpromazine\" outputclass=\"int-heading-drug\">chlorpromazine</ph> and <ph otherprops=\"panobinostat\" outputclass=\"int-drug\">panobinostat</ph> prolong the QT interval. Most manufacturers advise avoiding the use of two or more drugs that are associated with QT prolongation. Increasing age, female sex, cardiac disease, and some metabolic disturbances (notably hypokalaemia) predispose to QT prolongation. </p>"
							},
							"hasEvidence": "NotSet",
							"hasImportance": "Severe",
							"hasOrder": "1",
							"hasTextContent": "Both  chlorpromazine  and  panobinostat  prolong the QT interval. Most manufacturers advise avoiding the use of two or more drugs that are associated with QT prolongation. Increasing age, female sex, cardiac disease, and some metabolic disturbances (notably hypokalaemia) predispose to QT prolongation.  \n\n"
						}
					],
					"hasOrder": "234",
					"hasTitle": {
						"@type": "rdf:XMLLiteral",
						"@value": "<title>Panobinostat</title>"
					}
				},
				{
					"@id": "http://bnf.nice.org.uk/interaction/chlorpromazine#bnf_i1557280698606",
					"hasMessage": [
						{
							"@id": "http://bnf.nice.org.uk/interaction/chlorpromazine#bnf_i1557280698606_message_0",
							"hasDitaContent": {
								"@type": "rdf:XMLLiteral",
								"@value": "<p otherprops=\"Normal\" outputclass=\"int-message\">Both <ph otherprops=\"chlorpromazine\" outputclass=\"int-heading-drug\">chlorpromazine</ph> and <ph otherprops=\"papaveretum\" outputclass=\"int-drug\">papaveretum</ph> can have CNS depressant effects, which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in <xref format=\"dita\" href=\"guidance/guidance-on-prescribing.xml\" type=\"interaction\" rel=\"guidance\" bnfid=\"PHP97234\">Guidance on Prescribing</xref>).</p>"
							},
							"hasEvidence": "NotSet",
							"hasImportance": "NotSet",
							"hasOrder": "1",
							"hasTextContent": "Both  chlorpromazine  and  papaveretum  can have CNS depressant effects, which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in  Guidance on Prescribing ). \n\n"
						}
					],
					"hasOrder": "235",
					"hasTitle": {
						"@type": "rdf:XMLLiteral",
						"@value": "<title>Papaveretum</title>"
					}
				},
				{
					"@id": "http://bnf.nice.org.uk/interaction/chlorpromazine#bnf_i1557280698607",
					"hasMessage": [
						{
							"@id": "http://bnf.nice.org.uk/interaction/chlorpromazine#bnf_i1557280698607_message_0",
							"hasDitaContent": {
								"@type": "rdf:XMLLiteral",
								"@value": "<p otherprops=\"Severe\" outputclass=\"int-message\">Both <ph otherprops=\"chlorpromazine\" outputclass=\"int-heading-drug\">chlorpromazine</ph> and <ph otherprops=\"pasireotide\" outputclass=\"int-drug\">pasireotide</ph> prolong the QT interval. Most manufacturers advise avoiding the use of two or more drugs that are associated with QT prolongation. Increasing age, female sex, cardiac disease, and some metabolic disturbances (notably hypokalaemia) predispose to QT prolongation. </p>"
							},
							"hasEvidence": "NotSet",
							"hasImportance": "Severe",
							"hasOrder": "1",
							"hasTextContent": "Both  chlorpromazine  and  pasireotide  prolong the QT interval. Most manufacturers advise avoiding the use of two or more drugs that are associated with QT prolongation. Increasing age, female sex, cardiac disease, and some metabolic disturbances (notably hypokalaemia) predispose to QT prolongation.  \n\n"
						}
					],
					"hasOrder": "236",
					"hasTitle": {
						"@type": "rdf:XMLLiteral",
						"@value": "<title>Pasireotide</title>"
					}
				},
				{
					"@id": "http://bnf.nice.org.uk/interaction/chlorpromazine#bnf_i1557280698608",
					"hasMessage": [
						{
							"@id": "http://bnf.nice.org.uk/interaction/chlorpromazine#bnf_i1557280698608_message_0",
							"hasDitaContent": {
								"@type": "rdf:XMLLiteral",
								"@value": "<p otherprops=\"Severe\" outputclass=\"int-message\">Both <ph otherprops=\"chlorpromazine\" outputclass=\"int-heading-drug\">chlorpromazine</ph> and <ph otherprops=\"pazopanib\" outputclass=\"int-drug\">pazopanib</ph> prolong the QT interval. Most manufacturers advise avoiding the use of two or more drugs that are associated with QT prolongation. Increasing age, female sex, cardiac disease, and some metabolic disturbances (notably hypokalaemia) predispose to QT prolongation. </p>"
							},
							"hasEvidence": "NotSet",
							"hasImportance": "Severe",
							"hasOrder": "1",
							"hasTextContent": "Both  chlorpromazine  and  pazopanib  prolong the QT interval. Most manufacturers advise avoiding the use of two or more drugs that are associated with QT prolongation. Increasing age, female sex, cardiac disease, and some metabolic disturbances (notably hypokalaemia) predispose to QT prolongation.  \n\n"
						}
					],
					"hasOrder": "237",
					"hasTitle": {
						"@type": "rdf:XMLLiteral",
						"@value": "<title>Pazopanib</title>"
					}
				},
				{
					"@id": "http://bnf.nice.org.uk/interaction/chlorpromazine#bnf_i1557280698609",
					"hasMessage": [
						{
							"@id": "http://bnf.nice.org.uk/interaction/chlorpromazine#bnf_i1557280698609_message_0",
							"hasDitaContent": {
								"@type": "rdf:XMLLiteral",
								"@value": "<p otherprops=\"Severe\" outputclass=\"int-message\">\n  <ph outputclass=\"int-route\">Intravenous</ph> <ph otherprops=\"pentamidine\" outputclass=\"int-drug\">pentamidine</ph> <ph outputclass=\"int-effectQualifier\">potentially</ph> <ph outputclass=\"int-effect\">increases</ph> <ph outputclass=\"int-parameter\">the risk of QT-prolongation when given with</ph> <ph otherprops=\"chlorpromazine\" outputclass=\"int-heading-drug\">chlorpromazine</ph>. <ph outputclass=\"int-action\">Manufacturer advises caution</ph>.  </p>"
							},
							"hasEvidence": "Anecdotal",
							"hasImportance": "Severe",
							"hasOrder": "1",
							"hasTextContent": "Intravenous   pentamidine   potentially   increases   the risk of QT-prolongation when given with   chlorpromazine .  Manufacturer advises caution .    \n\n"
						}
					],
					"hasOrder": "238",
					"hasTitle": {
						"@type": "rdf:XMLLiteral",
						"@value": "<title>Pentamidine</title>"
					}
				},
				{
					"@id": "http://bnf.nice.org.uk/interaction/chlorpromazine#bnf_i1557280698610",
					"hasMessage": [
						{
							"@id": "http://bnf.nice.org.uk/interaction/chlorpromazine#bnf_i1557280698610_message_0",
							"hasDitaContent": {
								"@type": "rdf:XMLLiteral",
								"@value": "<p otherprops=\"Normal\" outputclass=\"int-message\">Both <ph otherprops=\"chlorpromazine\" outputclass=\"int-heading-drug\">chlorpromazine</ph> and <ph otherprops=\"pentazocine\" outputclass=\"int-drug\">pentazocine</ph> can have CNS depressant effects, which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in <xref format=\"dita\" href=\"guidance/guidance-on-prescribing.xml\" type=\"interaction\" rel=\"guidance\" bnfid=\"PHP97234\">Guidance on Prescribing</xref>).</p>"
							},
							"hasEvidence": "NotSet",
							"hasImportance": "NotSet",
							"hasOrder": "1",
							"hasTextContent": "Both  chlorpromazine  and  pentazocine  can have CNS depressant effects, which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in  Guidance on Prescribing ). \n\n"
						}
					],
					"hasOrder": "239",
					"hasTitle": {
						"@type": "rdf:XMLLiteral",
						"@value": "<title>Pentazocine</title>"
					}
				},
				{
					"@id": "http://bnf.nice.org.uk/interaction/chlorpromazine#bnf_i1557280698611",
					"hasMessage": [
						{
							"@id": "http://bnf.nice.org.uk/interaction/chlorpromazine#bnf_i1557280698611_message_0",
							"hasDitaContent": {
								"@type": "rdf:XMLLiteral",
								"@value": "<p otherprops=\"Normal\" outputclass=\"int-message\">Both <ph otherprops=\"chlorpromazine\" outputclass=\"int-heading-drug\">chlorpromazine</ph> and <ph otherprops=\"perampanel\" outputclass=\"int-drug\">perampanel</ph> can have CNS depressant effects, which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in <xref format=\"dita\" href=\"guidance/guidance-on-prescribing.xml\" type=\"interaction\" rel=\"guidance\" bnfid=\"PHP97234\">Guidance on Prescribing</xref>).</p>"
							},
							"hasEvidence": "NotSet",
							"hasImportance": "NotSet",
							"hasOrder": "1",
							"hasTextContent": "Both  chlorpromazine  and  perampanel  can have CNS depressant effects, which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in  Guidance on Prescribing ). \n\n"
						}
					],
					"hasOrder": "240",
					"hasTitle": {
						"@type": "rdf:XMLLiteral",
						"@value": "<title>Perampanel</title>"
					}
				},
				{
					"@id": "http://bnf.nice.org.uk/interaction/chlorpromazine#bnf_i1557280698612",
					"hasMessage": [
						{
							"@id": "http://bnf.nice.org.uk/interaction/chlorpromazine#bnf_i1557280698612_message_0",
							"hasDitaContent": {
								"@type": "rdf:XMLLiteral",
								"@value": "<p otherprops=\"Normal\" outputclass=\"int-message\">Both <ph otherprops=\"chlorpromazine\" outputclass=\"int-heading-drug\">chlorpromazine</ph> and <ph otherprops=\"pergolide\" outputclass=\"int-drug\">pergolide</ph> can increase the risk of hypotension.</p>"
							},
							"hasEvidence": "NotSet",
							"hasImportance": "NotSet",
							"hasOrder": "1",
							"hasTextContent": "Both  chlorpromazine  and  pergolide  can increase the risk of hypotension. \n\n"
						},
						{
							"@id": "http://bnf.nice.org.uk/interaction/chlorpromazine#bnf_i1557280698612_message_1",
							"hasDitaContent": {
								"@type": "rdf:XMLLiteral",
								"@value": "<p otherprops=\"Moderate\" outputclass=\"int-message\">\n  <ph otherprops=\"chlorpromazine\" outputclass=\"int-heading-drug\">Chlorpromazine</ph> <ph outputclass=\"int-effectQualifier\">is predicted to</ph> <ph outputclass=\"int-effect\">decrease</ph> <ph outputclass=\"int-parameter\">the effects of</ph> <ph otherprops=\"pergolide\" outputclass=\"int-drug\">pergolide</ph>. <ph outputclass=\"int-action\">Manufacturer advises avoid</ph>.  </p>"
							},
							"hasEvidence": "Theoretical",
							"hasImportance": "Moderate",
							"hasOrder": "2",
							"hasTextContent": "Chlorpromazine   is predicted to   decrease   the effects of   pergolide .  Manufacturer advises avoid .    \n\n"
						}
					],
					"hasOrder": "241",
					"hasTitle": {
						"@type": "rdf:XMLLiteral",
						"@value": "<title>Pergolide</title>"
					}
				},
				{
					"@id": "http://bnf.nice.org.uk/interaction/chlorpromazine#bnf_i1557280698613",
					"hasMessage": [
						{
							"@id": "http://bnf.nice.org.uk/interaction/chlorpromazine#bnf_i1557280698613_message_0",
							"hasDitaContent": {
								"@type": "rdf:XMLLiteral",
								"@value": "<p otherprops=\"Normal\" outputclass=\"int-message\">Both <ph otherprops=\"chlorpromazine\" outputclass=\"int-heading-drug\">chlorpromazine</ph> and <ph otherprops=\"perindopril\" outputclass=\"int-drug\">perindopril</ph> can increase the risk of hypotension.</p>"
							},
							"hasEvidence": "NotSet",
							"hasImportance": "NotSet",
							"hasOrder": "1",
							"hasTextContent": "Both  chlorpromazine  and  perindopril  can increase the risk of hypotension. \n\n"
						}
					],
					"hasOrder": "242",
					"hasTitle": {
						"@type": "rdf:XMLLiteral",
						"@value": "<title>Perindopril</title>"
					}
				},
				{
					"@id": "http://bnf.nice.org.uk/interaction/chlorpromazine#bnf_i1557280698614",
					"hasMessage": [
						{
							"@id": "http://bnf.nice.org.uk/interaction/chlorpromazine#bnf_i1557280698614_message_0",
							"hasDitaContent": {
								"@type": "rdf:XMLLiteral",
								"@value": "<p otherprops=\"Normal\" outputclass=\"int-message\">Both <ph otherprops=\"chlorpromazine\" outputclass=\"int-heading-drug\">chlorpromazine</ph> and <ph otherprops=\"pethidine\" outputclass=\"int-drug\">pethidine</ph> can have CNS depressant effects, which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in <xref format=\"dita\" href=\"guidance/guidance-on-prescribing.xml\" type=\"interaction\" rel=\"guidance\" bnfid=\"PHP97234\">Guidance on Prescribing</xref>).</p>"
							},
							"hasEvidence": "NotSet",
							"hasImportance": "NotSet",
							"hasOrder": "1",
							"hasTextContent": "Both  chlorpromazine  and  pethidine  can have CNS depressant effects, which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in  Guidance on Prescribing ). \n\n"
						}
					],
					"hasOrder": "243",
					"hasTitle": {
						"@type": "rdf:XMLLiteral",
						"@value": "<title>Pethidine</title>"
					}
				},
				{
					"@id": "http://bnf.nice.org.uk/interaction/chlorpromazine#bnf_i1557280698615",
					"hasMessage": [
						{
							"@id": "http://bnf.nice.org.uk/interaction/chlorpromazine#bnf_i1557280698615_message_0",
							"hasDitaContent": {
								"@type": "rdf:XMLLiteral",
								"@value": "<p otherprops=\"Normal\" outputclass=\"int-message\">Both <ph otherprops=\"chlorpromazine\" outputclass=\"int-heading-drug\">chlorpromazine</ph> and <ph otherprops=\"phenelzine\" outputclass=\"int-drug\">phenelzine</ph> can increase the risk of hypotension.</p>"
							},
							"hasEvidence": "NotSet",
							"hasImportance": "NotSet",
							"hasOrder": "1",
							"hasTextContent": "Both  chlorpromazine  and  phenelzine  can increase the risk of hypotension. \n\n"
						},
						{
							"@id": "http://bnf.nice.org.uk/interaction/chlorpromazine#bnf_i1557280698615_message_1",
							"hasDitaContent": {
								"@type": "rdf:XMLLiteral",
								"@value": "<p otherprops=\"Severe\" outputclass=\"int-message\">\n  <ph otherprops=\"phenelzine\" outputclass=\"int-drug\">Phenelzine</ph> <ph outputclass=\"int-effectQualifier\">is predicted to</ph> <ph outputclass=\"int-effect\">increase</ph> <ph outputclass=\"int-parameter\">the risk of neuroleptic malignant syndrome when given with</ph> <ph otherprops=\"chlorpromazine\" outputclass=\"int-heading-drug\">chlorpromazine</ph>. <ph outputclass=\"int-action\">Manufacturer makes no recommendation</ph>.  </p>"
							},
							"hasEvidence": "Theoretical",
							"hasImportance": "Severe",
							"hasOrder": "2",
							"hasTextContent": "Phenelzine   is predicted to   increase   the risk of neuroleptic malignant syndrome when given with   chlorpromazine .  Manufacturer makes no recommendation .    \n\n"
						}
					],
					"hasOrder": "244",
					"hasTitle": {
						"@type": "rdf:XMLLiteral",
						"@value": "<title>Phenelzine</title>"
					}
				},
				{
					"@id": "http://bnf.nice.org.uk/interaction/chlorpromazine#bnf_i1557280698616",
					"hasMessage": [
						{
							"@id": "http://bnf.nice.org.uk/interaction/chlorpromazine#bnf_i1557280698616_message_0",
							"hasDitaContent": {
								"@type": "rdf:XMLLiteral",
								"@value": "<p otherprops=\"Normal\" outputclass=\"int-message\">Both <ph otherprops=\"chlorpromazine\" outputclass=\"int-heading-drug\">chlorpromazine</ph> and <ph otherprops=\"phenobarbital\" outputclass=\"int-drug\">phenobarbital</ph> can have CNS depressant effects, which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in <xref format=\"dita\" href=\"guidance/guidance-on-prescribing.xml\" type=\"interaction\" rel=\"guidance\" bnfid=\"PHP97234\">Guidance on Prescribing</xref>).</p>"
							},
							"hasEvidence": "NotSet",
							"hasImportance": "NotSet",
							"hasOrder": "1",
							"hasTextContent": "Both  chlorpromazine  and  phenobarbital  can have CNS depressant effects, which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in  Guidance on Prescribing ). \n\n"
						},
						{
							"@id": "http://bnf.nice.org.uk/interaction/chlorpromazine#bnf_i1557280698616_message_1",
							"hasDitaContent": {
								"@type": "rdf:XMLLiteral",
								"@value": "<p otherprops=\"Moderate\" outputclass=\"int-message\">\n  <ph otherprops=\"chlorpromazine\" outputclass=\"int-heading-drug\">Chlorpromazine</ph> <ph outputclass=\"int-effect\">decreases</ph> <ph outputclass=\"int-parameter\">the concentration of</ph> <ph otherprops=\"phenobarbital\" outputclass=\"int-drug\">phenobarbital</ph> and <ph otherprops=\"phenobarbital\" outputclass=\"int-drug\">phenobarbital</ph> <ph outputclass=\"int-effect\">decreases</ph> <ph outputclass=\"int-parameter\">the concentration of</ph> <ph otherprops=\"chlorpromazine\" outputclass=\"int-heading-drug\">chlorpromazine</ph>. <ph outputclass=\"int-action\">Manufacturer makes no recommendation</ph>.  </p>"
							},
							"hasEvidence": "Study",
							"hasImportance": "Moderate",
							"hasOrder": "2",
							"hasTextContent": "Chlorpromazine   decreases   the concentration of   phenobarbital  and  phenobarbital   decreases   the concentration of   chlorpromazine .  Manufacturer makes no recommendation .    \n\n"
						}
					],
					"hasOrder": "245",
					"hasTitle": {
						"@type": "rdf:XMLLiteral",
						"@value": "<title>Phenobarbital</title>"
					}
				},
				{
					"@id": "http://bnf.nice.org.uk/interaction/chlorpromazine#bnf_i1557280698617",
					"hasMessage": [
						{
							"@id": "http://bnf.nice.org.uk/interaction/chlorpromazine#bnf_i1557280698617_message_0",
							"hasDitaContent": {
								"@type": "rdf:XMLLiteral",
								"@value": "<p otherprops=\"Normal\" outputclass=\"int-message\">Both <ph otherprops=\"chlorpromazine\" outputclass=\"int-heading-drug\">chlorpromazine</ph> and <ph otherprops=\"pimozide\" outputclass=\"int-drug\">pimozide</ph> can increase the risk of hypotension.</p>"
							},
							"hasEvidence": "NotSet",
							"hasImportance": "NotSet",
							"hasOrder": "1",
							"hasTextContent": "Both  chlorpromazine  and  pimozide  can increase the risk of hypotension. \n\n"
						},
						{
							"@id": "http://bnf.nice.org.uk/interaction/chlorpromazine#bnf_i1557280698617_message_1",
							"hasDitaContent": {
								"@type": "rdf:XMLLiteral",
								"@value": "<p otherprops=\"Severe\" outputclass=\"int-message\">Both <ph otherprops=\"chlorpromazine\" outputclass=\"int-heading-drug\">chlorpromazine</ph> and <ph otherprops=\"pimozide\" outputclass=\"int-drug\">pimozide</ph> prolong the QT interval. Most manufacturers advise avoiding the use of two or more drugs that are associated with QT prolongation. Increasing age, female sex, cardiac disease, and some metabolic disturbances (notably hypokalaemia) predispose to QT prolongation. </p>"
							},
							"hasEvidence": "NotSet",
							"hasImportance": "Severe",
							"hasOrder": "2",
							"hasTextContent": "Both  chlorpromazine  and  pimozide  prolong the QT interval. Most manufacturers advise avoiding the use of two or more drugs that are associated with QT prolongation. Increasing age, female sex, cardiac disease, and some metabolic disturbances (notably hypokalaemia) predispose to QT prolongation.  \n\n"
						},
						{
							"@id": "http://bnf.nice.org.uk/interaction/chlorpromazine#bnf_i1557280698617_message_2",
							"hasDitaContent": {
								"@type": "rdf:XMLLiteral",
								"@value": "<p otherprops=\"Normal\" outputclass=\"int-message\">Both <ph otherprops=\"chlorpromazine\" outputclass=\"int-heading-drug\">chlorpromazine</ph> and <ph otherprops=\"pimozide\" outputclass=\"int-drug\">pimozide</ph> can have CNS depressant effects, which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in <xref format=\"dita\" href=\"guidance/guidance-on-prescribing.xml\" type=\"interaction\" rel=\"guidance\" bnfid=\"PHP97234\">Guidance on Prescribing</xref>).</p>"
							},
							"hasEvidence": "NotSet",
							"hasImportance": "NotSet",
							"hasOrder": "3",
							"hasTextContent": "Both  chlorpromazine  and  pimozide  can have CNS depressant effects, which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in  Guidance on Prescribing ). \n\n"
						},
						{
							"@id": "http://bnf.nice.org.uk/interaction/chlorpromazine#bnf_i1557280698617_message_3",
							"hasDitaContent": {
								"@type": "rdf:XMLLiteral",
								"@value": "<p otherprops=\"Normal\" outputclass=\"int-message\">Both <ph otherprops=\"chlorpromazine\" outputclass=\"int-heading-drug\">chlorpromazine</ph> and <ph otherprops=\"pimozide\" outputclass=\"int-drug\">pimozide</ph> can cause antimuscarinic effects.</p>"
							},
							"hasEvidence": "NotSet",
							"hasImportance": "NotSet",
							"hasOrder": "4",
							"hasTextContent": "Both  chlorpromazine  and  pimozide  can cause antimuscarinic effects. \n\n"
						}
					],
					"hasOrder": "246",
					"hasTitle": {
						"@type": "rdf:XMLLiteral",
						"@value": "<title>Pimozide</title>"
					}
				},
				{
					"@id": "http://bnf.nice.org.uk/interaction/chlorpromazine#bnf_i1557280698618",
					"hasMessage": [
						{
							"@id": "http://bnf.nice.org.uk/interaction/chlorpromazine#bnf_i1557280698618_message_0",
							"hasDitaContent": {
								"@type": "rdf:XMLLiteral",
								"@value": "<p otherprops=\"Normal\" outputclass=\"int-message\">Both <ph otherprops=\"chlorpromazine\" outputclass=\"int-heading-drug\">chlorpromazine</ph> and <ph otherprops=\"pindolol\" outputclass=\"int-drug\">pindolol</ph> can increase the risk of hypotension.</p>"
							},
							"hasEvidence": "NotSet",
							"hasImportance": "NotSet",
							"hasOrder": "1",
							"hasTextContent": "Both  chlorpromazine  and  pindolol  can increase the risk of hypotension. \n\n"
						}
					],
					"hasOrder": "247",
					"hasTitle": {
						"@type": "rdf:XMLLiteral",
						"@value": "<title>Pindolol</title>"
					}
				},
				{
					"@id": "http://bnf.nice.org.uk/interaction/chlorpromazine#bnf_i1557280698619",
					"hasMessage": [
						{
							"@id": "http://bnf.nice.org.uk/interaction/chlorpromazine#bnf_i1557280698619_message_0",
							"hasDitaContent": {
								"@type": "rdf:XMLLiteral",
								"@value": "<p otherprops=\"Normal\" outputclass=\"int-message\">Both <ph otherprops=\"chlorpromazine\" outputclass=\"int-heading-drug\">chlorpromazine</ph> and <ph otherprops=\"pizotifen\" outputclass=\"int-drug\">pizotifen</ph> can have CNS depressant effects, which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in <xref format=\"dita\" href=\"guidance/guidance-on-prescribing.xml\" type=\"interaction\" rel=\"guidance\" bnfid=\"PHP97234\">Guidance on Prescribing</xref>).</p>"
							},
							"hasEvidence": "NotSet",
							"hasImportance": "NotSet",
							"hasOrder": "1",
							"hasTextContent": "Both  chlorpromazine  and  pizotifen  can have CNS depressant effects, which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in  Guidance on Prescribing ). \n\n"
						}
					],
					"hasOrder": "248",
					"hasTitle": {
						"@type": "rdf:XMLLiteral",
						"@value": "<title>Pizotifen</title>"
					}
				},
				{
					"@id": "http://bnf.nice.org.uk/interaction/chlorpromazine#bnf_i1557280698620",
					"hasMessage": [
						{
							"@id": "http://bnf.nice.org.uk/interaction/chlorpromazine#bnf_i1557280698620_message_0",
							"hasDitaContent": {
								"@type": "rdf:XMLLiteral",
								"@value": "<p otherprops=\"Normal\" outputclass=\"int-message\">Both <ph otherprops=\"chlorpromazine\" outputclass=\"int-heading-drug\">chlorpromazine</ph> and <ph otherprops=\"pramipexole\" outputclass=\"int-drug\">pramipexole</ph> can increase the risk of hypotension.</p>"
							},
							"hasEvidence": "NotSet",
							"hasImportance": "NotSet",
							"hasOrder": "1",
							"hasTextContent": "Both  chlorpromazine  and  pramipexole  can increase the risk of hypotension. \n\n"
						},
						{
							"@id": "http://bnf.nice.org.uk/interaction/chlorpromazine#bnf_i1557280698620_message_1",
							"hasDitaContent": {
								"@type": "rdf:XMLLiteral",
								"@value": "<p otherprops=\"Moderate\" outputclass=\"int-message\">\n  <ph otherprops=\"chlorpromazine\" outputclass=\"int-heading-drug\">Chlorpromazine</ph> <ph outputclass=\"int-effectQualifier\">is predicted to</ph> <ph outputclass=\"int-effect\">decrease</ph> <ph outputclass=\"int-parameter\">the effects of</ph> <ph otherprops=\"pramipexole\" outputclass=\"int-drug\">pramipexole</ph>. <ph outputclass=\"int-action\">Manufacturer advises avoid</ph>.  </p>"
							},
							"hasEvidence": "Theoretical",
							"hasImportance": "Moderate",
							"hasOrder": "2",
							"hasTextContent": "Chlorpromazine   is predicted to   decrease   the effects of   pramipexole .  Manufacturer advises avoid .    \n\n"
						}
					],
					"hasOrder": "249",
					"hasTitle": {
						"@type": "rdf:XMLLiteral",
						"@value": "<title>Pramipexole</title>"
					}
				},
				{
					"@id": "http://bnf.nice.org.uk/interaction/chlorpromazine#bnf_i1557280698621",
					"hasMessage": [
						{
							"@id": "http://bnf.nice.org.uk/interaction/chlorpromazine#bnf_i1557280698621_message_0",
							"hasDitaContent": {
								"@type": "rdf:XMLLiteral",
								"@value": "<p otherprops=\"Normal\" outputclass=\"int-message\">Both <ph otherprops=\"chlorpromazine\" outputclass=\"int-heading-drug\">chlorpromazine</ph> and <ph otherprops=\"prazosin\" outputclass=\"int-drug\">prazosin</ph> can increase the risk of hypotension.</p>"
							},
							"hasEvidence": "NotSet",
							"hasImportance": "NotSet",
							"hasOrder": "1",
							"hasTextContent": "Both  chlorpromazine  and  prazosin  can increase the risk of hypotension. \n\n"
						}
					],
					"hasOrder": "250",
					"hasTitle": {
						"@type": "rdf:XMLLiteral",
						"@value": "<title>Prazosin</title>"
					}
				},
				{
					"@id": "http://bnf.nice.org.uk/interaction/chlorpromazine#bnf_i1557280698622",
					"hasMessage": [
						{
							"@id": "http://bnf.nice.org.uk/interaction/chlorpromazine#bnf_i1557280698622_message_0",
							"hasDitaContent": {
								"@type": "rdf:XMLLiteral",
								"@value": "<p otherprops=\"Severe\" outputclass=\"int-message\">\n  <ph otherprops=\"prednisolone\" outputclass=\"int-drug\">Prednisolone</ph> <ph outputclass=\"int-effectQualifier\">is predicted to</ph> <ph outputclass=\"int-effect\">cause</ph> <ph outputclass=\"int-parameter\">hypokalaemia (potentially increasing the risk of torsade de pointes) when given with</ph> <ph otherprops=\"chlorpromazine\" outputclass=\"int-heading-drug\">chlorpromazine</ph>. <ph outputclass=\"int-action\">Manufacturer makes no recommendation</ph>.  </p>"
							},
							"hasEvidence": "Theoretical",
							"hasImportance": "Severe",
							"hasOrder": "1",
							"hasTextContent": "Prednisolone   is predicted to   cause   hypokalaemia (potentially increasing the risk of torsade de pointes) when given with   chlorpromazine .  Manufacturer makes no recommendation .    \n\n"
						}
					],
					"hasOrder": "251",
					"hasTitle": {
						"@type": "rdf:XMLLiteral",
						"@value": "<title>Prednisolone</title>"
					}
				},
				{
					"@id": "http://bnf.nice.org.uk/interaction/chlorpromazine#bnf_i1557280698623",
					"hasMessage": [
						{
							"@id": "http://bnf.nice.org.uk/interaction/chlorpromazine#bnf_i1557280698623_message_0",
							"hasDitaContent": {
								"@type": "rdf:XMLLiteral",
								"@value": "<p otherprops=\"Normal\" outputclass=\"int-message\">Both <ph otherprops=\"chlorpromazine\" outputclass=\"int-heading-drug\">chlorpromazine</ph> and <ph otherprops=\"pregabalin\" outputclass=\"int-drug\">pregabalin</ph> can have CNS depressant effects, which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in <xref format=\"dita\" href=\"guidance/guidance-on-prescribing.xml\" type=\"interaction\" rel=\"guidance\" bnfid=\"PHP97234\">Guidance on Prescribing</xref>).</p>"
							},
							"hasEvidence": "NotSet",
							"hasImportance": "NotSet",
							"hasOrder": "1",
							"hasTextContent": "Both  chlorpromazine  and  pregabalin  can have CNS depressant effects, which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in  Guidance on Prescribing ). \n\n"
						}
					],
					"hasOrder": "252",
					"hasTitle": {
						"@type": "rdf:XMLLiteral",
						"@value": "<title>Pregabalin</title>"
					}
				},
				{
					"@id": "http://bnf.nice.org.uk/interaction/chlorpromazine#bnf_i1557280698624",
					"hasMessage": [
						{
							"@id": "http://bnf.nice.org.uk/interaction/chlorpromazine#bnf_i1557280698624_message_0",
							"hasDitaContent": {
								"@type": "rdf:XMLLiteral",
								"@value": "<p otherprops=\"Normal\" outputclass=\"int-message\">Both <ph otherprops=\"chlorpromazine\" outputclass=\"int-heading-drug\">chlorpromazine</ph> and <ph otherprops=\"prilocaine\" outputclass=\"int-drug\">prilocaine</ph> can have CNS depressant effects, which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in <xref format=\"dita\" href=\"guidance/guidance-on-prescribing.xml\" type=\"interaction\" rel=\"guidance\" bnfid=\"PHP97234\">Guidance on Prescribing</xref>).</p>"
							},
							"hasEvidence": "NotSet",
							"hasImportance": "NotSet",
							"hasOrder": "1",
							"hasTextContent": "Both  chlorpromazine  and  prilocaine  can have CNS depressant effects, which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in  Guidance on Prescribing ). \n\n"
						}
					],
					"hasOrder": "253",
					"hasTitle": {
						"@type": "rdf:XMLLiteral",
						"@value": "<title>Prilocaine</title>"
					}
				},
				{
					"@id": "http://bnf.nice.org.uk/interaction/chlorpromazine#bnf_i1557280698625",
					"hasMessage": [
						{
							"@id": "http://bnf.nice.org.uk/interaction/chlorpromazine#bnf_i1557280698625_message_0",
							"hasDitaContent": {
								"@type": "rdf:XMLLiteral",
								"@value": "<p otherprops=\"Normal\" outputclass=\"int-message\">Both <ph otherprops=\"chlorpromazine\" outputclass=\"int-heading-drug\">chlorpromazine</ph> and <ph otherprops=\"primidone\" outputclass=\"int-drug\">primidone</ph> can have CNS depressant effects, which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in <xref format=\"dita\" href=\"guidance/guidance-on-prescribing.xml\" type=\"interaction\" rel=\"guidance\" bnfid=\"PHP97234\">Guidance on Prescribing</xref>).</p>"
							},
							"hasEvidence": "NotSet",
							"hasImportance": "NotSet",
							"hasOrder": "1",
							"hasTextContent": "Both  chlorpromazine  and  primidone  can have CNS depressant effects, which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in  Guidance on Prescribing ). \n\n"
						},
						{
							"@id": "http://bnf.nice.org.uk/interaction/chlorpromazine#bnf_i1557280698625_message_1",
							"hasDitaContent": {
								"@type": "rdf:XMLLiteral",
								"@value": "<p otherprops=\"Moderate\" outputclass=\"int-message\">\n  <ph otherprops=\"chlorpromazine\" outputclass=\"int-heading-drug\">Chlorpromazine</ph> <ph outputclass=\"int-effect\">decreases</ph> <ph outputclass=\"int-parameter\">the concentration of</ph> <ph otherprops=\"primidone\" outputclass=\"int-drug\">primidone</ph> and <ph otherprops=\"primidone\" outputclass=\"int-drug\">primidone</ph> <ph outputclass=\"int-effect\">decreases</ph> <ph outputclass=\"int-parameter\">the concentration of</ph> <ph otherprops=\"chlorpromazine\" outputclass=\"int-heading-drug\">chlorpromazine</ph>. <ph outputclass=\"int-action\">Manufacturer makes no recommendation</ph>.  </p>"
							},
							"hasEvidence": "Study",
							"hasImportance": "Moderate",
							"hasOrder": "2",
							"hasTextContent": "Chlorpromazine   decreases   the concentration of   primidone  and  primidone   decreases   the concentration of   chlorpromazine .  Manufacturer makes no recommendation .    \n\n"
						}
					],
					"hasOrder": "254",
					"hasTitle": {
						"@type": "rdf:XMLLiteral",
						"@value": "<title>Primidone</title>"
					}
				},
				{
					"@id": "http://bnf.nice.org.uk/interaction/chlorpromazine#bnf_i1557280698626",
					"hasMessage": [
						{
							"@id": "http://bnf.nice.org.uk/interaction/chlorpromazine#bnf_i1557280698626_message_0",
							"hasDitaContent": {
								"@type": "rdf:XMLLiteral",
								"@value": "<p otherprops=\"Normal\" outputclass=\"int-message\">Both <ph otherprops=\"chlorpromazine\" outputclass=\"int-heading-drug\">chlorpromazine</ph> and <ph otherprops=\"procyclidine\" outputclass=\"int-drug\">procyclidine</ph> can cause antimuscarinic effects.</p>"
							},
							"hasEvidence": "NotSet",
							"hasImportance": "NotSet",
							"hasOrder": "1",
							"hasTextContent": "Both  chlorpromazine  and  procyclidine  can cause antimuscarinic effects. \n\n"
						}
					],
					"hasOrder": "255",
					"hasTitle": {
						"@type": "rdf:XMLLiteral",
						"@value": "<title>Procyclidine</title>"
					}
				},
				{
					"@id": "http://bnf.nice.org.uk/interaction/chlorpromazine#bnf_i1557280698627",
					"hasMessage": [
						{
							"@id": "http://bnf.nice.org.uk/interaction/chlorpromazine#bnf_i1557280698627_message_0",
							"hasDitaContent": {
								"@type": "rdf:XMLLiteral",
								"@value": "<p otherprops=\"Normal\" outputclass=\"int-message\">Both <ph otherprops=\"chlorpromazine\" outputclass=\"int-heading-drug\">chlorpromazine</ph> and <ph otherprops=\"promethazine\" outputclass=\"int-drug\">promethazine</ph> can have CNS depressant effects, which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in <xref format=\"dita\" href=\"guidance/guidance-on-prescribing.xml\" type=\"interaction\" rel=\"guidance\" bnfid=\"PHP97234\">Guidance on Prescribing</xref>).</p>"
							},
							"hasEvidence": "NotSet",
							"hasImportance": "NotSet",
							"hasOrder": "1",
							"hasTextContent": "Both  chlorpromazine  and  promethazine  can have CNS depressant effects, which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in  Guidance on Prescribing ). \n\n"
						},
						{
							"@id": "http://bnf.nice.org.uk/interaction/chlorpromazine#bnf_i1557280698627_message_1",
							"hasDitaContent": {
								"@type": "rdf:XMLLiteral",
								"@value": "<p otherprops=\"Normal\" outputclass=\"int-message\">Both <ph otherprops=\"chlorpromazine\" outputclass=\"int-heading-drug\">chlorpromazine</ph> and <ph otherprops=\"promethazine\" outputclass=\"int-drug\">promethazine</ph> can cause antimuscarinic effects.</p>"
							},
							"hasEvidence": "NotSet",
							"hasImportance": "NotSet",
							"hasOrder": "2",
							"hasTextContent": "Both  chlorpromazine  and  promethazine  can cause antimuscarinic effects. \n\n"
						}
					],
					"hasOrder": "256",
					"hasTitle": {
						"@type": "rdf:XMLLiteral",
						"@value": "<title>Promethazine</title>"
					}
				},
				{
					"@id": "http://bnf.nice.org.uk/interaction/chlorpromazine#bnf_i1557280698628",
					"hasMessage": [
						{
							"@id": "http://bnf.nice.org.uk/interaction/chlorpromazine#bnf_i1557280698628_message_0",
							"hasDitaContent": {
								"@type": "rdf:XMLLiteral",
								"@value": "<p otherprops=\"Normal\" outputclass=\"int-message\">Both <ph otherprops=\"chlorpromazine\" outputclass=\"int-heading-drug\">chlorpromazine</ph> and <ph otherprops=\"propafenone\" outputclass=\"int-drug\">propafenone</ph> can cause antimuscarinic effects.</p>"
							},
							"hasEvidence": "NotSet",
							"hasImportance": "NotSet",
							"hasOrder": "1",
							"hasTextContent": "Both  chlorpromazine  and  propafenone  can cause antimuscarinic effects. \n\n"
						}
					],
					"hasOrder": "257",
					"hasTitle": {
						"@type": "rdf:XMLLiteral",
						"@value": "<title>Propafenone</title>"
					}
				},
				{
					"@id": "http://bnf.nice.org.uk/interaction/chlorpromazine#bnf_i1557280698629",
					"hasMessage": [
						{
							"@id": "http://bnf.nice.org.uk/interaction/chlorpromazine#bnf_i1557280698629_message_0",
							"hasDitaContent": {
								"@type": "rdf:XMLLiteral",
								"@value": "<p otherprops=\"Normal\" outputclass=\"int-message\">Both <ph otherprops=\"chlorpromazine\" outputclass=\"int-heading-drug\">chlorpromazine</ph> and <ph otherprops=\"propantheline\" outputclass=\"int-drug\">propantheline</ph> can cause antimuscarinic effects.</p>"
							},
							"hasEvidence": "NotSet",
							"hasImportance": "NotSet",
							"hasOrder": "1",
							"hasTextContent": "Both  chlorpromazine  and  propantheline  can cause antimuscarinic effects. \n\n"
						}
					],
					"hasOrder": "258",
					"hasTitle": {
						"@type": "rdf:XMLLiteral",
						"@value": "<title>Propantheline</title>"
					}
				},
				{
					"@id": "http://bnf.nice.org.uk/interaction/chlorpromazine#bnf_i1557280698630",
					"hasMessage": [
						{
							"@id": "http://bnf.nice.org.uk/interaction/chlorpromazine#bnf_i1557280698630_message_0",
							"hasDitaContent": {
								"@type": "rdf:XMLLiteral",
								"@value": "<p otherprops=\"Normal\" outputclass=\"int-message\">Both <ph otherprops=\"chlorpromazine\" outputclass=\"int-heading-drug\">chlorpromazine</ph> and <ph otherprops=\"propiverine\" outputclass=\"int-drug\">propiverine</ph> can cause antimuscarinic effects.</p>"
							},
							"hasEvidence": "NotSet",
							"hasImportance": "NotSet",
							"hasOrder": "1",
							"hasTextContent": "Both  chlorpromazine  and  propiverine  can cause antimuscarinic effects. \n\n"
						}
					],
					"hasOrder": "259",
					"hasTitle": {
						"@type": "rdf:XMLLiteral",
						"@value": "<title>Propiverine</title>"
					}
				},
				{
					"@id": "http://bnf.nice.org.uk/interaction/chlorpromazine#bnf_i1557280698631",
					"hasMessage": [
						{
							"@id": "http://bnf.nice.org.uk/interaction/chlorpromazine#bnf_i1557280698631_message_0",
							"hasDitaContent": {
								"@type": "rdf:XMLLiteral",
								"@value": "<p otherprops=\"Normal\" outputclass=\"int-message\">Both <ph otherprops=\"chlorpromazine\" outputclass=\"int-heading-drug\">chlorpromazine</ph> and <ph otherprops=\"propofol\" outputclass=\"int-drug\">propofol</ph> can increase the risk of hypotension.</p>"
							},
							"hasEvidence": "NotSet",
							"hasImportance": "NotSet",
							"hasOrder": "1",
							"hasTextContent": "Both  chlorpromazine  and  propofol  can increase the risk of hypotension. \n\n"
						},
						{
							"@id": "http://bnf.nice.org.uk/interaction/chlorpromazine#bnf_i1557280698631_message_1",
							"hasDitaContent": {
								"@type": "rdf:XMLLiteral",
								"@value": "<p otherprops=\"Normal\" outputclass=\"int-message\">Both <ph otherprops=\"chlorpromazine\" outputclass=\"int-heading-drug\">chlorpromazine</ph> and <ph otherprops=\"propofol\" outputclass=\"int-drug\">propofol</ph> can have CNS depressant effects, which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in <xref format=\"dita\" href=\"guidance/guidance-on-prescribing.xml\" type=\"interaction\" rel=\"guidance\" bnfid=\"PHP97234\">Guidance on Prescribing</xref>).</p>"
							},
							"hasEvidence": "NotSet",
							"hasImportance": "NotSet",
							"hasOrder": "2",
							"hasTextContent": "Both  chlorpromazine  and  propofol  can have CNS depressant effects, which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in  Guidance on Prescribing ). \n\n"
						}
					],
					"hasOrder": "260",
					"hasTitle": {
						"@type": "rdf:XMLLiteral",
						"@value": "<title>Propofol</title>"
					}
				},
				{
					"@id": "http://bnf.nice.org.uk/interaction/chlorpromazine#bnf_i1557280698632",
					"hasMessage": [
						{
							"@id": "http://bnf.nice.org.uk/interaction/chlorpromazine#bnf_i1557280698632_message_0",
							"hasDitaContent": {
								"@type": "rdf:XMLLiteral",
								"@value": "<p otherprops=\"Normal\" outputclass=\"int-message\">Both <ph otherprops=\"chlorpromazine\" outputclass=\"int-heading-drug\">chlorpromazine</ph> and <ph otherprops=\"propranolol\" outputclass=\"int-drug\">propranolol</ph> can increase the risk of hypotension.</p>"
							},
							"hasEvidence": "NotSet",
							"hasImportance": "NotSet",
							"hasOrder": "1",
							"hasTextContent": "Both  chlorpromazine  and  propranolol  can increase the risk of hypotension. \n\n"
						}
					],
					"hasOrder": "261",
					"hasTitle": {
						"@type": "rdf:XMLLiteral",
						"@value": "<title>Propranolol</title>"
					}
				},
				{
					"@id": "http://bnf.nice.org.uk/interaction/chlorpromazine#bnf_i1557280698633",
					"hasMessage": [
						{
							"@id": "http://bnf.nice.org.uk/interaction/chlorpromazine#bnf_i1557280698633_message_0",
							"hasDitaContent": {
								"@type": "rdf:XMLLiteral",
								"@value": "<p otherprops=\"Normal\" outputclass=\"int-message\">Both <ph otherprops=\"chlorpromazine\" outputclass=\"int-heading-drug\">chlorpromazine</ph> and <ph otherprops=\"quetiapine\" outputclass=\"int-drug\">quetiapine</ph> can increase the risk of hypotension.</p>"
							},
							"hasEvidence": "NotSet",
							"hasImportance": "NotSet",
							"hasOrder": "1",
							"hasTextContent": "Both  chlorpromazine  and  quetiapine  can increase the risk of hypotension. \n\n"
						},
						{
							"@id": "http://bnf.nice.org.uk/interaction/chlorpromazine#bnf_i1557280698633_message_1",
							"hasDitaContent": {
								"@type": "rdf:XMLLiteral",
								"@value": "<p otherprops=\"Normal\" outputclass=\"int-message\">Both <ph otherprops=\"chlorpromazine\" outputclass=\"int-heading-drug\">chlorpromazine</ph> and <ph otherprops=\"quetiapine\" outputclass=\"int-drug\">quetiapine</ph> can have CNS depressant effects, which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in <xref format=\"dita\" href=\"guidance/guidance-on-prescribing.xml\" type=\"interaction\" rel=\"guidance\" bnfid=\"PHP97234\">Guidance on Prescribing</xref>).</p>"
							},
							"hasEvidence": "NotSet",
							"hasImportance": "NotSet",
							"hasOrder": "2",
							"hasTextContent": "Both  chlorpromazine  and  quetiapine  can have CNS depressant effects, which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in  Guidance on Prescribing ). \n\n"
						}
					],
					"hasOrder": "262",
					"hasTitle": {
						"@type": "rdf:XMLLiteral",
						"@value": "<title>Quetiapine</title>"
					}
				},
				{
					"@id": "http://bnf.nice.org.uk/interaction/chlorpromazine#bnf_i1557280698634",
					"hasMessage": [
						{
							"@id": "http://bnf.nice.org.uk/interaction/chlorpromazine#bnf_i1557280698634_message_0",
							"hasDitaContent": {
								"@type": "rdf:XMLLiteral",
								"@value": "<p otherprops=\"Normal\" outputclass=\"int-message\">Both <ph otherprops=\"chlorpromazine\" outputclass=\"int-heading-drug\">chlorpromazine</ph> and <ph otherprops=\"quinagolide\" outputclass=\"int-drug\">quinagolide</ph> can increase the risk of hypotension.</p>"
							},
							"hasEvidence": "NotSet",
							"hasImportance": "NotSet",
							"hasOrder": "1",
							"hasTextContent": "Both  chlorpromazine  and  quinagolide  can increase the risk of hypotension. \n\n"
						},
						{
							"@id": "http://bnf.nice.org.uk/interaction/chlorpromazine#bnf_i1557280698634_message_1",
							"hasDitaContent": {
								"@type": "rdf:XMLLiteral",
								"@value": "<p otherprops=\"Moderate\" outputclass=\"int-message\">\n  <ph otherprops=\"chlorpromazine\" outputclass=\"int-heading-drug\">Chlorpromazine</ph> <ph outputclass=\"int-effectQualifier\">is predicted to</ph> <ph outputclass=\"int-effect\">decrease</ph> <ph outputclass=\"int-parameter\">the effects of</ph> <ph otherprops=\"quinagolide\" outputclass=\"int-drug\">quinagolide</ph>. <ph outputclass=\"int-action\">Manufacturer advises avoid</ph>.  </p>"
							},
							"hasEvidence": "Theoretical",
							"hasImportance": "Moderate",
							"hasOrder": "2",
							"hasTextContent": "Chlorpromazine   is predicted to   decrease   the effects of   quinagolide .  Manufacturer advises avoid .    \n\n"
						}
					],
					"hasOrder": "263",
					"hasTitle": {
						"@type": "rdf:XMLLiteral",
						"@value": "<title>Quinagolide</title>"
					}
				},
				{
					"@id": "http://bnf.nice.org.uk/interaction/chlorpromazine#bnf_i1557280698635",
					"hasMessage": [
						{
							"@id": "http://bnf.nice.org.uk/interaction/chlorpromazine#bnf_i1557280698635_message_0",
							"hasDitaContent": {
								"@type": "rdf:XMLLiteral",
								"@value": "<p otherprops=\"Normal\" outputclass=\"int-message\">Both <ph otherprops=\"chlorpromazine\" outputclass=\"int-heading-drug\">chlorpromazine</ph> and <ph otherprops=\"quinapril\" outputclass=\"int-drug\">quinapril</ph> can increase the risk of hypotension.</p>"
							},
							"hasEvidence": "NotSet",
							"hasImportance": "NotSet",
							"hasOrder": "1",
							"hasTextContent": "Both  chlorpromazine  and  quinapril  can increase the risk of hypotension. \n\n"
						}
					],
					"hasOrder": "264",
					"hasTitle": {
						"@type": "rdf:XMLLiteral",
						"@value": "<title>Quinapril</title>"
					}
				},
				{
					"@id": "http://bnf.nice.org.uk/interaction/chlorpromazine#bnf_i1557280698636",
					"hasMessage": [
						{
							"@id": "http://bnf.nice.org.uk/interaction/chlorpromazine#bnf_i1557280698636_message_0",
							"hasDitaContent": {
								"@type": "rdf:XMLLiteral",
								"@value": "<p otherprops=\"Severe\" outputclass=\"int-message\">Both <ph otherprops=\"chlorpromazine\" outputclass=\"int-heading-drug\">chlorpromazine</ph> and <ph otherprops=\"quinine\" outputclass=\"int-drug\">quinine</ph> prolong the QT interval. Most manufacturers advise avoiding the use of two or more drugs that are associated with QT prolongation. Increasing age, female sex, cardiac disease, and some metabolic disturbances (notably hypokalaemia) predispose to QT prolongation. </p>"
							},
							"hasEvidence": "NotSet",
							"hasImportance": "Severe",
							"hasOrder": "1",
							"hasTextContent": "Both  chlorpromazine  and  quinine  prolong the QT interval. Most manufacturers advise avoiding the use of two or more drugs that are associated with QT prolongation. Increasing age, female sex, cardiac disease, and some metabolic disturbances (notably hypokalaemia) predispose to QT prolongation.  \n\n"
						}
					],
					"hasOrder": "265",
					"hasTitle": {
						"@type": "rdf:XMLLiteral",
						"@value": "<title>Quinine</title>"
					}
				},
				{
					"@id": "http://bnf.nice.org.uk/interaction/chlorpromazine#bnf_i1557280698637",
					"hasMessage": [
						{
							"@id": "http://bnf.nice.org.uk/interaction/chlorpromazine#bnf_i1557280698637_message_0",
							"hasDitaContent": {
								"@type": "rdf:XMLLiteral",
								"@value": "<p otherprops=\"Normal\" outputclass=\"int-message\">Both <ph otherprops=\"chlorpromazine\" outputclass=\"int-heading-drug\">chlorpromazine</ph> and <ph otherprops=\"ramipril\" outputclass=\"int-drug\">ramipril</ph> can increase the risk of hypotension.</p>"
							},
							"hasEvidence": "NotSet",
							"hasImportance": "NotSet",
							"hasOrder": "1",
							"hasTextContent": "Both  chlorpromazine  and  ramipril  can increase the risk of hypotension. \n\n"
						}
					],
					"hasOrder": "266",
					"hasTitle": {
						"@type": "rdf:XMLLiteral",
						"@value": "<title>Ramipril</title>"
					}
				},
				{
					"@id": "http://bnf.nice.org.uk/interaction/chlorpromazine#bnf_i1557280698638",
					"hasMessage": [
						{
							"@id": "http://bnf.nice.org.uk/interaction/chlorpromazine#bnf_i1557280698638_message_0",
							"hasDitaContent": {
								"@type": "rdf:XMLLiteral",
								"@value": "<p otherprops=\"Severe\" outputclass=\"int-message\">Both <ph otherprops=\"chlorpromazine\" outputclass=\"int-heading-drug\">chlorpromazine</ph> and <ph otherprops=\"ranolazine\" outputclass=\"int-drug\">ranolazine</ph> prolong the QT interval. Most manufacturers advise avoiding the use of two or more drugs that are associated with QT prolongation. Increasing age, female sex, cardiac disease, and some metabolic disturbances (notably hypokalaemia) predispose to QT prolongation. </p>"
							},
							"hasEvidence": "NotSet",
							"hasImportance": "Severe",
							"hasOrder": "1",
							"hasTextContent": "Both  chlorpromazine  and  ranolazine  prolong the QT interval. Most manufacturers advise avoiding the use of two or more drugs that are associated with QT prolongation. Increasing age, female sex, cardiac disease, and some metabolic disturbances (notably hypokalaemia) predispose to QT prolongation.  \n\n"
						}
					],
					"hasOrder": "267",
					"hasTitle": {
						"@type": "rdf:XMLLiteral",
						"@value": "<title>Ranolazine</title>"
					}
				},
				{
					"@id": "http://bnf.nice.org.uk/interaction/chlorpromazine#bnf_i1557280698639",
					"hasMessage": [
						{
							"@id": "http://bnf.nice.org.uk/interaction/chlorpromazine#bnf_i1557280698639_message_0",
							"hasDitaContent": {
								"@type": "rdf:XMLLiteral",
								"@value": "<p otherprops=\"Normal\" outputclass=\"int-message\">Both <ph otherprops=\"chlorpromazine\" outputclass=\"int-heading-drug\">chlorpromazine</ph> and <ph otherprops=\"remifentanil\" outputclass=\"int-drug\">remifentanil</ph> can have CNS depressant effects, which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in <xref format=\"dita\" href=\"guidance/guidance-on-prescribing.xml\" type=\"interaction\" rel=\"guidance\" bnfid=\"PHP97234\">Guidance on Prescribing</xref>).</p>"
							},
							"hasEvidence": "NotSet",
							"hasImportance": "NotSet",
							"hasOrder": "1",
							"hasTextContent": "Both  chlorpromazine  and  remifentanil  can have CNS depressant effects, which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in  Guidance on Prescribing ). \n\n"
						}
					],
					"hasOrder": "268",
					"hasTitle": {
						"@type": "rdf:XMLLiteral",
						"@value": "<title>Remifentanil</title>"
					}
				},
				{
					"@id": "http://bnf.nice.org.uk/interaction/chlorpromazine#bnf_i1557280698640",
					"hasMessage": [
						{
							"@id": "http://bnf.nice.org.uk/interaction/chlorpromazine#bnf_i1557280698640_message_0",
							"hasDitaContent": {
								"@type": "rdf:XMLLiteral",
								"@value": "<p otherprops=\"Severe\" outputclass=\"int-message\">Both <ph otherprops=\"chlorpromazine\" outputclass=\"int-heading-drug\">chlorpromazine</ph> and <ph otherprops=\"ribociclib\" outputclass=\"int-drug\">ribociclib</ph> prolong the QT interval. Most manufacturers advise avoiding the use of two or more drugs that are associated with QT prolongation. Increasing age, female sex, cardiac disease, and some metabolic disturbances (notably hypokalaemia) predispose to QT prolongation. </p>"
							},
							"hasEvidence": "NotSet",
							"hasImportance": "Severe",
							"hasOrder": "1",
							"hasTextContent": "Both  chlorpromazine  and  ribociclib  prolong the QT interval. Most manufacturers advise avoiding the use of two or more drugs that are associated with QT prolongation. Increasing age, female sex, cardiac disease, and some metabolic disturbances (notably hypokalaemia) predispose to QT prolongation.  \n\n"
						}
					],
					"hasOrder": "269",
					"hasTitle": {
						"@type": "rdf:XMLLiteral",
						"@value": "<title>Ribociclib</title>"
					}
				},
				{
					"@id": "http://bnf.nice.org.uk/interaction/chlorpromazine#bnf_i1557280698641",
					"hasMessage": [
						{
							"@id": "http://bnf.nice.org.uk/interaction/chlorpromazine#bnf_i1557280698641_message_0",
							"hasDitaContent": {
								"@type": "rdf:XMLLiteral",
								"@value": "<p otherprops=\"Normal\" outputclass=\"int-message\">Both <ph otherprops=\"chlorpromazine\" outputclass=\"int-heading-drug\">chlorpromazine</ph> and <ph otherprops=\"riociguat\" outputclass=\"int-drug\">riociguat</ph> can increase the risk of hypotension.</p>"
							},
							"hasEvidence": "NotSet",
							"hasImportance": "NotSet",
							"hasOrder": "1",
							"hasTextContent": "Both  chlorpromazine  and  riociguat  can increase the risk of hypotension. \n\n"
						}
					],
					"hasOrder": "270",
					"hasTitle": {
						"@type": "rdf:XMLLiteral",
						"@value": "<title>Riociguat</title>"
					}
				},
				{
					"@id": "http://bnf.nice.org.uk/interaction/chlorpromazine#bnf_i1557280698642",
					"hasMessage": [
						{
							"@id": "http://bnf.nice.org.uk/interaction/chlorpromazine#bnf_i1557280698642_message_0",
							"hasDitaContent": {
								"@type": "rdf:XMLLiteral",
								"@value": "<p otherprops=\"Normal\" outputclass=\"int-message\">Both <ph otherprops=\"chlorpromazine\" outputclass=\"int-heading-drug\">chlorpromazine</ph> and <ph otherprops=\"risperidone\" outputclass=\"int-drug\">risperidone</ph> can increase the risk of hypotension.</p>"
							},
							"hasEvidence": "NotSet",
							"hasImportance": "NotSet",
							"hasOrder": "1",
							"hasTextContent": "Both  chlorpromazine  and  risperidone  can increase the risk of hypotension. \n\n"
						},
						{
							"@id": "http://bnf.nice.org.uk/interaction/chlorpromazine#bnf_i1557280698642_message_1",
							"hasDitaContent": {
								"@type": "rdf:XMLLiteral",
								"@value": "<p otherprops=\"Severe\" outputclass=\"int-message\">Both <ph otherprops=\"chlorpromazine\" outputclass=\"int-heading-drug\">chlorpromazine</ph> and <ph otherprops=\"risperidone\" outputclass=\"int-drug\">risperidone</ph> prolong the QT interval. Most manufacturers advise avoiding the use of two or more drugs that are associated with QT prolongation. Increasing age, female sex, cardiac disease, and some metabolic disturbances (notably hypokalaemia) predispose to QT prolongation. </p>"
							},
							"hasEvidence": "NotSet",
							"hasImportance": "Severe",
							"hasOrder": "2",
							"hasTextContent": "Both  chlorpromazine  and  risperidone  prolong the QT interval. Most manufacturers advise avoiding the use of two or more drugs that are associated with QT prolongation. Increasing age, female sex, cardiac disease, and some metabolic disturbances (notably hypokalaemia) predispose to QT prolongation.  \n\n"
						},
						{
							"@id": "http://bnf.nice.org.uk/interaction/chlorpromazine#bnf_i1557280698642_message_2",
							"hasDitaContent": {
								"@type": "rdf:XMLLiteral",
								"@value": "<p otherprops=\"Normal\" outputclass=\"int-message\">Both <ph otherprops=\"chlorpromazine\" outputclass=\"int-heading-drug\">chlorpromazine</ph> and <ph otherprops=\"risperidone\" outputclass=\"int-drug\">risperidone</ph> can have CNS depressant effects, which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in <xref format=\"dita\" href=\"guidance/guidance-on-prescribing.xml\" type=\"interaction\" rel=\"guidance\" bnfid=\"PHP97234\">Guidance on Prescribing</xref>).</p>"
							},
							"hasEvidence": "NotSet",
							"hasImportance": "NotSet",
							"hasOrder": "3",
							"hasTextContent": "Both  chlorpromazine  and  risperidone  can have CNS depressant effects, which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in  Guidance on Prescribing ). \n\n"
						}
					],
					"hasOrder": "271",
					"hasTitle": {
						"@type": "rdf:XMLLiteral",
						"@value": "<title>Risperidone</title>"
					}
				},
				{
					"@id": "http://bnf.nice.org.uk/interaction/chlorpromazine#bnf_i1557280698643",
					"hasMessage": [
						{
							"@id": "http://bnf.nice.org.uk/interaction/chlorpromazine#bnf_i1557280698643_message_0",
							"hasDitaContent": {
								"@type": "rdf:XMLLiteral",
								"@value": "<p otherprops=\"Normal\" outputclass=\"int-message\">Both <ph otherprops=\"chlorpromazine\" outputclass=\"int-heading-drug\">chlorpromazine</ph> and <ph otherprops=\"ropinirole\" outputclass=\"int-drug\">ropinirole</ph> can increase the risk of hypotension.</p>"
							},
							"hasEvidence": "NotSet",
							"hasImportance": "NotSet",
							"hasOrder": "1",
							"hasTextContent": "Both  chlorpromazine  and  ropinirole  can increase the risk of hypotension. \n\n"
						},
						{
							"@id": "http://bnf.nice.org.uk/interaction/chlorpromazine#bnf_i1557280698643_message_1",
							"hasDitaContent": {
								"@type": "rdf:XMLLiteral",
								"@value": "<p otherprops=\"Moderate\" outputclass=\"int-message\">\n  <ph otherprops=\"chlorpromazine\" outputclass=\"int-heading-drug\">Chlorpromazine</ph> <ph outputclass=\"int-effectQualifier\">is predicted to</ph> <ph outputclass=\"int-effect\">decrease</ph> <ph outputclass=\"int-parameter\">the effects of</ph> <ph otherprops=\"ropinirole\" outputclass=\"int-drug\">ropinirole</ph>. <ph outputclass=\"int-action\">Manufacturer advises avoid</ph>.  </p>"
							},
							"hasEvidence": "Theoretical",
							"hasImportance": "Moderate",
							"hasOrder": "2",
							"hasTextContent": "Chlorpromazine   is predicted to   decrease   the effects of   ropinirole .  Manufacturer advises avoid .    \n\n"
						}
					],
					"hasOrder": "272",
					"hasTitle": {
						"@type": "rdf:XMLLiteral",
						"@value": "<title>Ropinirole</title>"
					}
				},
				{
					"@id": "http://bnf.nice.org.uk/interaction/chlorpromazine#bnf_i1557280698644",
					"hasMessage": [
						{
							"@id": "http://bnf.nice.org.uk/interaction/chlorpromazine#bnf_i1557280698644_message_0",
							"hasDitaContent": {
								"@type": "rdf:XMLLiteral",
								"@value": "<p otherprops=\"Normal\" outputclass=\"int-message\">Both <ph otherprops=\"chlorpromazine\" outputclass=\"int-heading-drug\">chlorpromazine</ph> and <ph otherprops=\"ropivacaine\" outputclass=\"int-drug\">ropivacaine</ph> can have CNS depressant effects, which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in <xref format=\"dita\" href=\"guidance/guidance-on-prescribing.xml\" type=\"interaction\" rel=\"guidance\" bnfid=\"PHP97234\">Guidance on Prescribing</xref>).</p>"
							},
							"hasEvidence": "NotSet",
							"hasImportance": "NotSet",
							"hasOrder": "1",
							"hasTextContent": "Both  chlorpromazine  and  ropivacaine  can have CNS depressant effects, which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in  Guidance on Prescribing ). \n\n"
						}
					],
					"hasOrder": "273",
					"hasTitle": {
						"@type": "rdf:XMLLiteral",
						"@value": "<title>Ropivacaine</title>"
					}
				},
				{
					"@id": "http://bnf.nice.org.uk/interaction/chlorpromazine#bnf_i1557280698645",
					"hasMessage": [
						{
							"@id": "http://bnf.nice.org.uk/interaction/chlorpromazine#bnf_i1557280698645_message_0",
							"hasDitaContent": {
								"@type": "rdf:XMLLiteral",
								"@value": "<p otherprops=\"Normal\" outputclass=\"int-message\">Both <ph otherprops=\"chlorpromazine\" outputclass=\"int-heading-drug\">chlorpromazine</ph> and <ph otherprops=\"rotigotine\" outputclass=\"int-drug\">rotigotine</ph> can increase the risk of hypotension.</p>"
							},
							"hasEvidence": "NotSet",
							"hasImportance": "NotSet",
							"hasOrder": "1",
							"hasTextContent": "Both  chlorpromazine  and  rotigotine  can increase the risk of hypotension. \n\n"
						},
						{
							"@id": "http://bnf.nice.org.uk/interaction/chlorpromazine#bnf_i1557280698645_message_1",
							"hasDitaContent": {
								"@type": "rdf:XMLLiteral",
								"@value": "<p otherprops=\"Moderate\" outputclass=\"int-message\">\n  <ph otherprops=\"chlorpromazine\" outputclass=\"int-heading-drug\">Chlorpromazine</ph> <ph outputclass=\"int-effectQualifier\">is predicted to</ph> <ph outputclass=\"int-effect\">decrease</ph> <ph outputclass=\"int-parameter\">the effects of</ph> <ph otherprops=\"rotigotine\" outputclass=\"int-drug\">rotigotine</ph>. <ph outputclass=\"int-action\">Manufacturer advises avoid</ph>.  </p>"
							},
							"hasEvidence": "Theoretical",
							"hasImportance": "Moderate",
							"hasOrder": "2",
							"hasTextContent": "Chlorpromazine   is predicted to   decrease   the effects of   rotigotine .  Manufacturer advises avoid .    \n\n"
						}
					],
					"hasOrder": "274",
					"hasTitle": {
						"@type": "rdf:XMLLiteral",
						"@value": "<title>Rotigotine</title>"
					}
				},
				{
					"@id": "http://bnf.nice.org.uk/interaction/chlorpromazine#bnf_i1557280698646",
					"hasMessage": [
						{
							"@id": "http://bnf.nice.org.uk/interaction/chlorpromazine#bnf_i1557280698646_message_0",
							"hasDitaContent": {
								"@type": "rdf:XMLLiteral",
								"@value": "<p otherprops=\"Normal\" outputclass=\"int-message\">Both <ph otherprops=\"chlorpromazine\" outputclass=\"int-heading-drug\">chlorpromazine</ph> and <ph otherprops=\"sacubitril\" outputclass=\"int-drug\">sacubitril</ph> can increase the risk of hypotension.</p>"
							},
							"hasEvidence": "NotSet",
							"hasImportance": "NotSet",
							"hasOrder": "1",
							"hasTextContent": "Both  chlorpromazine  and  sacubitril  can increase the risk of hypotension. \n\n"
						}
					],
					"hasOrder": "275",
					"hasTitle": {
						"@type": "rdf:XMLLiteral",
						"@value": "<title>Sacubitril</title>"
					}
				},
				{
					"@id": "http://bnf.nice.org.uk/interaction/chlorpromazine#bnf_i1557280698647",
					"hasMessage": [
						{
							"@id": "http://bnf.nice.org.uk/interaction/chlorpromazine#bnf_i1557280698647_message_0",
							"hasDitaContent": {
								"@type": "rdf:XMLLiteral",
								"@value": "<p otherprops=\"Severe\" outputclass=\"int-message\">\n  <ph otherprops=\"salbutamol\" outputclass=\"int-drug\">Salbutamol</ph> <ph outputclass=\"int-effectQualifier\">is predicted to</ph> <ph outputclass=\"int-effect\">cause</ph> <ph outputclass=\"int-parameter\">hypokalaemia (potentially increasing the risk of torsade de pointes) when given with</ph> <ph otherprops=\"chlorpromazine\" outputclass=\"int-heading-drug\">chlorpromazine</ph>. <ph outputclass=\"int-action\">Manufacturer makes no recommendation</ph>.  </p>"
							},
							"hasEvidence": "Theoretical",
							"hasImportance": "Severe",
							"hasOrder": "1",
							"hasTextContent": "Salbutamol   is predicted to   cause   hypokalaemia (potentially increasing the risk of torsade de pointes) when given with   chlorpromazine .  Manufacturer makes no recommendation .    \n\n"
						}
					],
					"hasOrder": "276",
					"hasTitle": {
						"@type": "rdf:XMLLiteral",
						"@value": "<title>Salbutamol</title>"
					}
				},
				{
					"@id": "http://bnf.nice.org.uk/interaction/chlorpromazine#bnf_i1557280698648",
					"hasMessage": [
						{
							"@id": "http://bnf.nice.org.uk/interaction/chlorpromazine#bnf_i1557280698648_message_0",
							"hasDitaContent": {
								"@type": "rdf:XMLLiteral",
								"@value": "<p otherprops=\"Severe\" outputclass=\"int-message\">\n  <ph otherprops=\"salmeterol\" outputclass=\"int-drug\">Salmeterol</ph> <ph outputclass=\"int-effectQualifier\">is predicted to</ph> <ph outputclass=\"int-effect\">cause</ph> <ph outputclass=\"int-parameter\">hypokalaemia (potentially increasing the risk of torsade de pointes) when given with</ph> <ph otherprops=\"chlorpromazine\" outputclass=\"int-heading-drug\">chlorpromazine</ph>. <ph outputclass=\"int-action\">Manufacturer makes no recommendation</ph>.  </p>"
							},
							"hasEvidence": "Theoretical",
							"hasImportance": "Severe",
							"hasOrder": "1",
							"hasTextContent": "Salmeterol   is predicted to   cause   hypokalaemia (potentially increasing the risk of torsade de pointes) when given with   chlorpromazine .  Manufacturer makes no recommendation .    \n\n"
						}
					],
					"hasOrder": "277",
					"hasTitle": {
						"@type": "rdf:XMLLiteral",
						"@value": "<title>Salmeterol</title>"
					}
				},
				{
					"@id": "http://bnf.nice.org.uk/interaction/chlorpromazine#bnf_i1557280698649",
					"hasMessage": [
						{
							"@id": "http://bnf.nice.org.uk/interaction/chlorpromazine#bnf_i1557280698649_message_0",
							"hasDitaContent": {
								"@type": "rdf:XMLLiteral",
								"@value": "<p otherprops=\"Normal\" outputclass=\"int-message\">Both <ph otherprops=\"chlorpromazine\" outputclass=\"int-heading-drug\">chlorpromazine</ph> and <ph otherprops=\"sapropterin\" outputclass=\"int-drug\">sapropterin</ph> can increase the risk of hypotension.</p>"
							},
							"hasEvidence": "NotSet",
							"hasImportance": "NotSet",
							"hasOrder": "1",
							"hasTextContent": "Both  chlorpromazine  and  sapropterin  can increase the risk of hypotension. \n\n"
						}
					],
					"hasOrder": "278",
					"hasTitle": {
						"@type": "rdf:XMLLiteral",
						"@value": "<title>Sapropterin</title>"
					}
				},
				{
					"@id": "http://bnf.nice.org.uk/interaction/chlorpromazine#bnf_i1557280698650",
					"hasMessage": [
						{
							"@id": "http://bnf.nice.org.uk/interaction/chlorpromazine#bnf_i1557280698650_message_0",
							"hasDitaContent": {
								"@type": "rdf:XMLLiteral",
								"@value": "<p otherprops=\"Severe\" outputclass=\"int-message\">Both <ph otherprops=\"chlorpromazine\" outputclass=\"int-heading-drug\">chlorpromazine</ph> and <ph otherprops=\"saquinavir\" outputclass=\"int-drug\">saquinavir</ph> prolong the QT interval. Most manufacturers advise avoiding the use of two or more drugs that are associated with QT prolongation. Increasing age, female sex, cardiac disease, and some metabolic disturbances (notably hypokalaemia) predispose to QT prolongation. </p>"
							},
							"hasEvidence": "NotSet",
							"hasImportance": "Severe",
							"hasOrder": "1",
							"hasTextContent": "Both  chlorpromazine  and  saquinavir  prolong the QT interval. Most manufacturers advise avoiding the use of two or more drugs that are associated with QT prolongation. Increasing age, female sex, cardiac disease, and some metabolic disturbances (notably hypokalaemia) predispose to QT prolongation.  \n\n"
						}
					],
					"hasOrder": "279",
					"hasTitle": {
						"@type": "rdf:XMLLiteral",
						"@value": "<title>Saquinavir</title>"
					}
				},
				{
					"@id": "http://bnf.nice.org.uk/interaction/chlorpromazine#bnf_i1557280698651",
					"hasMessage": [
						{
							"@id": "http://bnf.nice.org.uk/interaction/chlorpromazine#bnf_i1557280698651_message_0",
							"hasDitaContent": {
								"@type": "rdf:XMLLiteral",
								"@value": "<p otherprops=\"Normal\" outputclass=\"int-message\">Both <ph otherprops=\"chlorpromazine\" outputclass=\"int-heading-drug\">chlorpromazine</ph> and <ph otherprops=\"selegiline\" outputclass=\"int-drug\">selegiline</ph> can increase the risk of hypotension.</p>"
							},
							"hasEvidence": "NotSet",
							"hasImportance": "NotSet",
							"hasOrder": "1",
							"hasTextContent": "Both  chlorpromazine  and  selegiline  can increase the risk of hypotension. \n\n"
						}
					],
					"hasOrder": "280",
					"hasTitle": {
						"@type": "rdf:XMLLiteral",
						"@value": "<title>Selegiline</title>"
					}
				},
				{
					"@id": "http://bnf.nice.org.uk/interaction/chlorpromazine#bnf_i1557280698652",
					"hasMessage": [
						{
							"@id": "http://bnf.nice.org.uk/interaction/chlorpromazine#bnf_i1557280698652_message_0",
							"hasDitaContent": {
								"@type": "rdf:XMLLiteral",
								"@value": "<p otherprops=\"Normal\" outputclass=\"int-message\">Both <ph otherprops=\"chlorpromazine\" outputclass=\"int-heading-drug\">chlorpromazine</ph> and <ph otherprops=\"sevoflurane\" outputclass=\"int-drug\">sevoflurane</ph> can increase the risk of hypotension.</p>"
							},
							"hasEvidence": "NotSet",
							"hasImportance": "NotSet",
							"hasOrder": "1",
							"hasTextContent": "Both  chlorpromazine  and  sevoflurane  can increase the risk of hypotension. \n\n"
						},
						{
							"@id": "http://bnf.nice.org.uk/interaction/chlorpromazine#bnf_i1557280698652_message_1",
							"hasDitaContent": {
								"@type": "rdf:XMLLiteral",
								"@value": "<p otherprops=\"Normal\" outputclass=\"int-message\">Both <ph otherprops=\"chlorpromazine\" outputclass=\"int-heading-drug\">chlorpromazine</ph> and <ph otherprops=\"sevoflurane\" outputclass=\"int-drug\">sevoflurane</ph> can have CNS depressant effects, which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in <xref format=\"dita\" href=\"guidance/guidance-on-prescribing.xml\" type=\"interaction\" rel=\"guidance\" bnfid=\"PHP97234\">Guidance on Prescribing</xref>).</p>"
							},
							"hasEvidence": "NotSet",
							"hasImportance": "NotSet",
							"hasOrder": "2",
							"hasTextContent": "Both  chlorpromazine  and  sevoflurane  can have CNS depressant effects, which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in  Guidance on Prescribing ). \n\n"
						}
					],
					"hasOrder": "281",
					"hasTitle": {
						"@type": "rdf:XMLLiteral",
						"@value": "<title>Sevoflurane</title>"
					}
				},
				{
					"@id": "http://bnf.nice.org.uk/interaction/chlorpromazine#bnf_i1557280698653",
					"hasMessage": [
						{
							"@id": "http://bnf.nice.org.uk/interaction/chlorpromazine#bnf_i1557280698653_message_0",
							"hasDitaContent": {
								"@type": "rdf:XMLLiteral",
								"@value": "<p otherprops=\"Normal\" outputclass=\"int-message\">Both <ph otherprops=\"chlorpromazine\" outputclass=\"int-heading-drug\">chlorpromazine</ph> and <ph otherprops=\"sildenafil\" outputclass=\"int-drug\">sildenafil</ph> can increase the risk of hypotension.</p>"
							},
							"hasEvidence": "NotSet",
							"hasImportance": "NotSet",
							"hasOrder": "1",
							"hasTextContent": "Both  chlorpromazine  and  sildenafil  can increase the risk of hypotension. \n\n"
						},
						{
							"@id": "http://bnf.nice.org.uk/interaction/chlorpromazine#bnf_i1557280698653_message_1",
							"hasDitaContent": {
								"@type": "rdf:XMLLiteral",
								"@value": "<p otherprops=\"Severe\" outputclass=\"int-message\">Both <ph otherprops=\"chlorpromazine\" outputclass=\"int-heading-drug\">chlorpromazine</ph> and <ph otherprops=\"sildenafil\" outputclass=\"int-drug\">sildenafil</ph> prolong the QT interval. Most manufacturers advise avoiding the use of two or more drugs that are associated with QT prolongation. Increasing age, female sex, cardiac disease, and some metabolic disturbances (notably hypokalaemia) predispose to QT prolongation. </p>"
							},
							"hasEvidence": "NotSet",
							"hasImportance": "Severe",
							"hasOrder": "2",
							"hasTextContent": "Both  chlorpromazine  and  sildenafil  prolong the QT interval. Most manufacturers advise avoiding the use of two or more drugs that are associated with QT prolongation. Increasing age, female sex, cardiac disease, and some metabolic disturbances (notably hypokalaemia) predispose to QT prolongation.  \n\n"
						}
					],
					"hasOrder": "282",
					"hasTitle": {
						"@type": "rdf:XMLLiteral",
						"@value": "<title>Sildenafil</title>"
					}
				},
				{
					"@id": "http://bnf.nice.org.uk/interaction/chlorpromazine#bnf_i1557280698654",
					"hasMessage": [
						{
							"@id": "http://bnf.nice.org.uk/interaction/chlorpromazine#bnf_i1557280698654_message_0",
							"hasDitaContent": {
								"@type": "rdf:XMLLiteral",
								"@value": "<p otherprops=\"Normal\" outputclass=\"int-message\">Both <ph otherprops=\"chlorpromazine\" outputclass=\"int-heading-drug\">chlorpromazine</ph> and <ph otherprops=\"sodium nitroprusside\" outputclass=\"int-drug\">sodium nitroprusside</ph> can increase the risk of hypotension.</p>"
							},
							"hasEvidence": "NotSet",
							"hasImportance": "NotSet",
							"hasOrder": "1",
							"hasTextContent": "Both  chlorpromazine  and  sodium nitroprusside  can increase the risk of hypotension. \n\n"
						}
					],
					"hasOrder": "283",
					"hasTitle": {
						"@type": "rdf:XMLLiteral",
						"@value": "<title>Sodium nitroprusside</title>"
					}
				},
				{
					"@id": "http://bnf.nice.org.uk/interaction/chlorpromazine#bnf_i1557280698655",
					"hasMessage": [
						{
							"@id": "http://bnf.nice.org.uk/interaction/chlorpromazine#bnf_i1557280698655_message_0",
							"hasDitaContent": {
								"@type": "rdf:XMLLiteral",
								"@value": "<p otherprops=\"Normal\" outputclass=\"int-message\">Both <ph otherprops=\"chlorpromazine\" outputclass=\"int-heading-drug\">chlorpromazine</ph> and <ph otherprops=\"sodium oxybate\" outputclass=\"int-drug\">sodium oxybate</ph> can increase the risk of hypotension.</p>"
							},
							"hasEvidence": "NotSet",
							"hasImportance": "NotSet",
							"hasOrder": "1",
							"hasTextContent": "Both  chlorpromazine  and  sodium oxybate  can increase the risk of hypotension. \n\n"
						},
						{
							"@id": "http://bnf.nice.org.uk/interaction/chlorpromazine#bnf_i1557280698655_message_1",
							"hasDitaContent": {
								"@type": "rdf:XMLLiteral",
								"@value": "<p otherprops=\"Normal\" outputclass=\"int-message\">Both <ph otherprops=\"chlorpromazine\" outputclass=\"int-heading-drug\">chlorpromazine</ph> and <ph otherprops=\"sodium oxybate\" outputclass=\"int-drug\">sodium oxybate</ph> can have CNS depressant effects, which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in <xref format=\"dita\" href=\"guidance/guidance-on-prescribing.xml\" type=\"interaction\" rel=\"guidance\" bnfid=\"PHP97234\">Guidance on Prescribing</xref>).</p>"
							},
							"hasEvidence": "NotSet",
							"hasImportance": "NotSet",
							"hasOrder": "2",
							"hasTextContent": "Both  chlorpromazine  and  sodium oxybate  can have CNS depressant effects, which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in  Guidance on Prescribing ). \n\n"
						}
					],
					"hasOrder": "284",
					"hasTitle": {
						"@type": "rdf:XMLLiteral",
						"@value": "<title>Sodium oxybate</title>"
					}
				},
				{
					"@id": "http://bnf.nice.org.uk/interaction/chlorpromazine#bnf_i1557280698656",
					"hasMessage": [
						{
							"@id": "http://bnf.nice.org.uk/interaction/chlorpromazine#bnf_i1557280698656_message_0",
							"hasDitaContent": {
								"@type": "rdf:XMLLiteral",
								"@value": "<p otherprops=\"Normal\" outputclass=\"int-message\">Both <ph otherprops=\"chlorpromazine\" outputclass=\"int-heading-drug\">chlorpromazine</ph> and <ph otherprops=\"solifenacin\" outputclass=\"int-drug\">solifenacin</ph> can cause antimuscarinic effects.</p>"
							},
							"hasEvidence": "NotSet",
							"hasImportance": "NotSet",
							"hasOrder": "1",
							"hasTextContent": "Both  chlorpromazine  and  solifenacin  can cause antimuscarinic effects. \n\n"
						}
					],
					"hasOrder": "285",
					"hasTitle": {
						"@type": "rdf:XMLLiteral",
						"@value": "<title>Solifenacin</title>"
					}
				},
				{
					"@id": "http://bnf.nice.org.uk/interaction/chlorpromazine#bnf_i1557280698657",
					"hasMessage": [
						{
							"@id": "http://bnf.nice.org.uk/interaction/chlorpromazine#bnf_i1557280698657_message_0",
							"hasDitaContent": {
								"@type": "rdf:XMLLiteral",
								"@value": "<p otherprops=\"Severe\" outputclass=\"int-message\">Both <ph otherprops=\"chlorpromazine\" outputclass=\"int-heading-drug\">chlorpromazine</ph> and <ph otherprops=\"sorafenib\" outputclass=\"int-drug\">sorafenib</ph> prolong the QT interval. Most manufacturers advise avoiding the use of two or more drugs that are associated with QT prolongation. Increasing age, female sex, cardiac disease, and some metabolic disturbances (notably hypokalaemia) predispose to QT prolongation. </p>"
							},
							"hasEvidence": "NotSet",
							"hasImportance": "Severe",
							"hasOrder": "1",
							"hasTextContent": "Both  chlorpromazine  and  sorafenib  prolong the QT interval. Most manufacturers advise avoiding the use of two or more drugs that are associated with QT prolongation. Increasing age, female sex, cardiac disease, and some metabolic disturbances (notably hypokalaemia) predispose to QT prolongation.  \n\n"
						}
					],
					"hasOrder": "286",
					"hasTitle": {
						"@type": "rdf:XMLLiteral",
						"@value": "<title>Sorafenib</title>"
					}
				},
				{
					"@id": "http://bnf.nice.org.uk/interaction/chlorpromazine#bnf_i1557280698658",
					"hasMessage": [
						{
							"@id": "http://bnf.nice.org.uk/interaction/chlorpromazine#bnf_i1557280698658_message_0",
							"hasDitaContent": {
								"@type": "rdf:XMLLiteral",
								"@value": "<p otherprops=\"Normal\" outputclass=\"int-message\">Both <ph otherprops=\"chlorpromazine\" outputclass=\"int-heading-drug\">chlorpromazine</ph> and <ph otherprops=\"sotalol\" outputclass=\"int-drug\">sotalol</ph> can increase the risk of hypotension.</p>"
							},
							"hasEvidence": "NotSet",
							"hasImportance": "NotSet",
							"hasOrder": "1",
							"hasTextContent": "Both  chlorpromazine  and  sotalol  can increase the risk of hypotension. \n\n"
						},
						{
							"@id": "http://bnf.nice.org.uk/interaction/chlorpromazine#bnf_i1557280698658_message_1",
							"hasDitaContent": {
								"@type": "rdf:XMLLiteral",
								"@value": "<p otherprops=\"Severe\" outputclass=\"int-message\">Both <ph otherprops=\"chlorpromazine\" outputclass=\"int-heading-drug\">chlorpromazine</ph> and <ph otherprops=\"sotalol\" outputclass=\"int-drug\">sotalol</ph> prolong the QT interval. Most manufacturers advise avoiding the use of two or more drugs that are associated with QT prolongation. Increasing age, female sex, cardiac disease, and some metabolic disturbances (notably hypokalaemia) predispose to QT prolongation. </p>"
							},
							"hasEvidence": "NotSet",
							"hasImportance": "Severe",
							"hasOrder": "2",
							"hasTextContent": "Both  chlorpromazine  and  sotalol  prolong the QT interval. Most manufacturers advise avoiding the use of two or more drugs that are associated with QT prolongation. Increasing age, female sex, cardiac disease, and some metabolic disturbances (notably hypokalaemia) predispose to QT prolongation.  \n\n"
						}
					],
					"hasOrder": "287",
					"hasTitle": {
						"@type": "rdf:XMLLiteral",
						"@value": "<title>Sotalol</title>"
					}
				},
				{
					"@id": "http://bnf.nice.org.uk/interaction/chlorpromazine#bnf_i1557280698659",
					"hasMessage": [
						{
							"@id": "http://bnf.nice.org.uk/interaction/chlorpromazine#bnf_i1557280698659_message_0",
							"hasDitaContent": {
								"@type": "rdf:XMLLiteral",
								"@value": "<p otherprops=\"Normal\" outputclass=\"int-message\">Both <ph otherprops=\"chlorpromazine\" outputclass=\"int-heading-drug\">chlorpromazine</ph> and <ph otherprops=\"spironolactone\" outputclass=\"int-drug\">spironolactone</ph> can increase the risk of hypotension.</p>"
							},
							"hasEvidence": "NotSet",
							"hasImportance": "NotSet",
							"hasOrder": "1",
							"hasTextContent": "Both  chlorpromazine  and  spironolactone  can increase the risk of hypotension. \n\n"
						}
					],
					"hasOrder": "288",
					"hasTitle": {
						"@type": "rdf:XMLLiteral",
						"@value": "<title>Spironolactone</title>"
					}
				},
				{
					"@id": "http://bnf.nice.org.uk/interaction/chlorpromazine#bnf_i1557280698660",
					"hasMessage": [
						{
							"@id": "http://bnf.nice.org.uk/interaction/chlorpromazine#bnf_i1557280698660_message_0",
							"hasDitaContent": {
								"@type": "rdf:XMLLiteral",
								"@value": "<p otherprops=\"Normal\" outputclass=\"int-message\">Both <ph otherprops=\"chlorpromazine\" outputclass=\"int-heading-drug\">chlorpromazine</ph> and <ph otherprops=\"sufentanil\" outputclass=\"int-drug\">sufentanil</ph> can have CNS depressant effects, which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in <xref format=\"dita\" href=\"guidance/guidance-on-prescribing.xml\" type=\"interaction\" rel=\"guidance\" bnfid=\"PHP97234\">Guidance on Prescribing</xref>).</p>"
							},
							"hasEvidence": "NotSet",
							"hasImportance": "NotSet",
							"hasOrder": "1",
							"hasTextContent": "Both  chlorpromazine  and  sufentanil  can have CNS depressant effects, which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in  Guidance on Prescribing ). \n\n"
						}
					],
					"hasOrder": "289",
					"hasTitle": {
						"@type": "rdf:XMLLiteral",
						"@value": "<title>Sufentanil</title>"
					}
				},
				{
					"@id": "http://bnf.nice.org.uk/interaction/chlorpromazine#bnf_i1557280698661",
					"hasMessage": [
						{
							"@id": "http://bnf.nice.org.uk/interaction/chlorpromazine#bnf_i1557280698661_message_0",
							"hasDitaContent": {
								"@type": "rdf:XMLLiteral",
								"@value": "<p otherprops=\"Normal\" outputclass=\"int-message\">Both <ph otherprops=\"chlorpromazine\" outputclass=\"int-heading-drug\">chlorpromazine</ph> and <ph otherprops=\"sulpiride\" outputclass=\"int-drug\">sulpiride</ph> can increase the risk of hypotension.</p>"
							},
							"hasEvidence": "NotSet",
							"hasImportance": "NotSet",
							"hasOrder": "1",
							"hasTextContent": "Both  chlorpromazine  and  sulpiride  can increase the risk of hypotension. \n\n"
						},
						{
							"@id": "http://bnf.nice.org.uk/interaction/chlorpromazine#bnf_i1557280698661_message_1",
							"hasDitaContent": {
								"@type": "rdf:XMLLiteral",
								"@value": "<p otherprops=\"Severe\" outputclass=\"int-message\">Both <ph otherprops=\"chlorpromazine\" outputclass=\"int-heading-drug\">chlorpromazine</ph> and <ph otherprops=\"sulpiride\" outputclass=\"int-drug\">sulpiride</ph> prolong the QT interval. Most manufacturers advise avoiding the use of two or more drugs that are associated with QT prolongation. Increasing age, female sex, cardiac disease, and some metabolic disturbances (notably hypokalaemia) predispose to QT prolongation. </p>"
							},
							"hasEvidence": "NotSet",
							"hasImportance": "Severe",
							"hasOrder": "2",
							"hasTextContent": "Both  chlorpromazine  and  sulpiride  prolong the QT interval. Most manufacturers advise avoiding the use of two or more drugs that are associated with QT prolongation. Increasing age, female sex, cardiac disease, and some metabolic disturbances (notably hypokalaemia) predispose to QT prolongation.  \n\n"
						},
						{
							"@id": "http://bnf.nice.org.uk/interaction/chlorpromazine#bnf_i1557280698661_message_2",
							"hasDitaContent": {
								"@type": "rdf:XMLLiteral",
								"@value": "<p otherprops=\"Normal\" outputclass=\"int-message\">Both <ph otherprops=\"chlorpromazine\" outputclass=\"int-heading-drug\">chlorpromazine</ph> and <ph otherprops=\"sulpiride\" outputclass=\"int-drug\">sulpiride</ph> can have CNS depressant effects, which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in <xref format=\"dita\" href=\"guidance/guidance-on-prescribing.xml\" type=\"interaction\" rel=\"guidance\" bnfid=\"PHP97234\">Guidance on Prescribing</xref>).</p>"
							},
							"hasEvidence": "NotSet",
							"hasImportance": "NotSet",
							"hasOrder": "3",
							"hasTextContent": "Both  chlorpromazine  and  sulpiride  can have CNS depressant effects, which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in  Guidance on Prescribing ). \n\n"
						}
					],
					"hasOrder": "290",
					"hasTitle": {
						"@type": "rdf:XMLLiteral",
						"@value": "<title>Sulpiride</title>"
					}
				},
				{
					"@id": "http://bnf.nice.org.uk/interaction/chlorpromazine#bnf_i1557280698662",
					"hasMessage": [
						{
							"@id": "http://bnf.nice.org.uk/interaction/chlorpromazine#bnf_i1557280698662_message_0",
							"hasDitaContent": {
								"@type": "rdf:XMLLiteral",
								"@value": "<p otherprops=\"Severe\" outputclass=\"int-message\">Both <ph otherprops=\"chlorpromazine\" outputclass=\"int-heading-drug\">chlorpromazine</ph> and <ph otherprops=\"sunitinib\" outputclass=\"int-drug\">sunitinib</ph> prolong the QT interval. Most manufacturers advise avoiding the use of two or more drugs that are associated with QT prolongation. Increasing age, female sex, cardiac disease, and some metabolic disturbances (notably hypokalaemia) predispose to QT prolongation. </p>"
							},
							"hasEvidence": "NotSet",
							"hasImportance": "Severe",
							"hasOrder": "1",
							"hasTextContent": "Both  chlorpromazine  and  sunitinib  prolong the QT interval. Most manufacturers advise avoiding the use of two or more drugs that are associated with QT prolongation. Increasing age, female sex, cardiac disease, and some metabolic disturbances (notably hypokalaemia) predispose to QT prolongation.  \n\n"
						}
					],
					"hasOrder": "291",
					"hasTitle": {
						"@type": "rdf:XMLLiteral",
						"@value": "<title>Sunitinib</title>"
					}
				},
				{
					"@id": "http://bnf.nice.org.uk/interaction/chlorpromazine#bnf_i1557280698663",
					"hasMessage": [
						{
							"@id": "http://bnf.nice.org.uk/interaction/chlorpromazine#bnf_i1557280698663_message_0",
							"hasDitaContent": {
								"@type": "rdf:XMLLiteral",
								"@value": "<p otherprops=\"Normal\" outputclass=\"int-message\">Both <ph otherprops=\"chlorpromazine\" outputclass=\"int-heading-drug\">chlorpromazine</ph> and <ph otherprops=\"tadalafil\" outputclass=\"int-drug\">tadalafil</ph> can increase the risk of hypotension.</p>"
							},
							"hasEvidence": "NotSet",
							"hasImportance": "NotSet",
							"hasOrder": "1",
							"hasTextContent": "Both  chlorpromazine  and  tadalafil  can increase the risk of hypotension. \n\n"
						}
					],
					"hasOrder": "292",
					"hasTitle": {
						"@type": "rdf:XMLLiteral",
						"@value": "<title>Tadalafil</title>"
					}
				},
				{
					"@id": "http://bnf.nice.org.uk/interaction/chlorpromazine#bnf_i1557280698664",
					"hasMessage": [
						{
							"@id": "http://bnf.nice.org.uk/interaction/chlorpromazine#bnf_i1557280698664_message_0",
							"hasDitaContent": {
								"@type": "rdf:XMLLiteral",
								"@value": "<p otherprops=\"Normal\" outputclass=\"int-message\">Both <ph otherprops=\"chlorpromazine\" outputclass=\"int-heading-drug\">chlorpromazine</ph> and <ph otherprops=\"tamsulosin\" outputclass=\"int-drug\">tamsulosin</ph> can increase the risk of hypotension.</p>"
							},
							"hasEvidence": "NotSet",
							"hasImportance": "NotSet",
							"hasOrder": "1",
							"hasTextContent": "Both  chlorpromazine  and  tamsulosin  can increase the risk of hypotension. \n\n"
						}
					],
					"hasOrder": "293",
					"hasTitle": {
						"@type": "rdf:XMLLiteral",
						"@value": "<title>Tamsulosin</title>"
					}
				},
				{
					"@id": "http://bnf.nice.org.uk/interaction/chlorpromazine#bnf_i1557280698665",
					"hasMessage": [
						{
							"@id": "http://bnf.nice.org.uk/interaction/chlorpromazine#bnf_i1557280698665_message_0",
							"hasDitaContent": {
								"@type": "rdf:XMLLiteral",
								"@value": "<p otherprops=\"Normal\" outputclass=\"int-message\">Both <ph otherprops=\"chlorpromazine\" outputclass=\"int-heading-drug\">chlorpromazine</ph> and <ph otherprops=\"tapentadol\" outputclass=\"int-drug\">tapentadol</ph> can have CNS depressant effects, which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in <xref format=\"dita\" href=\"guidance/guidance-on-prescribing.xml\" type=\"interaction\" rel=\"guidance\" bnfid=\"PHP97234\">Guidance on Prescribing</xref>).</p>"
							},
							"hasEvidence": "NotSet",
							"hasImportance": "NotSet",
							"hasOrder": "1",
							"hasTextContent": "Both  chlorpromazine  and  tapentadol  can have CNS depressant effects, which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in  Guidance on Prescribing ). \n\n"
						}
					],
					"hasOrder": "294",
					"hasTitle": {
						"@type": "rdf:XMLLiteral",
						"@value": "<title>Tapentadol</title>"
					}
				},
				{
					"@id": "http://bnf.nice.org.uk/interaction/chlorpromazine#bnf_i1557280698666",
					"hasMessage": [
						{
							"@id": "http://bnf.nice.org.uk/interaction/chlorpromazine#bnf_i1557280698666_message_0",
							"hasDitaContent": {
								"@type": "rdf:XMLLiteral",
								"@value": "<p otherprops=\"Severe\" outputclass=\"int-message\">Both <ph otherprops=\"chlorpromazine\" outputclass=\"int-heading-drug\">chlorpromazine</ph> and <ph otherprops=\"telavancin\" outputclass=\"int-drug\">telavancin</ph> prolong the QT interval. Most manufacturers advise avoiding the use of two or more drugs that are associated with QT prolongation. Increasing age, female sex, cardiac disease, and some metabolic disturbances (notably hypokalaemia) predispose to QT prolongation. </p>"
							},
							"hasEvidence": "NotSet",
							"hasImportance": "Severe",
							"hasOrder": "1",
							"hasTextContent": "Both  chlorpromazine  and  telavancin  prolong the QT interval. Most manufacturers advise avoiding the use of two or more drugs that are associated with QT prolongation. Increasing age, female sex, cardiac disease, and some metabolic disturbances (notably hypokalaemia) predispose to QT prolongation.  \n\n"
						}
					],
					"hasOrder": "295",
					"hasTitle": {
						"@type": "rdf:XMLLiteral",
						"@value": "<title>Telavancin</title>"
					}
				},
				{
					"@id": "http://bnf.nice.org.uk/interaction/chlorpromazine#bnf_i1557280698667",
					"hasMessage": [
						{
							"@id": "http://bnf.nice.org.uk/interaction/chlorpromazine#bnf_i1557280698667_message_0",
							"hasDitaContent": {
								"@type": "rdf:XMLLiteral",
								"@value": "<p otherprops=\"Normal\" outputclass=\"int-message\">Both <ph otherprops=\"chlorpromazine\" outputclass=\"int-heading-drug\">chlorpromazine</ph> and <ph otherprops=\"telmisartan\" outputclass=\"int-drug\">telmisartan</ph> can increase the risk of hypotension.</p>"
							},
							"hasEvidence": "NotSet",
							"hasImportance": "NotSet",
							"hasOrder": "1",
							"hasTextContent": "Both  chlorpromazine  and  telmisartan  can increase the risk of hypotension. \n\n"
						}
					],
					"hasOrder": "296",
					"hasTitle": {
						"@type": "rdf:XMLLiteral",
						"@value": "<title>Telmisartan</title>"
					}
				},
				{
					"@id": "http://bnf.nice.org.uk/interaction/chlorpromazine#bnf_i1557280698668",
					"hasMessage": [
						{
							"@id": "http://bnf.nice.org.uk/interaction/chlorpromazine#bnf_i1557280698668_message_0",
							"hasDitaContent": {
								"@type": "rdf:XMLLiteral",
								"@value": "<p otherprops=\"Normal\" outputclass=\"int-message\">Both <ph otherprops=\"chlorpromazine\" outputclass=\"int-heading-drug\">chlorpromazine</ph> and <ph otherprops=\"temazepam\" outputclass=\"int-drug\">temazepam</ph> can have CNS depressant effects, which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in <xref format=\"dita\" href=\"guidance/guidance-on-prescribing.xml\" type=\"interaction\" rel=\"guidance\" bnfid=\"PHP97234\">Guidance on Prescribing</xref>).</p>"
							},
							"hasEvidence": "NotSet",
							"hasImportance": "NotSet",
							"hasOrder": "1",
							"hasTextContent": "Both  chlorpromazine  and  temazepam  can have CNS depressant effects, which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in  Guidance on Prescribing ). \n\n"
						}
					],
					"hasOrder": "297",
					"hasTitle": {
						"@type": "rdf:XMLLiteral",
						"@value": "<title>Temazepam</title>"
					}
				},
				{
					"@id": "http://bnf.nice.org.uk/interaction/chlorpromazine#bnf_i1557280698669",
					"hasMessage": [
						{
							"@id": "http://bnf.nice.org.uk/interaction/chlorpromazine#bnf_i1557280698669_message_0",
							"hasDitaContent": {
								"@type": "rdf:XMLLiteral",
								"@value": "<p otherprops=\"Normal\" outputclass=\"int-message\">Both <ph otherprops=\"chlorpromazine\" outputclass=\"int-heading-drug\">chlorpromazine</ph> and <ph otherprops=\"terazosin\" outputclass=\"int-drug\">terazosin</ph> can increase the risk of hypotension.</p>"
							},
							"hasEvidence": "NotSet",
							"hasImportance": "NotSet",
							"hasOrder": "1",
							"hasTextContent": "Both  chlorpromazine  and  terazosin  can increase the risk of hypotension. \n\n"
						}
					],
					"hasOrder": "298",
					"hasTitle": {
						"@type": "rdf:XMLLiteral",
						"@value": "<title>Terazosin</title>"
					}
				},
				{
					"@id": "http://bnf.nice.org.uk/interaction/chlorpromazine#bnf_i1557280698670",
					"hasMessage": [
						{
							"@id": "http://bnf.nice.org.uk/interaction/chlorpromazine#bnf_i1557280698670_message_0",
							"hasDitaContent": {
								"@type": "rdf:XMLLiteral",
								"@value": "<p otherprops=\"Severe\" outputclass=\"int-message\">\n  <ph otherprops=\"terbutaline\" outputclass=\"int-drug\">Terbutaline</ph> <ph outputclass=\"int-effectQualifier\">is predicted to</ph> <ph outputclass=\"int-effect\">cause</ph> <ph outputclass=\"int-parameter\">hypokalaemia (potentially increasing the risk of torsade de pointes) when given with</ph> <ph otherprops=\"chlorpromazine\" outputclass=\"int-heading-drug\">chlorpromazine</ph>. <ph outputclass=\"int-action\">Manufacturer makes no recommendation</ph>.  </p>"
							},
							"hasEvidence": "Theoretical",
							"hasImportance": "Severe",
							"hasOrder": "1",
							"hasTextContent": "Terbutaline   is predicted to   cause   hypokalaemia (potentially increasing the risk of torsade de pointes) when given with   chlorpromazine .  Manufacturer makes no recommendation .    \n\n"
						}
					],
					"hasOrder": "299",
					"hasTitle": {
						"@type": "rdf:XMLLiteral",
						"@value": "<title>Terbutaline</title>"
					}
				},
				{
					"@id": "http://bnf.nice.org.uk/interaction/chlorpromazine#bnf_i1557280698671",
					"hasMessage": [
						{
							"@id": "http://bnf.nice.org.uk/interaction/chlorpromazine#bnf_i1557280698671_message_0",
							"hasDitaContent": {
								"@type": "rdf:XMLLiteral",
								"@value": "<p otherprops=\"Severe\" outputclass=\"int-message\">Both <ph otherprops=\"chlorpromazine\" outputclass=\"int-heading-drug\">chlorpromazine</ph> and <ph otherprops=\"tetrabenazine\" outputclass=\"int-drug\">tetrabenazine</ph> prolong the QT interval. Most manufacturers advise avoiding the use of two or more drugs that are associated with QT prolongation. Increasing age, female sex, cardiac disease, and some metabolic disturbances (notably hypokalaemia) predispose to QT prolongation. </p>"
							},
							"hasEvidence": "NotSet",
							"hasImportance": "Severe",
							"hasOrder": "1",
							"hasTextContent": "Both  chlorpromazine  and  tetrabenazine  prolong the QT interval. Most manufacturers advise avoiding the use of two or more drugs that are associated with QT prolongation. Increasing age, female sex, cardiac disease, and some metabolic disturbances (notably hypokalaemia) predispose to QT prolongation.  \n\n"
						}
					],
					"hasOrder": "300",
					"hasTitle": {
						"@type": "rdf:XMLLiteral",
						"@value": "<title>Tetrabenazine</title>"
					}
				},
				{
					"@id": "http://bnf.nice.org.uk/interaction/chlorpromazine#bnf_i1557280698672",
					"hasMessage": [
						{
							"@id": "http://bnf.nice.org.uk/interaction/chlorpromazine#bnf_i1557280698672_message_0",
							"hasDitaContent": {
								"@type": "rdf:XMLLiteral",
								"@value": "<p otherprops=\"Normal\" outputclass=\"int-message\">Both <ph otherprops=\"chlorpromazine\" outputclass=\"int-heading-drug\">chlorpromazine</ph> and <ph otherprops=\"tetracaine\" outputclass=\"int-drug\">tetracaine</ph> can have CNS depressant effects, which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in <xref format=\"dita\" href=\"guidance/guidance-on-prescribing.xml\" type=\"interaction\" rel=\"guidance\" bnfid=\"PHP97234\">Guidance on Prescribing</xref>).</p>"
							},
							"hasEvidence": "NotSet",
							"hasImportance": "NotSet",
							"hasOrder": "1",
							"hasTextContent": "Both  chlorpromazine  and  tetracaine  can have CNS depressant effects, which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in  Guidance on Prescribing ). \n\n"
						}
					],
					"hasOrder": "301",
					"hasTitle": {
						"@type": "rdf:XMLLiteral",
						"@value": "<title>Tetracaine</title>"
					}
				},
				{
					"@id": "http://bnf.nice.org.uk/interaction/chlorpromazine#bnf_i1557280698673",
					"hasMessage": [
						{
							"@id": "http://bnf.nice.org.uk/interaction/chlorpromazine#bnf_i1557280698673_message_0",
							"hasDitaContent": {
								"@type": "rdf:XMLLiteral",
								"@value": "<p otherprops=\"Normal\" outputclass=\"int-message\">Both <ph otherprops=\"chlorpromazine\" outputclass=\"int-heading-drug\">chlorpromazine</ph> and <ph otherprops=\"thalidomide\" outputclass=\"int-drug\">thalidomide</ph> can have CNS depressant effects, which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in <xref format=\"dita\" href=\"guidance/guidance-on-prescribing.xml\" type=\"interaction\" rel=\"guidance\" bnfid=\"PHP97234\">Guidance on Prescribing</xref>).</p>"
							},
							"hasEvidence": "NotSet",
							"hasImportance": "NotSet",
							"hasOrder": "1",
							"hasTextContent": "Both  chlorpromazine  and  thalidomide  can have CNS depressant effects, which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in  Guidance on Prescribing ). \n\n"
						}
					],
					"hasOrder": "302",
					"hasTitle": {
						"@type": "rdf:XMLLiteral",
						"@value": "<title>Thalidomide</title>"
					}
				},
				{
					"@id": "http://bnf.nice.org.uk/interaction/chlorpromazine#bnf_i1557280698674",
					"hasMessage": [
						{
							"@id": "http://bnf.nice.org.uk/interaction/chlorpromazine#bnf_i1557280698674_message_0",
							"hasDitaContent": {
								"@type": "rdf:XMLLiteral",
								"@value": "<p otherprops=\"Severe\" outputclass=\"int-message\">\n  <ph otherprops=\"theophylline\" outputclass=\"int-drug\">Theophylline</ph> <ph outputclass=\"int-effectQualifier\">is predicted to</ph> <ph outputclass=\"int-effect\">cause</ph> <ph outputclass=\"int-parameter\">hypokalaemia (potentially increasing the risk of torsade de pointes) when given with</ph> <ph otherprops=\"chlorpromazine\" outputclass=\"int-heading-drug\">chlorpromazine</ph>. <ph outputclass=\"int-action\">Manufacturer makes no recommendation</ph>.  </p>"
							},
							"hasEvidence": "Theoretical",
							"hasImportance": "Severe",
							"hasOrder": "1",
							"hasTextContent": "Theophylline   is predicted to   cause   hypokalaemia (potentially increasing the risk of torsade de pointes) when given with   chlorpromazine .  Manufacturer makes no recommendation .    \n\n"
						}
					],
					"hasOrder": "303",
					"hasTitle": {
						"@type": "rdf:XMLLiteral",
						"@value": "<title>Theophylline</title>"
					}
				},
				{
					"@id": "http://bnf.nice.org.uk/interaction/chlorpromazine#bnf_i1557280698675",
					"hasMessage": [
						{
							"@id": "http://bnf.nice.org.uk/interaction/chlorpromazine#bnf_i1557280698675_message_0",
							"hasDitaContent": {
								"@type": "rdf:XMLLiteral",
								"@value": "<p otherprops=\"Normal\" outputclass=\"int-message\">Both <ph otherprops=\"chlorpromazine\" outputclass=\"int-heading-drug\">chlorpromazine</ph> and <ph otherprops=\"thiopental\" outputclass=\"int-drug\">thiopental</ph> can increase the risk of hypotension.</p>"
							},
							"hasEvidence": "NotSet",
							"hasImportance": "NotSet",
							"hasOrder": "1",
							"hasTextContent": "Both  chlorpromazine  and  thiopental  can increase the risk of hypotension. \n\n"
						},
						{
							"@id": "http://bnf.nice.org.uk/interaction/chlorpromazine#bnf_i1557280698675_message_1",
							"hasDitaContent": {
								"@type": "rdf:XMLLiteral",
								"@value": "<p otherprops=\"Normal\" outputclass=\"int-message\">Both <ph otherprops=\"chlorpromazine\" outputclass=\"int-heading-drug\">chlorpromazine</ph> and <ph otherprops=\"thiopental\" outputclass=\"int-drug\">thiopental</ph> can have CNS depressant effects, which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in <xref format=\"dita\" href=\"guidance/guidance-on-prescribing.xml\" type=\"interaction\" rel=\"guidance\" bnfid=\"PHP97234\">Guidance on Prescribing</xref>).</p>"
							},
							"hasEvidence": "NotSet",
							"hasImportance": "NotSet",
							"hasOrder": "2",
							"hasTextContent": "Both  chlorpromazine  and  thiopental  can have CNS depressant effects, which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in  Guidance on Prescribing ). \n\n"
						}
					],
					"hasOrder": "304",
					"hasTitle": {
						"@type": "rdf:XMLLiteral",
						"@value": "<title>Thiopental</title>"
					}
				},
				{
					"@id": "http://bnf.nice.org.uk/interaction/chlorpromazine#bnf_i1557280698676",
					"hasMessage": [
						{
							"@id": "http://bnf.nice.org.uk/interaction/chlorpromazine#bnf_i1557280698676_message_0",
							"hasDitaContent": {
								"@type": "rdf:XMLLiteral",
								"@value": "<p otherprops=\"Normal\" outputclass=\"int-message\">Both <ph otherprops=\"chlorpromazine\" outputclass=\"int-heading-drug\">chlorpromazine</ph> and <ph otherprops=\"timolol\" outputclass=\"int-drug\">timolol</ph> can increase the risk of hypotension.</p>"
							},
							"hasEvidence": "NotSet",
							"hasImportance": "NotSet",
							"hasOrder": "1",
							"hasTextContent": "Both  chlorpromazine  and  timolol  can increase the risk of hypotension. \n\n"
						}
					],
					"hasOrder": "305",
					"hasTitle": {
						"@type": "rdf:XMLLiteral",
						"@value": "<title>Timolol</title>"
					}
				},
				{
					"@id": "http://bnf.nice.org.uk/interaction/chlorpromazine#bnf_i1557280698677",
					"hasMessage": [
						{
							"@id": "http://bnf.nice.org.uk/interaction/chlorpromazine#bnf_i1557280698677_message_0",
							"hasDitaContent": {
								"@type": "rdf:XMLLiteral",
								"@value": "<p otherprops=\"Normal\" outputclass=\"int-message\">Both <ph otherprops=\"chlorpromazine\" outputclass=\"int-heading-drug\">chlorpromazine</ph> and <ph otherprops=\"tiotropium\" outputclass=\"int-drug\">tiotropium</ph> can cause antimuscarinic effects.</p>"
							},
							"hasEvidence": "NotSet",
							"hasImportance": "NotSet",
							"hasOrder": "1",
							"hasTextContent": "Both  chlorpromazine  and  tiotropium  can cause antimuscarinic effects. \n\n"
						}
					],
					"hasOrder": "306",
					"hasTitle": {
						"@type": "rdf:XMLLiteral",
						"@value": "<title>Tiotropium</title>"
					}
				},
				{
					"@id": "http://bnf.nice.org.uk/interaction/chlorpromazine#bnf_i1557280698678",
					"hasMessage": [
						{
							"@id": "http://bnf.nice.org.uk/interaction/chlorpromazine#bnf_i1557280698678_message_0",
							"hasDitaContent": {
								"@type": "rdf:XMLLiteral",
								"@value": "<p otherprops=\"Normal\" outputclass=\"int-message\">Both <ph otherprops=\"chlorpromazine\" outputclass=\"int-heading-drug\">chlorpromazine</ph> and <ph otherprops=\"tizanidine\" outputclass=\"int-drug\">tizanidine</ph> can increase the risk of hypotension.</p>"
							},
							"hasEvidence": "NotSet",
							"hasImportance": "NotSet",
							"hasOrder": "1",
							"hasTextContent": "Both  chlorpromazine  and  tizanidine  can increase the risk of hypotension. \n\n"
						},
						{
							"@id": "http://bnf.nice.org.uk/interaction/chlorpromazine#bnf_i1557280698678_message_1",
							"hasDitaContent": {
								"@type": "rdf:XMLLiteral",
								"@value": "<p otherprops=\"Severe\" outputclass=\"int-message\">Both <ph otherprops=\"chlorpromazine\" outputclass=\"int-heading-drug\">chlorpromazine</ph> and <ph otherprops=\"tizanidine\" outputclass=\"int-drug\">tizanidine</ph> prolong the QT interval. Most manufacturers advise avoiding the use of two or more drugs that are associated with QT prolongation. Increasing age, female sex, cardiac disease, and some metabolic disturbances (notably hypokalaemia) predispose to QT prolongation. </p>"
							},
							"hasEvidence": "NotSet",
							"hasImportance": "Severe",
							"hasOrder": "2",
							"hasTextContent": "Both  chlorpromazine  and  tizanidine  prolong the QT interval. Most manufacturers advise avoiding the use of two or more drugs that are associated with QT prolongation. Increasing age, female sex, cardiac disease, and some metabolic disturbances (notably hypokalaemia) predispose to QT prolongation.  \n\n"
						},
						{
							"@id": "http://bnf.nice.org.uk/interaction/chlorpromazine#bnf_i1557280698678_message_2",
							"hasDitaContent": {
								"@type": "rdf:XMLLiteral",
								"@value": "<p otherprops=\"Normal\" outputclass=\"int-message\">Both <ph otherprops=\"chlorpromazine\" outputclass=\"int-heading-drug\">chlorpromazine</ph> and <ph otherprops=\"tizanidine\" outputclass=\"int-drug\">tizanidine</ph> can have CNS depressant effects, which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in <xref format=\"dita\" href=\"guidance/guidance-on-prescribing.xml\" type=\"interaction\" rel=\"guidance\" bnfid=\"PHP97234\">Guidance on Prescribing</xref>).</p>"
							},
							"hasEvidence": "NotSet",
							"hasImportance": "NotSet",
							"hasOrder": "3",
							"hasTextContent": "Both  chlorpromazine  and  tizanidine  can have CNS depressant effects, which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in  Guidance on Prescribing ). \n\n"
						}
					],
					"hasOrder": "307",
					"hasTitle": {
						"@type": "rdf:XMLLiteral",
						"@value": "<title>Tizanidine</title>"
					}
				},
				{
					"@id": "http://bnf.nice.org.uk/interaction/chlorpromazine#bnf_i1557280698679",
					"hasMessage": [
						{
							"@id": "http://bnf.nice.org.uk/interaction/chlorpromazine#bnf_i1557280698679_message_0",
							"hasDitaContent": {
								"@type": "rdf:XMLLiteral",
								"@value": "<p otherprops=\"Severe\" outputclass=\"int-message\">Both <ph otherprops=\"chlorpromazine\" outputclass=\"int-heading-drug\">chlorpromazine</ph> and <ph otherprops=\"tolterodine\" outputclass=\"int-drug\">tolterodine</ph> prolong the QT interval. Most manufacturers advise avoiding the use of two or more drugs that are associated with QT prolongation. Increasing age, female sex, cardiac disease, and some metabolic disturbances (notably hypokalaemia) predispose to QT prolongation. </p>"
							},
							"hasEvidence": "NotSet",
							"hasImportance": "Severe",
							"hasOrder": "1",
							"hasTextContent": "Both  chlorpromazine  and  tolterodine  prolong the QT interval. Most manufacturers advise avoiding the use of two or more drugs that are associated with QT prolongation. Increasing age, female sex, cardiac disease, and some metabolic disturbances (notably hypokalaemia) predispose to QT prolongation.  \n\n"
						},
						{
							"@id": "http://bnf.nice.org.uk/interaction/chlorpromazine#bnf_i1557280698679_message_1",
							"hasDitaContent": {
								"@type": "rdf:XMLLiteral",
								"@value": "<p otherprops=\"Normal\" outputclass=\"int-message\">Both <ph otherprops=\"chlorpromazine\" outputclass=\"int-heading-drug\">chlorpromazine</ph> and <ph otherprops=\"tolterodine\" outputclass=\"int-drug\">tolterodine</ph> can cause antimuscarinic effects.</p>"
							},
							"hasEvidence": "NotSet",
							"hasImportance": "NotSet",
							"hasOrder": "2",
							"hasTextContent": "Both  chlorpromazine  and  tolterodine  can cause antimuscarinic effects. \n\n"
						}
					],
					"hasOrder": "308",
					"hasTitle": {
						"@type": "rdf:XMLLiteral",
						"@value": "<title>Tolterodine</title>"
					}
				},
				{
					"@id": "http://bnf.nice.org.uk/interaction/chlorpromazine#bnf_i1557280698680",
					"hasMessage": [
						{
							"@id": "http://bnf.nice.org.uk/interaction/chlorpromazine#bnf_i1557280698680_message_0",
							"hasDitaContent": {
								"@type": "rdf:XMLLiteral",
								"@value": "<p otherprops=\"Normal\" outputclass=\"int-message\">Both <ph otherprops=\"chlorpromazine\" outputclass=\"int-heading-drug\">chlorpromazine</ph> and <ph otherprops=\"torasemide\" outputclass=\"int-drug\">torasemide</ph> can increase the risk of hypotension.</p>"
							},
							"hasEvidence": "NotSet",
							"hasImportance": "NotSet",
							"hasOrder": "1",
							"hasTextContent": "Both  chlorpromazine  and  torasemide  can increase the risk of hypotension. \n\n"
						},
						{
							"@id": "http://bnf.nice.org.uk/interaction/chlorpromazine#bnf_i1557280698680_message_1",
							"hasDitaContent": {
								"@type": "rdf:XMLLiteral",
								"@value": "<p otherprops=\"Severe\" outputclass=\"int-message\">\n  <ph otherprops=\"torasemide\" outputclass=\"int-drug\">Torasemide</ph> <ph outputclass=\"int-effectQualifier\">is predicted to</ph> <ph outputclass=\"int-effect\">cause</ph> <ph outputclass=\"int-parameter\">hypokalaemia (potentially increasing the risk of torsade de pointes) when given with</ph> <ph otherprops=\"chlorpromazine\" outputclass=\"int-heading-drug\">chlorpromazine</ph>. <ph outputclass=\"int-action\">Manufacturer makes no recommendation</ph>.  </p>"
							},
							"hasEvidence": "Theoretical",
							"hasImportance": "Severe",
							"hasOrder": "2",
							"hasTextContent": "Torasemide   is predicted to   cause   hypokalaemia (potentially increasing the risk of torsade de pointes) when given with   chlorpromazine .  Manufacturer makes no recommendation .    \n\n"
						}
					],
					"hasOrder": "309",
					"hasTitle": {
						"@type": "rdf:XMLLiteral",
						"@value": "<title>Torasemide</title>"
					}
				},
				{
					"@id": "http://bnf.nice.org.uk/interaction/chlorpromazine#bnf_i1557280698681",
					"hasMessage": [
						{
							"@id": "http://bnf.nice.org.uk/interaction/chlorpromazine#bnf_i1557280698681_message_0",
							"hasDitaContent": {
								"@type": "rdf:XMLLiteral",
								"@value": "<p otherprops=\"Severe\" outputclass=\"int-message\">Both <ph otherprops=\"chlorpromazine\" outputclass=\"int-heading-drug\">chlorpromazine</ph> and <ph otherprops=\"toremifene\" outputclass=\"int-drug\">toremifene</ph> prolong the QT interval. Most manufacturers advise avoiding the use of two or more drugs that are associated with QT prolongation. Increasing age, female sex, cardiac disease, and some metabolic disturbances (notably hypokalaemia) predispose to QT prolongation. </p>"
							},
							"hasEvidence": "NotSet",
							"hasImportance": "Severe",
							"hasOrder": "1",
							"hasTextContent": "Both  chlorpromazine  and  toremifene  prolong the QT interval. Most manufacturers advise avoiding the use of two or more drugs that are associated with QT prolongation. Increasing age, female sex, cardiac disease, and some metabolic disturbances (notably hypokalaemia) predispose to QT prolongation.  \n\n"
						}
					],
					"hasOrder": "310",
					"hasTitle": {
						"@type": "rdf:XMLLiteral",
						"@value": "<title>Toremifene</title>"
					}
				},
				{
					"@id": "http://bnf.nice.org.uk/interaction/chlorpromazine#bnf_i1557280698682",
					"hasMessage": [
						{
							"@id": "http://bnf.nice.org.uk/interaction/chlorpromazine#bnf_i1557280698682_message_0",
							"hasDitaContent": {
								"@type": "rdf:XMLLiteral",
								"@value": "<p otherprops=\"Normal\" outputclass=\"int-message\">Both <ph otherprops=\"chlorpromazine\" outputclass=\"int-heading-drug\">chlorpromazine</ph> and <ph otherprops=\"tramadol\" outputclass=\"int-drug\">tramadol</ph> can have CNS depressant effects, which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in <xref format=\"dita\" href=\"guidance/guidance-on-prescribing.xml\" type=\"interaction\" rel=\"guidance\" bnfid=\"PHP97234\">Guidance on Prescribing</xref>).</p>"
							},
							"hasEvidence": "NotSet",
							"hasImportance": "NotSet",
							"hasOrder": "1",
							"hasTextContent": "Both  chlorpromazine  and  tramadol  can have CNS depressant effects, which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in  Guidance on Prescribing ). \n\n"
						}
					],
					"hasOrder": "311",
					"hasTitle": {
						"@type": "rdf:XMLLiteral",
						"@value": "<title>Tramadol</title>"
					}
				},
				{
					"@id": "http://bnf.nice.org.uk/interaction/chlorpromazine#bnf_i1557280698683",
					"hasMessage": [
						{
							"@id": "http://bnf.nice.org.uk/interaction/chlorpromazine#bnf_i1557280698683_message_0",
							"hasDitaContent": {
								"@type": "rdf:XMLLiteral",
								"@value": "<p otherprops=\"Normal\" outputclass=\"int-message\">Both <ph otherprops=\"chlorpromazine\" outputclass=\"int-heading-drug\">chlorpromazine</ph> and <ph otherprops=\"trandolapril\" outputclass=\"int-drug\">trandolapril</ph> can increase the risk of hypotension.</p>"
							},
							"hasEvidence": "NotSet",
							"hasImportance": "NotSet",
							"hasOrder": "1",
							"hasTextContent": "Both  chlorpromazine  and  trandolapril  can increase the risk of hypotension. \n\n"
						}
					],
					"hasOrder": "312",
					"hasTitle": {
						"@type": "rdf:XMLLiteral",
						"@value": "<title>Trandolapril</title>"
					}
				},
				{
					"@id": "http://bnf.nice.org.uk/interaction/chlorpromazine#bnf_i1557280698684",
					"hasMessage": [
						{
							"@id": "http://bnf.nice.org.uk/interaction/chlorpromazine#bnf_i1557280698684_message_0",
							"hasDitaContent": {
								"@type": "rdf:XMLLiteral",
								"@value": "<p otherprops=\"Normal\" outputclass=\"int-message\">Both <ph otherprops=\"chlorpromazine\" outputclass=\"int-heading-drug\">chlorpromazine</ph> and <ph otherprops=\"tranylcypromine\" outputclass=\"int-drug\">tranylcypromine</ph> can increase the risk of hypotension.</p>"
							},
							"hasEvidence": "NotSet",
							"hasImportance": "NotSet",
							"hasOrder": "1",
							"hasTextContent": "Both  chlorpromazine  and  tranylcypromine  can increase the risk of hypotension. \n\n"
						},
						{
							"@id": "http://bnf.nice.org.uk/interaction/chlorpromazine#bnf_i1557280698684_message_1",
							"hasDitaContent": {
								"@type": "rdf:XMLLiteral",
								"@value": "<p otherprops=\"Severe\" outputclass=\"int-message\">\n  <ph otherprops=\"tranylcypromine\" outputclass=\"int-drug\">Tranylcypromine</ph> <ph outputclass=\"int-effectQualifier\">is predicted to</ph> <ph outputclass=\"int-effect\">increase</ph> <ph outputclass=\"int-parameter\">the risk of neuroleptic malignant syndrome when given with</ph> <ph otherprops=\"chlorpromazine\" outputclass=\"int-heading-drug\">chlorpromazine</ph>. <ph outputclass=\"int-action\">Manufacturer makes no recommendation</ph>.  </p>"
							},
							"hasEvidence": "Theoretical",
							"hasImportance": "Severe",
							"hasOrder": "2",
							"hasTextContent": "Tranylcypromine   is predicted to   increase   the risk of neuroleptic malignant syndrome when given with   chlorpromazine .  Manufacturer makes no recommendation .    \n\n"
						}
					],
					"hasOrder": "313",
					"hasTitle": {
						"@type": "rdf:XMLLiteral",
						"@value": "<title>Tranylcypromine</title>"
					}
				},
				{
					"@id": "http://bnf.nice.org.uk/interaction/chlorpromazine#bnf_i1557280698685",
					"hasMessage": [
						{
							"@id": "http://bnf.nice.org.uk/interaction/chlorpromazine#bnf_i1557280698685_message_0",
							"hasDitaContent": {
								"@type": "rdf:XMLLiteral",
								"@value": "<p otherprops=\"Normal\" outputclass=\"int-message\">Both <ph otherprops=\"chlorpromazine\" outputclass=\"int-heading-drug\">chlorpromazine</ph> and <ph otherprops=\"trazodone\" outputclass=\"int-drug\">trazodone</ph> can have CNS depressant effects, which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in <xref format=\"dita\" href=\"guidance/guidance-on-prescribing.xml\" type=\"interaction\" rel=\"guidance\" bnfid=\"PHP97234\">Guidance on Prescribing</xref>).</p>"
							},
							"hasEvidence": "NotSet",
							"hasImportance": "NotSet",
							"hasOrder": "1",
							"hasTextContent": "Both  chlorpromazine  and  trazodone  can have CNS depressant effects, which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in  Guidance on Prescribing ). \n\n"
						}
					],
					"hasOrder": "314",
					"hasTitle": {
						"@type": "rdf:XMLLiteral",
						"@value": "<title>Trazodone</title>"
					}
				},
				{
					"@id": "http://bnf.nice.org.uk/interaction/chlorpromazine#bnf_i1557280698686",
					"hasMessage": [
						{
							"@id": "http://bnf.nice.org.uk/interaction/chlorpromazine#bnf_i1557280698686_message_0",
							"hasDitaContent": {
								"@type": "rdf:XMLLiteral",
								"@value": "<p otherprops=\"Severe\" outputclass=\"int-message\">\n  <ph otherprops=\"triamcinolone\" outputclass=\"int-drug\">Triamcinolone</ph> <ph outputclass=\"int-effectQualifier\">is predicted to</ph> <ph outputclass=\"int-effect\">cause</ph> <ph outputclass=\"int-parameter\">hypokalaemia (potentially increasing the risk of torsade de pointes) when given with</ph> <ph otherprops=\"chlorpromazine\" outputclass=\"int-heading-drug\">chlorpromazine</ph>. <ph outputclass=\"int-action\">Manufacturer makes no recommendation</ph>.  </p>"
							},
							"hasEvidence": "Theoretical",
							"hasImportance": "Severe",
							"hasOrder": "1",
							"hasTextContent": "Triamcinolone   is predicted to   cause   hypokalaemia (potentially increasing the risk of torsade de pointes) when given with   chlorpromazine .  Manufacturer makes no recommendation .    \n\n"
						}
					],
					"hasOrder": "315",
					"hasTitle": {
						"@type": "rdf:XMLLiteral",
						"@value": "<title>Triamcinolone</title>"
					}
				},
				{
					"@id": "http://bnf.nice.org.uk/interaction/chlorpromazine#bnf_i1557280698687",
					"hasMessage": [
						{
							"@id": "http://bnf.nice.org.uk/interaction/chlorpromazine#bnf_i1557280698687_message_0",
							"hasDitaContent": {
								"@type": "rdf:XMLLiteral",
								"@value": "<p otherprops=\"Normal\" outputclass=\"int-message\">Both <ph otherprops=\"chlorpromazine\" outputclass=\"int-heading-drug\">chlorpromazine</ph> and <ph otherprops=\"trihexyphenidyl\" outputclass=\"int-drug\">trihexyphenidyl</ph> can cause antimuscarinic effects.</p>"
							},
							"hasEvidence": "NotSet",
							"hasImportance": "NotSet",
							"hasOrder": "1",
							"hasTextContent": "Both  chlorpromazine  and  trihexyphenidyl  can cause antimuscarinic effects. \n\n"
						}
					],
					"hasOrder": "316",
					"hasTitle": {
						"@type": "rdf:XMLLiteral",
						"@value": "<title>Trihexyphenidyl</title>"
					}
				},
				{
					"@id": "http://bnf.nice.org.uk/interaction/chlorpromazine#bnf_i1557280698688",
					"hasMessage": [
						{
							"@id": "http://bnf.nice.org.uk/interaction/chlorpromazine#bnf_i1557280698688_message_0",
							"hasDitaContent": {
								"@type": "rdf:XMLLiteral",
								"@value": "<p otherprops=\"Normal\" outputclass=\"int-message\">Both <ph otherprops=\"chlorpromazine\" outputclass=\"int-heading-drug\">chlorpromazine</ph> and <ph otherprops=\"trimipramine\" outputclass=\"int-drug\">trimipramine</ph> can increase the risk of hypotension.</p>"
							},
							"hasEvidence": "NotSet",
							"hasImportance": "NotSet",
							"hasOrder": "1",
							"hasTextContent": "Both  chlorpromazine  and  trimipramine  can increase the risk of hypotension. \n\n"
						},
						{
							"@id": "http://bnf.nice.org.uk/interaction/chlorpromazine#bnf_i1557280698688_message_1",
							"hasDitaContent": {
								"@type": "rdf:XMLLiteral",
								"@value": "<p otherprops=\"Normal\" outputclass=\"int-message\">Both <ph otherprops=\"chlorpromazine\" outputclass=\"int-heading-drug\">chlorpromazine</ph> and <ph otherprops=\"trimipramine\" outputclass=\"int-drug\">trimipramine</ph> can cause antimuscarinic effects.</p>"
							},
							"hasEvidence": "NotSet",
							"hasImportance": "NotSet",
							"hasOrder": "2",
							"hasTextContent": "Both  chlorpromazine  and  trimipramine  can cause antimuscarinic effects. \n\n"
						}
					],
					"hasOrder": "317",
					"hasTitle": {
						"@type": "rdf:XMLLiteral",
						"@value": "<title>Trimipramine</title>"
					}
				},
				{
					"@id": "http://bnf.nice.org.uk/interaction/chlorpromazine#bnf_i1557280698689",
					"hasMessage": [
						{
							"@id": "http://bnf.nice.org.uk/interaction/chlorpromazine#bnf_i1557280698689_message_0",
							"hasDitaContent": {
								"@type": "rdf:XMLLiteral",
								"@value": "<p otherprops=\"Normal\" outputclass=\"int-message\">Both <ph otherprops=\"chlorpromazine\" outputclass=\"int-heading-drug\">chlorpromazine</ph> and <ph otherprops=\"tropicamide\" outputclass=\"int-drug\">tropicamide</ph> can cause antimuscarinic effects.</p>"
							},
							"hasEvidence": "NotSet",
							"hasImportance": "NotSet",
							"hasOrder": "1",
							"hasTextContent": "Both  chlorpromazine  and  tropicamide  can cause antimuscarinic effects. \n\n"
						}
					],
					"hasOrder": "318",
					"hasTitle": {
						"@type": "rdf:XMLLiteral",
						"@value": "<title>Tropicamide</title>"
					}
				},
				{
					"@id": "http://bnf.nice.org.uk/interaction/chlorpromazine#bnf_i1557280698690",
					"hasMessage": [
						{
							"@id": "http://bnf.nice.org.uk/interaction/chlorpromazine#bnf_i1557280698690_message_0",
							"hasDitaContent": {
								"@type": "rdf:XMLLiteral",
								"@value": "<p otherprops=\"Normal\" outputclass=\"int-message\">Both <ph otherprops=\"chlorpromazine\" outputclass=\"int-heading-drug\">chlorpromazine</ph> and <ph otherprops=\"trospium\" outputclass=\"int-drug\">trospium</ph> can cause antimuscarinic effects.</p>"
							},
							"hasEvidence": "NotSet",
							"hasImportance": "NotSet",
							"hasOrder": "1",
							"hasTextContent": "Both  chlorpromazine  and  trospium  can cause antimuscarinic effects. \n\n"
						}
					],
					"hasOrder": "319",
					"hasTitle": {
						"@type": "rdf:XMLLiteral",
						"@value": "<title>Trospium</title>"
					}
				},
				{
					"@id": "http://bnf.nice.org.uk/interaction/chlorpromazine#bnf_i1557280698691",
					"hasMessage": [
						{
							"@id": "http://bnf.nice.org.uk/interaction/chlorpromazine#bnf_i1557280698691_message_0",
							"hasDitaContent": {
								"@type": "rdf:XMLLiteral",
								"@value": "<p otherprops=\"Normal\" outputclass=\"int-message\">Both <ph otherprops=\"chlorpromazine\" outputclass=\"int-heading-drug\">chlorpromazine</ph> and <ph otherprops=\"umeclidinium\" outputclass=\"int-drug\">umeclidinium</ph> can cause antimuscarinic effects.</p>"
							},
							"hasEvidence": "NotSet",
							"hasImportance": "NotSet",
							"hasOrder": "1",
							"hasTextContent": "Both  chlorpromazine  and  umeclidinium  can cause antimuscarinic effects. \n\n"
						}
					],
					"hasOrder": "320",
					"hasTitle": {
						"@type": "rdf:XMLLiteral",
						"@value": "<title>Umeclidinium</title>"
					}
				},
				{
					"@id": "http://bnf.nice.org.uk/interaction/chlorpromazine#bnf_i1557280698692",
					"hasMessage": [
						{
							"@id": "http://bnf.nice.org.uk/interaction/chlorpromazine#bnf_i1557280698692_message_0",
							"hasDitaContent": {
								"@type": "rdf:XMLLiteral",
								"@value": "<p otherprops=\"Normal\" outputclass=\"int-message\">Both <ph otherprops=\"chlorpromazine\" outputclass=\"int-heading-drug\">chlorpromazine</ph> and <ph otherprops=\"valsartan\" outputclass=\"int-drug\">valsartan</ph> can increase the risk of hypotension.</p>"
							},
							"hasEvidence": "NotSet",
							"hasImportance": "NotSet",
							"hasOrder": "1",
							"hasTextContent": "Both  chlorpromazine  and  valsartan  can increase the risk of hypotension. \n\n"
						}
					],
					"hasOrder": "321",
					"hasTitle": {
						"@type": "rdf:XMLLiteral",
						"@value": "<title>Valsartan</title>"
					}
				},
				{
					"@id": "http://bnf.nice.org.uk/interaction/chlorpromazine#bnf_i1557280698693",
					"hasMessage": [
						{
							"@id": "http://bnf.nice.org.uk/interaction/chlorpromazine#bnf_i1557280698693_message_0",
							"hasDitaContent": {
								"@type": "rdf:XMLLiteral",
								"@value": "<p otherprops=\"Severe\" outputclass=\"int-message\">Both <ph otherprops=\"chlorpromazine\" outputclass=\"int-heading-drug\">chlorpromazine</ph> and <ph otherprops=\"vandetanib\" outputclass=\"int-drug\">vandetanib</ph> prolong the QT interval. Most manufacturers advise avoiding the use of two or more drugs that are associated with QT prolongation. Increasing age, female sex, cardiac disease, and some metabolic disturbances (notably hypokalaemia) predispose to QT prolongation. </p>"
							},
							"hasEvidence": "NotSet",
							"hasImportance": "Severe",
							"hasOrder": "1",
							"hasTextContent": "Both  chlorpromazine  and  vandetanib  prolong the QT interval. Most manufacturers advise avoiding the use of two or more drugs that are associated with QT prolongation. Increasing age, female sex, cardiac disease, and some metabolic disturbances (notably hypokalaemia) predispose to QT prolongation.  \n\n"
						}
					],
					"hasOrder": "322",
					"hasTitle": {
						"@type": "rdf:XMLLiteral",
						"@value": "<title>Vandetanib</title>"
					}
				},
				{
					"@id": "http://bnf.nice.org.uk/interaction/chlorpromazine#bnf_i1557280698694",
					"hasMessage": [
						{
							"@id": "http://bnf.nice.org.uk/interaction/chlorpromazine#bnf_i1557280698694_message_0",
							"hasDitaContent": {
								"@type": "rdf:XMLLiteral",
								"@value": "<p otherprops=\"Normal\" outputclass=\"int-message\">Both <ph otherprops=\"chlorpromazine\" outputclass=\"int-heading-drug\">chlorpromazine</ph> and <ph otherprops=\"vardenafil\" outputclass=\"int-drug\">vardenafil</ph> can increase the risk of hypotension.</p>"
							},
							"hasEvidence": "NotSet",
							"hasImportance": "NotSet",
							"hasOrder": "1",
							"hasTextContent": "Both  chlorpromazine  and  vardenafil  can increase the risk of hypotension. \n\n"
						},
						{
							"@id": "http://bnf.nice.org.uk/interaction/chlorpromazine#bnf_i1557280698694_message_1",
							"hasDitaContent": {
								"@type": "rdf:XMLLiteral",
								"@value": "<p otherprops=\"Severe\" outputclass=\"int-message\">Both <ph otherprops=\"chlorpromazine\" outputclass=\"int-heading-drug\">chlorpromazine</ph> and <ph otherprops=\"vardenafil\" outputclass=\"int-drug\">vardenafil</ph> prolong the QT interval. Most manufacturers advise avoiding the use of two or more drugs that are associated with QT prolongation. Increasing age, female sex, cardiac disease, and some metabolic disturbances (notably hypokalaemia) predispose to QT prolongation. </p>"
							},
							"hasEvidence": "NotSet",
							"hasImportance": "Severe",
							"hasOrder": "2",
							"hasTextContent": "Both  chlorpromazine  and  vardenafil  prolong the QT interval. Most manufacturers advise avoiding the use of two or more drugs that are associated with QT prolongation. Increasing age, female sex, cardiac disease, and some metabolic disturbances (notably hypokalaemia) predispose to QT prolongation.  \n\n"
						}
					],
					"hasOrder": "323",
					"hasTitle": {
						"@type": "rdf:XMLLiteral",
						"@value": "<title>Vardenafil</title>"
					}
				},
				{
					"@id": "http://bnf.nice.org.uk/interaction/chlorpromazine#bnf_i1557280698695",
					"hasMessage": [
						{
							"@id": "http://bnf.nice.org.uk/interaction/chlorpromazine#bnf_i1557280698695_message_0",
							"hasDitaContent": {
								"@type": "rdf:XMLLiteral",
								"@value": "<p otherprops=\"Severe\" outputclass=\"int-message\">Both <ph otherprops=\"chlorpromazine\" outputclass=\"int-heading-drug\">chlorpromazine</ph> and <ph otherprops=\"vemurafenib\" outputclass=\"int-drug\">vemurafenib</ph> prolong the QT interval. Most manufacturers advise avoiding the use of two or more drugs that are associated with QT prolongation. Increasing age, female sex, cardiac disease, and some metabolic disturbances (notably hypokalaemia) predispose to QT prolongation. </p>"
							},
							"hasEvidence": "NotSet",
							"hasImportance": "Severe",
							"hasOrder": "1",
							"hasTextContent": "Both  chlorpromazine  and  vemurafenib  prolong the QT interval. Most manufacturers advise avoiding the use of two or more drugs that are associated with QT prolongation. Increasing age, female sex, cardiac disease, and some metabolic disturbances (notably hypokalaemia) predispose to QT prolongation.  \n\n"
						}
					],
					"hasOrder": "324",
					"hasTitle": {
						"@type": "rdf:XMLLiteral",
						"@value": "<title>Vemurafenib</title>"
					}
				},
				{
					"@id": "http://bnf.nice.org.uk/interaction/chlorpromazine#bnf_i1557280698696",
					"hasMessage": [
						{
							"@id": "http://bnf.nice.org.uk/interaction/chlorpromazine#bnf_i1557280698696_message_0",
							"hasDitaContent": {
								"@type": "rdf:XMLLiteral",
								"@value": "<p otherprops=\"Severe\" outputclass=\"int-message\">Both <ph otherprops=\"chlorpromazine\" outputclass=\"int-heading-drug\">chlorpromazine</ph> and <ph otherprops=\"venlafaxine\" outputclass=\"int-drug\">venlafaxine</ph> prolong the QT interval. Most manufacturers advise avoiding the use of two or more drugs that are associated with QT prolongation. Increasing age, female sex, cardiac disease, and some metabolic disturbances (notably hypokalaemia) predispose to QT prolongation. </p>"
							},
							"hasEvidence": "NotSet",
							"hasImportance": "Severe",
							"hasOrder": "1",
							"hasTextContent": "Both  chlorpromazine  and  venlafaxine  prolong the QT interval. Most manufacturers advise avoiding the use of two or more drugs that are associated with QT prolongation. Increasing age, female sex, cardiac disease, and some metabolic disturbances (notably hypokalaemia) predispose to QT prolongation.  \n\n"
						},
						{
							"@id": "http://bnf.nice.org.uk/interaction/chlorpromazine#bnf_i1557280698696_message_1",
							"hasDitaContent": {
								"@type": "rdf:XMLLiteral",
								"@value": "<p otherprops=\"Normal\" outputclass=\"int-message\">Both <ph otherprops=\"chlorpromazine\" outputclass=\"int-heading-drug\">chlorpromazine</ph> and <ph otherprops=\"venlafaxine\" outputclass=\"int-drug\">venlafaxine</ph> can have CNS depressant effects, which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in <xref format=\"dita\" href=\"guidance/guidance-on-prescribing.xml\" type=\"interaction\" rel=\"guidance\" bnfid=\"PHP97234\">Guidance on Prescribing</xref>).</p>"
							},
							"hasEvidence": "NotSet",
							"hasImportance": "NotSet",
							"hasOrder": "2",
							"hasTextContent": "Both  chlorpromazine  and  venlafaxine  can have CNS depressant effects, which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in  Guidance on Prescribing ). \n\n"
						}
					],
					"hasOrder": "325",
					"hasTitle": {
						"@type": "rdf:XMLLiteral",
						"@value": "<title>Venlafaxine</title>"
					}
				},
				{
					"@id": "http://bnf.nice.org.uk/interaction/chlorpromazine#bnf_i1557280698697",
					"hasMessage": [
						{
							"@id": "http://bnf.nice.org.uk/interaction/chlorpromazine#bnf_i1557280698697_message_0",
							"hasDitaContent": {
								"@type": "rdf:XMLLiteral",
								"@value": "<p otherprops=\"Normal\" outputclass=\"int-message\">Both <ph otherprops=\"chlorpromazine\" outputclass=\"int-heading-drug\">chlorpromazine</ph> and <ph otherprops=\"verapamil\" outputclass=\"int-drug\">verapamil</ph> can increase the risk of hypotension.</p>"
							},
							"hasEvidence": "NotSet",
							"hasImportance": "NotSet",
							"hasOrder": "1",
							"hasTextContent": "Both  chlorpromazine  and  verapamil  can increase the risk of hypotension. \n\n"
						}
					],
					"hasOrder": "326",
					"hasTitle": {
						"@type": "rdf:XMLLiteral",
						"@value": "<title>Verapamil</title>"
					}
				},
				{
					"@id": "http://bnf.nice.org.uk/interaction/chlorpromazine#bnf_i1557280698698",
					"hasMessage": [
						{
							"@id": "http://bnf.nice.org.uk/interaction/chlorpromazine#bnf_i1557280698698_message_0",
							"hasDitaContent": {
								"@type": "rdf:XMLLiteral",
								"@value": "<p otherprops=\"Severe\" outputclass=\"int-message\">\n  <ph otherprops=\"vilanterol\" outputclass=\"int-drug\">Vilanterol</ph> <ph outputclass=\"int-effectQualifier\">is predicted to</ph> <ph outputclass=\"int-effect\">cause</ph> <ph outputclass=\"int-parameter\">hypokalaemia (potentially increasing the risk of torsade de pointes) when given with</ph> <ph otherprops=\"chlorpromazine\" outputclass=\"int-heading-drug\">chlorpromazine</ph>. <ph outputclass=\"int-action\">Manufacturer makes no recommendation</ph>.  </p>"
							},
							"hasEvidence": "Theoretical",
							"hasImportance": "Severe",
							"hasOrder": "1",
							"hasTextContent": "Vilanterol   is predicted to   cause   hypokalaemia (potentially increasing the risk of torsade de pointes) when given with   chlorpromazine .  Manufacturer makes no recommendation .    \n\n"
						}
					],
					"hasOrder": "327",
					"hasTitle": {
						"@type": "rdf:XMLLiteral",
						"@value": "<title>Vilanterol</title>"
					}
				},
				{
					"@id": "http://bnf.nice.org.uk/interaction/chlorpromazine#bnf_i1557280698699",
					"hasMessage": [
						{
							"@id": "http://bnf.nice.org.uk/interaction/chlorpromazine#bnf_i1557280698699_message_0",
							"hasDitaContent": {
								"@type": "rdf:XMLLiteral",
								"@value": "<p otherprops=\"Severe\" outputclass=\"int-message\">Both <ph otherprops=\"chlorpromazine\" outputclass=\"int-heading-drug\">chlorpromazine</ph> and <ph otherprops=\"vinflunine\" outputclass=\"int-drug\">vinflunine</ph> prolong the QT interval. Most manufacturers advise avoiding the use of two or more drugs that are associated with QT prolongation. Increasing age, female sex, cardiac disease, and some metabolic disturbances (notably hypokalaemia) predispose to QT prolongation. </p>"
							},
							"hasEvidence": "NotSet",
							"hasImportance": "Severe",
							"hasOrder": "1",
							"hasTextContent": "Both  chlorpromazine  and  vinflunine  prolong the QT interval. Most manufacturers advise avoiding the use of two or more drugs that are associated with QT prolongation. Increasing age, female sex, cardiac disease, and some metabolic disturbances (notably hypokalaemia) predispose to QT prolongation.  \n\n"
						}
					],
					"hasOrder": "328",
					"hasTitle": {
						"@type": "rdf:XMLLiteral",
						"@value": "<title>Vinflunine</title>"
					}
				},
				{
					"@id": "http://bnf.nice.org.uk/interaction/chlorpromazine#bnf_i1557280698700",
					"hasMessage": [
						{
							"@id": "http://bnf.nice.org.uk/interaction/chlorpromazine#bnf_i1557280698700_message_0",
							"hasDitaContent": {
								"@type": "rdf:XMLLiteral",
								"@value": "<p otherprops=\"Severe\" outputclass=\"int-message\">Both <ph otherprops=\"chlorpromazine\" outputclass=\"int-heading-drug\">chlorpromazine</ph> and <ph otherprops=\"voriconazole\" outputclass=\"int-drug\">voriconazole</ph> prolong the QT interval. Most manufacturers advise avoiding the use of two or more drugs that are associated with QT prolongation. Increasing age, female sex, cardiac disease, and some metabolic disturbances (notably hypokalaemia) predispose to QT prolongation. </p>"
							},
							"hasEvidence": "NotSet",
							"hasImportance": "Severe",
							"hasOrder": "1",
							"hasTextContent": "Both  chlorpromazine  and  voriconazole  prolong the QT interval. Most manufacturers advise avoiding the use of two or more drugs that are associated with QT prolongation. Increasing age, female sex, cardiac disease, and some metabolic disturbances (notably hypokalaemia) predispose to QT prolongation.  \n\n"
						}
					],
					"hasOrder": "329",
					"hasTitle": {
						"@type": "rdf:XMLLiteral",
						"@value": "<title>Voriconazole</title>"
					}
				},
				{
					"@id": "http://bnf.nice.org.uk/interaction/chlorpromazine#bnf_i1557280698701",
					"hasMessage": [
						{
							"@id": "http://bnf.nice.org.uk/interaction/chlorpromazine#bnf_i1557280698701_message_0",
							"hasDitaContent": {
								"@type": "rdf:XMLLiteral",
								"@value": "<p otherprops=\"Normal\" outputclass=\"int-message\">Both <ph otherprops=\"chlorpromazine\" outputclass=\"int-heading-drug\">chlorpromazine</ph> and <ph otherprops=\"xipamide\" outputclass=\"int-drug\">xipamide</ph> can increase the risk of hypotension.</p>"
							},
							"hasEvidence": "NotSet",
							"hasImportance": "NotSet",
							"hasOrder": "1",
							"hasTextContent": "Both  chlorpromazine  and  xipamide  can increase the risk of hypotension. \n\n"
						},
						{
							"@id": "http://bnf.nice.org.uk/interaction/chlorpromazine#bnf_i1557280698701_message_1",
							"hasDitaContent": {
								"@type": "rdf:XMLLiteral",
								"@value": "<p otherprops=\"Severe\" outputclass=\"int-message\">\n  <ph otherprops=\"xipamide\" outputclass=\"int-drug\">Xipamide</ph> <ph outputclass=\"int-effectQualifier\">is predicted to</ph> <ph outputclass=\"int-effect\">cause</ph> <ph outputclass=\"int-parameter\">hypokalaemia (potentially increasing the risk of torsade de pointes) when given with</ph> <ph otherprops=\"chlorpromazine\" outputclass=\"int-heading-drug\">chlorpromazine</ph>. <ph outputclass=\"int-action\">Manufacturer makes no recommendation</ph>.  </p>"
							},
							"hasEvidence": "Theoretical",
							"hasImportance": "Severe",
							"hasOrder": "2",
							"hasTextContent": "Xipamide   is predicted to   cause   hypokalaemia (potentially increasing the risk of torsade de pointes) when given with   chlorpromazine .  Manufacturer makes no recommendation .    \n\n"
						}
					],
					"hasOrder": "330",
					"hasTitle": {
						"@type": "rdf:XMLLiteral",
						"@value": "<title>Xipamide</title>"
					}
				},
				{
					"@id": "http://bnf.nice.org.uk/interaction/chlorpromazine#bnf_i1557280698702",
					"hasMessage": [
						{
							"@id": "http://bnf.nice.org.uk/interaction/chlorpromazine#bnf_i1557280698702_message_0",
							"hasDitaContent": {
								"@type": "rdf:XMLLiteral",
								"@value": "<p otherprops=\"Normal\" outputclass=\"int-message\">Both <ph otherprops=\"chlorpromazine\" outputclass=\"int-heading-drug\">chlorpromazine</ph> and <ph otherprops=\"zolpidem\" outputclass=\"int-drug\">zolpidem</ph> can have CNS depressant effects, which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in <xref format=\"dita\" href=\"guidance/guidance-on-prescribing.xml\" type=\"interaction\" rel=\"guidance\" bnfid=\"PHP97234\">Guidance on Prescribing</xref>).</p>"
							},
							"hasEvidence": "NotSet",
							"hasImportance": "NotSet",
							"hasOrder": "1",
							"hasTextContent": "Both  chlorpromazine  and  zolpidem  can have CNS depressant effects, which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in  Guidance on Prescribing ). \n\n"
						}
					],
					"hasOrder": "331",
					"hasTitle": {
						"@type": "rdf:XMLLiteral",
						"@value": "<title>Zolpidem</title>"
					}
				},
				{
					"@id": "http://bnf.nice.org.uk/interaction/chlorpromazine#bnf_i1557280698703",
					"hasMessage": [
						{
							"@id": "http://bnf.nice.org.uk/interaction/chlorpromazine#bnf_i1557280698703_message_0",
							"hasDitaContent": {
								"@type": "rdf:XMLLiteral",
								"@value": "<p otherprops=\"Normal\" outputclass=\"int-message\">Both <ph otherprops=\"chlorpromazine\" outputclass=\"int-heading-drug\">chlorpromazine</ph> and <ph otherprops=\"zopiclone\" outputclass=\"int-drug\">zopiclone</ph> can have CNS depressant effects, which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in <xref format=\"dita\" href=\"guidance/guidance-on-prescribing.xml\" type=\"interaction\" rel=\"guidance\" bnfid=\"PHP97234\">Guidance on Prescribing</xref>).</p>"
							},
							"hasEvidence": "NotSet",
							"hasImportance": "NotSet",
							"hasOrder": "1",
							"hasTextContent": "Both  chlorpromazine  and  zopiclone  can have CNS depressant effects, which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in  Guidance on Prescribing ). \n\n"
						}
					],
					"hasOrder": "332",
					"hasTitle": {
						"@type": "rdf:XMLLiteral",
						"@value": "<title>Zopiclone</title>"
					}
				},
				{
					"@id": "http://bnf.nice.org.uk/interaction/chlorpromazine#bnf_i1557280698704",
					"hasMessage": [
						{
							"@id": "http://bnf.nice.org.uk/interaction/chlorpromazine#bnf_i1557280698704_message_0",
							"hasDitaContent": {
								"@type": "rdf:XMLLiteral",
								"@value": "<p otherprops=\"Normal\" outputclass=\"int-message\">Both <ph otherprops=\"chlorpromazine\" outputclass=\"int-heading-drug\">chlorpromazine</ph> and <ph otherprops=\"zuclopenthixol\" outputclass=\"int-drug\">zuclopenthixol</ph> can increase the risk of hypotension.</p>"
							},
							"hasEvidence": "NotSet",
							"hasImportance": "NotSet",
							"hasOrder": "1",
							"hasTextContent": "Both  chlorpromazine  and  zuclopenthixol  can increase the risk of hypotension. \n\n"
						},
						{
							"@id": "http://bnf.nice.org.uk/interaction/chlorpromazine#bnf_i1557280698704_message_1",
							"hasDitaContent": {
								"@type": "rdf:XMLLiteral",
								"@value": "<p otherprops=\"Severe\" outputclass=\"int-message\">Both <ph otherprops=\"chlorpromazine\" outputclass=\"int-heading-drug\">chlorpromazine</ph> and <ph otherprops=\"zuclopenthixol\" outputclass=\"int-drug\">zuclopenthixol</ph> prolong the QT interval. Most manufacturers advise avoiding the use of two or more drugs that are associated with QT prolongation. Increasing age, female sex, cardiac disease, and some metabolic disturbances (notably hypokalaemia) predispose to QT prolongation. </p>"
							},
							"hasEvidence": "NotSet",
							"hasImportance": "Severe",
							"hasOrder": "2",
							"hasTextContent": "Both  chlorpromazine  and  zuclopenthixol  prolong the QT interval. Most manufacturers advise avoiding the use of two or more drugs that are associated with QT prolongation. Increasing age, female sex, cardiac disease, and some metabolic disturbances (notably hypokalaemia) predispose to QT prolongation.  \n\n"
						},
						{
							"@id": "http://bnf.nice.org.uk/interaction/chlorpromazine#bnf_i1557280698704_message_2",
							"hasDitaContent": {
								"@type": "rdf:XMLLiteral",
								"@value": "<p otherprops=\"Normal\" outputclass=\"int-message\">Both <ph otherprops=\"chlorpromazine\" outputclass=\"int-heading-drug\">chlorpromazine</ph> and <ph otherprops=\"zuclopenthixol\" outputclass=\"int-drug\">zuclopenthixol</ph> can have CNS depressant effects, which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in <xref format=\"dita\" href=\"guidance/guidance-on-prescribing.xml\" type=\"interaction\" rel=\"guidance\" bnfid=\"PHP97234\">Guidance on Prescribing</xref>).</p>"
							},
							"hasEvidence": "NotSet",
							"hasImportance": "NotSet",
							"hasOrder": "3",
							"hasTextContent": "Both  chlorpromazine  and  zuclopenthixol  can have CNS depressant effects, which might affect the ability to perform skilled tasks (see 'Drugs and Driving' in  Guidance on Prescribing ). \n\n"
						}
					],
					"hasOrder": "333",
					"hasTitle": {
						"@type": "rdf:XMLLiteral",
						"@value": "<title>Zuclopenthixol</title>"
					}
				}
			],
			"hasSearchLabel": " Chlorpromazine  | Interactions",
			"hasSearchLink": {
				"@id": "http://bnf.nice.org.uk/interaction/chlorpromazine.html"
			},
			"hasTitle": {
				"@type": "rdf:XMLLiteral",
				"@value": "<title> Chlorpromazine </title>"
			},
			"rdfs:label": "chlorpromazine"
		}
	]
}